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7Forewords
 In 2010, the Department for Anti-drug Policy of the Government of Italy 
requested the assistance of UNICRI to establish a network of professionals to 
advocate for gender responsive policies and practices among policy makers and 
professionals. These professionals would also become focal points for supporting 
the amelioration of working practices in the prevention, treatment and recovery of 
addiction, and to more effectively meet the needs of women at risk or already using 
drugs.
 With its long-standing expertise in research on vulnerable population and 
special groups, gender based violence and the social consequences of addiction, 
UNICRI would bring a rich expertise to the development of this programme, as well 
as mobilize and engage its worldwide expert network.
 Almost two years later, thanks to the close collaboration between the 
International Relations Office of the Department for Anti-drug Policy of Italy and 
UNICRI, Project DAWN – Drugs and Alcohol Women Network – has grown to 
become a well recognized reference centre for professionals and policy makers in 
Italy and in countries of the Mediterranean Basin. It has established a solid and 
energetic network of professionals.
 In close relationship with the UNODC and the WHO, Project DAWN has 
contributed to the adoption of instruments and tools to assist the international 
community in the establishment of gender responsive prevention treatment and 
recovery programmes, such as guidelines, training modules and web-based 
platforms for distance learning.
 This book represents one of the tools originating from this project. It 
is a collection of essays, case studies, working experiences and good practices 
implemented at various levels, in different countries. It also contains essays on 
gender responsive services, the nature of the services they should offer, and how 
they should be structured to respond to the needs of women. This book aims to 
contribute to a reflection on the progress we have made in the implementation of 
the “gender mainstreaming approach” set forth in the Beijing Declaration and in the 
implementation of the good practices in this field. It examines the gender responsive 
approach and the place and the role of women in the post 2015 development era.
Giovanni Serpelloni
Head
Department for Anti-drug Policy
Italy
Jonathan Lucas
Director
United Nations Interregional 
Crime and Justice Research 
Institute
8Executive Summary
 This publication originates from the work carried out within the framework 
of the project entitled "Drugs and Alcohol Women Network" (DAWN), initiated by 
UNICRI in 2010 with the support of the Department for Anti-drug Policy of the 
Government of Italy.
 Project DAWN aims to establish a network of professionals who can 
actively advocate and promote interventions tailored for women to address the 
risks related to alcohol and drug abuse. The project promotes the development of 
a gender-sensitive approach among social and health practitioners to better meet 
the specific needs of female alcohol and drug abusers.
 Mainstreaming gender-sensitive approaches within professional and policy 
practice is an essential and powerful tool, at the grass-root of all development 
efforts in the post-2015 Millennium Development Agenda1. There can be no 
effective sustainable development as long as discrimination of sexes/gender 
exists2. The Millennium Development Goals Report 2010 stressed that access to 
care for women was still very problematic in several regions. 
 After the Beijing Conference, the ECOSOC in 1997, defined the gender 
mainstreaming “conceptual approach” as guaranteeing a perspective which valued 
the diversity between men and women by putting their respective needs, concerns 
and experiences at the centre of each policy and programme: “Mainstreaming a 
gender perspective is the process of assessing the implications for women and 
men of any planned action, including legislation, policies or programmes, in all 
areas and at all levels. The ultimate goal is to achieve gender equality”3.
 In the field of addiction prevention and recovery, many instruments have 
been developed over the years by the international community to address the 
relationship between gender and addiction. However, Commission on Narcotic 
Drugs resolution 55/5 entitled “Promoting strategies and measures addressing 
specific needs of women in the context of comprehensive and integrated drug 
demand reduction programmes and strategies”, represents an important 
cornerstone towards the attainment of gender responsive addiction policies and 
programmes. The resolution calls on governments “to consider incorporating 
female-oriented programmes in their drug policies and strategies” and encourages 
them “to integrate essential female-specific services in the overall design, 
implementation, monitoring and evaluation of policies and programmes addressing 
drug abuse and dependence”4.
1 Recently, the centrality of gender equality and women’s empowerment to sustainable development has 
been reiterated in various documents. The Rio+20 outcome document, the report of the High-level Panel of 
Eminent Persons, the UNDG report “A Million Voices”, among others, have all emphasized the importance of 
a strong focus on gender equality.
 2 Jones, N. Holmes, R. Espey, J. Gender and the MDGs: A gender lens is vital for pro-poor results. London: 
Overseas Development Institute, 2008.
3 ECOSOC agreed conclusions 1997/2 of 18 July 1997, in Report of the ECOSOC for 1997.
 4 ECOSOC, 2012 Before the 2012 CND Resolution, other documents called on the need to acknowledge 
the existence of specific needs of particular groups of the population such as women, starting from the 
9 Project DAWN has also developed a series of tools to assist professionals 
and policy makers in their efforts to mainstream gender in their working agenda, 
such as best practice manuals, specific guidelines prepared in collaboration with 
the UNODC and a comprehensive internet-based learning platform, available 24/7 
on a dedicated website.
 Along with the other tools and instruments developed within the project, 
the publication, “DAWN - Drugs and Alcohol Women Network: Promoting a Gender 
Responsive Approach to Addiction”, provides international professionals and 
decision makers with a practical guide to mainstream gender in the policy and 
programmes of substance abuse prevention and recovery.
 Protective and resilience factors, as well as the association with violence 
and trauma in the development of addiction, are some of the factors considered in 
the publication. The special characteristics of the female recovery process is also 
analysed. Good practices implemented in specific settings in various regions of the 
world and lessons learned on various aspects of female addiction are illustrated, 
as well as epidemiological data on the trends of young male and female drug 
users.
 The publication also raises the attention on the serious and complex 
problem of the misuse and abuse of prescription drugs, which requires urgent 
attention.
 As with other gender-related health aspects, the recognition that female 
substance abuse has different roots than male substance abuse, should serve 
to re-direct working practices of private and public services towards the goal of 
ensuring that women and men receive information, assistance and care tailored 
to their needs. In this process of recognition and re-direction, the consideration 
of female addiction could be reframed in a more coherent policy that would take 
into account its social and health determinants. Accessibility, affordability and 
acceptability of health and social services would also be aligned with women’s 
needs. Policy coherence across different areas would facilitate the effective use of 
resources in order to close gaps in treatment, overcome barriers to equitable care 
and build clinical capacity in creating a female focused research agenda.
Further information on the scope and objectives of the project is available 
on the UNICRI website: http://www.unicri.it/, in a dedicated website in Italian, 
http://dadnet.it and on the Department for Anti-drug Policy website: http://www.
politicheantidroga.it
20th Special Session of the General Assembly in 1998, during which Member States adopted the Political 
Declaration (A/RES/S-20/2), the Declaration on the Guiding Principles of Drug Demand Reduction (A/
RES/S-20/3), as well as the “Measures to enhance international cooperation to counter the world drug 
problem” (A/RES/S-20/4). After that historical session of the General Assembly, a series of documents were 
produced at the international level, focusing on women, their specific needs and health related issues.

Introduction
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Why a project on gender and addiction?
 In 2012, the Commission on Narcotic Drugs, in its resolution 55/5 entitled 
“Promoting strategies and measures addressing specific needs of women in the 
context of comprehensive and integrated drug demand reduction programmes and 
strategies”, invited the United Nations Interregional Crime and Justice Research 
Institute (UNICRI) to continue to assist and support Member States in developing 
and adapting measures and strategies, at the national, regional and international 
levels, addressing the specific needs of women as an essential element of more 
effective, just and human rights-based policies.
 UNICRI is mandated to address crime prevention and criminal justice policy 
and practice through research, training and documentation diffusion. The call from 
Member States in 2012 followed the launch, one year earlier, of the project entitled 
“Drugs, Alcohol and Women Network” (DAWN), with the support of the Department 
for Anti-drug Policy of the Government of Italy. 
 In the Declaration on the Guiding Principles of Drug Demand Reduction 
(General Assembly resolution S-20/3, annex) the international community indicated 
that demand reduction programmes should be accessible to those groups most at 
risk, taking into account differences in gender, culture and education. Resolution 
55/5 is motivated by the concern that women with substance abuse problems 
are often deprived of or limited in their access to effective treatment that takes 
into account their specific needs and circumstances. It represents an important 
cornerstone. For the first time, women and girls are identified as the target group 
for specific interventions, calling on governments to recognize their unique needs, 
when designing and implementing drug policies. The resolution specifically invites 
governments “to consider incorporating female-oriented programmes in their drug 
policies and strategies” and encouraged them “to integrate essential female-specific 
services in the overall design, implementation, monitoring and evaluation of policies 
and programmes addressing drug abuse and dependence”.
 There is nowadays ample evidence in the literature that biological and 
psychosocial differences between men and women influence the prevalence, 
Project DAWN: mainstreaming gender
in the prevention, treatment and 
recovery of addiction, a policy and 
operational agenda
Alessandra Liquori O’Neil (1) Jonathan Lucas (2)
(1)Programme Officer, United Nations Interregional Crime and Justice Research Institute
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presentation, co-morbidity, and treatment of substance use disorders1. Reasons for 
substance use initiation differ significantly in young women and men. Young women 
may start using drugs to cope with or overcome social anxiety and/or depression, 
while curiosity is often the main reason for substance use initiation in boys. Cigarette 
smoking and stimulants can be used by girls as part of their strategy to achieve and 
maintain their body image2. Females also show a tendency to experience with drugs 
at a younger age than males, possibly due to their earlier contacts with older age 
groups. Women also show differences in drug use. For example, they tend to be 
more susceptible than males to being admitted to emergency rooms for abuse of 
prescription drugs.
 Risk factors and signs associated with substance abuse are different 
between males and females. While men are more likely than women to become 
addicts3, studies have shown that compared to males, females are more affected 
by the consequences of substance abuse; they develop dependence more quickly4. 
Females are more likely to develop drug dependence as a result of post-traumatic 
stress disorder, since they are more at risk of physical abuse. Women who develop 
substance abuse report more severe mental and physical problems and experience 
more health and social-related consequences than men5. Women often have more 
difficulties in stopping the use of addictive substances and are more susceptible to 
relapse. These gender differences can have repercussions on treatment outcomes6.
 Studies focusing on gender differences and treatment of drug addiction have 
shown the existence of biological and psychological differences, as well as social and 
environmental factors, which can influence the motivation to seek assistance, the 
type of treatment or service and their effectiveness. For example, evidence shows 
that women respond and adhere better to treatment if included in psychotherapy 
and group counseling. Sexual education and family planning, as well as diagnosis 
of psychiatric co-morbidity, eating disorders and trauma related to sexual abuse and 
violence are priority issues that need to be integrated in the treatment agenda for 
women.
 Gender differences, as recommended in the principles for the treatment of 
drug addiction elaborated by UNODC/WHO in 20087 and in the NIDA guidelines of 
20128, should also keep into account the stigmatization of addicted women and the 
need for services to take the necessary actions to address this issue in all aspects 
1 Back SE, Contini R, Brady KT, Substance Abuse in Women: Does Gender Matter?, Psychiatric Times. 2006, 
Vol. 24 No. 1.
2 Brady K.T., Back S.E., Greenfiled S.F. (eds.), Women and Addiction, A Comprehensive Handbook, The Guilford 
Press, 2009.
3 A U.S. National Survey on Drug Use and Health, carried out in 2008, showed that 11.5% of 12 year-old 
and older males had a substance abuse or dependence problem, compared with 6.4% of females (U.S. 
Department of Health and Human Services, 2008).
4 Amaro, H., Blake, S. M., Schwartz, P. M., Flinchbaugh, L. J., Developing theory-based substance abuse 
prevention programs for young adolescent girls, Journal of Early Adolescence, 2001, 21(3), 256-293.
5 Bradley, K.A.; Badrinath, S.; Bush, K.; et al., Medical risks for women who drink alcohol, Journal of General 
Internal Medicine, 1998, 13:627–639.
6 Harvard Medical School, Addiction in Women, Newsletter, January 2010.
7 UNODC/WHO, Principles of Drug Dependence Treatment, 2008.
8 NIDA, Principles of Drug Addiction Treatment: A Research-Based Guide, (Third Edition), 2012.
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of care. This is most important in the case of alcohol or drug-dependent pregnant 
women and women with underage children.
 With regard to prevalence of drug use, throughout the world and across all 
substances, levels of illicit drug use are lower in females than in males. The United 
States shows smaller differences than other developed countries, with differences 
in drug use in 2010 about one-third lower for females than males, and 40% fewer 
females currently using drugs. In most of Europe, female drug use is approximately 
half that of males. In middle-income countries, the drug-use disparity between 
sexes is greater. In Argentina and Brazil in 2010 and 2005, respectively, female 
drug use was two-thirds lower than that of males. Other countries show the largest 
differences between the sexes, with surveys in India, Pakistan, Indonesia, and the 
Philippines showing female prevalence of drug use to be 13% or lower than male 
use9 10 11. Statistics available from many countries, however, must be interpreted with 
caution. The lack of resources to collect reliable data and limited awareness of the 
problem, as well as negative attitudes towards women’s substance abuse and their 
subordinate position in some societies, may result in women being underrepresented 
in epidemiological samples or not answering surveys and interviews accurately. In 
addition, many women who use drugs may be homeless or involved with sex work 
and thus are underrepresented in samples12 13.
 The differences in drug use prevalence are the result of a few factors. Socio-
cultural barriers and “traditional” roles of women in society may prevent them from 
using drugs. Women who do not work or have access to disposable income often do 
not have the means to purchase drugs. Urbanization may also be a factor, as urban 
areas tend to have a higher prevalence of drug use. However, with gender barriers 
breaking down in many countries, and expanding urbanization, improved access 
may lead to an increase in female drug use14.
 Project DAWN has been working closely with experts, governments and 
other United Nations agencies and programmes such as the UNODC, the WHO and 
the UNWOMEN to foster the mainstreaming approach15 in addiction prevention and 
recovery and to raise awareness on the unique needs of women and girls affected 
by addiction. The project has established a network of professionals who can actively 
advocate and promote interventions tailored for women to address the risks related 
to alcohol and drinking abuse.
9 United Nations Office on Drugs and Crime  World Drug Report 2012.
10 Ibid.
11 United Nations Office on Drugs and Crime. Substance Abuse Treatment and Care for Women: Case Studies 
and Lessons Learned, 2004. 
12 Health Canada (2001). Best Practices: Treatment and Rehabilitation for Women With Substance Use 
Problems.  Available from: http://www.hc-sc.gc.ca/hc-ps/pubs/adp-apd/bp_women-mp_femmes/index-
eng.php
13 United Nations Office on Drugs and Crime World Drug Report, 2012.
14 Ibid.
15 “Mainstreaming a gender perspective is the process of assessing the implications for women and men 
of any planned action, including legislation, policies or programmes, in all areas and at all levels. It is a 
strategy for making women’s as well as men’s concerns and experiences an integral dimension of the design, 
implementation, monitoring and evaluation of policies and programmes in all political, economic and 
societal spheres so that women and men benefit equally and inequality is not perpetuated. The ultimate goal 
is to achieve gender equality” (ECOSOC, 1997).
15
 As stipulated in resolution 55/5, female substance abuse has different “roots” 
and “routes” than male substance abuse. This will hopefully open the way towards 
future policies and practices re-framed and re-directed towards the goal of ensuring 
that women and men receive information, assistance and care tailored to their needs, 
according to a gender mainstreaming approach. Project DAWN will continue to assist 
in creating more synergy among all actors and to facilitate optimization of resources. 
The goal is to offer gender-responsive programmes, delivered in “an environment 
through site selection, staff selection, program development, content, and material 
that reflects an understanding of the realities of women’s lives, and is responsive to 
the issues of the clients16.
Project DAWN and the Post-2015 Millennium 
Development Agenda
 Project DAWN was initiated within the guidelines of the United Nations 
actions to promote gender equality and the empowerment of women, as reflected 
in the Millennium Development Goals with an emphasis on health equality, child 
and maternal health, HIV/AIDS and addiction related diseases. The Millenium 
Development Goals Report 2010 stressed that access to care for women was 
still very problematic in several regions. The project aims to provide a substantive 
contribution to the formulation of coherent policies to assist in overcoming barriers 
to equitable care, build clinical capacity in the development of new treatment 
and recovery models and create a female-focused addiction research agenda. 
The project has identified three factors which have a direct influence on the 
effectiveness and the efficacy of the provision of gender responsive addiction 
services to women:
 ●   accessibility, both at the individual and at the organizational level 
(distance, opening/ closing hours; length of consultation, waiting lists);
 ●   affordability, pertaining to the individual or household financial status, 
health insurance protection and to the health financing system in place in 
the countries and the type of coverage offered to citizens;
 ●   acceptability, individual motivation to change, individual perception of 
effectiveness of services delivered, of staff, of level of stigma based on 
sex, race, religion, ethnicity.
 Project DAWN aims to further promote the debate among its expert network 
on how to close the current gaps in the provision of drug abuse treatment services 
to women, in the context of the current debate on universal health coverage and 
universal access to health17. The above mentioned factors are, in fact, key points 
in the Post-2015 Millennium Development Agenda debate on health provisions. 
16 Covington. S., Creating gender-responsive programs: The next step for women’s services, Corrections 
Today, February 2001, 63, 85-87.
17 Evans D.B., Hsu J.& Boerma T., ” Universal health coverage and universal access”, Bulletin of the WHO 91:8, 
2013
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However, they become critically important in those settings where the status of 
women may be diminished due to discrimination and inequality, as these affect not 
only the possibility for health service access, but, more broadly, the right to obtain 
recognition at the political, legislative and economic levels.
 As the debate on the Post-2015 Millennium Agenda progresses, project 
DAWN seeks to provide a strong contribution to the identification and application 
of a “stand alone goal”18, encompassing all female-related issues as reflected in the 
Millennium Development Goals. This effort entails a systematic and coordinated 
action by all parts of society to support women’s equity, equality and empowerment, 
through strengthening the rule of law, the political and the education systems 
and the economic and social integration of women, taking into consideration their 
reproductive role and the burden of the unpaid care and unpaid work weighing on 
women and girls worldwide.
 The need for integration of goals becomes even clearer when one 
examines the achievements of Goal n.3 of the Millenium Declaration “gender 
equality and empowerment of women”. Notwithstanding the many instruments 
and tools developed to address the gender divide and the tangible progress made 
in the health and education fields, the success and effectiveness of the MDGs is 
often overshadowed by the modest performance that countries, including the more 
developed ones, show in the social and economic integration areas, where gender 
inequality is still high. According to the 2013 UNDP Human Development Report19, 
the world average score for the Gender Inequality Index (GII) in 2012 was equal to 
0.463, indicating almost 42% loss in potential human development due to gender 
inequality.
 A similar approach and outcome is reflected in the 2013 World Economic 
Forum Report on Gender Equity, which measured a series of economic, educational 
and political benchmarks, to show the gaps that have been closed in the health, 
education, economic participation and political empowerment sectors. The 136 
countries included in the Report, representing over 90% of the world’s population, 
have closed almost 96% of the gap in health outcomes between women and men 
and almost 93% of the gap in educational attainment. However, the gap between 
women and men in economic participation and political empowerment remains wide: 
only 60% of the economic outcomes gap and only 21% of the political outcomes 
gap have been closed20. In both reports, gender inequality and discrimination are 
considered as some of the principal obstacles/factors in slowing the progress 
towards the achievement of the Millennium Goals and the main factor “to cause and 
perpetuate poverty and vulnerability in the society as a whole”21.
18 See more at: http://www.unwomen.org/en/news/stories/2013/10/lakshmi-puri-speech-on-sexual-andrep 
roductive-health-rights#sthash.PmC5dvoj.dpuf
19 Human Development Report, UNDP, 2013
20 Report on Gender Equity, World Economic Forum, 2013.
21 Jones N., Holmes R., Espey J. Gender and the MDGs: A gender lens is vital for pro-poor results. London: 
Overseas Development Institute, 2008.
17
Project DAWN objectives and concrete 
interventions to promote a gender responsive 
approach to addiction
 Project DAWN includes a number of interventions targeted at:
 ●  Girls and women who do not use drugs, but are exposed to this risk;
 ●  Girls and women who use drugs occasionally;
 ●   Girls and women who use drugs regularly and/or are affected by substance 
use and addictive disorders.
 The secondary targets of the project are the policy makers and the 
professionals, who require a deeper understanding and knowledge of gender 
differences in order to better respond to the prevention, treatment and recovery 
needs of women. Social workers, parents and teachers are also included. Training 
on gender issues should be provided to them so that they are in a better position to 
deal with the education of young women who are currently not using drugs, but are 
at risk of having contact with them.
 Sensitizing teachers, parents, and local social and health services of the 
importance of gender differences in drug addiction will positively affect the lives of 
young and adult women, since these groups are among their frequent contacts22. 
Parents in particular are a target for interventions, especially those caring for girls 
in their adolescence. In this regard, Project DAWN is also developing educational 
strategies to counter the often negative effects of the media, its portrayal of women 
and its message to women.
 Project DAWN has promoted the development of a number of professional 
tools, such as best practice manuals, internet-based learning platform, and training 
courses, to support the improvement of substance abuse prevention and recovery 
policies and practices. 
 With regard to policy guidelines, project DAWN has developed, in collaboration 
with the UNODC, guidelines for planning and delivering prevention, treatment and 
rehabilitation programmes that can be relevant and effective for women and girls. To 
assist in the professional updating, Project DAWN has developed a comprehensive 
distance learning platform, available free of charge 24/7 on a dedicated website. The 
platform provides access to user friendly learning modules on specific aspects of 
women’s health, addiction treatment and recovery. The modules are available in the 
main UN languages and are regularly updated through the direct contributions of the 
network of professionals established through the project.
 Information days, special events and conferences are also used by the 
project as a strategy to raise awareness on specific topics related to women and 
addiction. In this regard, a series of tool-kits have been developed to assist local 
authorities to organize information events, addressed to various audiences such 
as children, adolescents, professionals and policy makers. Information events are 
regularly organized on the occasion of the celebration of relevant United Nations 
22 UNODC - WHO, Principles of Drug Dependence Treatment, 2008.
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Days, in Italy and in countries of the Mediterranean Basin, with the support of the 
local project’s focal points and with participation of high school students, mental 
health professionals and policy makers.
 Information/awareness events are also held regularly within drug addiction 
and mental health services as well as rehabilitation communities with participation 
of girls who are not affected by drugs or adult women who have addiction disorder. 
The participation of role models and testimonials brings a drug free lifestyle 
example by sharing their former experience with drugs23. On such occasions, 
women and young girls are able to interact with each other and ask questions on 
problems related to drugs. The project also supports the setting up of help-lines in 
schools, universities and women associations, in order to assist women and girls 
in avoiding drug-facilitated sexual abuse risks, drug abuse related violence and to 
prevent exploitation of minors.
 Project DAWN will also work with the WHO to support the application of the 
good practices in the management of pregnancy in women who use drugs24, are 
affected by infectious diseases and in the management of their newborns. These 
initiatives also include training and specific professional information on child care and 
delivery, as well as support to parental functions. Project DAWN has also adopted a 
protocol, developed and piloted in Italy, to promote clinical interventions for the safe 
procreation in couples with differing HIV serological status.
 National and international Expert Working groups have been identified and 
are actively involved in the project’s implementation, representing the focal points in 
each country. Questionnaires and surveys have been administered to women clients 
of treatment centers, to better understand their expectations and identify their needs. 
Data are currently being analysed and additional surveys are planned to take place 
with the involvement of the Mediterrranean Basin countries which are part of the 
Council of Europe Pompidou Group MedNet.
 The focus of the project is on gender differences in addiction. Its added 
value is the creation of an international network of social and health professionals 
who can  support and lead in the development of a gender-sensitive approach to 
better meet the specific needs of female drug abusers. This network is instrumental 
in achieving the necessary re-orientation of working practices of private and public 
services in the treatment, prevention and rehabilitation strategies of women.
The DAWN manual: good practices for a gender 
responsive approach to addiction
 The manual “DAWN - Drugs and Alcohol Women Network: Promoting a 
Gender Responsive Approach to Addiction” represents one of the key tools that the 
project is developing to assist professionals and decision makers to mainstream 
23 On the occasion of the 2013 UN Day on Women, Project DAWN organized in collaboration with local 
drug addiction services and the San Patrignano Rehabilitation Community, an awareness event on gender 
differences in drug addiction, addressed to high school students. The event was held simultaneously in nine 
Italian cities and involved more than 2.000 students.  
24 See also Gender Equity and Human Rights at www.who.int/gender
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gender in the policy and practice of substance use prevention and recovery. The 
manual is a collection of good practices, lessons learned and case studies from 
experts, specialized agencies and governmental organizations, implemented at 
various levels, in different countries. A number of contributions also provide an in-
depth reflection on the nature of a gender responsive service and how it should be 
structured to respond to the needs of women.
 Chapter I opens with an overview of the United Nations actions towards 
gender equality and of the key international instruments and documents focused on 
gender, including various instruments dealing with violence against women. The next 
contribution, by Niki Miller, Senior Programme Associate at Advocates for Human 
Potential, provides an articulated essay on the concept of gender mainstreaming 
and on how close the international community has come to keeping the promises of 
the 1995 Beijing Conference. Prof. Miller moves to discuss the connections between 
gender and addiction, the relevant biological and sociological aspects and the 
historical context in which female addiction has developed. The implementation of 
the “gender mainstreaming approach” can only be effective if society recognizes the 
value of recovery as a continuum involving the individual, the communities and the 
system of care.
 In Chapter II, two essays, one from Kevin A. Sabet, Director of the Drug 
Policy Institute at the University of Florida and coll. and the other from Federica 
Vigna-Taglianti, Department of Clinical and Biological Sciences, University of Turin 
and coll. discuss the role of gender and its impact on the effectiveness of various 
prevention programmes. Both contributions analyze the prevalence of use for 
various substances by males and females, as well as the different risk factors and 
signs associated with substance use during adolescence.
 Studies have shown that compared to males, females are more affected 
by substance abuse consequences and acquire dependency more quickly. Women 
show differences in drug use as compared to males in relation to age groups and 
are more susceptible than males to being admitted to emergency rooms for abuse 
of prescription drugs. Females are more likely to develop drug dependence as a 
result of post-traumatic stress disorder, and they tend to try substances at a younger 
age than males due to earlier contact with older age groups. Women also differ 
in the motivation and modalities for acquiring drugs. For instance, women tend to 
use substances to lose weight, increase sexual activity, overcome inhibitions, reduce 
stress, increase self-confidence, and to elevate moods. Also, females are frequently 
sold drugs without being asked for their age and are more likely to receive free drugs 
in exchange for other things, like sexual favours. Males mainly use drugs to enhance 
their position within their social groups and to seek excitement25.
 Prof. Vigna Taglianti describes the programme “Unplugged”, a social 
influence school-based curriculum for the prevention of tobacco, alcohol and drug 
use among adolescents, which was developed in the framework of the European 
Drug Abuse Prevention study in 2003. Supported by the European Community 
Public Health Program, “Unplugged” has involved more than 7,000 pupils from 
seven European countries between 2004 and 2007. Through the use of interactive 
25 Amaro, H., Blake, S. M., Schwartz, P. M., Flinchbaugh, L. J., Developing theory-based substance abuse 
prevention programs for young adolescent girls, Journal of Early Adolescence, 2001, 21(3), 256-293.
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techniques, teachers provided information on the effects of drugs, as well as playing 
a leading role in the development of student’s interpersonal skills (assertiveness, 
problem solving, self control and creative thinking) as well as intrapersonal skills 
such as non verbal communication, expression of negative feelings, coping skills. 
The curriculum effectiveness was evaluated in a randomized trial. 
 Two contributions from the Department for Anti-drug Policy in Italy, analyse 
the differences in the risk factors of illicit drug use among young Italian females and 
males aged 15-19 years and the characteristics and prevalence of prescription drugs 
misuse in women. In the first contribution, by Giovanni Serpelloni and coll., the data 
collection is based on the ESPAD Study26 and the risk factors for consumption of 
psychotropic substances are assessed through a logistic regression model. The 
sample surveyed is constituted by 35,980 students, of which 50% were females. 
Approximately 20% of students had used drugs in the previous year and the most 
used substance was cannabis, followed by cocaine and sedatives. Compared to 
males, females are more likely to start using drugs if offered by their siblings or 
by their partners or if they are under the influence of alcohol. Families, friends and 
teachers can all play a decisive role in protective factors. The results of the study 
highlight the need to better identify differences in risk factors between males and 
females in order to better plan targeted interventions.
 In the second contribution from the Department for Anti-drug Policy of Italy, 
Elisabetta Simeoni and coll., raise attention to the serious and complex problems 
of the misuse and abuse of prescription drugs, which is becoming an alarming 
phenomenon in Europe. According to data presented, 2.8% of the US population 
older than 12 has used prescription drugs for non-medical purposes. Australia also 
faces an alarming raise, with at least 3% of the population having used prescription 
drugs for non-medical purposes. Data from the International Narcotics Control Board 
show that Canada has become the second biggest consumer of opioids per capita, 
with an increase in overdoses, between 1999 and 2004, of 416%. Authors analyse 
prescription drugs abuse by women of various age groups, also reporting on the 
modalities in which these substances are obtained without prescription. Specific 
recommendations are provided on how to prevent and treat this type of abuse and 
support women with treatment and avoid overdoses.
 Joan Colom, from the Programme on Substance Abuse of the Public Health 
Agency of Catalonia and coll. propose a model for the early identification, prevention 
and management of intimate partner violence related to substance abuse. According 
to the authors, the integration of substance abuse professionals, intimate partner 
violence experts, with regular professional training, are essential for effective 
interventions. This approach facilitates synergy among all stakeholders in the health 
system, as well as promotes change in the working practices and the policy agenda.
 Gender differences have been identified as heavy determinants in the 
onset of addictive behaviours. In Chapter III, Christine E. Grella, from the Integrated 
Substance Abuse Programme at UCLA, offers a very poignant essay on gender 
responsive treatment approaches for women with substance abuse disorders, 
highlighting the different pathways that bring men and women into treatment and 
the different outcomes. Professor Grella brings extensive literature in support of 
26 The European School Survey Project on Alcohol and Other Drugs – ESPAD – www.espad.org
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the conclusion that women treated in gender responsive programmes have better 
retention rates. Residential treatment facilities offering additional services, such as 
child care and social assistance, have better outcomes, with regard to treatment 
completion but also with regard to other important social and health factors, such as 
reduced or no substance use, HIV risk reduction, employment, and improved mental 
status. The essay also examines the urgent need to provide gender responsive 
treatment to women within the criminal justice system, who generally present a 
more severe clinical profile than men. It concludes by commenting on a number of 
evidence-based treatment strategies available to date.
 The EMCDDA monitors and analyzes information on the drug situation in 
the EU Member States to provide good practices and support Member States to 
address drug use problems in the most effective and evidence based manner. The 
contribution by Marica Ferri and coll. presents an in-depth overview of treatment 
strategies provided in the EU, the evidence of their effectiveness and the analysis 
of treatment strategies for women who are pregnant and use substances and their 
newborns and children. It provides recommendations and guidelines, based on a 
EMCDDA official publication released in 201227.
 From a national perspective, Paola Burroni and coll., from the Drug Addiction 
Department and University of Turin, Italy, present epidemiological data on one of 
the largest cohort of heroin users undergoing treatment between 1998 and 2001. 
Thanks to the extent of the cohort, gender differences at intake and at follow up could 
be investigated to understand treatment retention and its determinants among men 
and women.
 Through the administration of a qualitative interview to a sample of 
individuals using both licit and illicit substances, but not seeking nor receiving 
treatment, Gail Gilchrist, Research Institut, Hospital del Mar, in Barcelona, and coll. 
offer a perspective on the factors representing barriers to treatment access, including 
the consideration of sex differences. Barriers reported by patients, both males and 
females, include a lack of motivation, perception of the quality of treatment as poor 
or ineffective, location of services, stigma, negative staff attitudes, poor health, 
and concerns about treatment access, related to appointments, referrals, waiting 
lists etc. The authors offer recommendations for improving access to treatment 
and for enhancing retention, especially through the offer of more flexible and non-
stigmatising services. Although no substantial differences were reported between 
males and females in their perception of the obstacles to treatment, some issues 
were identified as typically relevant to females such as fear of losing child custody, 
violence and more severe and diffused history of violence and trauma. These issues 
need to be taken into consideration when planning gender responsive services.
 Alcohol abuse should not be underestimated in women. Although the 
prevalence of use and abuse is significantly higher in males, women who abuse 
alcohol have a higher vulnerability to alcohol-related morbidity and mortality than 
men. Risk of breast cancer and hormone imbalances are also reported in the literature 
due to the effects of alcohol. The direct damaging effects of alcohol abuse on the 
foetus are well known and have been broadly studied. In this contribution Prof. Flavia 
Franconi, Department of Biomedical Sciences, University of Sassari, Italy, and coll., 
27 Pregnancy childcare and the family EMCDDA, 2012.
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highlight how gender differences influence treatment from a biological and a clinical 
point of view. Starting from the idea that males and females should be considered 
as two separate categories of subjects, the authors point out how women respond to 
medical treatments differently from men. However, as they are less studied than men 
from this perspective, they might receive less evidence-based treatment. The article 
underlines a very important point: “gender medicine” is still considered a developing 
discipline. Women in clinical studies are underrepresented and more efforts should 
be made to improve the knowledge of the pharmacokinetics of medical treatments 
on women who use alcohol and other drugs, especially during pregnancy. In this 
regard, the authors highlight the need for including a sex-gender perspective in all 
clinical and pre-clinical studies. This would ensure more reliable efficiency and safety 
profiles for each sex, increase access and compliance to therapies, and ensure the 
availability of tailored treatments.
 “Guiding the Recovery of Women” (GROW) is a comprehensive training 
curriculum developed by a panel of experts set up by the Bureau of International 
Narcotics and Law Enforcement Affairs (INL) of the US State Department, to respond 
to the growing number of substance abusing women worldwide. Teddi Shihadeh 
presents the training programmes delivered in a number of countries, with a focus 
on the training activities carried out in Afghanistan, where INL opened the first and 
only women’s residential substance abuse treatment centre, providing treatment to 
an average of 200 women a year.
 Prof. Richard Isralowitz and coll. at the Ben Gurion University, in Israel, 
considers the perspective of immigrants, their acculturation problems and relation to 
drug use, by describing the profiles of women who have migrated to Israel from Russia 
and Ukraine. Immigration of former Soviet Union nationals to Israel between 1989 and 
1998 brought into Israel one million immigrants mostly from Russia and Ukraine. The 
authors report that Russian speaking immigrants make up for 13% of the population, 
but represent 25% of the illicit drug users in the country. With data on approximately 
one thousand former Soviet Union immigrants, Isralowitz and coll. present a very 
precise close up not only on women immigrants and their substance abuse profiles, 
but also their acculturation difficulties and their special needs in terms of treatment and 
recovery. The case study of Nika, a woman who came to Israel in her twenties, already 
using drugs, provides a very poignant example of the drug using career of immigrant 
women and their path towards recovery, which can present additional obstacles when 
followed in a foreign country. The Authors recommend the establishment of specific 
gender responsive services rather than services for immigrants only, which might 
hinder integration. It is of critical importance to consider cultural and ethnic diversities 
when addressing treatment of special populations, such as immigrant women.
 Prof. Stephanie S. Convington, Center for Gender and Justice at the Institute 
for Relational Development in La Jolla, USA, opens Chapter IV with a thorough 
overview of the special characteristics of the female recovery process, through 
the lenses of the “Women’s Integrated Treatment” (WIT) model, based on three 
foundational theories: relational/cultural, addiction and trauma. The Author considers 
that no treatment can be effective for women who use drugs, if professionals do not 
acknowledge the realities of those women’s lives, which, in the case of drug users, 
are most of the times tainted with previous experiences of violence and abuse. The 
acknowledgement of the weight that trauma, deriving from violence and abuse, can 
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impact on women’s lives is the starting point for any recovery process. Professor 
Covington describes this process as a downward spiral into addiction, around which 
women’s lives rotate more and more tightly, while their substance of choice dominates 
every aspect of their lives. The recovery spiral is an upward one, where a woman’s 
life still revolves around the drug, but in progressively expanded circles, away from 
addiction and into a fuller existence, where a new self can develop by joining healthy 
activities, relationships and transformed sexual and spiritual life. It is important that 
clinicians and all professionals involved in the recovery process become “trauma 
informed”, i.e. understand trauma theory as a conceptual map to be followed in their 
clinical practice in order to provide trauma informed services, which are, in point 
of fact, concretely gender-responsive. In her long career with women’s recovery, 
Prof. Covington has developed a number of gender-responsive, trauma-informed 
curricula to be used in treatment services for women and girls and in the criminal 
justice system. These curricula have been evaluated and tested in various research 
studies which showed an overall decrease in psychological distress, depression and 
trauma symptoms. Women in correctional facilities and women participating in drug 
court treatment programmes, showed higher percentages of treatment compliance, 
improvement of mental health symptoms and reduction of anger and hostility 
than women who did not undergo the Women Integrated Treatment (WIT) model. 
Overall, this model is based on the creation of a gender-responsive trauma-informed 
environment, where women can feel safe, express their anxiety and learn coping skills.
 The importance of the links between violence and drug abuse in women 
is brought back in the next contribution by Lluisa Garcia Esteve, Psychiatric and 
Psychology Service, Institute of Neuroscience in Barcelona, and coll., which 
describes the activities of the Programme for the Prevention and Treatment of the 
Psychic Effects in Sexually Assaulted Women (AGRESX-TEPT) established in 2006 
at the Hospital Clinic of Barcelona. The Programme is based on a complete protocol, 
which includes emergency care at presentation and clinical and judicial follow up of 
the victims of sexual assault. At the emergency room, victims follow a circuit, which 
brings them into the care of a number of professionals (nurses, social workers, 
gynecologists, forensic doctors, psychiatrists, infectious diseases specialists) each 
performing his/her own part in the most efficient and coordinated ways, to avoid re-
victimization. Women are accompanied throughout the circuit and they are offered 
the possibility to speak with a police officer to report the crime. When discharged, 
women are cared for in outpatient clinics and are provided with a guide for victims 
of sexual assault, prepared by the Hospital professionals. The authors point out 
how, in their experience, early intervention has been shown to reduce the possibility 
for chronicization of the psychological symptoms that the majority of women who 
are victims of sexual assault experience during the first weeks and that, if going 
untreated, can result in profound changes in personality, PSTD, depression and 
substance abuse. The Programme has also recently focused on victims of drug-
facilitated sexual assault (DFSA), trying to establish a protocol for the emergency 
care and follow up of this type of victims, which account for as much as 20%-50% of 
the total number of victims, at any given period.
 Two residential treatment approaches are presented from the US State of 
California, which were personally visited by the Editors of this volume. Speaking of 
“safe” recovery environments, the SHIELDS for Families’ Exodus Programme, is 
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a unique model of family-based therapeutic community treatment located in South 
Central Los Angeles, which allows for the entire family to live in individual family 
apartments, in an 86-apartment compound offering treatment, follow-up and related 
social services. After completion treatment, families can remain in their apartment for 
a transitional time of up to one year, to develop their vocational and education skills, 
which will allow them to move ahead in their personal and family life. In addition to drug 
abuse treatment programmes, the SHIELDS for Families’ Exodus Programme offers 
a wide array of services and support such as health education groups which include 
family planning, family focused groups, relapse prevention, lifetime aftercare services 
and child development services. At entrance, children are included in a programme to 
ensure a healthy emotional, physical and social development and readiness for school. 
Parenting classes are provided weekly. The Heros and Sheros programme, for youth 
and adolescents aged 5-18, provides after-school activities and full day care during 
summer breaks for children whose parents are involved in treatment. The programmes 
include self esteem groups, development of protective factors, improvement of family 
and peer-to-peer relationships, decision making and school performance.
 Project Pride is a section of the East Bay Community Recovery Project 
(EBCRP) in Oakland (CA). Started in 1994, with funding from the Federal 
Government, it was designed as a pilot model for addressing alcohol and other 
drug use in pregnant and postpartum women. In 2009, program completion rates 
averaged between 60-75%. Criminal justice involvement was significantly reduced 
by 90%. Sixty-five percent of the women were employed or in-job training at the time 
of discharge and 75% were reunified with their children. A case study is presented 
to describe how the programme works and how interventions are structured. Also in 
this case, the approach is a gender responsive and trauma informed approach that 
allows for women to come to terms with their psychological distress and to find ways 
to cope with it, while developing life skills. This programme includes a very important 
component on the creation of a safe environment, where the recovery process 
can nurture itself. Empathic connection with professionals and other members of 
the group is also important in letting communication of vulnerabilities, anxiety and 
anger become instrumental in the motivation to change. Bringing children into the 
residential treatment programme and offering parenting skills learning techniques 
are also ways to empower women to regain their parental role while achieving a 
drug free life. One of the innovations of Project Pride is the “Celebrating Families 
programme”, which directly involves family members in the women’s recovery 
process, to promote healthy reunification and healing of past emotional conflicts. 
The re-building of family ties is also instrumental to assist the re-entrance into society 
after release from residential treatment.
 The World Health Organization (WHO) states that health is “the dynamic 
state of complete physical, mental, spiritual, and social well-being and not merely the 
absence of disease or infirmity”. Project DAWN has fully adopted this approach and 
strives to make health care policy and development more focused on females. In line 
with Commission resolution 55/5 it encourages member States to provide on wide 
range of measures that match the specific needs of women affected by drug abuse, 
including pregnant women and women who are parents or guardians with children. In 
this bigger picture, implementing this health care change is an important step towards 
reaching the goal of gender equality. This book hopes to bring us closer to that goal.
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 Gender equality has been at the forefront of the United Nations agenda 
since its establishment in 1945.
 The United Nations commitment to the advancement of women began 
with the signing of the United Nations Charter in San Francisco in 1945. Its 
Preamble reaffirmed faith “in fundamental human rights, in the dignity and worth 
of the human person, in the equal rights of men and women and of nations large 
and small…”. One of the purposes of the United Nations set forth in Article 1 is “To 
achieve international co-operation […] in promoting and encouraging respect for 
human rights and for fundamental freedoms for all without distinction as to race, 
sex, language, or religion.”1
 In 1946 the Economic and Social Council established its Commission 
on the Status of Women as the principal global policy-making body dedicated 
exclusively to gender equality and the advancement of women. The Commission 
on the Status of Women (CSW) first met at Lake Success, New York, in 
February 1947, soon after the founding of the United Nations. All 15 government 
representatives were women. From its inception, the Commission was supported 
by a unit of the United Nations that later became the Division for the Advancement 
of Women (DAW) in the UN Secretariat. The CSW forged a close relationship 
with non-governmental organizations, and in particular those in consultative 
status with the UN Economic and Social Council (ECOSOC) invited to participate 
as observers.
 CSW is an intergovernmental deliberative body, the leader on issues 
related to gender equality and the empowerment of women at the global level, 
where Governments and civil society meet to take stock of progress and commit to 
further action. Each year, the Commission attracts very large national delegations, 
including dozens of Ministers, as well as around 2000 NGOs’ representatives 
coming from all regions of the world.
1 United Nations Charter, Retrieved from: https://www.un.org/en/documents/charter/
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 Women’s rights have been highlighted in key instruments such as 
the Universal Declaration of Human Rights (1948)2 and the 1976 International 
Covenants on Civil and Political Rights and Economic, Social, and Cultural Rights.
 In addition to these broader documents, gender equality has been 
specifically addressed in a number of conventions, declarations and resolutions.
Convention on the Political Rights of Women
Opened for signature and ratification by General Assembly resolution 640 
(VII), entered into force on 7 July 1954, the Convention on the Political Rights 
of Women focuses on equality for public service roles and voting. This includes 
allowing women to vote in all elections, be eligible for election to public office, 
and to hold public office and exercise all functions on equal terms with men. 
The Convention has 47 signatories and 122 parties3.
Convention on the Elimination of All Forms of Discrimination Against 
Women (CEDAW) and the Optional Protocol
Often described as the international bill of rights for women, CEDAW was 
adopted by the UN General Assembly on 18 December 1979 and entered into 
force on 3 September 1981.
CEDAW was the culmination of over 30 years of work by the UN Commission 
on the Status of Women, and focuses primarily on equality and human rights 
concerns. The Convention covers civil rights issues, including re-stating the 
Convention on the Political Rights of Women and affirming rights to non-
discrimination in education, employment, and economic and social activities. 
Reproductive rights are also addressed, including shared responsibility of child 
rearing by both the mother and father, as well as the right to reproductive 
choices. Lastly, the Convention seeks to recognize the influence of culture 
and tradition on restricting women’s rights, such as customs, norms, and 
stereotypes that constrain women’s freedoms. CEDAW has 99 signatories and 
187 parties4.
Optional protocols are often added to human rights treaties to develop 
procedures regarding the treaty or to address an area related to the treaty. 
Optional protocols are treaties on their own and are open to signature, 
accession, or ratification to countries that are party to the original treaty5.
The optional protocol to CEDAW was adopted by the UN General Assembly 
without a vote on October 6, 1999 and entered into force on December 22, 
2000. It contains a communications procedure, which gives women the right 
2 In contributing to the drafting of the Universal Declaration of Human Rights, the CSW successfully argued 
against references to “men” as a synonym for humanity, and succeeded in introducing new, more inclusive 
language.
3 Convention on the Political Rights of Women, Signed in New York 31 March 1953 (No. 2613). United Nations 
Treaty Series 193, p. 135.
4 Convention on the Elimination of All Forms of Discrimination Against Women, Signed in New York 18 
December 1979 (No. 20378). United Nations Treaty Series 1249, p. 13.
5 United Nations Women Watch (2000). What is an Optional Protocol? Retrieved from: http://www.un.org/
womenwatch/daw/cedaw/protocol/whatis.htm
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to report CEDAW violations to the Committee, as well as an inquiry procedure, 
which allows the Committee to initiate inquiries into cases of violations against 
women’s rights. The optional protocol has 80 signatories and 104 parties6.
Declaration on the Protection of Women and Children in Emergency and 
Armed Conflict
The UN General Assembly proclaimed the Declaration on the Protection of 
Women and Children in Emergency and Armed Conflict on 14 December 1974. 
The declaration prohibits and condemns attacks and bombings on civilian 
populations (particularly on women and children), chemical and biological 
warfare, and inhumane treatment of women and children. Women and children 
are to be spared from war, and shall not be deprived of food, shelter, and 
medical care7.
1985 - Third World Conference on Women in Nairobi8
The Nairobi Conference recognized that gender equality was not an isolated 
issue, but encompassed all areas of human activity.
Declaration on the Elimination of Violence Against Women
The UN General Assembly adopted the Declaration on the Elimination of 
Violence Against Women on December 20, 1993. The Declaration defines 
violence against women as physical, sexual, or psychological violence 
occurring against women or children in the family, general community, or by the 
state. It declares that women are entitled to life, equality, and security, equal 
protection under the law, safe working conditions, freedom from discrimination, 
and freedom from torture or other inhumane treatment. States are to condemn 
violence against women and should not condone any customs or traditions 
that go against this idea. Legislation is to be developed to punish and prevent 
acts of violence against women. The Declaration instructs all UN agencies to 
promote fair and equitable treatment of women9.
Beijing Declaration and Platform for Action
The Governments participating in the Fourth World Conference on Women 
in September 1995 adopted the Beijing Declaration and Platform for Action, 
a group of priority actions to ensure equality for women. The Declaration 
encompassed a number of goals, including 12 critical priority areas:
6 Optional Protocol to the Convention on the Elimination of All Forms of Discrimination Against Women, 
Signed in New York 6 October 1999 (No. 20378). United Nations Treaty Series 2131, p. 83.
7 United Nations General Assembly, Declaration on the Protection of Women and Children in Emergency and 
Armed Conflict, 14 December 1974, 3318 (XXIX). Retrieved from: http://www2.ohchr.org/english/law/pdf/
protectionwomen.pdf
8 Report of The World Conference to Review and Appraise the Achievements of the United Nations Decade 
for Women: Equality, Development and Peace, Nairobi, 15-26 July 1985 United Nations New York, 1986. 
Retrieved from: http://www.un.org/womenwatch/confer/nfls/Nairobi1985report.txt
9 United Nations General Assembly, Declaration on the Elimination of Violence Against Women, 20 December 
1993, A/RES/48/104. Retrieved from: http://www.un.org/documents/ga/res/48/a48r104.htm
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1. Poverty Eradication: develop strategies that address the needs of 
women in poverty; ensure equal access to economic resources, savings, and 
credit institutions.
2. Education and Training: ensure equal access to education; eradicate 
illiteracy; improve access to vocational and continuing education; promote 
lifelong education; ensure that education and training programs are non-
discriminatory and of equal quality to those available to men.
3. Health: increase access to affordable, quality healthcare; strengthen 
preventive programs; develop sexual and reproductive health education 
programs; prevent and eliminate violence against women; eliminate human 
and sexual trafficking.
4. Violence against Women: prevent and eliminate violence against 
women; eliminate human and sexual trafficking.
5. Armed Conflicts: increase the participation of women in conflict resolution; 
reduce military expenditures and control the availability of weapons; promote 
non-violent forms of conflict resolution and promote women’s contributions to 
fostering peace; provide protection and assistance to refugee women.
6. Economic Rights: promote access to safe working conditions; eliminate 
segregation and employment discrimination.
7. Politics and Government: ensure equal access and full participation in 
government decision-making.
8. Institutional Mechanisms: create governmental bodies to help advance 
women; integrate gender perspective in legislation.
9. Human Rights: promote and protect the human rights of women; ensure 
equality and non-discrimination; achieve legal literacy.
10. Media: increase women’s participation in media and communications; 
promote a balance and non-stereotypical portrayal of women in the media.
11. Environment: involve women in environmental decision-making; 
integrate gender concerns into programs for sustainable development.
12. Female Children: eliminate all forms of discrimination and violence 
against girls; eliminate child labor; strengthen the role of the family10.
Millennium Declaration, Millennium Development Goals and Post-2015 
Development Agenda
In September 2000, building upon a decade of major United Nations 
conferences and summits, world leaders came together at the United Nations 
Headquarters in New York to adopt the United Nations Millennium Declaration, 
committing their nations to a new global partnership to reduce extreme poverty 
and setting out a series of time-bound targets - with a deadline of 2015 - that 
have become known as the Millennium Development Goals (MDGs):
1. Eradicate extreme poverty and hunger.
2. Achieve universal primary education.
10 United Nations, Beijing Declaration and Platform of Action, Adopted at the Fourth World Conference on 
Women, 27 October 1995. Retrieved from: http://www.un.org/womenwatch/daw/beijing/platform/.
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3. Promote gender equality and empower women.
4. Reduce child mortality.
5. Improve maternal health.
6. Combat HIV/AIDS, malaria, and other diseases.
7. Ensure environmental sustainability.
8. Develop a global partnership for development11 12.
As 2015 is approaching, a post-2015 task team has been established. Co-
led by the UN Development Programme and UN Department of Economic 
and Social Affairs, the task team will evaluate the program’s framework, 
identify successes and difficulties, review development trends, and prepare 
recommendations to formulate a development agenda after 201513.
On 25 September 2013, the President of the UN General Assembly hosted a 
Special Event to follow up on efforts made towards achieving the Millennium 
Development Goals. At the Special Event towards achieving the MDGs, 
UN Secretary-General Ban Ki-moon presented to Member States his report 
entitled “A Life of Dignity for All”14. In the outcome document15, adopted by 
Member States, world leaders renewed their commitment to meet the MDG’s 
targets and agreed to hold a high-level Summit in September 2015 to adopt a 
new set of Goals building on the achievements of the MDGs.
Women are an integral part to all of the MDGs; gender equality and empowerment 
are crucial to the framework in order to best maximize the potential of women 
in the home, workplace, and government, and to maintain sustainable growth 
and poverty reduction16.
As the leading organization with a global mandate to promote gender 
equality, women’s rights and women’s empowerment, UN Women17 called 
for a commitment to achieving gender equality, women’s rights and women’s 
empowerment in the Post-2015 development framework and Sustainable 
Development Goals (SDGs), as well as robust mainstreaming of gender 
considerations across all parts of the framework.
11 United Nations General Assembly, United Nations Millennium Declaration, 18 September 2000, A/
RES/55/2, Retrieved from: http://www.un.org/millennium/declaration/ares552e.pdf
12 United Nations Development Programme (2012). Millennium Development Goals. Retrieved from: http://
www.undp.org/content/undp/en/home/mdgoverview/
13 United Nations Economic and Social Council (2012). Millennium Goals and the Post-2015 Development 
Agenda. Retrieved from: http://www.un.org/en/ecosoc/about/mdg.shtml
14 UN Department of Public Information, Report of the UN Secretary-General: A Life of Dignity for All, New 
York, September 2013. Retrieved from: http://www.un.org/millenniumgoals/pdf/SG_Report_MDG_EN.pdf
15 United Nations General Assembly, Outcome document of the special event to follow up efforts made 
towards achieving the Millennium Development Goals, 1 October 2013, A/68/L.4. Retrieved from: http://
www.un.org/en/ga/search/view_doc.asp?symbol=A/68/L.4
16 UNIFEM, Making Change Happen: Actions Necessary to Accelerate the Achievement of all Millennium 
Development Goals, New York 2010, UNIFEM/UN Women. Retrieved from: http://www.unifem.org/
attachments/products/MDGsAndGenderEquality_1_MakingChangeHappen.pdf
17 The United Nations Entity for Gender Equality and the Empowerment of Women.
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The United Nations Entity for Gender Equality 
and the Empowerment of Women (UN Women)
 The UN Entity for Gender Equality and the Empowerment of Women, 
known as UN Women, was created through a unanimous vote at the UN General 
Assembly in 2010. UN Women merged four distinct offices that focused on gender 
equality and women’s empowerment: the Division of the Advancement of Women, 
the Office of the Special Adviser on Gender Issues and the Advancement of 
Women, the International Research and Training Institute for the Advancement of 
Women and the UN Development Fund for Women18. 
 UN Women became operational on 1 January 2011 and works to eliminate 
discrimination against women and girls, empower women and achieve equality 
between women and men. Its main roles are to support inter-governmental bodies 
in the formulation of policies, global standards, and norms; to help Member States 
implement these standards with technical and financial support, if necessary, and 
to develop partnerships with civil society organizations; and to hold the UN system 
accountable for its own commitments on gender equality19.UN Women’s top priority 
is for equal participation in politics and economic empowerment, while focusing on 
ending gender-based violence, including gender equality in government initiatives, 
and including women in peace and security measures20.
 During 2011, UN Women participated in 106 joint UN country programmes 
around the world, and signed 30 global partnership agreements with other UN 
agencies. UN Women, the Food and Agriculture Organization, the International Fund 
for Agricultural Development and the World Food Programme embarked on a joint 
initiative of economic empowerment for rural women and girls. 2012 saw the debut of 
the UN’s System-Wide Action Plan on Gender Equality, spearheaded by UN Women21.
 In 2012, with UN Women’s assistance, women gained seats in seven 
national elections. Twenty-six countries reformed laws and policies increasing 
women’s access to economic assets and social protection, while 30 improved 
services for survivors of gender-based violence. Fifteen nations incorporated 
gender equality priorities in national plans and budgets. These achievements come 
against a global backdrop of continued improvements, such as historic numbers 
of women in political leadership and a record 125 countries having adopted laws 
against domestic violence22.
 In June 2013 UN Women, in order to address the structural causes 
of gender-based discrimination and to support true transformation in gender 
18 United Nations General Assembly, Resolution Adopted by the General Assembly, 21 July 2010, A/
RES/64/289, Retrieved from: http://www.un.org/Docs/journal/asp/ws.asp?m=A/res/64/289
19 UN Women. About UN Women. New York 2011. Retrieved from: http://www.unwomen.org/about-us/about-
un-women/
20 UN Women. Annual Report 2011-2012. New York 2012: UN Women.
21 UN Women, Annual Report 2011-2012, New York 2012. Retrieved from: http://www.unwomen.org/~/
media/Headquarters/Attachments/Sections/Library/Publications/2012/UN-Women-AR-2012%20pdf.pdf
22 UN Women, Annual Report 2012-2013, New York 2013. Retrieved from: http://www.unwomen.org/~/
media/Headquarters/Attachments/Sections/Library/Publications/2013/6/UNwomen-AnnualReport2012-
2013-en%20pdf.pdf
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relations, released the publication “A transformative stand-alone goal on achieving 
gender equality, women’s rights and women’s empowerment: imperatives and key 
components”. The document proposes an integrated approach that addresses 
three critical target areas of gender equality, women’s rights and women’s 
empowerment23.
 UN Women is also responsible for providing substantive support to the 
Commission on the Status of Women in all aspects of its work. One of the most 
decisive sessions of the CSW took place at the United Nations Headquarters in New 
York from 4 to 15 March 201324.The Commission’s priority theme for the session 
was “The elimination and prevention of all forms of violence against women and 
girls.” Governments reached a historic consensus on a blueprint of actions to be 
taken to end violence against women and girls. Actions range from strengthening 
legal and policy frameworks for prevention to improved responses and services 
for survivors. The final text adopted by Governments is forward-looking. The 
document strongly emphasizes that violence against women is a human rights 
violation and underlines that it is the duty of all States, regardless of their political, 
economic and cultural systems, to promote and protect all human rights, which are 
universal and indivisible.
Gender and Peacekeeping
Stressing the importance of women’s equal and full participation as active 
agents in the prevention and resolution of conflicts, peace-building and 
peacekeeping, the Security Council adopted unanimously the first Resolution 
on women, peace and security on 31 October 2000, the UNSCR 1325.
The UNSCR 132525 is a landmark international legal framework that addresses 
not only the inordinate impact of war on women, but also the pivotal role women 
should and do play in conflict management, conflict resolution and sustainable 
peace.
The Resolution also stressed the importance of gender perspective in post-
conflict processes as well as women’s equal and full participation as active 
agents in peace and security with key provisions:
1. Increased participation and representation of women at all levels of 
decision-making
2. Attention to specific protection needs of women and girls in conflict.
3. Gender perspective in post-conflict processes.
4. Gender perspective in UN programming, reporting and in SC missions.
5. Gender perspective and training in UN peace support operations.
Other six supporting resolutions have been adopted by the Security Council 
23 UN Women, A transformative stand-alone goal on achieving gender equality, women’s rights and women’s 
empowerment: Imperatives and key components, New York 2013, Retrieved from: http://www.unwomen.
org/~/media/Headquarters/Attachments/Sections/Library/Publications/2013/10/UNWomen_post2015_
positionpaper_English_final_web%20pdf.pdf
24 Retrieved from: http://www.unwomen.org/en/csw/previous-sessions/csw57-2013
25 United Nations Security Council, Resolution 1325 (2000), 31 October 2000, S/RES/1325 (2000). Retrieved 
from: http://www.un.org/en/ga/search/view_doc.asp?symbol=S/RES/1325%282000%29
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ever since: 182026, 188827, 188928, 196029, 201630 and 212231. The six 
resolutions focus on three key goals:
Strengthening women’s participation in decision-making - Resolution 
1325 (2000) calls for strengthening women’s agency as peacemakers and 
peacebuilders, including their participation in conflict prevention and peace 
processes, early recovery, governance and in peace operations. Resolution 
1889 (2009) complements 1325 by calling for the establishment of global 
indicators to measure progress on its implementation.
Resolution 2122 (2013) recognizes the need for consistent implementation 
of resolution 1325 (2000) on women, peace and security in its own work, 
and expressed its intention to focus more on women’s leadership in conflict 
resolution and peacebuilding.
Ending sexual violence and impunity - Resolution 1820 (2008) calls for an end 
to widespread conflict-related sexual violence and for accountability in order 
to end impunity. Resolution 1888 (2009) focuses on strengthening leadership, 
expertise and other institutional capacities within the United Nations and in 
member states to help put an end to conflict-related sexual violence.
Resolution 2106 (2013 adds greater operational detail to previous resolutions 
on this topic, reiterates that all actors, including not only the Security Council 
and parties to armed conflict, but all Member States and United Nations 
entities, must do more to implement previous mandates and combat impunity 
for these crimes. UN Women is particularly encouraged that Resolution 2106 
affirmed the centrality of gender equality and women’s political, social, and 
economic empowerment.
Provide an accountability system - Resolution 1960 mandates the Secretary-
General to list those parties credibly suspected of committing or being 
responsible for patterns of sexual violence in situations on the Council’s agenda. 
Relevant sanctions committees will be briefed by the Special Representative 
of the Secretary-General on Sexual Violence in Conflict, and may take action 
against listed parties. SCR 1960 also calls for the establishment of monitoring, 
analysis, and reporting arrangements specific to conflict-related sexual 
violence.
26 United Nations Security Council, Resolution 1820 (2008), 19 June 2008, S/RES/1820 (2008). Retrieved 
from: http://www.un.org/en/ga/search/view_doc.asp?symbol=S/RES/1820%282008%29
27 United Nations Security Council, Resolution 1888 (2009), 30 September 2009, S/RES/1888 (2009). Retrieved 
from: http://www.securitycouncilreport.org/atf/cf/%7B65BFCF9B-6D27-4E9C-8CD3-CF6E4FF96FF9%7D/
WPS%20SRES%201888.pdf
28 United Nations Security Council, Resolution 1889 (2009), 5 October 2009, S/RES/1889 (2009). Retrieved 
from: http://www.womenpeacesecurity.org/media/pdf-scr1889.pdf
29 United Nations Security Council, Resolution 1960 (2010), 16 December 2010, S/RES/1960 (2010), 
Retrieved from: http://www.un.org/en/ga/search/view_doc.asp?symbol=S/RES/1960%282010%29
30 United Nations Security Council, Resolution 2016 (2013), 24 June 2013, S/RES/2106 (2013). Retrieved from: 
http://www.securitycouncilreport.org/atf/cf/%7B65BFCF9B-6D27-4E9C-8CD3-CF6E4FF96FF9%7D/s_
res_2106.pdf
31 United Nations Security Council, Resolution 2122 (2013), 18 October 2013, S/RES/2122 (2013), Retrieved 
from: http://www.securitycouncilreport.org/atf/cf/%7B65BFCF9B-6D27-4E9C-8CD3-CF6E4FF96FF9%7D/s_
res_2122.pdf
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Convention on Preventing and Combating 
Violence against Women and Domestic Violence
 The Council of Europe Committee of Ministers adopted on 7 April 2011 the 
Convention on Preventing and Combating Violence against Women and Domestic 
Violence (Istanbul Convention) which builds on the work carried out in various fora, 
including the afore mentioned United Nations milestones such as the Convention 
on the Elimination of All Forms of Discrimination against Women, complemented 
by General Recommendation 19 of the CEDAW Committee32, the Declaration 
on the Elimination of Violence against Women, and the Beijing Declaration and 
Platform for Action.
 Opened for signature in May 2011, on the occasion of the 121st Session 
of the Committee of Ministers in Istanbul, the Convention is the first legally binding 
instrument in Europe to prevent and combat violence against women and domestic 
violence. In terms of scope, it is the most far-reaching international treaty to tackle 
this serious violation of human rights.
 The Istanbul Convention will enter into force following its ratification by 10 
countries (as of January 2014, 8 Member Countries of the Council of Europe have 
ratified the Convention and 24 have signed it). An independent group of experts 
(GREVIO) will monitor the implementation of the Convention.
The Convention is also the first international treaty to contain a definition of gender. 
Gender is defined in Article 3(c) as “the socially constructed roles, behaviours, 
activities and attributes that a given society considers appropriate for women and 
men”.
 The Deputy Executive Director of UN Women Lakshimi Puri underlined 
how “The Istanbul Convention complements other standards, and it expands the 
international framework on gender equality and the empowerment of women” and 
how the Convention represents “a strong, legally-binding convention which sets out 
very clear directives and commitments for taking action on preventing, protecting, 
prosecuting and responding to violence against women and in particular domestic 
violence, which for so long was seen as a private issue, not to be tackled by the 
State”33.
 UN Women is working closely with the Council of Europe to disseminate 
the value of the Convention and to inspire accession, including by non-members 
of the Council of Europe.
32 CEDAW, General recommendations made by the Committee on the Elimination of Discrimination against 
Women. Retrieved from: http://un.org/womenwatch/daw/cedaw/recommendations/recomm.htm
33 Statement by Ms. Lakshmi Puri Deputy Executive Director of UN Women at Regional Conference on the 
Istanbul Convention. 17 January 2013. Retrieved from: http://www.unwomen.org/en/news/stories/2013/1/
pushing-the-frontiers-on-the-elimination-of-violence-against-women-the-upcoming-commission-on-the-
s/#sthash.9laCV6CJ.vpYSRDaX.dpuf
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The promise of gender 
mainstreaming
Niki Miller
Senior Program Associate, Advocates for Human Potential, Inc., 
with contributions from Kristen King, and Darby Penney
Introduction
 The United Nations has made a fundamental commitment to gender 
equality in many areas of development work worldwide, conveying a consistent 
message that equality between men and women is essential to sustained social 
and economic progress. Since 1995, when the Fourth World Conference on 
Women took place in Beijing, the unique capacities of the United Nations have 
helped align women’s empowerment with peacekeeping, policymaking, cross-
national data collection and program planning through the strategic application of 
gender-mainstreaming.
Defined
 The following definition was set forth in the Report on the Fourth World 
Conference: “Mainstreaming a gender perspective is the process of assessing 
the implications for women and men of any planned action, including legislation, 
policies or programmes, in all areas and at all levels. It is a strategy for making 
women’s as well as men’s concerns and experiences an integral dimension of the 
design, implementation, monitoring and evaluation of policies and programmes in 
all political, economic and societal spheres so that women and men benefit equally 
and inequality is not perpetuated. The ultimate goal is to achieve gender equality”.
 The Convention on the Elimination of All Forms of Discrimination against 
Women, adopted by the United Nations General Assembly in 1979, was the 
foundation for expanded dialogue regarding the human rights of women. It defines 
the right of women to be free from discrimination and includes gender-based 
violence as a form of discrimination. It sets the core principles to protect this right 
through an agenda for national action to end discrimination and ensure equal 
access to, and equal opportunities in, political and public life as well as education, 
health, and employment. It is one of the most widely ratified international treaties, 
and the only human rights treaty that affirms the reproductive rights of women 
(U.N. Population Fund, 2008). At the 1993 human rights conference in Vienna, the 
United Nations declared that women’s rights were in fact Human Rights and called 
for an end to all forms of violence against women.
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Purpose
 Acknowledging women’s rights as human rights, rather than secondary to 
them, paved the way for gendered analyses of women’s experiences and needs in a 
variety of traditional and nontraditional domains and service systems (U.N. Department 
of Economic and Social Affairs, 2012). It has allowed for consideration of the specific 
consequences of economic, social, and justice policies for women and families.
 Gender mainstreaming is a means for achieving equality between men and 
women, rather than an end in itself. It aims to create the infrastructure necessary 
to accommodate progress toward gender justice (True & Mintrom, 2001). It also 
ensures that development activities maximize opportunities to dissolve gender 
disparities, not deepen them, particularly in countries where women may already 
be subject to violence and oppression.
 Gender mainstreaming acknowledges the historical and potential effects of 
globalization on women, children, and other groups without power. Yet, in addition 
to inducing rapid economic change, globalization can effect radical changes during 
periods of social, political, legal, or economic infrastructure development. It affirms 
that inherent in globalization’s influence is its transformative potential and its promise.
Background
 Gender mainstreaming originated in the 1970s as a feminist development 
practice, but was adopted through transnational feminist networks that applied the 
principle to complex inequalities. The consideration of gender became interwoven 
into diverse cultural beliefs, socio-political realities, poverty, violence, and wealth 
(Walby, 2005). In addition to ensuring economic development and human service 
interventions benefit women and men equally, gender mainstreaming has had 
broad implications across disciplines, from transforming public spaces and urban 
centers to promoting health equity in medical research and practice. In Vienna, 
Austria, it has been applied to the design of urban parks and in Finland to urban 
planning, achieving safer environments for women and children that incorporate 
better lighting, clearer lines of sight, and fewer isolated areas (Travers et al., 
2008). In the Netherlands, gender mainstreaming is part of healthcare quality 
improvement and a multiyear initiative to transform physicians’ training, (Verdonk, 
Benschop, De Haes and Lagro-Janssen, 2008). United Nations programmes to 
prevent the spread of HIV and programmes to increase health equity by the World 
Health Organization (2009) are now evaluated on gender-responsive outcome 
measures. This requires collection of gender-disaggregated baseline data, 
and gender-specific project monitoring metrics (U.N. Evaluation Group, 2011). 
Gendered analyses of government budgets allow women a voice in the allocation 
of public resources at the highest levels.
 Each of these examples of gendered perspectives has brought new and 
original thinking to research, needs assessment, stakeholder and community 
involvement, and service delivery. Ideally, the results include increased participation 
of women at all levels - as researchers, planners, providers, and recipients of 
services - as well as empowerment, inclusion, and recognition of the value of 
women’s contributions (Gülser Corat & Ruprecht, 2009).
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Application
 According to Walby (2005), the European Union has largely focused gender 
mainstreaming efforts in the areas of employment and economic development, 
where the application is somewhat more clearly defined than in mainstreaming 
gender in social programs and behavioral health. However, the strategy has also 
broadened the arenas in which gender equity is typically considered. For example, 
gender mainstreaming has transformative implications for public transit and is a 
consideration in transit planning in several nations.
 In developed nations, gender mainstreaming has gained broader influence. 
According to pharmaceutical industry analyst Farah Ramadan, “This is changing in 
more advanced markets like the UK, the Nordics, and Canada, which have started 
to mainstream gender in their healthcare policy-making procedures, but it is often 
non-existent in developing or under-developed countries where the health gap hits 
most” (Ramadan, 2012). The diffusion of gender mainstreaming is uneven at this 
time. No nation has fully implemented it. One criticism of gender mainstreaming is 
that the mere adoption of rhetoric is not necessarily an indication of real change.
 National policy is traditionally developed autonomously. The worldwide 
human rights movement and the movement to end violence against women are 
both supported by transnational feminist networks and other transnational entities, 
including the United Nations. The potential to influence policy through gender 
mainstreaming is greatest in transnational and global initiatives with conduits that 
promote international standards, such as the World Health Organization. These 
networks and organizations also may be relevant to mainstreaming gender into 
newly developed areas by influencing oversight mechanisms and credentialing 
bodies.
Gender mainstreaming and women’s drug and alcohol use
 Specific application of gender mainstreaming to drug policy ensures 
that women and men benefit equally from drug demand-reduction activities, 
from prevention and recovery programming, and from alternative development 
in drug producing and trafficking regions (UN Office on Drugs and Crime, 2012) 
by systematically installing the necessary capacities in existing programs and 
mainstreaming planning for service expansion that is equally responsive to women 
and men. Methodologies for effecting increasingly gender-responsive programming 
involve specific steps:
 ● Include women in all aspects of planning and research.
 ● Collect baseline data on females.
 ● Conduct gendered analyses and needs assessments.
 ● Pilot new and modified programs and evaluate their impact.
 ●  Perform in-depth analyses that review gender-specific elements (UN 
Office on Drugs and Crime, 2004).
 Women’s gateways to substance use, their pathways to addiction, and 
their barriers to treatment are each distinct from men’s and are quite diverse in 
their own right. Sex-linked differences in physiological effects of substances apply 
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to all women and girls, universally. Gender differences are refracted through the 
lens of culture; they exist universally but are changeable and differ in their impact. 
Individuals also differ in their degree of acceptance of cultural beliefs about gender. 
(Levant, Richmond, Cook, House & Aupont, 2007). Dynamic factors include varying 
social norms regarding substance use, spiritual and religious traditions, availability 
of substances to women and girls, and the freedoms afforded to women in a given 
social context.
 Expanding effective gender responsive services and approaches requires 
good information, dialogue and consensus, understanding of current and historical 
trends in women and girls’ use of substances, and deliberate and focused efforts 
to include the voices of recovering women. Compiling knowledge across cultures 
about prevention for girls, effective treatment practices, and ongoing recovery 
for women is a laudable effort made possible by a growing international network. 
Locating ourselves in these unified efforts offers inclusive opportunities to inform 
the work that lies ahead.
 What are the priorities for gender mainstreaming, regarding women, drugs, 
and alcohol, and should they differ in under-developed nations? Is an analysis of 
current gender responsive practices in developed nations a valuable undertaking 
that will yield best practice guidelines? Could they be diffused through transnational 
conduits? Perhaps there are model programs that could be implemented right 
away. Or is the prime opportunity influencing social, health and justice policy in 
developing nations? The intent of the text that follows is not to offer up answers, but 
rather to frame questions that will inspire all who devote themselves to improving 
the lives of at-risk and recovering women and girls, worldwide.
Standing on common ground
 When I was first approached about contributing to an international volume 
on women and addiction, my initial joy was quickly supplanted by anxiety. What did 
I really know about the global status of prevention and treatment for women and 
girls? In the United States, advances in women’s drug and alcohol treatment have 
been gratifying to see but arduous to sustain. 
 Progress with services for at-risk girls has been incremental at best. 
Like many champions of gender-responsive services, I have been knee-deep in 
domestic policy, trudging through years of targeted advocacy at the local, regional, 
and national level. Had I been too busy acting locally to think globally? Then, it 
occurred to me that my situation is probably not unique. Women in communities 
across the world have also been busy plowing through mountains of research, 
talking with hundreds of recovering women, sitting in on countless meetings, and 
presenting a never-ending stream of PowerPoint slides that could probably circle 
the globe.
 The themes we explore from our discrete latitudes are the same: the 
centrality of trauma, stigma, criminalization, and increasing numbers of girls and 
women whose lives are lived at risk. The stigma and social isolation that recovering 
survivors, and those advocating for them, must overcome is well conveyed by 
feminist criminologist, Carol Smart, when she maintains that empathy for the victim 
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is mediated by judgments of her worthiness (1998). Experiences of violent and 
sexual victimization among women involved with drugs and alcohol transcend 
borders and cultures. Melissa Farley’s landmark study compared trauma severity 
among women engaged in prostitution in South Africa, Turkey, Zambia, Thailand, 
and the United States (Farley, Baral, Kiremire & Sezgin, 1998). The proportion of 
these women who made use of substances as a matter of psychic and emotional 
survival was the same in Zambia (72% alcohol) as it was on the streets of Los 
Angeles (75% drugs).
 How much have things really changed since our mothers’ time? My mother 
quit smoking for each pregnancy, despite the cigarette advertisements of her day 
that warned, “You can’t hide fat clumsy ankles… ‘Reach for a Lucky instead.’’’ 
Although the image of a visibly pregnant woman still puffing away was not deemed 
nearly as abhorrent in the fifties as it is today, my mother was convinced that 
babies of women who smoked during pregnancy were scrawny and fussy. In 1956, 
a male doctor, concerned about her excessive weight gain, wrote a prescription 
for amphetamines that my mother was to take for the duration of her pregnancy. 
Several months passed before I reluctantly emerged, already drug-exposed and 
eager for more. Another obstetrician had advised my mother to drink beer when 
she nursed her first two children, so I didn’t have long to wait. Whether or not 
any anomalies noted during my early years stemmed from in-utero amphetamine 
exposure never occurred to my mother or to her doctors.
 What will we accomplish in our daughters’ time? Some warn that as 
nations develop and adopt policies that increase women’s equality, problems with 
substance use among women in these regions will also increase. If we collectively 
accept a Pandora’s Box of new health risk behaviors as the price of social and 
economic progress for women, we may miss the transformational opportunities. 
Gender mainstreaming in developing nations affords us an opportunity to learn 
more about how cultural strengths act as protective factors for many girls, and 
may advance the study of gender-specific prevention worldwide. Truly gender-
responsive prevention programming would mean girls in developing regions and 
in other parts of the world would not be at risk. They would be at promise.
 I have high hopes for a global exchange because of Ester, an African 
psychologist who works with female inmates in Nairobi, Kenya. A friend who works 
with HIV-positive women brought her to me when I served as Administrator of 
Women Offenders for a Northeastern U.S. state. Ester was visiting to observe 
women’s programmes. Our afternoon together was a gift of great magnitude to me. 
After we talked trauma, empowerment, and the universal demographic of disparity 
and profile of marginalization that the growing numbers of incarcerated women 
worldwide share, I had a surprise for Ester. She was delighted as she left my office 
with a volume of Lisa Najavits’ “Seeking Safety” (2002), a treatment manual for 
substance abuse and post-traumatic stress disorder (PTSD), to bring back for the 
women in Nairobi. Two weeks later, I received an email from Ester telling me that 
the women loved the groups. If we, as women, take a stand for safety, it appears 
we are all standing on common ground.
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Sex and gender: biological and sociological 
distinctions
 Gender refers to a person’s identity formation and presentation as male 
or female, the ways social institutions respond to a person based on perception 
of masculinity or femininity, and the amount of power a person has. Gender roles 
influence family and community life and may dictate socio-economic status, 
responses to authority, and socially acceptable standards of behavior, often without 
question, for men and women.
 Tobias and Amanda are teenagers who both decide to drink alcohol at a 
party. Amanda passes out after five drinks. Tobias passes out after nine. Eventually, 
they both make it home with help from friends leaving the party. The next day 
at school, no one really mentions Tobias, but rumors fly about Amanda. Other 
students, male and female, whisper about Amanda’s morals, her appearance, her 
wardrobe choices, her family, and her alcohol use with disdain. Nothing happened 
to Tobias while he was passed out. But gender happened to Amanda.
 Biological differences dictate the amount of alcohol males and females 
can metabolize before they pass out and the amount that results in impairment 
and intoxication. Media messages, parental warnings, or religious beliefs cannot 
influence this outcome. But, a girl’s vulnerability, the stigma, and the shame that 
go along with her use of substances are all based on her failure to meet gendered 
expectations that a girl will hold herself above the drunkenness around her. The 
pass extended to boys allowing them to experiment with substances, with a degree 
of impunity that girls do not enjoy, is based on their success in meeting gendered 
expectations that view drinking as a normative rite of passage for males.
 Gender is usually based in biology, but it is shaped by social and cultural 
influences and individual experiences. Although gender and addiction may not be 
a main focus of epigenetics, research suggests that specific markers are likely 
to manifest as depression in women and alcoholism in men (Corryell, Winoker, 
Keller, Schefner & Endicott, 1992). The more intriguing research question of 
whether this is attributable to sex-linked (i.e., biological) differences or gendered 
(i.e., sociological) constructions of acceptability has not yet been answered. Data 
have also suggested addiction and even substance abuse may be more heritable 
for men than for women, although recent research confirms the strong influence of 
genetics is comparable for both. There is still some disagreement about whether the 
degree of heritability is greater and whether it differs depending on the substance 
(Nolen-Hoeksema, 2004). Some researchers have suggested that genetics exert 
more influence on women’s initiation of use and on men’s maintenance of use.
 Gender-based social stigma seems to be universal to women’s substance 
use across cultures (EMCDDA, 2009), influencing when and where women enter 
doorways to treatment. Research in the United States has shown that women, 
but not men, commonly report stigma as one of the top reasons they do not 
seek treatment for substance use disorders (CSAT, 2009). However, sex-linked 
physiological vulnerabilities can also make it difficult for women to initiate or 
maintain recovery.
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Sex: After her car accident, Sylvia took pain medication for a short time. She 
was surprised at how quickly she got used to having it. She even felt a little 
sick for the day she stopped using it, and thought about taking more just to feel 
better, even though her pain was gone
 Women’s physiological responses to substances differ significantly from 
those of men. The window from experimentation to addiction is narrow; women 
can become physically dependent in a shorter period of time at lower levels of 
consumption and tend to experience more severe withdrawal (NIDA, 2005), 
therefore, early intervention is critical.
 Drugs, including prescription drugs, alcohol, tobacco, and others, are not 
metabolized as efficiently in women as in men. They are broken down more slowly, 
stay in the female bloodstream longer, and tend to have a more potent effect on a 
woman’s system. This is caused by a number of physiological factors ranging from 
stomach enzymes to body fat to water ratios. These differences are just beginning 
to be understood, and the magnitude of the medical implications is not fully known 
(APA, 1996; NIDA, 2005).
 Women’s brains are more vulnerable to the damage that alcohol and 
drugs cause in men, and may also sustain types of damage unique to females. 
For example, girls who binge drink at an early age may also experience hormonal 
changes that increase their lifelong vulnerability to estrogenic diseases such as 
breast cancer (CASA, 2003). This does not seem to be true for boys. Several 
studies have suggested that maternal substance use during pregnancy has 
greater effects on female babies, in utero, and their future development (NIDA, 
2005).
Gender: Sylvia described to her doctor how her body responded to the 
medication. He got out his prescription pad and wrote her another 30-day 
supply of the pills. Sylvia refused and asked if he forgot that she was recovering 
from substance abuse.
 Medical practice is not immune to the influence of gender stereotypes. 
Doctors often miss signs of addiction in females and fail to diagnose older women 
and younger girls with substance abuse. They are more likely to write a prescription 
for a female patient and more likely to prescribe sedatives and analgesics to female 
patients (CASA, 2003; WHO, 2004).
 Women’s behavioral health needs differ from men’s in complex ways and 
have a dynamic relationship with their social status and safety. Women with alcohol 
and drug problems contend with high rates of victimization, childhood abuse 
(U.S. Dept. of Health and Human Services, 2010), histories of sexual abuse and 
domestic violence, and current danger from violent partners (CSAT, 2009; Downs 
& Miller, 2002). Many experience multiple intersecting forms of discrimination 
and racism, and live in dangerous conditions. They often have sustained great 
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personal losses. Addiction treatment that is “gender neutral” does not consider 
any of these issues and therefore is gender blind, as it is based on the needs 
of the dominant gender (Harris, 1998). In some cases this kind of treatment has 
been re-traumatizing for women or driven them away. The centrality of trauma in 
the lives of women who are addicted to substances makes them vulnerable to re-
traumatization and relapse when they feel unsafe in a treatment setting (Harris, 
1998; Women Co-occurring Disorders, 2003). Safety is fundamental for women to 
make progress in recovery (Herman, 1992).
 Additionally, women tend enter treatment at a much later stage of addiction 
compared to men. They tend to access services in mental health settings rather 
than substance treatment settings (CSAT, 2009), and stigma may compel them 
to hide their use. Competing demands, finances, and limited treatment options all 
contribute to delayed entry into treatment. They arrive with more serious health 
complications due to the accelerated rate of physiological damage they sustain 
from substance use.
 Gender-based social determinates of health and disparities can adversely 
affect women’s overall medical care needs, as well as their recovery from addiction. 
For example, women are twice as likely as men to become infected with HIV 
during sexual intercourse, and are frequently infected as a result of sexual assault, 
with infection rates increasing rapidly around the globe – making AIDS the leading 
cause of death for women ages 15 to 49 worldwide. Yet, ideal therapeutic levels of 
medications prescribed to treat HIV/AIDS have not been determined for women; 
current dosages are based on amounts proven effective in men. Women with 
HIV/AIDS experience more severe adverse effects from combination therapies 
compared to men (NIDA, 2011). Because drugs stay in a woman’s system 
longer, it is possible that women may experience the therapeutic benefit of these 
medications at lower doses, but it is not possible to know this without gender-
specific pharmaceutical research.
Historical context of gender and addiction
 During the last several decades, the majority of the treatment population 
has been male. Although men’s rates of alcohol use have always exceeded 
women’s, the same cannot be said about drug use. Not so long ago, excessive 
alcohol consumption among women was an unacceptable breach of gendered 
expectations and a social taboo. Women’s drinking was synonymous with 
amorality, child neglect, and sexual concupiscence. Cheap gin was “epidemic” 
among impoverished women by 1750 in England, who were reviled and despised 
(Straussner & Brown, 2002). William White (1998) wrote about Benjamin Rush, 
father of American psychiatry, who attributed women’s drunkenness to self-
medication of “breeding sickness” (menstruation).
 The Victorian era brought increased disdain for women who drank. They 
could not expect to recover their standings as potential marriage partners or mothers. 
Beginning in the late 1800s, the recommended treatment for women alcoholics who 
did not respond to routine interventions was “de-sexualization” (removal of uterus 
and ovaries). In subsequent years this was watered down to mere “sterilization” 
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(Straussner &Brown, 2002). In his research interviews for his 1998 history of addiction 
recovery, in “Slaying the Dragon”, William White spoke with many women committed 
to institutions for alcoholism, as recently as the 1950s, who were forced to consent 
to sterilization prior to discharge. Their medical records verified the procedures and 
contained their coerced signatures on consent forms.
 At the turn of the 19th century, women’s use of “medicines” was not only 
socially accepted, but in the United States, women were the largest consumers of 
opioid compounds (Keire, 1998). Historians place the proportion of female opium 
addicts at well over 50% and as high as 80% (White, 1998). Iatrogenic addiction 
among women was also rampant (Aldrich, 1994). In their 1972 publication on licit 
and illicit drugs, Brecher and the Editors of Consumer Reports attribute this to “the 
widespread medical custom of prescribing opiates for menstrual and menopausal 
discomfort” (p. 17). In 1880, with the introduction of the hypodermic needle, 
injectable morphine replaced laudanum. It was prescribed for a laundry list of 
female conditions (Aldrich, 1994).
 The first opiate prohibition law in the western world was the Pharmacy Act 
of 1868, passed in London, banning laudanum unless prescribed by a physician. 
It was aimed at curtailing the common practice of infant doping to calm screaming 
babies (Berridge & Edwards, 1987). This suggests that small doses of laudanum 
might have been used to medicate the withdrawal symptoms of infants born to 
women physically dependent on opioids during pregnancy. The law went into 
effect after infant mortality studies in London were completed.
 In Europe, another development around this time was Freud’s pioneering 
use of talk therapy, specifically free association. It produced a uniform response 
among many women with psychosomatic complaints, illnesses with no apparent 
physiological cause, and a diagnosis of hysteria. The common complaint of 
childhood sexual abuse by Freud’s female patients led him to theorize that it is 
a major cause of neurosis (Herman, 1982). Freud had no idea how far ahead of 
his time he had been before he abandoned this view in favor of his more well-
known theoretical contentions, which reclassified women’s narratives of childhood 
abuse as sexual fantasies (Webster, 1995). Today, research shows that a history 
of childhood sexual abuse is common among women with mental health problems 
(Clark, 2001; CSAT, 2009; WHO, 2004). Typically, survivors of abuse tend to have 
a number of somatic complaints and are at much higher risk for substance misuse 
and addiction (Felitti, 2002).
 Despite widespread substance use among women, the first treatments 
evolved with little attention to their needs. Ethnographic studies of early addiction 
treatment show that women were heavily outnumbered by males, and incidents 
of sexual abuse by staff and other clients were reported (Inciardi, Lockwood & 
Pottieger, 1993). Early treatment programs for pregnant women were modeled 
after high-intensity men’s programs, with crammed schedules six days of the week. 
This interfered with the natural bond women develop with their newborn during 
pregnancy and after delivery. Strengthening that bond creates a powerful motivation 
to recover and should be a central goal of addiction treatment for pregnant women 
(Pursley-Crotteau, 2001). The need to consider the specific situation of women in 
addiction treatment arose out of such conditions, and out of unsatisfactory outcomes 
in treatment access, retention, and completion (CSAT, 2009).
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Iatrogenic addiction
 Attributing “hysteria” to the female gender served to institutionalize 
women’s acceptable need for the occasional sedative in medical and psychiatric 
practice. According to the World Health Organization (2004), being female is 
predictive of being prescribed a psychotropic medication. Studies have shown that 
women in the United States are 30 times more likely to emerge from a doctor’s 
office with a prescription for a mood-altering drug than are men (CASA, 1998). 
Older women are the largest users of prescription drugs in the United States and 
in the European Union (UNODC, 2004).
 Many physicians tend not to screen, educate, or caution adolescent girls 
with regard to alcohol and drug use (CASA, 2003); they may fail to detect signs 
of depression; and they typically rely on gender stereotypes when determining 
diagnoses (WHO, 2004). Doctors are also likely to prescribe highly addictive, 
short-acting benzodiazepines to women for long-term use for any number of 
complaints, including depression, while prescribing them to men as recommended 
(i.e., for short-term use to control acute anxiety; CASA, 1998; Curie, 2004; 
Mellinger, Balter & Uhlenhuth, 1984). Research shows that physicians often 
misdiagnosed women older than age 55 who displayed symptoms of alcoholism, 
determining instead that they were depressed and offering them anti-depressant 
medications (WHO, 2004). One promising strategy for the early identification of 
problem drinking among women is to provide screening and brief intervention in 
primary care settings for females across the life span. Including women in the 
development of effective training for medical professionals will be essential to the 
success of screening and brief intervention.
Evolution of treatment for women
 Gender-specific and gender-responsive alcohol and drug policies, 
practices, and programs have been implemented in various communities and 
nations for several years. In British Columbia, single-gender treatment for women 
was underway as early as 1976 at the Aurora House, sustained throughout the 
1980s, and with gender-specific aspects well defined by the 1990s (Women’s 
Addiction Foundation, n. d.). Elizabeth Ettore began researching women in alcohol 
treatment and pregnant women’s substance use in the United Kingdom in 1978 
(FEAD, 2011). In the United States, a percentage of funding was earmarked for 
women’s treatment; multi-site pilot programs for pregnant and parenting women 
began in 1989 (CSAT, 2009). More than two decades ago, advocates first called 
upon European policy makers to focus on gender differences and women’s needs 
(EMCDDA, 2006). In 1987, Joy Barlow began to raise funds in Scotland for 
residential treatment where women could bring their children (FEAD, 2009). More 
recently, New Zealand and Australia have compiled qualitative research, using 
participatory methodologies to understand the trauma and addiction confluence 
among aboriginal women in prison (Kengi, 2000; Lawrie, 2003).
 The process of becoming gender responsive has unfolded over time, often 
through predictable stages and periods of adjustment. Services evolved through 
the following major phases of development:
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 ●  Single-sex programs: removed from the predominance of males, women 
no longer are a small minority among a powerful majority. They interact 
with their peers as equals.
 ●  Gender-specific programs: with the shift in power dynamics a new focus 
comes on how substance abuse affects women’s relationships, child 
rearing, and valued family roles.
 ●  Gender-responsive programs: services are transformed in response to 
women’s experiences of addiction, trauma, and loss. Safety is primary 
in treatment and fundamental to recovery.
 Theoretically, the first two are not considered gender-transformative. 
For practical purposes, all three have value and an important role in addressing 
health disparities that impact women and girls. Many women have experienced 
gender-specific treatment as profoundly transformative. In a very real sense, 
understanding the needs of women in addiction treatment began with single-
sex groups, comprised only of female participants. Some of the advantages 
to single-sex programs include a greater sense of safety and increased 
engagement, participation, and retention. Ashley, Marsden & Brady (2003) 
reviewed 38 studies on women’s treatment and found single-sex programming to 
be one of six characteristics that predict effectiveness. Research on gender and 
group norms has shown that men display a broader emotional range in mixed-
gender groups, whereas women tend to hang back, limit their participation, and 
focus on the needs of others when males are present (Hodgins, el-Gruebaly 
& Addington, 1997). However, the absence of men does not make a program 
gender responsive. Not all single-sex treatment responds to the needs of 
women. Female boot camps and “shock incarceration” have been common in 
correctional treatment. Some women’s therapeutic communities still encourage 
confrontation, which is contraindicated.
 Nevertheless, the fundamental needs of women were easier to discern 
within the context of single-sex programs. The centrality of trauma, the value 
placed on relationships, accommodations for children, healthcare needs, and 
the importance of family were among them; peer recovery services, family skills 
programs, and trauma-specific treatments were targeted services that came out 
of this increased awareness of women’s needs. Gender-specific enhancements 
in group work raised issues central to women. Gender-specific interventions 
may be situated in both single-sex and mixed-gender programs. For example, 
parenting programs and accommodations for children and child care during 
groups were specific enhancements for women. Policies and protocols to ensure 
safety planning and collaboration with domestic violence services are also gender-
specific enhancements that have benefited women and girls.
 Truly gender-responsive programs are transformative and person-centered. 
Gender responsive implies that women in the community work with treatment 
providers to bring their lived recovery experience to planning and evaluation 
in a dynamic process that improves treatment satisfaction and encourages 
participation, and shared decision making. Gender-responsive programs collect, 
disaggregate, and analyze evaluation data and client satisfaction measures; 
stay current with the latest research and practice guidelines; and structure the 
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meaningful participation of recovering women in program planning and delivery, 
policy reform and evaluation. Participation is empowering and culturally respectful, 
and recognizes and reinforces women’s strengths (WHO, 2004).
 An example of this dynamic process occurred in a program that piloted 
enhancements such as child care and transportation for pregnant women in 
treatment. Surprisingly, childcare was the least used despite the fact that it was a 
service included in the needs assessment. Women did not feel comfortable with 
providers right away and were reluctant to entrust their children to them. Many 
women feared their parenting would be under scrutiny and that Social Services 
could become involved. Others were survivors of childhood sexual abuse and 
avoided leaving their children with strangers (Comfort, Loverro & Kaltenbach, 
2000). Once the women trusted the staff enough to talk with them about their fears, 
things fell into place.
 The challenge of gender-responsive programming is to ensure the presence 
of this type of exchange between the women who use the services and the women 
delivering them. Informal opportunities and formalized program elements that invite 
women to have the highest degree of agency possible with regard to their own 
treatment and recovery are the hallmark of trauma-informed care, responsive to both 
gender and culture. This empowerment approach assumes that the best source of 
knowledge about what a women needs in order to feel safe in treatment and what 
she will need to feel safe when she leaves treatment is the woman herself.
Addiction, treatment and pregnancy
 Use of drugs, alcohol and tobacco by women during pregnancy is arguably 
one of the most stigmatized health risk behaviors professionals encounter. 
Prevention, education and intervention can reduce both the number of woman using 
substances during pregnancy and also the frequency and intensity of substance 
use (i.e., harm reduction). However, policies that support intervention rather than 
discourage it are required to achieve positive results. Interventions with substance-
using parents and pregnant women have been very effective, particularly in the 
European Union, where several member states link families to supportive services 
that remain available until the child begins school (EMCDDA, 2006).
 Punitive responses to substance use during pregnancy have ranged 
from termination of parental rights to arrest and incarceration. Several U.S. states 
consider evidence of drug use during pregnancy as presumptive neglect, grounds 
for removing a child from the home and action from child welfare. No member 
countries of the European Union consider substance use during pregnancy 
presumptive neglect, but it is reportable. Norway and several U.S. states include 
pregnant women in laws that allow for civil commitment of individuals on the 
basis of substance use (CSAT, 2009; EMCDDA, 2006).There is no evidence that 
punitive policies deter women from using drugs and alcohol during pregnancy, but 
evidence suggests that they do deter women from seeking treatment and from 
receiving prenatal care, because physicians must follow guidelines for drug testing 
and reporting (Gareau, 2011; Paltrow & Flavin, 2013).
 The most important opportunity for intervention with women is pregnancy. 
If policies that deter women from seeking medical care and help for substance 
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abuse proliferate, it may not be possible to significantly reduce drug use during 
pregnancy. A woman who is jailed or imprisoned during her pregnancy is likely 
to not receive the same quality of prenatal care that she would receive in the 
community (Lewin, 1997). She will have little or no support, may be shackled 
during labor, and could be separated from her infant within an hour of delivery. 
It is simple to understand why this is such a deterrent to seeking treatment and 
receiving prenatal care.
 The earliest treatment programmes for pregnant women focused on 
opioid addiction; however, the advent of crack use among women and public 
perception of the “crack baby” prompted a flurry of funding for addiction research 
and model programmes for pregnant women. In 1994, the National Institutes of 
Health released guidelines on the inclusion of women and minorities in research, 
and empirical studies on women’s treatment increased (CSAT, 2009).
 Unfortunately, crack cocaine was also a catalyst for punitive public policy 
based on visceral responses rather than accurate information (Ashley, Marsden 
& Brady, 2003). Even the objectivity of the scientific research community was 
affected. As sensational stories funneled through mainstream media sources, 
The Lancet released an article that showed a bias in acceptance of research 
studies for publication, with more elegant research studies that suggested 
less virulent and permanent effects rejected in favor of studies that attributed 
a number of negative birth outcomes and developmental issues to crack use, 
without controlling for poverty, poly-substance use (including cigarettes and 
alcohol), prenatal battering, and quality of prenatal care (Koren, Graham, Shear 
& Einarson, 1989).
 Pregnancy and substance use is an emotionally charged issue for 
everyone concerned, including treatment professionals and policy makers. 
However, when policies are based on emotional responses rather than the best 
information available, everyone loses, including infants (Paltrow & Flavin, 2013). 
For example, in 1997, as a result of a judicial ruling (not legislation), South Carolina 
became the only state to authorize the prosecution of pregnant women who use 
drugs for child abuse (Lewin, 1997). Studies of women’s treatment admissions 
before and after the court ruling found a change in patterns of women’s treatment 
admissions, with more women avoiding substance abuse treatment (Gareau, 
2011).
Mind the gaps
 Gender mainstreaming may help improve access to recovery, clinical 
practice, community support and health equity. There will always be a need for 
specialty programmes that offer housing safety and comprehensive wrap around 
services for pregnant and parenting women. However, it is neither economically 
sustainable nor clinically indicated to provide treatment for all women with drug and 
alcohol problems in such a modality. It is also critical to apply gender mainstreaming 
to early detection and intervention with girls, who are more vulnerable to the effects 
of substances and develop addiction and health impairment at an accelerated 
pace (NIDA, 2005).
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The gender gap
 The difference in the numbers of women and men who drink or use 
other drugs is known as the gender gap. It is one gender gap we do not want 
to close. It is also the gap our daughters are busy closing. International studies 
show that the gender gap is narrowing for alcohol, with women and girls drinking 
nearly as much as their male counterparts in several countries (Poole & Dell, 
2005), including Canada, Australia, Spain, and the United States (EMCDDA, 
2005; EMCDDA, 2012a; NIDA, 2010). This is a dramatic departure from historical 
trends. For example, 1975 rates from a large U.S. population-based national 
survey of students, Monitoring the Future, showed boys’ binge drinking rates at 
23 percentage points higher than those of girls (NIDA, 2013). Less than 40 years 
later, current youth surveys have reported rates of binge drinking among girls ages 
10-13 that exceed boys’ (Centers for Disease Control, 2008). A 2011 report on girls 
in the UK showed that at age 15 their binge drinking rate (50%) exceeded the rate 
of boys and was among the highest reported (European School Survey, 2011). In 
February 2013, an Australian study by the Institute of Health and Welfare showed 
that girls’ rates of binge drinking were exceeding boys’.
 The gender gap differs by substance, with women’s illicit use of 
tranquilizers, sedatives, and certain other psychotherapeutics typically surpassing 
or equaling men’s rates of use. However, in several countries there is now little or 
no difference between women’s and men’s use of a number of other substances, 
with women trending higher in use of methamphetamine and other stimulants 
and of non-heroin opioids. The gender gap for drugs also differs by age group 
(EMCDDA, 2005; OAS, 2011; SAMHSA, 2012).
 Dr. Nora Volkow, Director of the National Institutes on Drug Abuse, calls 
the use trends among girls “quite worrisome,” because between 12 and 17 years 
of age, girls have significantly high errates of abuse for all psychotherapeutics, 
including opioids. Stimulant abuse is 60% to 70% higher among girls; they have 
higher rates of ecstasy and inhalant use (NIDA, 2010). This suggests a failure of 
prevention efforts to reach girls and to reduce their rates of substance use.
 Yet, data are commonly and inaccurately generalized to female youth. 
The press release headline for the results of a recent survey boasts “Adolescent 
Smoking and Drinking at Historic Lows” (NIDA, 2013). A gendered analysis of these 
same data could produce a different, but still accurate, headline: “Girls at Historically 
High Risk.” There is no disagreement that the gender gap is narrowing, but there is 
a surprising dearth of information and conversation on how dramatic and significant 
the increases are. Sounding an alarm is the first step in containment. The second 
step is comprehensive gendered analyses of available data to identify trends over 
time. The third is ensuring that alcohol and drug prevention and intervention services 
respond to girls’ unique risk and protective factors (CASA, 2003).
The treatment gap
 The difference between the proportion of individuals accessing treatment 
and the proportion needing it is known as the treatment gap. Contrary to old 
thinking, women are at least as likely to benefit from treatment as men are, but 
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men are more likely to enter treatment (Najavits, 2006). In Europe, the rates of 
substance use among women are definitely higher than their rates of treatment 
utilization, but an exact figure is not available. In the United States, the treatment 
gap for women has hovered between 80% and 90% (CSAT, 2011; CASA, 2007).
 The data tell us that many women entering addiction treatment in the 
United States are in immediate danger from violent partners (47%) and may need 
legal representation and victim’s advocacy services (Downs & Miller, 2002); may 
have depression, anxiety, and complex PTSD; and may benefit from mental health 
services (Zweben, 1996). They are typically difficult to retain in treatment if their 
children are not with them, and they benefit when services are extended to their 
children (CSAT, 2009).
 When providers do not have the capacity to deliver or facilitate essential 
services such as trauma recovery support, mental health treatment, pregnancy and 
parenting supports, and safety from domestic violence, it can discourage women 
from seeking treatment (Women, Co-occurring Disorder and Violence, 2003). 
Initiating treatment requires trust, sacrifices, and significant risks for women. It 
is difficult for women to trust a system of care that asks them to choose between 
mental health services or addiction treatment. It does not feel like empathy when a 
single mother is told she can enter treatment but cannot bring her children (Clark, 
2001). A domestic violence survivor does not feel safe unless agency protocols 
and staff have measures in place to protect her (Straussner & Brown, 2002).
 A  gender-responsive recovery continuum involves creating a forum for 
community support, collaboration, and a cross-agency response to a population 
served by public health, prevention, behavioral health, children’s services, and 
primary care (CSAT, 2009). Gender mainstreaming affords an opportunity to create 
collaborative linkages between multiple services and increase coordinated care for 
families in recovery before, during, and after treatment (EMCDDA, 2006). This 
integrated approach connects treatment, prevention, and maternal and child health. 
Efforts to counter stigma and misinformation and to change public perceptions 
are important. Women heal, recover, and live in the context of their communities 
and families, not in treatment centers, institutions, or hospitals. Partnerships of 
grassroots advocates, service providers, policy makers and women in recovery, 
dedicated to improving the lives of at-risk and recovering women, girls, and families 
can keep the issue at the forefront through collaboration and visibility.
 When women experience relapse, it is often the result of situational 
stressors and competing demands; men tend to experience relapse when they are 
doing well and become overconfident (CSAT, 2009). Parenting stress definitely 
creates relapse conditions for women in early recovery. For a variety of reasons, 
women in recovery may be under pressure to reunify with their children as quickly as 
possible or face loss of custody, leading to the phenomenon of “shock motherhood.” 
Women re-entering from correctional facilities or long term treatment programs are 
presented with children on the doorstep, often within hours of release, but given 
little parenting support. Mothering can be challenging under any circumstances, 
but as Nancy D. Campbell points out, “there are few mothers who encounter as 
little support as those who depend on drugs to navigate their everyday (and every 
night) lives” (Hurst, 2013).
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 Community prevention coalitions are particularly non-stigmatizing ways 
to deliver family and parenting skills groups and other recovery-oriented, gender-
responsive supports (UNODC, 2010). Providing skills and supports for recovering 
women, mothers, and at-risk families are pre emptive strikes against addiction 
in the next generation (Kumpfer, 1998). Best practices recommend working with 
women on what they see as their most immediate needs to build a therapeutic 
alliance and provider credibility (Zweben, 1996).
The intervention gap
 The intervention gap for women results in late entry into treatment, with 
more serious health conditions, complex psycho-social consequences, and the 
need for the most expensive levels of care. One of the authors of “Gendering 
Addiction: The Politics of Drug Treatment in a Neurochemical World” (Campbell & 
Ettorre, 2011) commented in a recent interview: “I don’t think that more treatment 
is going to lessen these disadvantages - we can’t treat our way out of the problem. 
Better treatment would be great, but it won’t lessen the gap. We have to think 
about why so many women are in pain in the first place, and do what we can to 
reduce pain and hardship” (Hurst, para. 11, 2013).
 Clearly, the points of early intervention for men are not casting a net that 
includes women who are appropriate for selected or indicated prevention or low-
threshold intervention and treatment services. Gender mainstreaming applied to the 
complete continuum of care, from prevention through long-term recovery support, 
has the potential to drastically reduce the fiscal and human costs associated with 
advanced stage addiction in women.
 Examples of open-access, low-threshold services for women are 
highlighted in the United Nations Office of Drugs and Crime publication 
“Substance Abuse Treatment and Care for Women: Case Studies and Lessons 
Learned” (2004). Included are snapshots of peer support programs from Senegal, 
street outreach in Slovakia, drop-in centers in the Islamic Republic of Iran, and 
other community-based programs aimed at engaging women at earlier junctures. 
Switzerland has just introduced a realignment of its prevention priorities based 
on a public health model (Swiss Federal Office of Public Health, 2010), with the 
substances that do the most harm (regardless of whether they are legal or not), 
at the top of list. In Canada, a program called “Motherisk” maintains helplines 
and a database of information about medications and substances and their 
impact on pregnancy and breastfeeding. Women can call anonymously and get 
information on any substance from one of the leading centers for maternal and 
child health, including “legal” medications, which can also have effects on fetal 
and early childhood development even when prescribed by a physician and taken 
as directed (Thompson, Levitt & Stanwood, 2009). In Germany, the substance 
abuse agenda for women includes early intervention and prevention (ECMDDA, 
2012b).
 Research shows women are more likely than men to seek help in general 
and to seek health care specifically, but are less likely to enter alcohol and drug 
treatment (Najavits, 2002). Studies also find that the probability of using any 
abusable prescription drug is 48% greater for women than for men (Simoni-
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Wastila, 2000). Because women are likely to seek help in mental health settings 
(CSAT, 2009; Price & Simmel, 2002), it is crucial that use of medications with 
a high potential for addiction be managed properly and carefully by health care 
providers, or the result, especially for older women, can be a compounding of their 
alcoholism with a prescription drug addiction (CASA, 1998).
 Analysis of treatment admission data from the United States and the 
European Union consistently show that the smallest differences in use patterns and 
in treatment admissions between males and females occur during adolescence 
and young adulthood (SAMHSA, 2012; EMCDDA, 2012a). It may be that it is easier 
for women to engage in treatment before having child-rearing responsibilities and 
facing the risk of losing child custody. If this is true, then applying a gendered 
perspective to policies, early intervention strategies, and increasing treatment 
capacity for girls and young women may be necessary.
Leadership and advocacy
 There are chasms in the knowledge base about girls’ and women’s use 
patterns. Women of childbearing age have often received contradictory public 
health information, and research findings from studies on males have been 
inappropriately applied to females. Knowledge gaps and inaccuracies contribute 
to ineffective prevention programs, stigma, punitive policies, and disparities 
in access to effective treatment. Advocating for gender-responsive women’s 
services requires informing the public with the facts about the importance of 
prevention, the effectiveness of treatment, and the role community plays in 
supporting prevention and recovery.
 Women have a tendency to assume responsibility for the family’s health 
and can act as the fulcrum that leverages family members into recovery, breaking 
intergenerational patterns (Kumpfer, 2008). Strategic action and leadership 
development can increase the participation of women with lived recovery 
experience. Creating opportunities for them to speak publicly or anonymously and 
participate in research, needs assessment, outreach, and peer support services 
can be empowering for women who choose to take part (Miller, 2011). Gathering 
good qualitative data and relying on participatory research methodologies that 
empower communities to determine measures of effectiveness are some of the 
strategies that work well in developing regions (EMCDDA, 2000). A qualitative 
research publication that unifies the voices of recovering women from several 
countries provided the following quote (EMCDDA, 2009): “Gender-responsive 
policies and programming for women do not fall from the sky. They are anchored 
in ‘Nothing about us without us’ principles with systematic inclusion of women 
drug users in the design, planning, implementing, monitoring and evaluation of 
policies, strategies and programmes” (Hankins in EMCDDA, 2009).
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Trauma, gender and justice
 Trauma can be devastatingly interpersonal for women and children. 
Sexual or violent victimization in childhood, intimate partner violence, and sexual 
assault are types of traumatic events common among girls and women. They 
are often perpetrated by a loved one the victim has trusted and must depend on. 
The sense of deep betrayal that accompanies these violations is also traumatic 
(Downs & Miller, 2002), and likely to contribute to serious mental health problems, 
drug and alcohol addiction, fear and distrust of intimate relationships, and drastic 
alterations in beliefs about the world (Najavits, 2002). The combination of trauma 
and addiction can also increase the likelihood of criminal justice involvement; but 
when it intersects with ethnicity, arrest is even more likely (Komarovskaya, 2009). 
This is blatantly demonstrated in the U.S. prison system where African Americans 
are six times more likely to be incarcerated than whites (NAACP, 2013).
 Women from cultural groups that have historically been subject to 
disenfranchisement, racism, discrimination, enslavement, social exclusion, and 
genocide are impacted by intergenerational cultural trauma (Eyerman, 2001). They 
often carry this trauma for their families, their tribe, or their children in addition to 
their own personal experiences of trauma. Responses to trauma are “pathologized” 
by professional behavioral health providers or criminalized among communities 
when there is violence. Substances may serve to keep trauma responses under 
control, to help the survivor feel powerful, or to not feel at all. Criminal justice 
policies regarding drug use have hit these women hard, and increases in women’s 
imprisonment, worldwide, has resulted in a human rights crisis in some regions.
Addictions, PTSD and co-occurring disorders
 For many women, past trauma emerges or re-emerges when they attempt 
to stop using substances. This triggering effect can be more intense in a correctional 
environment (Miller & Najavits, 2012). Traditional substance abuse treatment and 
detoxification programs that are not designed to address the co-occurrence of 
trauma often are limited in their ability to engage and retain women or to result in 
lasting treatment gains (Messina, Grella, Cartier & Torres, 2010). To ensure that 
women detoxifying from substances receive appropriate services when entering 
correctional facilities, trauma-informed correctional approaches and intake staff 
competencies that include basic stabilizing skills are necessary (Clements-
Nolde, Wolden & Bargmann-Losche, 2009). Intake and accurate classification of 
women offenders should be couched in the awareness that many women have 
immediate and overwhelming emotional responses rooted in past trauma shortly 
after they cease to use drugs or alcohol (Farley et al., 2004). In a correctional 
environment, women offenders with histories of addiction will benefit from 
immediate skill building aimed at giving them more authority over their responses. 
Gender-responsive addiction treatment and trauma-informed programming can 
help incarcerated women who have experienced trauma to make progress in all 
aspects of rehabilitation (Najavits, 2006).
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Indigenous women in custody
 In Australia, Aboriginal women are 31% of the prison population and 2% 
of the general population (Australian Bureau, 2012). The situation of indigenous 
women in Australia, unfortunately, is not unique. Maori women in New Zealand 
make up between 51% and 60% of the prison population, although they are less 
than 10% of the total population (NZDOC, 2012). In Canada, indigenous women 
are 32% of the prison population although only 4% of the country’s population is 
indigenous (Wesley, 2012).
 The Speak Out Speak Strong study and report (Lawrie, 2003) was 
commissioned by the Aboriginal Justice Advisory Council to look at the needs and 
experiences of Aboriginal women imprisoned in New South Wales, Australia. The 
qualitative study methodology consisted of a survey crafted by members of the 
Aboriginal Justice Advisory Council working with researchers. Aboriginal research 
assistants administered the survey to 50 incarcerated women and followed up with 
narrative interviews of a segment of the sample. The methodology was as respectful 
and as inclusive as possible of the research participants and of the Aboriginal 
leadership, given the constraints of a correctional setting. One remarkable finding 
was that 70% of Aboriginal women in custody reported being sexually assaulted as 
children, and 98% of those women reporting sexual abuse were addicted to drugs. 
Although high rates of sexual abuse are common among groups of incarcerated 
women (Blackburn, Mullings & Marquart, 2008; Gilfus, 2002), the clear and direct 
pathway for almost all of the women, from sexual abuse, to drug use, to prison, 
was remarkable. This may be the result of the intersection of sexual abuse and 
cultural trauma, defined as “a dramatic loss of identity and meaning, a tear in 
the social fabric, affecting a group of people that has achieved some degree of 
cohesion” (Eyerman, 2001).
 Given the vulnerability of indigenous women and girls in many areas of 
the world, and the rates of drug addiction and incarceration among the groups 
mentioned, investigating the role of trauma interventions and early protective 
therapeutic prevention programming for indigenous girls would be worthwhile 
(Battle et al., 2002).
 Sometimes justice is as necessary for healing as is counseling. Justice 
requires that gender mainstreaming includes efforts to ensure that all human 
service systems become trauma informed. When economic and health disparities 
result in vulnerability to addiction, and to violent and sexual victimization, justice 
has to be part of the answer. But can justice be found in a prison? A gender 
responsive program in a minimum security prison in Hawaii (U.S.A.), that houses 
disproportionate numbers of women of Native Hawaiian descent, raises the 
possibility that it can (see box).
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Creating a place of healing and forgiveness: The Trauma Informed Care 
Initiative of the Women’s Community Correctional Center of Hawaii34
Recognizing that most inmates are trauma survivors and many common prison 
routines can re-traumatize women, the Women’s Community Correctional 
Center of Hawaii, under the leadership of Warden Mark Kawika Patterson, 
works to create “a place of healing and forgiveness” through its Trauma-
Informed Care Initiative (TICI). TICI emphasizes educating staff, inmates, 
community partners, and the public about the value of trauma-informed 
environments and practices in healing.
Warden Patterson was inspired by the Hawaiian concept of the pu`uhonua, a 
place of refuge, asylum, peace, and safety
Under the ancient system of laws known as kapu, in which law-breaking was 
punishable by death, someone who broke a law and was able to reach a 
pu`uhonua would receive sanctuary. There, a priest performed a ritual that 
absolved the person of blame, which allowed the law-breaker to return to their 
village and resume their life. The spirit of pu`uhonua - the opportunity to heal 
and live a forgiven life - informs the vision that is changing the environment for 
both incarcerated women and staff at WCCC.
The impact of historical trauma is of particular concern for the 40% of WCCC 
inmates of Native Hawaiian descent, who are disproportionately represented 
among the prison population (Native Hawaiians make up only 10% of the 
state’s general population). For Native Hawaiians, the trauma of the cultural 
disruptions that resulted from the U.S. overthrow of the Hawaiian monarchy 
in 1893 is still evident. Native Hawaiian culture was traditionally matriarchal, 
so women may feel the loss of traditional roles especially keenly. This can 
make them vulnerable to trauma responses such as elevated suicide rates, 
substance abuse, mental health problems, coping mechanisms that appear 
self-sabotaging, unresolved grief, and physical ailments.
When Warden Patterson and his team recognized that the vast majority of 
women at WCCC were survivors of trauma, they understood that many of 
the crimes that led to incarceration, particularly drug offenses, were rooted 
in women’s responses to traumatic experiences. They realized, too, that 
the prison environment and many of the routine practices in the correctional 
system had the potential to re-traumatize women. In response, Warden 
Patterson and his colleagues created the TICI as a unique collaboration 
among the facility administration, staff and inmates; community-based non-
profit organizations and foundations; state and federal government agencies; 
educators and researchers, and volunteers from churches, civic organizations 
and the broader community.
34 Adapted with permission from a 2013 brief titled Creating a Place of Healing and Forgiveness: The Trauma-
Informed Care Initiative of the Women’s Community Correctional Center of Hawaii. This technical assistance 
document was developed by the National Association of State Mental Health Program Directors (NASMHPD) 
and Advocates for Human Potential, Inc. (AHP), under contract number HHSS2832007000201 for the 
Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and 
Human Services (HHS), and was written by Darby Penney, MLS. Its content is solely the responsibility of the 
author and does not necessarily represent the position of NASMHPD, AHP, or SAMHSA. 
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Women are offered a choice of effective treatments and supports that specifically 
target trauma-related difficulties. Other elements of the program include:
Maintaining the Bonds Between Mothers and Children - activities 
designed to maintain a bond with children and to promote safe and nurturing 
environments.
Enhancing the Physical Environment - women inmates participate in creating 
gardens and comfortable places onsite, including comfort/sensory rooms.
Community Outreach/Community Volunteers - women inmates go into the 
community to discuss impact of trauma or read from their creative writing.
Identity, gender and transformation
 Gender is both central to identity and inseparable from the culture that 
constructs it and the social context that defines its parameters. Rigid gender role 
assignments are the reality in some parts of the world, where consequences of 
gender nonconformity are still overt and intense; they exist with varying degrees 
of subtlety in most cultures. However, today in many places, post-modern gender 
flexibility has prompted the reconceptualization of gender as a continuum instead 
of fixed categories. The concept acknowledges that men or women may have 
behaviors and characteristics that fall anywhere on the gender continuum. It also 
accommodates the biological variants of sex (Meyer-Bahlburg, 2009), all degrees 
of gender transition, and indigenous cultural traditions that embrace diverse gender 
expressions and identities (Roscoe, 1998).
 Identity is also germane to discussions of addiction recovery. Research on 
identity transformation found that people who acquired an identity of a person in 
recovery were more likely to transform their lives than those who retained their addict 
identity (Katskutas, 1994). Women’s recovery narratives included reconstruction 
of identity, discoveries relating to identity and motherhood (Baker, 2000), and 
reflections on sustaining dramatic transformations (Anderson, 1993). Cognitive 
shifts also form the basis for theories of identity transformation among women 
offenders who desist from criminal behaviors, including drug use, and change 
their lives upon release (Giordano, Cernkovich & Rudolph, 2002; Paternoster & 
Bushway, 2009).
 Neither women nor men are a homogeneous group with innate universal 
traits, identifying with their gender as the only reference group. Intersectionality 
is a way of recognizing the layered quality of identity and the overlays of race, 
class, immigration status, ability, age, etc. Marginalization may be compounded 
by multiple forms of oppression that influence interactions with social institutions 
and political and legal systems (Mason, 2010), but intersectionality is a way to see 
that the whole is greater than the sum of its parts. “Intersectional discrimination is 
not understood by merely adding together the consequences of race, class and 
gender discrimination. […] A person may be discriminated against in qualitatively 
different ways as a consequence of the combination of the aspects of their identity” 
(Social Justice Report, 2002, pp. 154-156).
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 Thus, the alcoholic’s social isolation plus the discrimination experienced 
by women does not equal the extreme stigma at the intersection of woman 
and alcoholic. The drug addict’s exposure to violence plus women’s risk of 
sexual victimization does not equal the exponential impact of sexual and violent 
victimization on women addicted to drugs (Miller & McDonald, 2009).
 Intersectionality lessens the fragmentation of women’s identities. Mono-
issue advocacy and support can have unintended consequences. Crenshaw 
(1991) points out in her article on violence against women of color, “The narratives 
of gender are based on the experience of white, middle-class women, and the 
narratives of race are based on the experience of black men” (1991, p. 1298). 
Women from racial and ethnic groups that are subject to discrimination experience 
the totality of impact at the intersection of gender, race, and class, manifesting as 
multiple vulnerabilities that compromise their safety and health and that of their 
families. This is especially important for women from cultural groups that have 
been targets of various forms of cultural genocide.
 Although vulnerabilities meet at the intersections, strengths and resiliencies 
may also be compounded. Leaders often emerge from adversity and disadvantage 
by virtue of tenacity and optimism. After experiencing a broader spectrum of social 
identities, they are capable of forming natural alliances with multiple affinity groups 
(Fraga, Matinez-Eber, Lopez &Ramirez, 2005). Women in conflict-ridden regions 
who endure intersecting forms of oppression related to gender, class, ethnicity, 
and health status survive losses and degradations of such magnitude that we have 
no instrument to measure them. Nor do we have an explanation for the resiliencies 
they are capable of drawing upon.
Conclusion
 The epistemology of women’s recovery has become an international 
pursuit, or perhaps it has always been. This is a call to unity that draws upon the 
power of women’s protective and healing prowess. What this can mean to women, 
men, families, and communities affected by drug and alcohol addiction has yet to 
be written.
 Social inclusion, acceptance, and renewed connections to informal 
networks help promote healing, particularly for those dealing with stigmatized 
conditions (Betancourt et al., 2010; White, 1998). When people expand networks 
of community and peer support after drug and alcohol treatment, they maintain 
abstinence at higher rates (Fiorentine & Hillhouse, 2000; Moos & Moos, 2004). 
Public elocution of commitments, goals, and milestones is common to many 
cultures, a therapeutic technique, and a recovery community tradition (NIDA, 
1978). Therefore, change undertaken at the macro level can encourage and 
support change at the micro level, creating synergy between individual and 
systemic transformation.
 Transforming women’s lives also involves transforming systems of care, 
and communities. Treatment is a very time-limited event in the life of a recovering 
woman. Treatment is successful if, upon completion, it is able to:
 ● expand her support networks;
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 ● strengthen positive relationships with family and others close to her;
 ● make new connections with people in recovery;
 ● access services that increase her (or her family’s) well-being.
 The continuum of prevention, intervention, treatment, and ongoing 
recovery are all related strongholds in the community that connect women to 
recovery-oriented supports.
 In many ways, men and women who use drugs and alcohol are more 
alike than different. They both respond to motivational interviewing, incentives, 
cognitive-behavioral therapies, medication-assisted treatment, peer support, 
social inclusion, and trauma treatment. The diverse needs of men and women in 
addiction recovery are the result of both sex and gender differences, playing out in 
an infinite array of social and cultural contexts. The profound influences on women’s 
initiation of substance use and their response to it require a gender-mainstreamed, 
biopsychosocial approach. The ways women sustain, interrupt, and heal from 
addiction are defined by these differences, as are their help-seeking behaviors and 
the unique intervention opportunities women of childbearing age present. When 
these considerations become fundamental to creating and delivering services that 
protect and engage vulnerable girls and women, we can achieve full equity in 
access to recovery.
 It is hoped that these informed perspectives on gender-responsive 
prevention, intervention, and treatment, and the transformed lives of women in 
sustained recovery help inspire new leadership and new capacities. Inserting 
gender into the mainstream of alcohol and drug research, program planning, and 
evaluation, and setting an agenda for practice improvement and policy reform 
can transform systems of care. Gender mainstreaming promises new information 
and perspectives, shared progress and collective responsibility among nations 
committed to reducing drug demand worldwide, increasing gender equality, and 
improving the health of families.
A nation is not conquered until the hearts of its women are on the ground.
Cheyenne Proverb
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Prevalence estimates
 Underlying gender trends and examining the role of prevention can be 
understood only by examining the considerable variation in the data, for both 
different countries and different drugs. Patterns, however, are detectible. For 
example in Europe, gender equality in cannabis use and binge alcohol consumption 
is higher in countries with a higher prevalence of use. Female prevalence rates 
remain lower for the most severe drug use. The explanations may lie in lifestyle 
influences that are intrinsically related to gender, or in the ever-changing factors 
that determine the stages of developing drug fashions across Europe (EMCDDA, 
2006).
 Detailed analysis of differences in male and female drug use can yield 
important information about changing lifestyles in relation to patterns of drug use 
and about the potential efficacy of drug prevention and drug treatment services 
for different client groups. If young females are increasingly likely to experiment 
with drugs in the same manner as their male counterparts, the likely impact on 
future drug use trends must be determined. It is necessary to identify the different 
influences of each sex on overall trends in order to understand their direction and 
develop appropriate responses. Also, the markedly higher proportion of female 
to male students who have used tranquillisers or sedatives without a doctor’s 
prescription and possible increases in male use of these substances merits future 
research attention.
 In general in the world, drug use is considerably more common among 
men than among women, especially when regular, intensive, or problematic use 
is considered. Some national research studies suggest that, based on some 
consumption measure, the gender gap may be narrowing in a few countries for 
some types of drug use. However, parity, or near parity, of drug use among males 
and females is found only in lifetime prevalence among school students, and even 
then only in a minority of countries (EMCDDA, 2006).
 Female problem drug users have overall similar or lower mortality rates 
than males, but their excess risk of death is higher than of their male counterparts, 
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also due to lower population mortality rates. This elevated excess risk in female 
drug users is illustrated by the COSMO study carried out in eight European cities 
(Bargagli et al., 2006). In Barcelona, the risk of death among drug-using women 
was found to be 54 times that of women in the general population, whereas drug-
using men had a risk 21 times that of men in the general population. In Rome, 
the respective figures were 38 for female drug users and 14 for male drug users 
(Bargagli et al., 2006).
 The gap in drug use prevalence between males and females in the United 
States has narrowed, particularly in lower grades, as females have younger 
initiations into drug use. In 8th grade, females have higher rates of using inhalants, 
cocaine (powder and crack cocaine), prescription painkillers, amphetamines, 
tranquilizers, and over-the-counter cough and cold medicines, though by 12th 
grade, rates of male drug use for all of these substances as well as heroin and 
hallucinogens, though the difference in marijuana use is small (Johnston, O’Malley, 
Bachman, and Schulenberg, 2011).
Effectiveness of prevention and gender 
differences
 Prevention programs are cost effective; in the United States in 2002, an 
estimated $18 would be saved for every $1 invested in effective school-based 
intervention programs, and substance abuse initiation would be delayed for 
an average of 2 years for 1.5 million children and adolescents. State and local 
governments would save $1.3 billion within two years, reduced social costs from 
substance abuse-related medical care, resources, and lost productivity over a 
lifetime would be approximately $33.5 billion, and preserve $65 billion in quality of 
life costs over a lifetime (Miller and Hendrie, 2008).
Table 1: Some differences in male and female drug use in the European data (EMCDDA, 2012b)
Cannabis use is generally higher among males. For example, the 
ratio of males to females among young adults reporting cannabis 
use in the last year ranges from six in Portugal to about 1 in Norway.
For lifetime use the ratio is ranging from unity in Spain, France, and 
Romania to about 2.5 boys to each girl in Greece and Cyprus.
Amphetamines users entering treatment show a ratio of 2, lower than 
for any other illicit drug.
Use of ecstasy in the last year is generally reported more often by 
males than by famales in all countries.
In 16 of the EMCDDA's reporting countries, last year's male to female 
ratio of cocaine use among young adults is at least two.
CANNABIS
AMPHETAMINES
ECSTASY
COCAINE
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 Protective factors that are particularly effective for girls include strong 
family bonds and a close relationship with at least one adult, especially the mother; 
a group of supportive peers; and clear family rules against substance use. Strong 
universal and selective prevention programs take these factors into account and 
help girls develop knowledge about the harms of substance use, teach them how 
not to succumb to peer pressure, and how to cope with stress. Programs that 
include family and community components are particularly strong. Sexual abuse, 
violence, and trauma as well as eating disorders are strongly related to female 
substance abuse, though there is a lack of programs working to prevent substance 
use in these populations outside of treatment settings.
Challenges of gender in selective versus universal 
prevention: differences in messages and 
strategies
 Prevention programs may be universal or selective: targeting entire 
populations or subsets of populations, or selected groups with increased risk 
factors, respectively. Most drug prevention programs are aimed at children and 
adolescents ages 10-20. The goals of prevention programs most often include 
increasing knowledge about drugs and drug use, reducing use and abuse of 
drugs, delaying onset of first or repeated use, and minimizing the harm caused 
by drugs. School-based drug prevention programs are particularly popular, as 
they are universal and aim to target children before they start using drugs. 
Social Learning Theory is most often cited in successful prevention programs. 
It assumes that young people are susceptible to peer pressure and to social 
influences and attitudes towards drugs, and that they need an opportunity 
to practice modeled behavior and to be positively reinforced in order to 
successfully change behavior. These programs work to make students aware 
of these pressures and teach them appropriate skills to avoid them. Overall, 
interactive presentations with discussions, interaction, and role-playing, are 
more successful at preventing drug use (Midford, 2009; Cuijpers, 2003; Turner 
and Shepherd, 1999).
 Evidence of the effectiveness of universal prevention programs is mixed 
when observing differences between the sexes. Project SMART was successful 
in preventing cigarette, alcohol, and marijuana use for girls but not boys 
(Graham, Johnson, Hansen, Flay, and Gee, 1999). However, the Keepin’ it REAL 
prevention program had no gender differences in recent substance use, and 
was more effective in developing anti-drug norms for boys than for girls (Kulis, 
Yabiku, Marsiglia, Nieri, and Crossman, 2007). An evaluation of Drug Abuse 
Resistance Education Plus (D.A.R.E Plus) program, which includes a peer-led 
parental class, extracurricular activities, mailings, and community programming 
involving parents, found that the program reduced drug, alcohol, and cigarette 
use for boys, but not girls (Perry, Komro, Veblen-Mortenson, Bosma, Farbakhsh, 
and Munson, et al., 2003).
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 Results for preventive interventions for high-risk girls are mixed as 
well. For example, a program called ALERT Plus extended ‘Project ALERT’ 
through 9th grade. Project ALERT teaches the consequences of drug use, 
thus reducing barriers to resisting drug use, and highlighting the benefits 
of non-use. Additional sessions kept the themes of Project ALERT, while 
taking into account the social and developmental changes beginning in high 
school. The additional programming session significantly reduced weekly 
alcohol and marijuana use, reduced perceptions of favorable outcomes 
of drug and alcohol use, and increased the ability to resist peer pressure 
(Longshore, Ellickson, McCaffrey, and St. Clair, 2007). However, in a 
selective intervention of high-risk female adolescents that aimed to improve 
social skills and restructure peer groups, the program was not effective in 
improving the acceptability and perceived consequences of drug use, and 
in fact was counterproductive, as girls in the intervention group were nearly 
three times more likely to use marijuana after the program (Palinkas, Atkins, 
Miller, and Ferreira, 1996).
 Studies have found that gender-specific approaches to both 
universal and selective drug prevention programs may increase program 
effects. Certain techniques and settings are more helpful for girls than 
boys. Girls benefit more from reducing tension and stress, and by learning 
stress-reduction techniques and facilitating expression, while focusing on 
behaviorally-oriented life skills. Girls prefer small group settings that allow 
for expression and casual exchange, and the trainer should be female 
and share personal experiences (European Monitoring Centre for Drugs 
and Drug Addiction, 2006). Programs with the highest rates of success for 
girls include three elements: first, they teach girls social resistance skills 
in order to reduce the effects of peer pressure, second, they teach the 
skills necessary to avoid the influence of antisocial peers and to increase 
their networks of positive friends, and third, they teach girls to estimate the 
prevalence of drug and alcohol use among their peers, to counteract the 
idea that “everyone is doing it” (Kumpfer, Smith, and Summerhays, 2008).
 A computer-based universal intervention designed specifically to 
prevent drug use in adolescent girls has shown promising results. The 
program emphasized the role of stress in girls’ lives, focusing on what 
stress is, the relationship between drugs and stress, dealing with stress, 
and techniques to reduce stress. Compared to the control group (which 
received a universal prevention program), participants receiving the tailored 
intervention were more likely to use healthy stress-reduction techniques, 
were less likely to approve alcohol, drugs, and cigarettes, and were less 
vulnerable to peer pressure (Schinke and Schwinn, 2005).
 Gender-specific interventions, both selective and universal, may 
be more successful for girls if they include certain elements that are of 
particular concern, and if these issues are discussed without the presence 
of boys. These issues include the role of drugs and weight control as well 
as body image; pregnancy, sexual abuse, and menstruation; skills training 
to cope with stress; and addressing males’ roles in introducing women to 
drugs (Rohrbach and Milam, 1993).
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Protective factors in prevention
 While many factors for risk and prevention of drug use are similar for 
men and women, there are some that are gender-specific. In a study of risk and 
protective factors for drug and alcohol use among Swedish adolescents, Bränström, 
Sjöström, and Andréasson (2007) found that among females, having antisocial or 
norm-breaking friends predicted alcohol and cannabis use, but having a positive 
attitude toward restrictions and drug and alcohol prevention programs, as well as 
having a curfew, were protective. Among adolescent girls and their mothers in New 
York City, girls who went home after school (rather than engaging in unstructured 
activities) drank less alcohol and used fewer inhalants. Girls who reported having 
positive body image drank less and used fewer prescription drugs inappropriately. 
Families that had rules against substance use or encouraged daughters to abstain 
from alcohol and drug use were also preventative, as their girls had lower rates 
of alcohol and inhalant use. Mothers’ knowledge of their daughters’ whereabouts, 
activities, and companions, as well as mothers’ availability to be contacted by her 
daughter reduced alcohol, inhalant, and illicit prescription drug use (Schinke, Fang, 
and Cole, 2008). In addition, a strong attachment or relationship with parents, 
commitment to school and a strong academic record, and involvement in religious 
activities are preventive (Hawkins, Catalano, and Miller, 1992; Griffin, Scheier, 
Botvin, and Diaz, 2000). Females brought up with traditional gender-role attitudes 
are less likely to drink or use drugs, as these roles discourage substance use 
among women (Rohrbach and Milam, 2003).
Peer education
 Peer education has become an increasingly popular method of health 
promotion interventions, particularly in terms of risky sexual behavior. There are 
multiple forms of peer education, including teaching an entire class or subset of a 
class, informal meetings or discussions in groups or individually, and counseling. 
There are a few assumptions that underlie peer education, though it is not guided 
by a specific theory as traditional prevention programs are:
 ●  By sharing experience, status, or background, peers may be more 
credible sources of information than adults or outside educators.
 ●  Peers can continually reinforce learning through ongoing contact and as 
positive role models.
 ●  Children and adolescents are more likely to talk with their peers about 
sensitive subjects, such as drug use or sex, as they are not seen as 
authority figures.
 ●  Peer education can be beneficial for educating harder-to-reach children 
and adolescents.
 ● It is more cost-effective than traditional methods.
 Overall, however, there are very few well-designed outcome evaluations, 
and the majority of peer education programs focus on HIV and pregnancy prevention 
rather than on drug use. In addition, a review of peer education programs for sexual 
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health in the European Union found no clear evidence of effectiveness (Harden, 
Oakley, and Oliver, 2001; Tolli, 2012; Turner and Shepherd, 1999).
 Tolli (2012) identifies certain contributing factors to the success of a peer 
education program. First, by recruiting appropriate peer educators, who need 
to be accepted by the intervention group and have natural leadership skills. 
Second, peer educators need to have a say in the content and direction of the 
intervention program, as they are most aware of the specific concerns of the group 
and because it increases their motivation for participating in the intervention. 
Finally, peer educators must be appropriately trained and supervised. According 
to the European Guidelines for Youth AIDS Peer Education (Svenson, 1998), 
training programs should have a preparatory meeting, teach formal knowledge, 
focus on personal development and cultural issues, and provide skills training, 
supplementary training and assistance, and continuing support.
 One of the few tested peer interventions to prevent drug use is The 
Friendly PEERsuasion program, which was developed based on social influence 
and life skills models, and uses a combination of adult leadership and peer 
reinforcement to develop support systems, knowledge, and skills that help girls 
avoid social pressures and negative messages. Girls ages 11-14 first participated 
in a program led by an adult that focused on harmful effects of substance abuse, 
ways to manage stress, and how to recognize peer pressure to use drugs. After 
completing this program, girls were certified as peer educators, and went on to plan 
and implement a substance abuse prevention program for younger children (ages 
6-10). Friendly PEERsuasion significantly reduced initial or repeat substance use, 
and helped girls leave situations where substances, alcohol in particular, were 
being used (Weiss and Nicholson, 1998).
Addressing gender differences within families 
and communities
 As mentioned before, strong family relationships are particularly important 
protective factors for female substance abuse, particularly a strong relationship with 
the mother. Community programs that aim to change norms and attitudes toward 
drug use are important as well. Environment-level theories posit that changing 
these norms and attitudes, enabling the implementation of prevention programs, 
and empowering community leaders to take responsibility for preventing drug use 
will help decrease drug use (Pentz, 1996).
 Family and parenting programs have been developed due to the strong 
correlation between parents’ behavior and their relationships with their children 
and risk of drug use. The programs teach the importance of modeling behavior, 
attitudes towards substance use, identifying risk factors for substance use, and 
family relationships and parenting and conflict management skills (Midford, 2009; 
Cuijpers, 2003). Prevention programs that involve parents need to be engaging, 
affordable, and flexible in order to impact the largest number of families. In 
response to these needs, Schinke, Fang, and Cole (2009) developed a self-
guided, computer-delivered intervention (either internet-based or CD-ROM) for 
mothers and daughters to use together. Mothers were taught communication 
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skills, to monitor their daughters’ activities, increase their daughters’ self-esteem 
and self-image, develop family rituals and traditions, and to establish rules and 
consequences about substance use, while girls were taught to manage stress, 
mood, and conflict, identify and refuse peer pressure, enhance self-esteem and 
body image, and assess the prevalence of drug, alcohol, and tobacco use of 
their peers. Two years after the program, mothers reported significantly improved 
communication and closeness to their daughters, establishing rules against 
substance use, monitoring their daughters’ time away from home, observance 
of family rituals, and decreased weekly alcohol consumption. Girls also reported 
significantly more positive communication and closeness with their mothers, 
knowledge of family rules about substance use and that their mothers were 
monitoring their whereabouts, ability to cope with stress, ability to refuse offers of 
alcohol, drugs, and cigarettes, and awareness that substance us is not normative 
behavior. In addition, girls who participated in the program reported less use of 
alcohol, marijuana, inhalants, and illicit use of prescription drugs, and had lower 
intentions to use drugs, alcohol, and tobacco in the future.
 In addition to family prevention, community programs have been developed 
to compliment the messages children receive in school-based programs. These 
community interventions result from a growing belief among practitioners and 
scientists that combining multiple interventions at different levels (e.g., school, 
family, community) is more effective than a single intervention. Community 
interventions may include mass media campaigns, community mobilizing 
committees, educational activities in various venues throughout the community, 
and general trainings for people who work with adolescents. Activities are not only 
aimed at children, but also at parents and organizations throughout the community 
(Midford, 2009; Cuijpers, 2003).
 Well-designed community interventions are difficult, but there have been 
studies that have provided reliable results. Biglan, Ary, Smolkowski, Duncan, 
and Black (2000) conducted a community intervention to prevent adolescent 
tobacco use. Towns randomized to receive both a school-based and community 
intervention (rather than school-based alone) were provided with media messages, 
including billboards, ads or public service announcements on the radio; mailings 
and presentations; activities; give-aways and presentations; guides for parents 
about family communication; and education and campaigns to prevent stores from 
selling cigarettes to minors. Towns that received the community and school-based 
preventions had significantly lower rates of smoking prevalence than towns that 
only received the school-based intervention.
 The Midwestern Prevention Project targeted reducing alcohol, tobacco, 
and marijuana use in middle or junior high school. The community-level intervention 
consisted of media coverage, videotapes and commercials, a school-based 
program in with parental participation, parent-principal meetings and parent-child 
communication instruction, organization and training of community leaders to 
develop action groups, and policy changes, including refining drug-free school zone 
policies and funding mandates for substance prevention and treatment. Cigarette 
and marijuana use were reduced 8-15%. Three years after the intervention, there 
were significant reductions in tobacco and marijuana use, and reductions were 
equivalent in adolescents at both higher- and lower-risk. Beyond the three-year 
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mark, heavy use rates or daily cigarettes, monthly drunkenness, and marijuana 
use more than twice per week were reduced more in the community intervention 
group than for the school-based program alone (Pentz, 2000; Johnson, Pentz, 
Weber, Dwyer, Baer, and MacKinnon, et al., 1990).
 A community-based prevention and treatment program is currently 
undergoing evaluation in Italy. Project DAWN (Drugs and Alcohol Women Network) 
has been designed specifically to address gender differences in substance abuse, 
addiction and treatment, and to re-orient prevention and treatment programs 
to a gender mainstreaming approach. The program has three primary targets: 
adolescent women who are at risk for substance dependence but have not yet 
initiated use, women who use drugs occasionally, and women who use drugs 
regularly and need intervention and treatment. Additionally, the program works to 
help drug addiction professionals understand gender differences and substance 
use, and to educate parents, teachers, and social workers about how best to 
educate young women about addiction. While constructing these programs, 
Project DAWN creates a national network of drug addiction professionals who are 
able to draft guidelines and effectively train the public about gender and addiction 
(Presidenza del Consiglio dei Ministri, 2009; O’Neil, 2011). Furthermore, DAWN 
is developing guidelines that focus on the signs and symptoms of drug use for 
parents, teachers, and health and school professionals, in order to specifically 
target adolescents at risk of substance dependence. Likewise, a website tailored 
for adolescent girls with information about addiction and training courses for 
parents that focus on female-specific concerns about drug use and addiction are 
also being developed. To help women who casually use drugs, Project DAWN will 
create a help line for drug dependence questions and concerns, develop meetings 
with professionals where women can come and address their concerns, and 
provide psychosocial counseling. For women who are addicted to substances, 
tailored services will be developed, women will be provided with information on 
how best to protect themselves from HIV and other sexually transmitted infections, 
and guidelines will be developed for pregnant women with drug dependence and 
their newborns (Presidenza del Consiglio dei Ministri, Italy, 2009)
Empowerment, resilience and co-silience
 Empowerment and self-efficacy are key concepts in Social Learning 
Theory, which as mentioned earlier is the basis for many successful drug 
prevention programs. These concepts are critical for developing the confidence 
and ability to adopt a particular behavior and to shape a person’s expectations 
that he or she will succeed, as young people are more likely to practice socially 
learned behavior if they believe it will be effective. Role-playing and discussion 
around pressures to use drugs can empower participants in drug prevention 
programs and make it more likely that the intervention will succeed (Turner and 
Shepherd, 1999).
 Resiliency is the ability to cope in the face of adversity. It is grounded 
in Social Learning Theory and says behavior is learned through watching other 
people and how they behave and how others respond to their behavior. Cognitive 
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Behavioral Therapy, posits that people’s thoughts about themselves are of primary 
importance. Health Realization Theory says people innately are able to function 
with self-esteem and good judgment, and secure and positive feelings emerge 
from learning and acting upon good moods (Turner, Norman, and Zunz, 1995).
 Resiliency is most strongly influenced by self-esteem and self-efficacy, 
though resilient people often also have intellectual capabilities, particularly 
good verbal and communication skills and a sense of direction or mission, 
an easy temperament that helps attract positive responses from adults, good 
social and problem-solving skills, a sense of humor, and strong empathy skills, 
as well as the ability to psychologically separate from unhealthy situations and 
environments. There are a number of protective factors that enhance resiliency, 
including having a warm, positive relationship with a caring adult, membership 
in a cohesive and supportive family with high but realistic expectations, parents 
who have good parenting and communication skills, are positive role models, 
have strong traditions and rituals, and being in a school and community that is 
supportive and caring. For girls, specifically, additional protective factors include 
having a mother who is employed, a father who has attained a high level of 
education, having relationships with caring adults outside the family, popularity 
with peers, positive high school experiences, having responsibilities within the 
family, assertiveness, problem-solving skills and participation in sports (Turner, 
Norman, and Zunz, 1995; Norman, 1997).
 Drug prevention programs should incorporate gender-specific resiliency 
to help girls develop the ability to avoid peer pressure and overcome difficult 
home or school environments, if necessary. Techniques may include teaching 
ways to enhance self-esteem, self-efficacy, and problem-solving skills, as these 
are protective factors for drug use. Same-sex groups are also recommended, as 
girls are more comfortable to talk about subjects they otherwise might not, such 
as sexual issues, concerns about puberty, and dating and relationships (Turner, 
Norman, and Zunz, 1995)
Sexual abuse, violence and trauma
 In 2010, the rate of intimate partner violence in the United States (including 
rape or sexual assault, robbery, aggravated assault, and simple assault) was 3.6 
per 1,000 population, and 80% of the victims were female. Women between the 
ages of 18-34 suffered from the highest rates of intimate partner violence (Catalano, 
2012).
 Victims of intimate partner violence and trauma suffer a number of health 
consequences, both physical and psychological. After post-traumatic stress 
disorder (PTSD) and depression, alcohol and drug abuse is the mental health 
problem most often seen in victims of violence and trauma in industrialized 
countries (Campbell, 2002). Additionally, researchers have found that 55-95% of 
women in drug treatment facilities were sexually abused as children (Kumpfer, 
Smith, and Summerhays, 2008).
 Three theories seek to explain the relationship between assault and 
trauma and substance use. First, women with substance use problems may be 
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more vulnerable to assault because of the lifestyle associated with substance use, 
impaired ability to detect predators, and increased likelihood of engaging in high-
risk behaviors. In support of this idea, it was found that hard drug and marijuana 
users are 5.06 and 1.46 times more likely to be assaulted, respectively. The second 
theory is that assault leads to substance use to cope with PTSD or other mental 
health problems stemming from a traumatic incident. Drugs may quickly reduce 
negative emotions and allow for an escape from the situation. Third, substance 
abuse and assault may have a reciprocal or “vicious cycle” relationship, in which 
assault increases the likelihood of substance abuse, which in turn leads to further 
assault and trauma and the need to continue using drugs (Kilpatrick, Acierno, 
Resnick, Saunders, & Best, 1997).
Eating disorders
 Eating disorders have long been associated with alcohol and drug abuse. 
This co-morbidity is particularly pronounced in women suffering from bulimia 
nervosa and bulimia behaviors; studies estimate that 20-40% of women with 
bulimia have a history of alcohol and drug abuse (Holderness, Brooks-Gunn, & 
Warren, 1994; Conanson, Kolmek, & Sher, 2006). In a study of drug use among 
women with eating disorders, patients with bulimia nervosa were more likely to 
have used alcohol, amphetamines, barbiturates, marijuana, tranquilizers, and 
cocaine than women with anorexia nervosa, and women with binge eating disorder 
were more likely to use tranquilizers (Wiederman & Pryor, 1996). However, while 
women with anorexia nervosa are less likely to use substances than women with 
bulimia, approximately 7-23% of patients abuse alcohol or illicit drugs; most often 
substances that will promote thinness, such as amphetamines or cocaine, which 
suppress appetite and increase metabolism (Krahn, 1991; Wiederman & Pryor, 
1996; Kumpfer, Smith, and Summerhays, 2008).
 A few theories exist regarding the co-morbidity of substance abuse and 
eating disorders. First, there are personality traits that strongly correlate with 
eating disorders and drug use. Impulsivity is linked to both bulimia and binge 
eating disorder, as well as to substance abuse. There may also be an underlying 
predisposal to addiction, in which individuals who develop an addiction to one 
substance or behavior are more vulnerable to developing another. Females 
with a ruminative response style or with “the tendency to repetitively focus on 
symptoms of distress and possible causes and consequences of these symptoms 
without engaging in active problem solving,” have an increased risk of bulimia and 
substance abuse, as the behaviors may help avoid self-directed ruminations (Watts 
& Ellis, 1992; Conanson et al., 2006; Holderness et al., 1994; Nolen-Hoeksema, 
Stice, Wade, and Bohon, 2007).
 Second, eating disorders and substance use may be forms of self-
medication and coping mechanisms for women with depression, anxiety, guilt, or 
difficulty with family or peers. In some cases, the initial substance use or eating 
disorder may arise from these difficulties, while in others substance use may begin 
to escape the depression and anxiety brought about from an eating disorder. 
While substance use is more typically used as a form of self-medication, eating 
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disordered behaviors can provide a psychological release, despite their self-
destructive nature (Watts & Ellis, 1992; Conanson et al., 2006; Holderness et al., 
1994).
 Third, social factors and family are thought to play a role. Family and 
peer group attitudes toward alcohol, drugs, food, and body weight directly impact 
substance abuse and eating disorders. Families of women with anorexia tend 
to be more dysfunctional than those without eating disorders, and many first-
degree relatives of women with eating disorders have addiction, affective or eating 
disorders as well, possibly indicating a genetic basis for these problems (Watts & 
Ellis, 1992; Conanson et al., 2006; Holderness et al., 1994, Krahn, 1991).
 The ATHENA (Athletes Targeting Healthy Exercise and Nutrition 
Alternatives) Program is designed to prevent both eating disorders and substance 
abuse, and is delivered to female high school athletes. The curriculum is led by 
coaches and student leaders, and delivered during normal team practices. The 
program seeks to address issues such as depression and societal pressures to 
be thin, and to increase self-esteem, and promote healthy norms. It also includes 
discussions of media messages for cigarettes and alcohol. Though short-term 
findings found ATHENA only to be helpful for decreasing disordered eating and use 
of diet pills and drugs, long-term findings (1-3 years after high school graduation) 
indicated that the beneficial behavioral outcomes increased over time. The effects 
on positive body image continued, and intervention participants had significantly 
less marijuana use, cigarette use, and alcohol use (Elliot, Goldberg, Moe, 
DeFrancesco, Durham, and McGinnis, et al., 2008). Unfortunately, the ATHENA 
program is fairly unique; more programs that address prevention of both eating 
disorders and substance use are needed (Kumpfer, Smith, and Summerhays, 
2008).
Conclusions
 This chapter has shown that prevention must take into account gender-
specific needs in order to be effective. Though doing so can often be uncertain 
and difficult, it is sure to reap rewards and save resources for governments and 
families alike.
84
Biglan, A., Ary, D. V., Smolkowski, K., Duncan, T., & Black, C. (2000). A randomized 
controlled trial of a community intervention to prevent adolescent tobacco use. Tobacco 
Control, 9:24-32.
Bränström, R., Sjöström, E., & Andréasson, S. (2007). Individual, group, and 
community risk and protective factors for alcohol and drug use among Swedish 
adolescents. European Journal of Public Health, 18(1):12-18.
Campbell, J. C. (2002). Health consequences of intimate partner violence. The Lancet, 
359(9314):1331-1336.
Catalano, S. (2012). Intimate partner violence: 1993-2010. Washington, DC: Bureau of 
Justice Statistics. Available at: http://www.bjs.gov/content/pub/pdf/ipv9310.pdf
Conanson, A. H., Klomek, A. B., & Sher, L. (2006). Recognizing alcohol and drug abuse 
in patients with eating disorders. Quarterly Journal of Medicine, 99:335-339.
Cuijpers, P. (2003). Three decades of drug prevention research. Drugs: Education, 
Prevention, and Policy, 10(1):7-20.
Elliot, D. L., Goldberg, L., Moe, E. E., DeFrancesco, C. A., Durham, M. B., & McGinnis, 
W., et al. (2008). Long-term outcomes of the ATHENA (athletes targeting healthy 
exercise and nutrition alternatives) program for female high school athletes. Journal of 
Alcohol and Drug Education, 52(2):73-92.
European Monitoring Centre for Drugs and Drug Addiction (2006). A gender 
perspective on drug use and responding to drug problems. Lisbon: European Union.
Graham, J. W., Johnson, C. A., Hansen, W. B., Flay, B. R., & Gee, M. (1990). Drug use 
prevention programs, gender, and ethnicity: Evaluation of three seventh-grade Project 
SMART cohorts. Preventive Medicine, 19(3):305-313.
Griffin, K. W., Scheier, L. M., Botvin, G. J., & Diaz, T (2000). Ethnic and gender 
differences in psychosocial risk, protection, and adolescent alcohol use. Prevention 
Science, 1(4):199-212.
Harden, A., Oakley, A., & Oliver, S. (2001). Peer-delivered health promotion for young 
people: A systematic review of different study designs. Health Education Journal, 
60(4):339-353.
Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992). Risk and protective factors for 
alcohol and other drug problems in adolescence and early adulthood: Implications for 
substance abuse prevention. Psychological Bulletin, 112(1):64-105.
Holderness, C. G., Brooks-Gunn, J., & Warren, M. P. (1994). Co-morbidity of eating 
disorders and substance abuse: Review of the literature. International Journal of Eating 
Disorders, 16(1):1-34.
References
85
Johnson, C. A., Pentz, M., Weber, M. D., Dwyer, J. H., Baer, N., & MacKinnon, D. P., et 
al. (1990). Relative effectiveness of comprehensive community programming for drug 
abuse prevention with high-risk and low-risk adolescents. Journal of Consulting and 
Clinical Psychology, 58(4):447-456.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring 
the Future national survey results on drug use, 1975-2010: Volume I, Secondary school 
students. Ann Arbor: Institute for Social Research, The University of Michigan.
Kilpatrick, D. G., Acierno, R., Resnick, H. S., Saunders, B. E., & Best, C. L. (1997). A 
2-year longitudinal analysis of the relationships between violent assault and substance 
use in women. Journal of Consulting and Clinical Psychology, 65(5):834-847.
Krahn, D. D. (1991). The relationship of eating disorders and substance abuse. Journal 
of Substance Abuse, 3:239-253.
Kulis, S., Yabiku, S. T., Marsiglia, F. F., Nieri, T., & Crossman, A. (2007). Differences 
by gender, ethnicity, and acculturation in the efficacy of the Keepin’ it REAL model 
prevention program. Journal of Drug Education, 37(2):123-144.
Kumpfer, K. L., Smith, P., & Summerhays, J. F. (2008). A wakeup call to the prevention 
field: Are prevention programs for substance use effective for girls? Substance Use and 
Misuse, 43:978-1001.
Longshore, D., Ellickson, P. L., McCaffrey, D. F., & St. Clair, P. A. (2007). School-based 
drug prevention among at-risk adolescents: Effects of ALERT plus. Health Education 
and Behavior, 34:651-668.
Midford, R. (2009). Drug prevention programmes for young people: Where have we 
been and where should we be going? Addiction, 105:1688-1695.
Miller, T., & Hendrie, D. (2008). Substance abuse prevention dollars and cents: A cost-
benefit analysis, DHHS Pub. No. (SMA) 07-4298. Rockville, MD: Center for Substance 
Abuse Prevention, Substance Abuse and Mental Health Services Administration.
Nolen-Hoeksema, S., Stice, E., Wade, E., & Bohon, C. (2007). Reciprocal relations 
between rumination and bulimic, substance abuse, and depressive symptoms in female 
adolescents. Journal of Abnormal Psychology, 116(1):198-207.
Norman, E. (1997). New Directions: Looking at psychological dimensions in resiliency 
enhancement. Drug-free youth, 73-93.
O’Neil, A. L. (2011). Gender Equality and the Empowerment of Women in the UN 
Millennium Development Goals. Presentation given at the Drug Abuse Warning Network 
Conference, March 2-4 2011, Rome.
Palinkas, L. A., Atkins, C. J., Miller, C., & Ferreira, D. (1996). Social skills training for 
drug prevention in high-risk female adolescents. Preventive Medicine, 25(6):692-701.
Pentz, M. A. (2000). Preventing drug abuse through the community: Multicomponent 
programs make the difference. Putting research to work for the community (NIDA 
Publication No. 98-4293, 73-86.
86
Perry, C. L., Komro, K. A., Veblen-Mortenson, S., Bosma, L. M., Farbakhsh, K., and 
Munson, K. A. et al. (2003). A randomized controlled trial of the middle and junior high 
school DARE and DARE plus programs. Archives of Pediatrics and Adolescent Medicine, 
157(2):178-184.
Presidenza del Consiglio dei Ministri: Dipartimento Politiche Antidroga (2009). 
Project DAWN: Drugs and Alcohol Women Network: Summary. Application of the Fifth 
National Conference on Drug Policy: Trieste.
Rohrbach, L. A., & Milam, J. (2003). Gender issues in substance abuse prevention. In 
Handbook of Drug Abuse Prevention: Theory, Science, and Practice, Eds. Z. Sloboda 
and W. J. Bukoski. New York: Kluwer Academic, p. 351-363.
Schinke, S. P., Fang, L., & Cole, K. C. (2008). Substance use among early adolescent 
girls: Risk and protective factors. Journal of Adolescent Health, 43(2):191-194.
Schinke, S. P., Fang, L., & Cole, K. C. (2009). Computer-delivered, parent-involvement 
intervention to prevent substance use among adolescent girls. Preventive Medicine, 
49:429-435.
Schinke, S., & Schwinn, T. (2005). Gender-specific computer-based intervention for 
preventing drug abuse among girls. American Journal of Drug and Alcohol Abuse, 
31(4):609-616.
Svenson, G. (1998). European guidelines for youth AIDS peer education. Malmö: 
Department of Community Medicine, Lund University & European Commission.
Tolli, M. V. (2012). Effectiveness of peer education interventions for HIV prevention, 
adolescent pregnancy prevention and sexual health promotion for young people: A 
systematic review of European studies. Health Education Research, 27(5):904-913.
Turner, S., Norman, E., & Zunz, S. (1995). Enhancing resiliency in girls and boys: A 
case for gender specific adolescent prevention programming. The Journal of Primary 
Prevention, 16(1):25-38.
Turner, G., & Shepherd, J. (1999). A method in search of a theory: Peer education and 
health promotion. Health Education Research, 14(2):235-247.
Watts, W. D., & Ellis, A. M. (1992). Drug abuse and eating disorders: Prevention 
Implications. Journal of Drug Education, 22(3):223-240.
Weiss, F. L., & Nicholson, H. J. (1998). Friendly PEERsuasion against substance use: 
The girls incorporated model and evaluation. Drugs and Society, 12(1-2):7-22.
Wiederman, M. W., & Pryor, T. (1996). Substance use among women with eating 
disorders. International Journal of Eating Disorders, 20(2):163-168.
87
Gender differences in the 
effectiveness of the “Unplugged” 
prevention programme
Federica Vigna-Taglianti (1), Rosaria Galanti (2)
(1) Department of Clinical and Biological Sciences, University of Torino, Italy
Piedmont Centre for Drug Addiction Epidemiology, ASL TO3, Torino, Italy
(2) Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden,Centre for 
Epidemiology and Community Medicine, Stockholm Health Care District
 “Unplugged” is a social influence school-based curriculum for the 
prevention of tobacco, alcohol and drug use among adolescents, developed in the 
framework of the European Drug Abuse Prevention study in 2003. The study was 
funded by the European Community Public Health Program and involved more 
than 7,000 pupils of seven European countries between 2004 and 2007.
 The effectiveness of the curriculum was evaluated through a cluster 
randomized trial taking place simultaneously in Austria, Belgium, Germany, 
Greece, Italy, Spain and Sweden. Schools were selected on the basis of 
inclusion criteria and of willingness to cooperate, and randomly assigned to 
either intervention or control group. An anonymous self-completed questionnaire 
investigating substance use and personal and social skills, together with other 
individual and family characteristics was administered at the beginning of the 
school year and approximately 3 months after the end of the program (Faggiano, 
2007).
 The intervention took place during the 2004-2005 school year and consisted 
in a 12-sessions standardized curriculum named “Unplugged”, based on Social 
Influence model (van der Kreeft 2009). The program was taught by class teachers 
using interactive techniques and aimed to develop and enhance interpersonal 
skills (group dynamics, assertiveness, problem solving, creative thinking and 
self control), and intrapersonal skills (verbal and nonverbal communication, 
expression of negative feelings, coping skills). Sessions on normative education 
and information on effects of smoking and drug use were also provided.
Effectiveness of the intervention
 The effectiveness of the intervention was investigated performing 
multilevel regression models taking into account the hierarchical structure of the 
data, the differences in prevalence of substance use between countries, and the 
baseline differences between control and intervention pupils. The study sample 
at baseline consisted of 7079 students (3532 in control schools and 3547 in 
88
intervention schools). The analytical sample for effectiveness analysis consisted of 
6370 students who participated at both the baseline and the first follow-up survey. 
Program effects were found for daily cigarette smoking, sporadic and frequent 
episodes of drunkenness, and cannabis use (Faggiano 2008).
 Gender stratified analysis showed gender differences in the effectiveness 
of the program. In this chapter, we provide a synthesis of gender differences in 
Unplugged effectiveness as published in a specific publication which we refer for 
further details on methods and results (Vigna-Taglianti 2009).
Table 1. Behaviours and attitudes at baseline, by gender
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Gender differences at baseline
 The analysis of the baseline survey conducted on October 2004 showed 
some gender differences in use behaviours and attitudes (Table 1).
 At enrolment, boys were more likely than girls to have used cannabis 
(4.2% vs 2.4%, p<0.001) and illicit drugs (5.6% vs 4.1%, p=0.005) at least once 
in the past 30 days, while girls had a higher prevalence of any cigarette smoking 
in the past 30 days (15.9% vs 12.7%, p<0.001). The proportion reporting recent 
episodes of drunkenness was slightly higher among males, but the difference was 
not statistically significant (6.5% vs 5.4%, p=0.07).
 At baseline, a lower proportion of girls scored high on a positive self-
esteem score (83.2% vs 87.7%, p<0.001). No appreciable gender differences 
were observed concerning positive expectations towards smoking, while boys 
endorsed more often than girls positive expectations towards alcohol (“feel 
relaxed”: 21.2% vs 18.5%, p=0.008, “become more popular”: 17.3% vs 14.7%, 
p=0.005) and cannabis (“feel relaxed”: 41.8% vs 37.5%, p=0.001, “become more 
popular”: 21.4% vs 18.6%, p=0.006).
Gender differences in the effectiveness of the 
program
 A graphical representation of Unplugged effects on daily smoking, 
drunkenness episodes and cannabis use among boys and girls is provided in 
Figure 1, 2 and 3.
 On the follow-up survey conducted three months after the completion of 
the experimental school curriculum, significant program effects were observed 
among boys both for daily smoking (32% reduction of frequent smokers, 51% 
of daily smokers), drunkenness episodes (36% reduction of any episodes), and 
cannabis use (38% reduction of any cannabis users, 40% of frequent users).
 Among girls, there was an indication of decreased risk of sporadic and 
frequent drunkenness, but the estimates did not attain the statistical significance. 
As shown in the figures, no effect of the program on tobacco smoking and cannabis 
use was detected among girls, with almost equal prevalence of use among girls of 
intervention and control classes.
 These gender differences were found in all countries, and were maintained 
after exclusion of current users at baseline.
Differences of transitions by stages of use
 Gender differences were found also in the transition patterns between 
different stages of substance use. Among boys, the proportion of pupils progressing 
to more advanced stages of smoking was lower among those who received the 
experimental curriculum compared to controls, while the proportion regressing 
was higher. Among girls a similar but less pronounced pattern was observed. Daily 
smokers were not affected by the intervention in either gender, but among girls 
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Figure 1. Effect of Unplugged on daily smoking among boys and girls
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Figure 2. Effect of Unplugged on drunkenness episodes among boys and girls
Figure 3. Effect of Unplugged on cannabis use among boys and girls
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a higher proportion of the control group regressed from daily use, compared to 
the intervention group. Similar patterns emerged in the use of other substances: 
delayed progression and enhanced regression were higher in the intervention 
group among boys, while no, minimal or reverse differences were observed among 
girls.
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Influence of self-esteem
 When the gender-specific estimates of program effect were analysed in 
separate strata of the self-esteem indicator, some differences emerged although 
based on not statistically significant estimates. Among boys, level of self-esteem 
did not substantially affect the curriculum effect. On the contrary, among girls, the 
program was rather associated to a tendency towards unfavourable effect in the 
low self-esteem group.
Influence of age
 When the gender-specific estimates of program effect were analysed by 
age, an indication of risk reduction for girls exposed to the experimental curriculum 
compared to controls was found for all the indicators of smoking and drunkenness, 
among girls in the youngest age group (11-12 years at baseline).
 Among boys, program effects were similar in both age groups for 
drunkenness, cannabis an illicit drugs use, but for smoking that was more affected 
by the program in the oldest age group (13-18 years at baseline).
Summary and conclusions
 In a multi-national sample of European students we found pronounced 
gender differences in substance use behaviours and in the effectiveness of a 
social influence school-based prevention curriculum. These differences indicated 
a higher use of cannabis and illicit drugs among boys and a higher prevalence of 
cigarette smoking among girls. A greater preventive potential of the curriculum was 
found among boys.
 Differences in prevalence of tobacco, alcohol and substance use among 
adolescent boys and girls are well documented (EMCDDA 2006, Degenhardt 
2008). Differences in the effect of prevention programs among boys and girls have 
been recently underlined, but the direction of the differences is still unclear. Our 
finding was somewhat unexpected, since programs based on the enhancement 
of social skills are generally considered more effective, if anything, among girls 
than among boys (Blake 2001). However, when only school-based social influence 
interventions are examined, the evidence is actually rather mixed, with results 
in favour of boys in the Oslo Youth Study (Klepp 1993), North Karelia Youth 
Programme (Vartiainen 1998), and Project Towards No Drug Abuse (Sussman 
2003), and in favour of girls in Project SMART (Graham 1990) and ALERT Plus 
(Longshore 2007).
 Some explanations for the gender differences observed in our study can 
be hypothesized. First, the developmental stage in terms of general life skills 
and coping mechanisms may differ between genders, given an attained age 
(Amaro 2001, Hess 1999), with acquisition of skills and competences still being 
susceptible to modifications among boys, less so among girls. In fact, girls must 
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cope with puberty-related social and emotional changes at an earlier age than boys 
(Hess 1999). Consistently, we found indications that the program may have been 
effective among very young girls (11-12 years old), while the effectiveness among 
boys did not differ by the age-range of the study. Although caution is needed when 
interpreting these results, due to lack of statistical significance, previous studies 
support the conclusion that most programs based on skill enhancement achieve 
better results among girls when administered at young ages (Blake 2001, Kumpfer 
2008). Moreover, a replication of the EU-Dap trial in five East European countries 
using the same curriculum, and taking place in 2009-2010 school year among 
11-13 years old pupils, did not find gender differences (unpublished results), 
strengthening the hypothesis of no difference in effectiveness at an earlier age. 
A second possible explanation is that boys and girls may differ in moderators of 
programs’ effects such as personality characteristics. In our study, self-esteem 
modified the program’s effectiveness in the two genders, with girls with low self-
esteem having the least benefit from the program. A differential gender effect 
linked to self-esteem is not surprising. In fact, there is some evidence that lack 
of self-esteem can be a stronger risk factor for drug use among girls than among 
boys (Crump 1997, Amaro 2001). Theoretical models suggest that girls are more 
influenced by family protective factors, while boys are more influenced by school 
or community environment (Sale 2003). Among girls, self-esteem is strongly 
dependent on a positive relationship with parents (Kumpfer 2008).
 The emphasis on self-esteem is justified by the fact that this is not a key 
element of social influence programs, that focus on normative beliefs and on social 
and personal skills. It is therefore possible that the Unplugged curriculum, heavily 
relying on the development of social skills, was not able to deal with lack of intra-
personal traits, such as self-esteem.
 In conclusion, our findings suggest that school curricula based on 
comprehensive social influence against substance misuse may perform differently 
among girls and boys, possibly due to developmental and personality factors. 
When developing new prevention programs, gender-specific components should 
always be considered in order to reduce disparity of effects between boys and 
girls. Moreover, results of gender stratified analysis should be taken into account 
when applying prevention interventions on a large scale, e.g. anticipating their 
delivery in early grades of the compulsory school.
 Finally, given the inconsistent results observed in the literature, gender 
differences become an important issue in all intervention studies. In fact, if 
a sensitive subgroup exists, this is not only important to guide the program’s 
application, but it may also cast light on the mechanisms of the program effect.
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Introduction
 The consumption of psychotropic substances, legal or illegal, is a wide 
social-health problem, which can considerably affect the lives of people. As reported 
by many scholars, the use of these substances may affect many aspects of health, 
for example the growth of children and adolescents, the general health status and 
the life quality, and may also have important socio-economic consequences [1].
 The consumption of illegal drugs is a widespread phenomenon especially 
in the youth age group and is often associated with other dangerous behaviour (e.g. 
alcohol consumption, cigarette smoking, dangerous driving, antisocial behaviours, 
etc.), with a consequent increase in the likelihood of causing harm to the health [2].
In Europe, the monitoring of the consumption of psychotropic substances 
constitutes the starting point for the planning of further intervention studies and the 
completion of the cognitive profile of young populations, which are necessary for 
the definition and orientation of new and effective counter-actions [3].
 In Italy the population-based study on student drug use started in 2000, and 
was carried out on an annual basis in all the classes of secondary schools. The Italian 
study presents some peculiarities, largely attributable to two aspects: the annual 
repetition of the study, able to meet the information needs of the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) [4], and the extent of the study to the 
entire student population in secondary school (15-19 years old), unlike the European 
survey [5], which is limited to the age group between 15 and 16 years old.
 The overall purpose of the drug consumption survey in the student 
population between 15 and 19, is to monitor the phenomenon over time, both 
in quantitative terms (prevalence of drugs consumption) and in qualitative terms 
(characteristics of psychotropic substances users). The adoption of standard 
protocols allowed the pursuit of a second goal, no less important than the first, 
which concerns the comparison of the data on the consumption of tobacco, alcohol 
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and other illicit substances among the school population at the national level, with 
the results obtained in other European countries adopting the same standard 
protocols [6].
 The large sample size of the students interviewed, for each age, allowed 
in-depth analyses according also to the gender. Several studies have shown, in 
fact, that there are a lot of differences between males and females concerning 
drug use [2, 6-18]. As shown by many studies, this phenomenon involves mainly 
males, probably because of the greater susceptibility to get involved with and 
to try new experiences, but also generally highlighting that teenage drug use, 
for both males and females, increases with age [6, 11-12, 14, 18-20]. Many 
studies show that young people have an understandable preference for the use 
of cannabis, which is the most widely used substance of all, especially among 
males [6, 11, 13, 16, 18]. On the other hand, young female students prefer the 
consumption of tranquillizers or sedatives without medical prescription, with an 
estimated average consumption, at least once in their lifetime, equal to 8%, at 
the European level in 2011 [6, 11]. In general, the people with whom students 
take drugs for the first time seem to be friends in the case of the male gender, 
and partners in the case of the female gender [7-9].
 A study conducted among Spanish and Portuguese adolescents 
showed that a satisfactory relationship with family members, friends, classmates 
and teachers may have protective effects against substance consumption by 
adolescents [14]; a finding that was also confirmed by a study conducted on 
a sample of 1,090 students in Milan [18]. The main risk factors for drug abuse 
seem to be, instead, friends who take illegal drugs [14,15], and alcohol abuse 
[17].
 In this respect, it becomes essential for the effectiveness of prevention and 
intervention strategies, which currently tend to ignore gender differences, to learn 
more about the different motivations and risk factors that drive the adolescents, 
male and female, towards the use of psychotropic substances. Based on this aim 
and on the data collected through the 2012 Italian survey on drug abuse among 
the student population [3], the behaviour and the characteristics of students aged 
15 to 19 have been investigated, identifying all the possible risk factors for the 
consumption of illicit substances, individually for males and females.
Methods
Study design
 A two-stage probabilistic sampling method was implemented, according 
to which the first stage units are represented by the high schools and the second 
stage units by classes of students (all ages); for each class the students were 
selected according to a cluster sampling. The adopted sampling structure allows 
prevalence estimates for single ages, genders and single geographical areas 
(north-west, north-east, centre, south/islands). The selection of the first stage units 
was carried out in a proportionate way according to the region and the type of 
the institute (secondary school or high school formally specializing in education, 
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polytechnic institute, vocational institute, arts academy), assuming that the 
morphological characteristics of the different geographical areas and the different 
types of school may affect the prevalence of substance use [3].
 This sampling procedure allows, on the one hand, to obtain a sample 
structure that faithfully reproduces the real student population under study, and 
on the other hand, to substantially improve the efficiency of the sampling method 
[21]. In this case, in fact, since the groupings identified in the population are 
characterized by a lower variability than that of the total population, the precision 
of the estimates will be higher. The calculation of the estimates precision for each 
single stratum was obtained, like in the case of the total sample, using the sample 
size of the considered stratum [3].
Data collection
 The instrument applied in this study is based on the international protocol 
adopted by the ESPAD (European School Survey Project on Alcohol and Other 
Drugs) study, which in 2011 involved 35 European countries [5]. The questionnaire, 
administered during the first semester of 2012, is divided into several sections, 
each of which aims to collect information on different aspects, such as habits, 
behaviours, use of psychotropic substances and family characteristics of the 
respondents. The questionnaire was completed online through a specific web 
site, after assigning anonymous usernames and passwords to each student. 
This web site also includes more detailed information on the organization and the 
implementation of the survey.
Data analysis
 In order to investigate the characteristics of young people aged between 
15 and 19 years, some descriptive statistical analyses have been conducted 
regarding the habits and the behaviours, the interpersonal relationships with their 
family and friends, the self-esteem and the psychotropic substances consumption 
(i.e. cigarette smoking, alcohol and illegal drugs use). In order to assess the 
presence of statistically significant differences between genders, the Student T 
tests were used to analyze continuous variables and the Pearson Chi-Square 
test (χ2) was used to analyze categorical variables. If they were not applicable, 
analogous non-parametric tests were used (Wilcoxon’s rank-sum test or Fisher’s 
exact test).
 The estimation of the risk factors of psychotropic substances consumption 
in males and females was assessed using a logistic regression model. The 
covariates included in this model, were selected using a univariate analysis using 
the Pearson Chi-Square test (χ2). Through the logistic regression model, the 
estimate of the Odds Ratio (OR) was possible, which expresses how many times 
the presence of the risk factor examined, increases the likelihood for a subject to 
be a drug user.
 All the statistical analyses were implemented using the SPSS statistical 
software [22], release 18.0. A p-value<0.05 was used to establish statistical 
significance.
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Results
Characteristics of the sample
 The survey involved 35,980 students attending 490 schools throughout the 
national territory, evenly distributed by age (about 20% for each age investigated) 
and gender (50.0% females and 50.0% males). 39.2% of the students interviewed 
attend schools of the southern and insular part of Italy, 27.4% go to schools in the 
Northwest, 16.5% in the schools of the Northeast, while 16.8% are students of the 
schools of the central Italy (Table 1). There have been no significant differences 
between the distributions by geographical area and gender.
 Regarding the habits and the behaviours of teenagers interviewed it 
was found that, on weekly basis, females between 15 and 19 years read more 
than males (9.8% vs. 20.4%, p-value<0.001), play with the computer for fun 
less that males (68.0% vs. 38.1%, p-value<0.001), play with the slot machines 
or video poker less than males (5.1% vs. 1.7%, p-value<0.001), practice sport 
less than males (64.0% vs. 41.0%, p-value<0.001) and go out in the evening 
during the week less frequently than males (39.2% vs. 30.0%, p-value<0.001) 
(Table 2). Moreover, a lower percentage of females than males asserted to 
have missed two or more days of school due to lack of will (22.0% vs. 19.9%, 
p-value<0.001).
Table 1. Distribution of the socio-demographic characteristics of the students, by gender
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Table 2. Distribution of the habits, the behaviours and the interpersonal relationships of the students, 
by gender
 Concerning the interpersonal relationships, it was found that females 
are more dissatisfied with the relationship with their parents than males, both 
with their mother (5.1% vs. 7.1%, p-value<0.001) and with their father (7.3% 
vs. 11.3%, p-value<0.001); moreover females are more dissatisfied than males 
with their relationships with classmates (6.2% vs. 8.6%, p-value<0.001) (Table 
2). Confirmation of this result can be found in a study of 1,589 Portuguese 
adolescents and 4,191 Spanish students: females have more conflicts in 
relationships with peers, are more vulnerable to rejection, and may be more 
sensitive to the influences of their peers than males [14]. An almost equivalent 
level of dissatisfaction, however, is perceived in the relationships with friends, 
even if not statistically significant (3.7% for males and 4.0% for females, 
p-value=0.237).
 Moreover, regarding the feelings that students have about themselves 
(Table 2), females are characterized by a less positive idea about themselves than 
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males: 17.8% of the females, in fact, assert to not be satisfied with themselves 
against 8.4% of males (p-value<0.001). The majority of females (51.1%) believes 
to be useless, unlike the 39.7% of males (p-value<0.001); furthermore 21.1% of 
females, stated to have a negative attitude towards themselves against 10.7% 
of males (p-value<0.001). In addition, with reference to the last 7 days, females 
affirm to feel more depressed and sad compared to males (9.0% males vs. 19.5% 
females and 15.8% males vs. 33.7% females, respectively - p-values<0.001).
 On the contrary, males adolescents seem to be more involved in dangerous 
behaviours than female peers: 10.1% of males are involved in fights at school or 
at home against 2.9% of females (p-value<0.001), and males cause purposely 
damage at school or at public places (parks, roads, etc.) more than females (6.2% 
vs. 1.5%, p-value<0.001).
Characteristics of legal and illegal psychotropic 
substance users
 37.9% of the students interviewed stated they have smoked in the last 
30 days, this phenomenon involves more males than females (38.8% vs. 37.0%, 
p-value<0.001); moreover, females smoke quantitatively fewer cigarettes than 
Table 3. Tobacco and alcohol consumption, by gender
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males (Table 3). In fact, over the past 30 days, 41.1% of males claim to have 
smoked more than six cigarettes per day, while this quantity is consumed by 
34.1% of females (p-value<0.001).
Comparing the consumption of cigarettes by age, it can be noticed that the 16 
year old females smoke more than peer males (32.4% vs. 35.1%, p-value=0.015), 
while, among students aged 18 and 19 years, males smoke the highest number 
of cigarettes (47.0% males vs. 42.9% female, p-value<0.001 and 49.1% males 
vs. 42.7% females, p-value<0.001, respectively).
 Concerning the consumption of alcoholic beverages, a greater number of 
males claim to have been drunk and to drink more frequently than females; this 
behaviour is highlighted with statistically significant differences (p-value<0.001), 
also for age. The same trend was observed in a study conducted on a sample 
of 1,090 students in Milan (Italy), in which there were statistically significant 
differences between gender and between the different age groups, with respect to 
the alcohol consumption (p-value=0.003 and p-value<0.0001, respectively) [18].
Table 4. Illegal substances consumption in the last 12 months and people with whom the first use of 
substances is experienced, by gender
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 Looking at the alcohol consumption in the last month, the difference 
between males and females is significant: 17.7% of males stated to have drunk 
more than 10 times compared to 8.5% of females (p-value<0.001) (Table 3).
 The consumption of at least one illegal substance in the last 12 months 
is reported by approximately 20% of all students interviewed, with a higher 
prevalence of males than females (24.2% vs. 16.2%, p-value<0.001). The same 
trend is observed within each age (p-value≤0.005), where it can be noticed 
that the drug consumption is higher for males than females. In general, for all 
the analysed illegal drugs, greater prevalence of consumption in males than in 
females is observed (Table 4).
 The illicit drug mostly taken by the students interviewed is cannabis 
(marijuana or hashish): 23.1% of males asserted they have tried it at least once in 
the last 12 months against 15.2% of females (p-value<0.001). At the same time, 
females between 15 and 19 years seem less interested in the use of cocaine 
than males: 2.1% of the males shows to have taken cocaine at least once in the 
last year compared with 1.0% of female students (p-value<0001).
 The consumption of tranquilizers or sedatives characterizes especially 
the younger female students (Table 4): the use of this drug without a medical 
prescription, over the last 12 months, is stated by 2.4% of females compared to 
1.1% of males (p-value<0.001).
 With regard to the people with whom the first use of illegal substances 
occurs, friends are of primary importance, both for males and females (81.3% 
vs. 77.2%, p-value<0.001). Unlike males, females stated that the partner plays 
a crucial role in relation to the first use of psychotropic drugs (1.9% vs. 7.9%, 
p-value<0.001). For males, on the contrary, there is the greater tendency 
to experiment an illegal substance for the first time alone (5.7% vs. 4.5%, 
p-value=0.021) (Table 4).
 The poly-drug use of psychoactive substances, legal and illegal, is 
becoming the most popular and prevalent style of consumption among students 
and young people. In the case of adolescents, some studies have shown 
that around this way of drug consumption an out-and-out “culture” has been 
developed, in which substances are taken in a particular order, quantity and 
context, depending on the effects sought by the drug users [20]. Concerning 
students who asserted to have taken more than one substance in the last 30 
days (of which at least one illegal), it can be noticed that the most common 
combination of substances is alcohol, tobacco and cannabis: 64.0% of males 
stated to have used these substances, while this percentage drops to 62.6% for 
females, without a statistically significant difference (p-value=0.315) (Table 5). 
The combination of more than three substances was the second most frequent 
modality of poly-drug users: 15.4% of males and 13.9% of females claimed to 
have consumed three or more drugs in the 30 days preceding the interview, also 
in this case without a statistically significant difference (p-value=0.146). 
 Moreover, analyzing the poly-drug phenomenon with regard to the age 
of the students, it can be observed that, for each age, this phenomenon involves 
mainly males than females (p-value<0.001 for young people aged 16 and over), 
with an increasing trend (Table 5)
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Risk factor analysis
For both genders, in order to estimate the risk factors of drug abuse, statistically 
associated with the consumption of illegal substances, the covariates selected for 
the logistic regression model were the following:
 ●  the number of days in which young people go out in the night (disco, 
bars, parties, etc.);
 ●  the number of days in which teenagers play with slot machines or video 
poker and similar;
 ●  school days lost due to lack of will;
 ●  the number of times, considering the lifetime period, the students are 
drunk;
 ● the presence of friends/siblings who use substances;
 ● the satisfaction with the relationship with parents;
 ● the lack of precise rules regarding the behaviour outside their own home;
 ●  the parents knowledge about the places where their children spent 
Saturday night;
 ● the amount of money spent without parental supervision;
 ● alcohol consumption during the 30 days preceding the interview.
 On the basis of the covariates selected for the multivariate analysis, two 
logistic regression models by gender were implemented, and the results are 
described in Table 6.
 The most important risk factor of drug abuse seems to be the presence 
of friends/siblings who use illicit drugs: male drug consumers have a 10.7-fold 
increase in the risk of psychotropic drugs consumption than those who did not 
know people who take drugs. Also for the females this risk is high and it is equal 
to 12.0 (Odds Ratio). In addition, the experience of drunkenness at least once 
in the students’ lifetime is a significant risk factor, more for females than males 
(OR=5.7 vs. OR=4.6, respectively), as well as the consumption of alcoholic 
Table 5. Poly-drug users, legal and illegal substances, in the last 30 days, by gender
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beverages during the 30 days preceding the interview (OR=2.0 for females vs. 
OR=1.8 for males).
 Concerning the interpersonal relationships with parents, the dissatisfaction 
is a risk factor for both genders: the OR is approximately 1.5 both for males and for 
females. The analysis shows also that the Odds Ratio for females whose parents 
have little knowledge about the places where they spent Saturday night is slightly 
higher than males (1.7 for females vs. 1.5 for males).
 Accuracy of the estimated logistic regression model was assessed using 
the Hosmer-Lemeshow test [23]: the value of this test for the females’ model is 
equal to 4.410 and the p-value equal to 0.818, while for the males’ model the 
test is 3.699 and its p-value is equal to 0.883. These values lead to accept, or 
at least not reject the null hypothesis (H0), for which there are no differences 
between the observed and the expected values. So, it can be concluded that the 
estimated models satisfactorily reflect the data.
 Finally, in order to complete the evaluation of these multivariate analyses, 
other validity measures, expressed in terms of probability, have been considered 
[24]. Sensitive and specific statistical measures evaluate the proportion of 
positive cases which are correctly identified as such (the true positive rate) and 
the proportion of negative cases which are correctly identified as such (the true 
negative rate), respectively.
 The analysis of the classification tables obtained from the estimated 
logistic regression models, lead to quite highly specific evaluations (84.8% for 
the females’ model and 80.4% for males) and satisfactory sensitivity evaluations 
(73.3% for females and 75.4% for males). Moreover, the percentage of cases 
correctly classified is quite high and equal to 82.5% for the logistic regression 
model estimated for female students and to 79.0% for the males’ model.
Table 6. Parameter estimates of the logistic regression model, by gender
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Discussion
 The results obtained from this study suggest giving a greater consideration 
to the degree of satisfaction of young people, especially of the females, with 
regards to themselves and their life [25]. A good level of satisfaction and resilience 
in life, constitute, in fact, a protective element against unhealthy behaviours such 
as the consumption of alcohol, tobacco and illegal drugs.
 The family context and the relationships with parents seems to be equally 
important, not so much in relation to the presence and strictness of the rules, 
but according to the quality of the relationships with adults with reference to their 
role. The parents’ lack of interest about the places frequented by their children 
and their friendships can be a signal for a possible use of drugs. It is well known 
that, in general, males are subject to a lower control and supervision by parents 
compared to females, and this can lead to a greater probability of being involved 
by disreputable friends, and to a possible use of illegal substances [19]. Also 
other studies show that teenagers who have unsatisfactory relationships with 
their parents are most driven towards substance abuse, increasing the risk of 
developing problematic behaviours [18].
 One additional consideration should be made with respect to the 
presence of psychological/psychiatric problems in the family context, also in 
relation to the inappropriate use of tranquilizers and sedatives. Use and abuse 
of tranquilizers and sedatives, both regularly prescribed by a doctor and used 
without a medical prescription, characterizes in fact to a greater extent the Italian 
young females. Confirmation of these results can also be achieved at European 
level: the 2011 ESPAD report on the use of psychoactive substances in the 36 
European participating countries, states that, on average, the tranquillizers and 
the sedatives without a medical prescription are mainly abused by females (8% 
for females vs. 5% for males, 15-16 year olds) [6]. Also the report of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA), published in 2005, 
compares the consumption of substances by gender, stating that among the 
secondary school students (15-16 years old) the consumption of tranquilizers 
and sedatives is higher among the female students in all the European Union 
countries, with the exception of 4 Member States (Cyprus, Ireland, Norway and 
the UK). [11]
 The inability of some females to solve their personal or family problems 
could be the gateway to the use of illegal substances. Specifically for females, 
more attention should be paid to the meaning and the value of their relationship 
with their partner, especially because of the central role that the boyfriend has in 
their first contact with psychotropic substances. The scientific studies confirm the 
results obtained in our study; in particular, the survey by Giusti et al. on 105 treated 
adolescents between 10 and 17 years of age [7], shows that, for both genders, the 
first contact with illegal drugs is carried out with peers (friends or classmates) for 
males, while for the females the partner plays a crucial role in the case of the first 
use of psychotropic substances.
 Furthermore, our study shows that for all the analysed illegal substances, 
higher prevalence of consumption is observed for males than females, a result 
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also confirmed by international scholars [6, 11-12, 14, 18-20]. In addition, the most 
commonly taken drug among the students interviewed is cannabis (hashish or 
marijuana), with an increasing prevalence among males in relation to the time 
periods considered (at least once in the life, at least once in the last year, at least 
one once in the last month). In Europe, it was found on average, that 21% of males 
between 15 and 16 years have experienced at least one illicit drug in their lifetime, 
compared with 15% of females [6]. Moreover, the majority of the young people who 
have experienced a drug have used cannabis, and this is more likely to happen 
among males than females [11].
 On the other hand, this study has some limitations. The main one is related 
to the self reported characteristic of the survey: since the main objective concerns 
the use of drugs, there may be an underestimation of some behaviours, for which 
the percentages of consumption may be biased. These aspects have been widely 
discussed in literature [26], other studies have reported that the “underreporting 
reports are relatively minor” [27-28].
 Finally, even if the study involves both public and private schools, 
representing therefore the entire scholastic population, it does not encompass 
those leaving school, who are subjects that could potentially be at greater risk of 
drug consumption [29]. This limit is however obstructed by the investigation of all 
the age groups (15-19 years), considering that the dropping out of school is more 
common after the first two-year period [30].
Conclusion
 The female gender seems to be less vulnerable to the illegal drug 
consumption. Nevertheless, within it there is a group at risk: in our study we have 
identified some risk factors for drug consumption in the female gender that are 
mainly the presence of friends/siblings who use illegal drugs, the experience of 
drunkenness at least once in the student’s lifetime, the consumption of alcoholic 
beverages during the 30 days prior to the interview.
 For this reason it is important to continue with research and studies in order 
to increase and improve the knowledge and the understanding of the dangerous 
behaviours, focusing on the socio-relational aspects of the respondents, in order 
to better identify and implement best practices and models of prevention, providing 
some selective interventions aimed at those who, more than others, run the risk of 
becoming regular drugs users.
 Some examples of actions to be taken by parents, may be the intensification 
of family support, offering selected interpretations and tools in order to help the 
parent-child relationship and, in the cases of dangerous behaviour, intervene with 
actions of early detection. At the base of all the possible interventions which aim to 
prevent the use of psychotropic substances, a moderate but consistent discipline 
of the children and the presence of well-defined family rules stand out, that, when 
absent must be developed and supported in the family context.
 In addition to these primary actions, information and education on the 
psychotropic substances are needed in order to improve knowledge about the 
effects and damages of these drugs and give family the opportunity to discuss 
about the abuse of the legal and illegal substances.
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Introduction
 Before addressing the issue of prescription drugs, we consider worthwhile 
defining some essential terms which are fundamental in addressing this subject. We 
offer the following definitions for the terms “Addiction”; “Overdose”; “Off-label use”; 
“Misuse”; “Abuse”; “Occupational Exposure”:
Addiction: complex and severely disabling brain disease which is linked to 
behavioural disorders, risks of contracting infectious diseases and psychiatric 
risks, all of which have severe consequences for the individual social life and 
health.
Drug addiction is a disease which generally seems to be as a consequence of 
an initially voluntary behaviour of drugs consumption, but this condition brings 
serious risk to person’s health. To become affected by the disease, the use of 
psychotropic substances, after an initially voluntary use, creates, a progressive 
state of neuro-psychobiological alteration and pathological suffering capable of 
reducing a person’s ability to independently evaluate reality or decisions to be 
taken. The impact on subject’s ability to act of his or her own free will, depends 
on to the presence of compulsive behaviour characterised by a desire-seek-use 
pattern of drug use. Addiction is characterized by inability (caused by craving) to 
consistently abstain, impairment in behavioural control, diminished recognition 
of significant problems with one’s behaviour and interpersonal relationships, and 
a dysfunctional emotional response.
Overdose: it is an acute intoxication due to medication taking. This means 
the taking of a quantity of medicines, whether taken singularly or cumulatively, 
which is above the maximum recommended dose according to the authorised 
information on the product.
Off-label use: this refers to situations in which the medicine is intentionally used 
for medical purposes which do not match the product’s authorised information.
Misuse: this refers to situations in which the medicine is intentionally and 
inappropriately used in a way which does not match the product’s authorised 
information.
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Data taken from the presentation by Prof. Nicholas Lintzeris at the Gmh meeting in Vilnius, Lithuania, 
September 2013
Abuse: this refers to intentional and excessive use of the medicine, whether 
sporadically or persistently, accompanied by harmful physical or psychological 
effects.
Occupational exposure: this refers to exposure to a medicine as the result of a 
professional or other commitment.
 Considering drug addiction as an illness is a necessary premise. Addiction 
to prescription drugs should, therefore, also be considered an illness. This addiction 
leads to the same symptoms found in people who are addicted to illegal substances: 
problems with memory loss, inability to consistently abstain, damage to interpersonal 
abilities. As with other illnesses, addiction to prescription drugs entails cycles of 
relapses and withdrawal which, without suitable treatment, can lead to serious 
disabilities or premature death.
 In the United States, Canada, South Africa, Australia but also in Europe, the 
phenomenon of the misuse and abuse of prescription drugs has become extremely 
worrying: it involves an increasing number of individuals in an increasingly chronic 
and dangerous fashion. The spontaneous and not medically supervised use of 
prescription drugs is illegal and second only to the use of marijuana. In the United 
States, from 1997 to 2007, the use of prescription opioids in milligrams per person 
rose by 402%, from 74 to 369 milligrams, with an increase in the sales of these 
substances, from 2000 to 2009 of 48%. Again in the U.S.A., 2.8% of the population 
aged over 12, corresponding to 7 million people, has used prescription drugs for non-
medical purposes. In Australia, in the last 12 months, at least 3% of the population 
has used prescription drugs for non-medical purposes. Canada has become, 
16
14
12
10
8
6
4
2
0
Number of dispensing episodes and medicine class
M
ill
io
ns
N
um
be
r o
f d
is
pe
ns
in
g 
ep
is
od
es
Antidepressants
Opioids
Benzodiazepines
Antipsychotics
Stimulants
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
111
according to the International Narcotics Control Board, the second biggest consumer 
of opioids, with an increase in overdoses, between 1999 and 2004, of 416%.
 In Europe there is still no precise data available as well as in other countries, 
but according to the existing data there is reason to believe that the misuse and 
abuse of prescription drugs has grown markedly in Europe too. It is therefore clear 
that it is a global health emergency. Millions of people are victim in numerous 
countries, and this phenomenon presents a danger to society comparable to that 
of the use and abuse of illicit drugs.
Prescription drugs and women
 From the studies carried out so far one fact emerges: women are 
the social category which has most been affected by the emergence of the 
phenomenon of the misuse-abuse of prescription drugs. According to the Center 
for Disease Control and Prevention, in the United States, from 1999 to 2010, 
the number of women who died due to overdosing on prescription drugs rose by 
more than 400%, while the number of men who died for the same causes rose 
by 265%. In absolute terms still more men than women die due to overdosing 
on medicines or drugs generally, but almost 50% of women who die due to 
overdose are killed by an overdose of prescription drugs. Every three minutes 
an American woman undergoes emergency care for the misuse or abuse of 
prescription drugs.
 There may be a range of reasons underlying this new scenario. There are 
physiological reasons: women are two or three times more likely to suffer from 
chronic pain and depression than men. Some studies have shown that women 
are, therefore, more likely to be prescribed prescription drugs, be given higher 
doses, and use them for longer periods than men. The level of risk of abusing 
Image and data taken from CDC, Vitalsigns, Prescription Painkiller Overdoses
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prescription drugs is therefore higher for women than for men. However, there 
are also cultural reasons. According to the CASA of Columbia University, women 
are less willing to report their drug addiction and, thus, have less chance of 
entering drug addiction treatment. Moreover, it seems that social disapproval 
of drug abuse is lower when it is a matter of non-medical use of prescription 
drugs, especially by women. American women have also shown themselves to 
be more inclined to “doctor shopping”, the practice of a patient requesting care 
from multiple physicians, often simultaneously, without informing the physicians 
of the multiple caregivers.
 It is a problem which must be addressed with the appropriate means. 
The use of opioids, benzodiazepine and anti-depressants for medical reasons 
is a right of sick people, which was hard won through technical and scientific 
progress. Many illnesses can now be treated and cured better than in the past: side 
effects have been reduced as chemical substances become pharmacologically 
safer, and the risk of addiction from these drugs has markedly fallen, although 
it still exists. It is therefore necessary to guarantee this right, but not to allow 
that an increasing number of people fall victim to addiction to these substances. 
Policies which are based on an approach which addresses these two facts seem 
to be the most appropriate way to start to effectively combat a socially dangerous 
phenomenon. It is dangerous not only for women - and this should capture the 
attention of policy makers, healthcare professionals, and specialists and drive 
them to seek to stem this tide - but also for the health of their own children. 
The abuse of prescription drugs by pregnant women threatens the health of the 
foetus. In the United States there was a 300% increase in the symptoms of 
neonatal abstinence syndrome between 2000 and 2009. Even if not afflicted by 
this illness, there remains the problem that children born from a mother who has 
this addiction might not be guaranteed adequate parental care. Starting to study 
this phenomenon adopting a gender perspective, which recognises the particular 
physiological and cultural aspects of women, is an imperative which is enforced 
on us by the respect that each individual deserves, in terms of his/her intrinsic 
dignity, but above all for the respect we owe to the future of the world, i.e. to our 
children.
Image and data taken from CDC, Vitalsigns, Prescription Painkiller Overdoses
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 It is absolutely essential to try to draw up and implement a global plan 
to combat this phenomenon with particular regard to women. However, such a 
broad plan of action requires common grounds among policy makers, physicians 
and scientists. Addiction to prescription drugs is, and must be recognised as, an 
illness which must be treated in the same way as addiction to traditional drugs such 
as cocaine and heroin. As well as illegal drugs, the non-medical use of opioids, 
benzodiazepine and anti-depressants can kill. And this must be considered by 
everyone as an unacceptable phenomenon which must be fought and avoided.
Health through awareness
 The studies conducted so far highlight one fact: the subjects most at risk 
from the misuse or abuse of prescription drugs tend to be better educated women 
with a higher than average income and aged over 35. However, younger women 
too are an at-risk category: among European students they are more likely to use 
prescription drugs for non-medical purposes or for an off-label use.
 A statistical survey undertaken in 2010 by the NIH, American National 
Institute of Health, confirms this trend: women were more inclined than men 
(1.59 times) to use opioids in the month prior to the survey, and (1.50 times) to 
have recently abused opioids. The NIH’s study also looked into the ways in which 
women procured medicines. Here below we set out the data on Vicodin, one of the 
most commonly used painkillers in the United States.
 Most women (44.6%) procured Vicodin from family and friends, secondly 
(33.7%) from dealers and only as a final resort as a regularly prescribed drug 
(25.4%). The research showed that a favoured way to obtain medicines for non-
medical use is social networks and the Internet.
 It is therefore necessary to plan and implement an awareness-raising 
plan to make women aware of the risk they run by using prescription drugs for 
non-medical purposes. The composition of this particularly at-risk category has 
characteristics which suggest an action plan at several levels in order to increase 
awareness, not only among women, but also among policy makers and in the 
scientific community.
Young women
 Young women (over the age of twelve) are one of the most at-risk categories 
for the misuse and abuse of prescription drugs. There are cultural reasons for the 
phenomenon of the addiction to prescription drugs: users are very often convinced 
that they are not harmful. This ignorance, combined with a relative ease in finding 
such medicines in the drug cabinets of relatives and friends, or even better online, 
may potentially lead to the phenomenon exploding and it could then become even 
more difficult to control.
 Making people aware of the danger in using prescription drugs for non-
medical purposes must therefore be a priority. Also the use of prescription drugs 
can, like cannabis, represent the entry point for the use of other drugs such as 
amphetamines, cocaine or heroin. This is the message which must be launched 
and which we must ensure is clear and fully understood.
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Women aged over 35
 This is currently the category of most concern. While it is true that many 
people, women and men, young and old, use prescription drugs for non-medical 
purposes, it is also true that women over 35 constitute the group which makes the 
most use of prescription drugs. This means that women over 35 have developed, or 
are at risk of developing, a specific addiction to prescription drugs. The ignorance 
of most women about the possible negative effects from the use of prescription 
drug seems to be confirmed by the survey carried out by the NIH in 2010: more 
than 90% of intoxication from prescription opioids was unintentional. The reasons 
which can be put forward to explain this phenomenon are various, but certainly the 
increased availability on the legal and illegal market and ignorance of the negative 
effects of such substances are a leading factor.
What can be done
 In light of the above, policy makers should draw up a strategic plan targeting 
all those involved in the problem of the misuse and abuse of prescription drugs. The 
plan should: appropriately collect data to monitor and understand the phenomenon, 
raise the awareness of medical doctors to a more responsible and less casual 
approach to drug prescription, and make women aware of the risks they run by using 
prescription drugs without following medical indications and/or supervision.
 Specifically, policy makers should collect data to monitor the phenomenon 
and to establish its real extent in order to intervene with effective measures 
contained in a structured strategic plan. The well-respected CDC, Centre for 
Disease and Control Prevention, in a recent publication drew up a plan which we 
set out below:
 ●  Take steps to improve PDMPs (Prescription Drug Monitoring Program), 
such as real time data reporting and access, integration with electronic 
health records, proactive unsolicited reporting, incentives for provider 
use, and interoperability with other states.
 ●  Identify improper prescribing of painkillers and other prescription drugs 
by using PDMPs and other data.
 ●  Increase access to substance abuse treatment, including getting 
immediate treatment help for pregnant women.
 ●  Consider steps that can reduce barriers (such as lack of childcare) to 
substance abuse treatment for women.
 Another category which should be considered is the one of health care 
providers. Still today there is some reluctance on the part of doctors to recognise 
that women could be at risk of prescription drug overdose. Having medical 
doctors, dentists and pharmacists who are aware of the risk inherent in the casual 
prescription and sale of benzodiazepine, opioids and anti-depressants, above all 
to women, is essential in order to combat this problem which the United States’ 
Government has not hesitated to label as an “epidemic”.
 The CDC has drawn up a guideline which healthcare providers should 
follow, in particular when dealing with pregnant women. We set it out below.
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 ● Recognize that women can be at risk of prescription drug overdose.
 ●  Discuss pain treatment options, including ones that do not involve 
prescription drugs.
 ●  Discuss the risks and benefits of taking prescription painkillers, especially 
during pregnancy. This includes when painkillers are taken for chronic 
conditions.
 ● Follow guidelines for responsible painkiller prescribing, including:
  o   Screening and monitoring for substance abuse and mental 
health problems.
  o   Prescribing only the quantity needed based on appropriate pain 
diagnosis.
  o   Using patient-provider agreements combined with urine drug 
tests for people using prescription painkillers long term.
  o   Teaching patients how to safely use, store, and dispose of 
drugs.
  o   Avoiding combinations of prescription painkillers and 
benzodiazepines (such as Xanax and Valium) unless there is a 
specific medical indication.
 ●  Talk with pregnant women who are dependent on prescription painkillers 
about treatment options, such as opioid agonist therapy.
 ●  Use prescription drug monitoring programs (PDMPs) - electronic 
databases that track all controlled substance prescriptions in the state - 
to identify patients who may be improperly using prescription painkillers 
and other drugs.
 However, women themselves must be considered as a category to which 
an awareness raising plan should be directed. Being aware that they are just as 
at-risk as men is very important. Women themselves must take an active part in 
the battle against this serious phenomenon. The CDC has done an excellent job 
in setting out what women should do to avoid falling into the addiction trap, or how 
they can get out of it if they are already victims. Here below are the indications of 
the CDC.
 ●  Discuss all medications they are taking (including over-the-counter) with 
their health care provider.
 ●  Use prescription drugs only as directed by a health care provider, and 
store them in a secure place.
 ●  Dispose of medications properly, as soon as the course of treatment is 
done. Do not keep prescription medications around “just in case.”
 ●  Help prevent misuse and abuse by not selling or sharing prescription 
drugs. Never use another person’s prescription drugs.
 ●  Discuss pregnancy plans with their health care provider before taking 
prescription painkillers.
 ● Get help for substance abuse problems.
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Introduction
Justification
 Violent conduct related to alcohol and substance abuse, particularly 
intimate partner violence (IPV) has long been recognized as a serious psychosocial, 
healthcare, and judicial problem (WHO European Centre for Environment and 
Health, 2005). Both the acute effects (i.e. intoxication) and the chronic patterns 
(e.g. addiction) of alcohol and drug consumption are associated with violence in 
emotional relationships, not only when exercising but also when suffering, and 
a growing number of empirical studies worldwide corroborate this relationship 
(Klostermann and Fals-Stewart, 2006).
 Studies indicate that between 25 and 33 percent of domestic violence 
is carried out after drinking alcohol and that a smaller proportion of victims 
have also drunk alcohol before being assaulted (Leonard, 2001; Finney, 2004; 
Kaufman, Kantor and Straus, 1990). In Spain, a representative survey shows 
that consuming alcohol or other drugs multiplies the probability of both inflicting 
and suffering violence in a romantic relationship by three to ninefold (Sánchez et 
al., 2004).
 According to various studies on specialized services in the treatment of 
substance abuse, between 40 and 80 percent of those who receive treatment 
there, are either perpetrators or victims of domestic violence (Bennet and 
Williams, 2003; Murphy et al., 2001; Brown et al., 1998; for a review Fals-Stewart 
and Kennedy, 2005). Other studies produce similar results for men in domestic 
violence rehabilitation services (Bennett and Williams, 2003; Gondolf, 2002; 
Moore and Stuart, 2004).
 A meta-analysis by Stith et al. (2004) on different risk factors for the use 
of physical intimate partner violence calculated a medium correlation of r = .24 
with alcohol abuse (from 22 studies with a total number of 14,541 respondents) 
and of r = .31 with illegal drug abuse (from 5 studies with a total number of 
4,496 respondents). Another meta-analysis of the relationship between alcohol 
consumption and IPV (Gil-González et al., 2006) confirmed that the probability 
of using violence against a partner was on average 4.5 times higher for men who 
drink alcohol than for those who do not (from 11 studies with a total number of 
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25,116). More recently, two meta-analytical studies summarized, statistically, the 
research on the relationship between IPV and alcohol consumption (Foran and 
O’Leary, 2008) and the consumption of other drugs (Moore et al., 2008). Foran 
and O’Leary (2008) summarize 55 studies published between 1980 and 2006 
regarding the correlation found between alcohol consumption and violence used 
against the partner including different moderating variables that may have an 
influence thereon. From 47 studies with 21,155 male respondents, the average 
correlation between alcohol consumption and physical violence used by men 
against their partner was r = .23, while, in the case of women, this correlation 
was only r = .14 (based on 8 studies with a total of 3,003 women). On the other 
hand, Moore et al. (2008) summarize the results of 96 published and unpublished 
studies between 1966 and 2005 on the relationship between indicators of drug 
consumption (use, abuse, dependence, problems) and different types of IPV 
(physical, psychological, sexual, mixed). The principal results of the relationship 
between drug use (both by the victim and by the aggressor) and IPV (perpetrated 
by both men and women, users or not) are the following: the medium on all types 
of drugs and all types of violence was d = 0.32. The drug most related to IPV 
was cocaine (d = 0.45), followed by multiple consumption or mixed consumption 
(d = 0.38), marijuana (d = 0.22), other stimulants (d = 0.19), hallucinogens (d = 
0.12), sedatives and tranquilizers (d = 0.10) and opiates (d = 0.04). For types of 
violence, the one most related to drug use was psychological (d = 0.42), followed 
by physical (d = 0.33), mixed (d = 0.31) and sexual abuse and coercion (d = 
0.28).
 In summary, an increasing number of empirical studies corroborate the 
correlation between substance use and intimate partner violence, a fact which 
has led various authors to highlight the necessity to tackle the twin problems in 
treatment services (Fernández- Montalvo, López-Goñi and Arteaga, 2011; Temple, 
Stuart and O’Farrell, 2009).
 In this regard, the Program on Substance Abuse of the Public Health 
Agency of Catalonia, which is responsible for the administration of the Network of 
Substance Abuse Treatment Centers (XAD) attending around 13,000 people per 
year, carries out actions designed to promote research on these two problems, to 
improve the training of professionals, and to seek prevention and care solutions. 
This network’s efforts led to the creation of the Programme for addressing intimate 
partner violence in substance abuse treatment centres, which is briefly described 
later in this chapter.
Institutional frame
 The Programme for addressing intimate partner violence in substance 
abuse treatment centres is framed, firstly, within the continued efforts that are being 
made by the Public Health Agency of Catalonia to integrate the gender perspective 
in its health promotion and prevention efforts (for example relating to tobacco, 
mother-infant health, drugs, etc.). Secondly, it is framed within the commitments 
orchestrated by the “Framework Protocol for a Coordinated Intervention against 
Gender-based Violence” (Catalan Women’s Institute, 2009) and the National 
commission for a coordinated intervention against gender-based violence, which 
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aims to provide a unified, coordinated and appropriate response to gender-based 
violence in Catalonia, thus consistent with Law 5/2008 of 24th April, on the right of 
women to eradicate sexist violence.
 This protocol has been translated into two relevant documents: the 
Protocol for Tackling Sexist Violence in the Ambit of Health in Catalonia, published 
in December 2009, and the corresponding Operative Document On Substance 
Abuse, published in February 2010.
Terminology
 Acknowledging that intimate partner violence is more often committed 
by men against women, and without wishing to minimize it in any way, we have 
opted for the World Health Organization’s definition of IPV (Krug et al., 2002, p.89) 
because violent acts committed against partners by women and/or in homosexual 
relationships would be explicitly excluded by the definitions of sexist violence1 or 
gender-based violence2 given by Catalan and Spanish law, respectively.
“Intimate partner violence refers to any behaviour within an intimate relationship 
that causes physical, psychological or sexual harm to those in the relationship. 
Such behaviour includes:
 ●  Acts of physical aggression – such as slapping, hitting, kicking and beating.
 ●  Psychological abuse – such as intimidation, constant belittling and 
humiliating.
 ● Forced intercourse and other forms of sexual coercion.
 ●  Various controlling behaviours – such as isolating a person from their 
family and friends, monitoring their movements, and restricting their 
access to information or assistance.
[...] Intimate partner violence occurs in all countries, irrespective of social, 
economic, religious or cultural group. 
 Although women can be violent in relationships with men, and violence 
is also sometimes found in same-sex partnerships, the overwhelming burden of 
partner violence is borne by women at the hands of men.” (WHO, 2005)
1 Law 5/2008, of 24th April, on the right of women to eradicate sexist violence, defines this as “violence that 
is perpetrated against women as a manifestation of discrimination and the situation of inequality in the 
framework of a system of power relations of men over women and which, produced by physical, economic or 
psychological means, including threats, intimidation and coercion, results in physical, sexual or psychological 
harm or suffering, whether it is produced in the public or private spheres”.
2 Organic Law 1/2004 of 28 December, on Comprehensive Protection Measures against Gender-based 
Violence defines this as that “violence exercised against women by their present or former spouses or by men 
with whom they maintain or have maintained analogous affective relations, with or without cohabitation, as 
an expression of discrimination, the situation of inequality and the power relations prevailing between the 
sexes” and “encompasses all acts of physical and psychological violence, including offences against sexual 
liberty, threats, coercion and the arbitrary deprivation of liberty.”
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Background
 In 2005, the Program on Substance Abuse created a working group 
on drugs and violence formed by experts both in the ambit of substance abuse 
treatment and that of intervention in intimate partner violence with the objective of 
leading and coordinating the necessary actions to make the program possible.
 In the ensuing sections, the group’s main efforts (listed below) are briefly 
summarized:
 ●  Bibliographic review on the relationship between substance abuse 
and intimate partner violence, and the creation of a conceptual and 
explanatory model.
 ●  Survey of opinions, practices, and needs in order to address intimate 
partner violence in substance abuse treatment centers.
 ● Advocacy and participation in the formulation of strategic documents.
 ● Training of professionals.
 ●  Study on the prevalence of intimate partner violence and its risk factors 
in men attending substance abuse treatment centers.
 ●  The creation of guides for professionals: a general one for addressing 
and preventing intimate partner violence at the individual level, and one 
for preventing and addressing the issue in groups.
Review of the literature and proposal for a model to
explain the relationship between substance use and 
intimate partner violence
 This document outlines the conceptual and theoretical bases of the program 
through a critical review of the relevant literature and by proposing a conceptual 
model. The processual and multidimensional model proposed is founded on the 
empirical evidence extracted from the different bibliographical sources consulted 
and seeks to integrate the different explanatory levels (biological, psychological, 
relational and socio-cultural) encountered.
Principal perspectives on the relationship between 
substance use and intimate partner violence
1 There’s empirical evidence from different theoretical levels that 
corroborates and explains the relationship between alcohol or drug 
consumption and violence. We distinguish four principal perspectives 
from which the relationship between alcohol consumption and violence 
has been studied:
The biological perspective maintains that the ingestion of alcohol or other 
substances produces physiological changes at a synaptic and hormonal 
level, which dis-inhibit the centers of cerebral control, provoking an 
outbreak of conducts habitually inhibited, such as violence. It establishes 
that the ingestion of alcohol has a pharmacological effect that increases 
aggressiveness in humans (Exum, 2006). These explanations focus 
principally on alterations or deficits in the cognitive system and the control 
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of impulses (Giancola, 2007, Pihl et al., 2003, George et al., 2004).
2 The psychological perspective is founded on theories of learning that 
affect personal belief systems and expectations about the use of alcohol, 
which would have a significant influence on violent conduct. Thus, models 
of social learning will play an important role in the development of both 
substance use and intimate partner violence (White and Widom, 2003; 
Boles and Miotto, 2003; Chermarck and Giancola, 1997).
3 The relational and interpersonal perspective maintains that the 
characteristics and dynamics of family and partner relationships may lead 
to both alcohol and drug consumption, and violent behavior (Bowlby, 1984; 
Babcock et al., 2000;  Crittenden, 2000; Crittenden and Claussen, 
2002; Fonagy, 2001).
4 The socio-cultural perspective is based on the processes of socialization. It 
gives particular importance to socially permitted and prohibited conducts, 
and to the processes that culturally promote attribution, justification, 
and explanation of one’s own behavior when alcohol or another drug is 
ingested. The socio-cultural perspective maintains that drug abuse and 
gender violence problems are understood principally through aspects 
referring to the dynamics of power and the manner of transmission of 
these cultural practices that prescribe behaviors aimed at establishing and 
maintaining power and control in a relationship (Fox, 2008; Zubretsky and 
Digirolamo, 1996; Leonard, 2002; Galvani, 2004).
A complex processual model
 The proposed complex processual model considers the four explanatory 
levels described above, and enables us to understand the close relationship that 
Figure 1: Model of the relationship between substance use and intimate partner violence
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exists between substance use and situations of intimate partner violence. The 
model has as its starting point four basic suppositions:
1 Interpretation of the phenomenon, from a perspective oriented to 
processes, as an evolutionary framework inserted within a praxis of living, 
and not as an isolated, de-contextualized and a historical fact.
2 Consideration that a single reason or explanatory level for the phenomenon 
does not exist.
3 Acknowledgement of the “epistemic subject,” a proactive subject who 
constructs his or her own reality and takes a position, rather than a neutral 
and passive observer before the world.
Table 1: Risk factors / processes common to substance use and intimate partner violence
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4 A gender perspective, which considers that the dynamics of power and 
the ways in which cultural practices for becoming a man or a woman are 
transmitted, are aimed at establishing and maintaining the power and 
control of some over the others.
 From a processual perspective we consider these two problems 
(substance abuse and IPV) as expressions or manifestations of an evolutionary 
personal process of living (Figure 1). This evolutionary process generates forms of 
self-regulation and self-organization which will become established and translated 
into a definite position before existence, a praxis of living, and a way of acting 
when faced with different situations (Guidano, 1991, Crittenden, 2000, Mahoney, 
1991, Arciero, 2004). It is formed principally by three dimensions:
 ●  Adaptation: the creation of a regularity, which makes possible the 
constitution of a “familiar” world and which continues in time, and can be 
anticipated.
 ●  Integration: enables the assimilation of elements and occurrences that 
are inconsistent with this continuity.
 ●  Intersubjectivity: provides a symbolic reality which superimposes itself 
upon material “reality”, generating a personal and shared meaning of 
one’s own world, and that of others.
 The evolutionary process of living and its dimensions (adaptation, 
integration and intersubjectivity) are affected by modifiers (evasion and 
compensation) that are habitual in human processes, but critical to the 
organization of identities of persons with problems with drugs and/or violence. 
Therefore, in the first instance, the concurrence of a process or episode of 
violence and a process or episode of substance abuse can occur in parallel, 
due to an evolutionary process of living with risk factors and processes common 
to both phenomena.
 Among the common distal risk factors, we can highlight those family 
conditions that shape attachment relationships during the first years of life. 
Among the common proximal risk factors, we include those which are most 
contingent to the present processes of substance abuse and/or intimate partner 
violence (Table 1).
 Another area of interaction is shaped by mediating factors, which act 
as bridges between the processes of violence and the processes of substance 
abuse, or vice versa, and which act on the different levels previously mentioned 
(biological, psychological, relational and social) leading a person with a problem of 
substance abuse to use violence, or vice versa (Table 2).
Survey of opinions, practices and needs to address 
intimate partner violence in substance abuse treatment 
centers
 A survey (Jou, Valls and Segura, 2008) was conducted at 34 centers 
(57% of all the substance abuse treatment centers in Catalonia). The following is 
a summary of the results:
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Table 2: Processes / factors mediating between substance use and intimate partner violence
 ●  The detection of possible victims is only regularly done in 32% of the 
centres and the detection of possible aggressors in only 27%.
 ●  In 85% of the centers there is no system of detection of violence upon 
the first visit.
 ●  More than half of the centers (53%) do not have a protocol for action 
on intimate partner violence.
 ●  Only 35% of the centers have trained professionals to act in cases of IPV.
 ●  In 94% of centers there is no recordings of cases of IPV.
 ●  47% of centers strongly agree with the need to have a protocol of action.
 ●  70% agree fairly strongly or strongly with the need to have a single 
model for recording IPV.
 ●  88% of centers agree fairly strongly or strongly with the idea of 
designing a guide to recommendations and action.
 ●  90% of centers say that specific training in the XAD is necessary and 
should focus particularly on the acquisition of skills and knowledge of 
the resources available.
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 Substance Abuse Treatment Centers (CAS) are in a privileged position for 
the detection, diagnosis and prevention of intimate partner violence in substance 
users who are often victims or aggressors of a variety of typologies of violence. 
Their continued and prolonged therapeutic relationship permits early detection and 
intervention of both problems.
Advocacy and participation in the formulation of 
strategic documents
 Members of the working group participated in formulating two strategic 
documents: the Protocol for Addressing Sexist Violence in the Health Sector 
In Catalonia (Department of Health, 2009), and the corresponding Operative 
Document on Substance Abuse (Department of Health, 2010). In the protocol 
the consumption of substances was included, with no difficulties, as a risk factor. 
In the operative document, significant stress was placed on the specificities of 
the context of substance abuse and possible profiles, but also on the practical 
sections on addressing intimate partner violence in prevention, detection, and 
intervention as well as referral to specialist services and coordination with them.
 At the level of advocacy, among other things, the program has been 
presented in different work sessions of the Barcelona Circuit to combat violence 
against women in both 2009 and 2010, which allowed creating links of collaboration 
and exchange with the network of attention for intimate partner violence.
Training of professionals
 To address the need for training detected in the above-mentioned survey 
of centers, the “Course for professionals of the XAD: Intimate partner violence 
and its relationship with consumption of alcohol and other substances” was 
designed, with a duration of two days (16 hours), consisting of the following 
basic modules which, in different editions, are complemented with examples of 
the praxis of different centers of the XAD:
 ● Gender perspective in substance abuse.
 ●  The relationship between substance use and intimate partner violence: 
empirical data and explanatory model.
 ●  Profiles of victims and aggressors being treated in substance abuse 
treatment centers.
 ● Intimate partner violence: the professionals’ perspective.
 ● Legal aspects and the process of judicial intervention.
 ● Strategies, tools, and skills for interviewing women (presumed victims).
 ● Strategies, tools, and skills for interviewing men (presumed aggressors).
 ●  Children of victims and aggressors who are consumers: consequences 
and approach.
 ● Protocols, circuits and resources related to gender violence;
 ● Experiences in substance abuse treatment centers and case work.
 ●  Addressing intimate partner violence in the XAD: debate and 
conclusions.
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 From the five courses that have been administered thus far, over 100 
professionals have been trained from more than 30 different CAS. These 
professionals have provided especially positive evaluations in response to the 
“interest and relevance of the [course] contents”, the fulfillment of expectations, 
and satisfaction with the course.
 Furthermore, we have trained professionals from the local circuits to 
combat violence against women in the city of Barcelona, in which basic concepts 
were covered regarding prevalence and the theoretical explanation of the dual 
problem, as well as strategies for addressing it in the participating services. 
These training sessions contributed to the elimination of myths and false beliefs 
about the relationship between substance use and intimate partner violence, 
raising awareness of the work done by substance abuse treatment centers in this 
sector and thus promoting collaboration and coordination between professionals 
and services from both attention areas.
Study of the prevalence of intimate partner violence in 
men under treatment for substance abuse
 The study Men, Relationships and Health (Gilchrist et al., forthcoming) 
sought to determine the prevalence of intimate partner violence among men who 
are receiving treatment in centers for substance abuse treatment in Catalonia 
and the associated risk factors to corroborate whether the data found on the 
international level can be applied to our setting.
 The research consisted of two phases and used a mixed methodology 
(qualitative and quantitative), which was divided into a transversal study through 
questionnaires and some qualitative interviews with male consumers who had 
perpetrated IPV. 33% of all the substance abuse treatment centers in Catalonia 
were chosen at random to participate in the study.
 The first stage of the study included a questionnaire, consisting of 
validated questions or scales to measure the perpetration of different types of 
violence on the one hand, and variables identified as possible risk factors (such 
as, among others, having witnessed inter-parental violence, having suffered 
abuse in infancy, having divorced or absent parents, criminal record, rage, 
personality disorders, consumption of alcohol or drugs, unemployment, beliefs 
about aggressiveness related with consumption and about masculinity) on the 
other.
 Of the 219 men from 20 substance abuse treatment centers, 34% had 
perpetrated some type of violence (sexual or physical) against their partner during 
the last year of their relationship, and 68% had used psychological violence in 
the last twelve months of the relationship.
 Furthermore, the principal risk factors associated with the use of violence 
against a partner were having experienced the separation of one’s parents during 
childhood, having suffered physical or sexual abuse before the age of 16, having 
abused alcohol in the previous year, or being in treatment for cocaine use.
 The second, qualitative stage sought to determine the reasons for 
perpetrating violence against women, through an analysis of what men say 
about their violence and its causes. Two thematic axes were identified in their 
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arguments: a) minimizing and using euphemisms to describe the violence 
perpetrated, and b) various justifications and claims that the violence was an 
effect of their substance use, their jealousy, a provocation by the partner, and/or 
negative experiences from childhood.
 The following treatment implications are drawn from this study: A) the 
need for interventions to reduce intimate partner violence and improve couple 
relations; B) the need to incorporate treatments for intimate partner violence in 
treatment for substance use disorder; often, substance users are excluded from 
interventions for perpetrators and victims with drug use problems feel stigmatized 
in groups of “non-consumer” victims; C) the need to address the problem of 
“acceptance” of intimate partner violence, on the part of service-givers, as being 
“the lifestyle” of substance users, and; D) the lack of appropriate staff for dealing 
with intimate partner violence.
Creation of two guidelines for professionals of the XAD
 In order to address the need for specific guidelines and recommendations 
for professional use, two guides were created, one for addressing intimate partner 
violence on the individual level, and another for prevention and intervention in 
group work.
Intimate partner violence and substance use: guidelines 
for professionals of the XAD
 These guidelines (Valls, Geldschläger et al., 2013) were created in order 
to assist professionals of substance abuse treatment centers when addressing 
intimate partner violence. The guidelines are structured around detection, 
intervention, referral, and coordination, and they include chapters on basic concepts 
on violence, profiles of possible victims and aggressors, and general indications 
for action in centers. In the section on detection, specific indicators and questions 
are highlighted regarding intimate partner violence both for women and for men, 
as well as the importance of exploring the different consumption constellations 
of the couple (both consume, only the aggressor, or only the victim). The section 
on intervention distinguishes different situations: a) there is no suspicion of IPV, 
b) there is suspicion of IPV, but the user does not express it verbally, and c) the 
user verbally expresses a situation of IPV, indications are made to assess the 
risk, and a safety plan is prepared for the victim, as well as protection for children 
and adolescents. Furthermore, the annex contains documents to go more deeply 
into some theoretical and practical aspects (such as prevention, the judicial area) 
as well as forms to use during treatment (such as a model for the request for a 
protection order and a safety plan).
Intimate partner violence and substance use: guide for 
group work
 This guide (Valls, LaFarga, et al., 2013) seeks to prevent the occurrence of 
intimate partner violence, and to facilitate its early detection within centers. Taking 
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advantage of the long trajectory of group work in substance abuse treatment 
centers, it offers activities which can be adapted to the needs of every treatment 
group for substance users.
 The activities are prepared for groups of women, groups of men, and mixed 
groups, and are divided into three thematic blocks: A) socialization, stereotypes, 
and gender roles, B) emotions and relationships, and C) violence. For each group 
dynamic proposed, there are clear guidelines on the objectives of the activity, the 
materials needed, its duration and level of difficulty, and instructions on how to run 
the activity, with a file containing the principal material.
The programme for addressing intimate partner 
violence at the network of substance abuse 
treatment centers (XAD)
Objectives
 The objective of the Programme for addressing intimate partner violence 
at the Network of Substance Abuse Treatment Centers is to improve the safety 
of those treated at these centers, which also suffer intimate partner violence. The 
specific objectives of the programme are:
 ●  To reduce the false beliefs and/or myths surrounding intimate partner 
violence related with substance use.
 ●  To promote recognition of the dual problem and the specific needs for 
addressing it.
 ●  To improve detection of possible victims and aggressors of intimate 
partner violence among the people using the center.
 ●  To promote specific prevention and intervention on intimate partner 
violence.
 ●  To improve the knowledge and skills of when addressing intimate partner 
violence in the context of addiction.
 ●  To create informative spaces for discussion and ongoing training, on the 
subject matter.
 ●  To promote referral to services specialized in intimate partner violence.
 ●  To improve the coordination and collaboration between substance 
abuse treatment centers and centers for specifically addressing intimate 
partner violence.
 ●  To detect and reduce difficulties of access to services of the network 
of attention for intimate partner violence presented by people who use 
substances.
Who is the program intended for?
 The program is aimed principally for:
 ●  Professionals of substance abuse treatment centers.
 ●  Professionals of the services which participate in local circuits against 
intimate partner violence.
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 ●  Other professionals working with to people who consume substances or 
have problems of intimate partner violence.
Implementation in Catalonia
 Between May 2012 and January 2013 a pilot project was carried out at 
a selected CAS with the objective of evaluating its viability, and detecting and 
correcting possible difficulties or problems before extending it to the rest of the 
XAD. This pilot project was carried out at the Fontsanta CAS in Cornellà de 
Llobregat, in close collaboration with the Circuit against sexist violence in St. Joan 
Despí, one of the municipalities served by the Fontsanta CAS.
Implemented actions
 The following actions were carried out:
 ●  Joint training of the professionals of the CAS and the Circuit, lasting 
six hours and consisting of mutual presentation and familiarization 
of services and professionals, a training session on the correlation 
between the two phenomena to create a common conceptual base, and 
joint work on referral of cases and coordination between services.
 ●  Specific training to the whole team of the Fontsanta CAS (nine professionals) 
lasting six hours and focusing on detection and approach to women who 
are possible victims and men who are possible aggressors, and on case 
work, while promoting the practical application of the guides.
 ● Two sessions of feedback and follow-up on the pilot project, one at 
CAS Fontsanta and the other at the St. Joan Despí Circuit against sexist 
violence.
Evaluation of the project
 The project was evaluated using a mixed quantitative and qualitative 
methodology and pre-post design of A) the results of the implementation, which 
includes a pre-post comparison of indicators relevant to the objectives of the 
programme and B) the process of implementation which includes the evaluation of 
the actions carried out by the people participating, professionals of the Fontsanta 
CAS and of the services participating in the St. Joan Despí Circuit against sexist 
violence. 
Interviews were carried out both before and after the pilot project:
 ●  With the Fontsanta CAS team about their knowledge of and their 
professional praxis regarding detection, intervention, and referral to 
intimate partner violence services and, in the post-test, about changes 
and assessments of the project.
 ●  With professionals from services of attention for male gender violence 
about referrals and coordination with the CAS, as well as about their 
knowledge of and professional praxis related to cases with problematic 
consumption of alcohol or other drugs. The questions were identical or 
complementary to those of the interviews with CAS professionals.
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 ●  With users of the CAS, in convenience samples which approached a 
representative distribution according to the drug for which they were 
admitted and their sex, about the actions of the professionals on intimate 
partner violence.
 Files and clinical histories of CAS users were selected according to a 
representative distribution by drug for which they were admitted and their sex, 
and analyzed qualitatively and quantitatively with regard to records of detections, 
interventions, referrals, and co-ordinations in cases of intimate partner violence.
 Annual reports and statistics were analyzed, not only from domestic 
violence services (on the referrals and co-ordinations with the CAS as well as 
the detection of cases with substance use) but also from the CAS (on detections, 
interventions, referrals and co-ordinations in cases of intimate partner violence).
 The results indicate improvements, although not statistically significant, 
A) in the detection of IPV and referrals by professionals of the CAS (according to 
the interviews with service users and analysis of files) and B) in the evaluation that 
the professionals make in the interviews regarding their knowledge and actions. In 
the CAS more questions are asked about IPV and more IPV is detected in women 
users than in men, and significant changes have occurred in the way that violence 
is recorded in the files of the CAS, reducing the number of unclear records or those 
that implied a justification of the violence and increasing the number of explicit 
records which define the problem as IPV and the records which state that IPV has 
been asked about but not detected.
 Moreover, the professionals provided a positive evaluation of the project, 
particularly of training in the CAS, the exchange between services and professionals 
from both ambits, and the materials created. They also highlight the importance 
of having tools of detection and having continuity in the support and counselling 
of the program in the form of training and clinical sessions and supervisions, for 
example. One of the most significant results is the fact that the professionals from 
the circuit against sexist violence also asked to have specific training and materials 
on addressing drug use in their services.
Next steps
 We propose the progressive roll-out of this program to all of Catalonia’s 
Substance abuse Treatment Network by means of, among other things, the 
identification of a professional of reference in each unit of the XAD. In this way, 
the person of reference in each unit will receive specific training in order to be 
able to pass on the information and train his or her team, will participate in the 
corresponding circuit against sexist violence, and will receive continued support 
and counselling from the program.
 The Programme for addressing intimate partner violence at the Network of 
Substance Abuse Treatment Centers will offer:
 ●  Support for coordination and networking between the XAD and the 
circuits of attention for violence through joint training actions.
 ●  Specific training sessions that will enable the persons of reference in 
the units of the XAD to transmit to their teams the expertise to address 
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intimate partner violence, making the materials developed available for 
use.
 ●  Continued counselling and support for persons of reference both in the 
management of incidents and to improve coordination.
 ●  Occasional clinical sessions or supervision of cases to deal with incidents 
or difficulties, such as addressing aggressors.
 ●  A virtual space for exchange, consultation, and up to date information.
 ●  Materials and action guides.
 ●  A tool to detect intimate partner violence for the whole XAD.
 ●  Inclusion of the programme activities in the contract of the services of 
the XAD.
 ●  An up to date list of resources for addressing sexist violence throughout 
Catalonia.
 In addition to identifying a person of reference in the program, the 
participating units of the XAD will commit themselves to creating an organizational 
and work context of support in order to promote the approach (detection, prevention, 
intervention) and the registering of intimate partner violence, as well as referral 
and co-ordination with specialist services and evaluation of actions.
 The next step will be to analyse the present situation and to identify the 
different needs of each resource in the territory, by means of the evaluation of the 
charter of services and interviews with the coordinators of the CAS and the territorial 
circuits against sexist violence. Furthermore, both the introduction of a unified 
instrument to detect intimate partner violence at the XAD and the development of 
prevention materials will be agreed upon through a consensus process. Finally, 
the interdepartmental coordination has to guarantee the coordinated rollout in 
the territory, both in the circuits against male gender violence and in other health 
services.
Conclusions
 From the experience accumulated in the Programme to address intimate 
partner violence in the XAD we can extract the following conclusions and 
recommendations to achieve sustained improvements in the prevention of and 
approach to this dual problem:
 ●  The collaboration of specialists on substance abuse and on intimate 
partner violence at every phase and level of the program (constitution of 
the working group, institutional cooperation, creation of guide, training of 
professionals, implementation) is fundamental to design specific actions 
and materials which are useful in practice.
 ●  Corroborating the empirical data from international studies in the local 
context helps to convince both the professionals in the centers and those 
responsible at the institutional level of the need for a specific program.
 ●  Basing the actions of the program on a survey on current practices 
and needs in substance abuse treatment centers promotes its practical 
usefulness and the involvement of the centers in the project.
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 ●  Presenting a complex and processual model of the dual problem 
avoids simplistic causal interpretations, destroys myths, and creates 
the conceptual base for interventions adapted to the complexity of the 
phenomenon and for collaboration between services and professionals 
from both fields of attention.
 ●  Bearing in mind and addressing the specific contexts of substance abuse 
when creating guides and training sessions for addressing intimate 
partner violence enables their acceptance and application on the part of 
the professionals. Specifically, it is necessary to give tools for addressing 
violence with men, who represent the vast majority of the people in 
substance abuse treatment centers (Fernández-Montalvo et al., 2011), 
since in the general protocols for health services the corresponding 
indications or tools are scarce (Kimberg, 2008). Moreover, specific 
profiles, indicators, and procedures must be provided for the detection of 
violence suffered by women substance users, to overcome their double 
stigmatization.
 ●  A specific training for professionals working in substance abuse, to 
transmit the expertise and skills for addressing intimate partner violence, 
is necessary (Timko et al., 2012), but not sufficient for achieving a 
sustained change in treatment practice. Measures that promote changes 
at the organizational or system level, such as the implementation of a 
consensual tool of detection and recording, are also necessary (Kunins 
et al., 2007), creating a favorable working environment and improving the 
professionals’ confidence when faced with this dual problem (Anderson 
et al., 2003).
 ●  To achieve improvements in the referral, coordination, and collaboration 
between the two ambits, as well as providing a common conceptual 
framework, it is essential to promote case work, and as much as 
possible, joint planning of treatment (Macy & Goodbourn, 2012).
 Besides the progressive implementation of the program throughout 
Catalonia, the main challenges we may face in the future are as follows:
 ●  To create specific guidelines on addressing problematic substance 
abuse and tools for detecting and recording it in treatment services for 
intimate partner violence and to update the corresponding training for 
professionals.
 ●  To identify and reduce the barriers to treatment services for intimate 
partner violence, which are still encountered by people who are 
substance users, both victims and aggressors.
 ●  Going beyond coordinated and parallel responses to the dual problem, 
to create services that give an integrated response to female substance 
users who suffer intimate partner violence and to male substance users 
who practice it (Timko et al., 2012).
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	 Gender	has	an	important	influence	on	the	development	and	progression	
of	substance	use	disorders,	pathways	 that	 individuals	 take	 to	 treatment,	clinical	
profile	 and	 treatment	 needs	 of	 patients,	 and	 the	 outcomes	 of	 their	 treatment	
participation.	In	the	past	two	decades,	traditional	approaches	to	substance	abuse	
treatment	have	been	modified	to	take	account	of	gender	differences,	particularly	
the	higher	severity	profile	of	substance-abusing	women,	their	exposure	to	abuse	
and	trauma,	and	their	needs	for	services	related	to	parenting,	employment,	and	
mental	and	physical	health	problems.	A	growing	body	of	research	has	examined	
these	gender-specific	treatment	programs	and	approaches,	and	evidence-based	
interventions	have	been	developed,	or	modified,	to	specifically	address	treatment	
for	women.	This	chapter	provides	a	 review	of	how	gender	 influences	 treatment	
utilization,	needs,	and	outcomes	of	women	with	substance	use	disorders;	research	
on	the	characteristics	of	gender-specific	treatment	programs	for	women	and	the	
outcomes	 of	 women	 treated	 in	 these	 programs;	 specific	 issues	 pertaining	 to	
substance-abusing	women	in	the	criminal	 justice	system;	and	current	evidence-
based	treatments	 that	have	been	developed	for	 treating	women	with	substance	
use	disorders.
Treatment access and utilization among women 
with substance use disorders
	 The	pathways	into	substance	abuse	treatment	for	men	and	women	are	
strongly	 differentiated	 based	 on	 an	 individual’s	 economic,	 employment,	 and	
parental	status,	which	may	serve	as	barriers	or	facilitators	of	treatment	utilization.	
In	the	United	States,	a	much	higher	proportion	of	men	than	women	are	referred	
into	 treatment	 through	 the	 criminal	 justice	 system	 (40%	 vs.	 28%),	 whereas	
about	twice	as	many	women	access	treatment	by	referral	from	other	community	
agencies	(e.g.,	welfare,	child	welfare,	health	care	providers;	15%	vs.	6%;	Office	
of	Applied	Studies	[OAS],	2006).	Studies	have	shown	that	women	are	more	likely	
than	men	 to	enter	 treatment	via	 the	mental	health	and	child	welfare	systems,	
whereas	 men	 are	 more	 likely	 to	 enter	 treatment	 through	 the	 criminal	 justice	
system	(Schmidt	&	Weisner,	1995).	Similarly,	there	are	differences	between	men	
and	women	in	their	sources	of	payment	for	treatment,	with	a	greater	proportion	
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of	men	reporting	self-pay	(26%	vs.	18%)	and	a	relatively	greater	proportion	of	
women	being	dependent	upon	public	 insurance	 to	pay	 for	 treatment	 (26%	vs.	
12%;	OAS,	2006).
	 Moreover,	men	and	women	may	view	their	substance	use	differently,	in	
ways	that	either	hinder	or	facilitate	their	treatment	entry.	In	a	study	of	50	alcoholics	
in	outpatient	treatment,	half	of	whom	were	women,	the	women	frequently	failed	
to	 identify	 their	 drinking	 as	 problematic	 and	were	 averse	 to	 being	 labeled	 as	
“alcoholic”	(Thom,	1986).	They	minimized	the	harmfulness	of	their	drinking	and	
emphasized	that	 their	drinking	had	not	 impaired	their	ability	 to	fulfill	 their	roles	
as	wives	and	mothers.	In	fact,	for	many	women,	drinking	with	their	spouses	was	
integral	 to	 their	marital	relationships,	and	their	spouses	contributed	to	defining	
their	drinking	as	non-problematic.	In	contrast,	nearly	all	of	the	men	in	the	study	
who	were	living	with	a	spouse	or	partner	reported	that	they	had	been	encouraged	
or	supported	by	that	person	to	enter	treatment	(Thom,	1987).	Similarly,	another	
study	showed	that	more	negative	social	consequences	related	to	drinking,	such	
as	traffic	accidents,	arrests,	and	family-,	legal-,	and	work-related	problems,	were	
associated	with	 treatment	entry	among	men,	but	not	among	women;	however,	
employment	and	prior	treatment	history	were	related	to	treatment	entry	for	both	
men	and	women	(Weisner,	1993).
	 There	 are	 similar	 findings	 with	 respect	 to	 individuals	 with	 drug	 use	
disorders.	A	 study	 of	 couples	 in	 methadone	 treatment	 in	 the	 1980s	 showed	
that	 patterns	 of	 drug	 use	 and	 decisions	 to	 enter	 treatment	were	 often	 jointly	
made	(Anglin,	Kao,	Harlow,	Peters,	&	Booth,	1987).	Other	research	has	shown	
that	a	greater	adherence	to	traditional	gender	roles	among	men	in	methadone	
treatment	 is	 positively	 related	 to	 psychological	 dominance	 and	 “couple	 drug	
involvement,”	 which	 in	 turn	 is	 associated	 with	 their	 perpetration	 of	 intimate	
partner	 violence	 (El	 Bassel	 et	 al.,	 2004).	 Substance-abusing	men	 who	 were	
in	 relationships	with	women	who	also	used	 illicit	drugs	were	more	 than	 twice	
as	likely	as	men	in	relationships	with	non-using	partners	to	perpetrate	intimate	
partner	violence,	and	nearly	four	times	as	likely	to	perpetrate	“severe”	forms	of	
violence	(El-Bassel,	Gilbert,	Wu,	Chang,	&	Fontdevila,	2007).	This	effect	may	
be	exacerbated	among	pregnant	women	who	are	in	abusive	relationships.	One	
study	showed	that,	among	pregnant	women	in	substance	abuse	treatment,	those	
who	were	in	abusive	relationships	were	more	likely	to	have	partners	who	also	
used	alcohol	and	drugs,	had	more	severe	alcohol	and	family/social	problems,	
and	 had	 higher	 rates	 of	 psychiatric	 problems	 and	 comorbidity	 compared	 to	
those	who	were	not	in	abusive	relationships	(Tuten,	Jones,	Tran,	Svikis,	2004).	
Hence,	the	threat	of	intimate	partner	violence	may	limit	women’s	ability	to	enter	
and	stay	in	treatment	if	drug	use	is	embedded	within	the	relationship	(Tuten	&	
Jones,	2003).
	 A	 study	 conducted	 with	 individuals	 in	 drug	 treatment	 demonstrates	
the	contrary	influences	of	marital	relationships	and	social	stigma	on	treatment	
participation	for	men	and	women.	Using	data	from	a	national	multi-site	treatment	
outcome	 study	 in	 the	 United	 States,	 Grella	 and	 Joshi	 (1999)	 examined	 the	
factors	associated	with	having	a	history	of	substance	abuse	treatment	among	
individuals	who	were	 sampled	 from	 residential,	 outpatient,	 hospital	 inpatient,	
and	 methadone	 maintenance	 programs.	 More	 severe	 drug	 use	 history	 and	
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greater	involvement	in	criminal	behavior	were	related	to	treatment	participation	
for	both	men	and	women.	Yet,	among	men,	prior	drug	treatment	was	associated	
with	higher	 levels	of	 family	opposition	 to	 their	drug	use	and	more	support	 for	
their	 treatment	 participation.	 Men	 were	more	 likely	 to	 have	 been	 referred	 to	
prior	 treatment	by	 their	 family,	an	employer,	or	 the	criminal	 justice	system.	 In	
contrast,	 treatment	participation	 for	women	was	associated	with	having	been	
referred	by	a	social	worker,	having	a	diagnosis	of	antisocial	personality	disorder,	
having	engaged	in	sex	work,	and	having	initiated	treatment.	Hence,	the	factors	
that	 facilitate	or	 inhibit	 treatment	participation	 for	men	and	women	are	highly	
variable.
	 Given	the	greater	centrality	of	their	role	as	caregivers	for	children,	the	
potential	 effects	 of	 women’s	 treatment	 participation	 (or	 non-participation)	 on	
their	relationships	with	children	may	have	a	central	influence	on	their	decisions	
whether	or	not	to	enter	treatment.	Several	studies	have	shown	that	most	women	
entering	into	substance	abuse	treatment	are	mothers	of	dependent	children,	and	
at	least	half	have	had	contact	with	child	welfare	(Conners	et	al.,	2004;	Grella,	
Scott,	Foss,	Joshi,	&	Hser,	2003).	However,	less	than	half	of	mothers	entering	
treatment	are	living	with	all	of	their	children,	and	up	to	one	third	have	lost	their	
parental	rights	to	at	least	one	child	(Knight	&	Wallace,	2003;	Schilling,	Mares,	&	
El-Bassel,	2004;	Tracy	&	Martin,	2007).	Mothers	involved	with	the	child	welfare	
system	have	been	shown	to	be	younger,	 to	have	a	history	of	physical	abuse,	
and	to	have	fewer	economic	resources	than	other	mothers	in	treatment	(Grella,	
Hser,	&	Huang,	2006).	One	study	showed	that	mothers,	who	were	injecting	drug	
users,	were	more	likely	to	enter	into	methadone	maintenance	treatment	(versus	
other	forms	of	treatment)	if	they	were	living	with	their	children,	compared	with	
mothers	who	did	not	reside	with	their	children	(Lundgren,	Schilling,	Fitzgerald,	
Davis,	&	Amodeo,	2003).	Mothers	entering	into	methadone	maintenance	were	
also	 more	 likely	 to	 be	 employed	 and	 stably	 housed	 compared	 with	 others,	
underscoring	the	importance	of	economic	resources	for	their	ability	to	participate	
in	treatment.
	 The	 influence	 of	 children	 on	 parental	 substance	 use	 and	 mothers’	
motivation	for	and	participation	in	treatment	is	complex	(Collins,	Grella,	&	Hser,	
2003).	Children	(and	pregnancy)	may	impede	treatment	participation	if	women	
fear	 it	will	 jeopardize	 their	 custody	 of	 their	 children	 (Haller,	Miles,	&	Dawson,	
2003).	This	was	evident	in	a	study	in	which	involvement	with	child	welfare	was	
negatively	associated	with	treatment	motivation	among	mothers	(Wilke,	Kamata,	
&	 Cash,	 2005).	 The	 authors	 suggested	 that	 the	 negative	 influence	 of	 child-
welfare	 involvement	on	treatment	motivation	reflects	the	practical	or	emotional	
issues	associated	with	having	to	leave	children	with	other	caregivers,	as	well	as	
the	 fear	of	 losing	custody	of	 their	 children.	Similarly,	another	study	 found	 that	
among	mothers	who	were	opiate	users,	greater	parenting	responsibility,	defined	
as	number	of	children,	was	inversely	related	to	number	of	treatment	episodes,	
although	 this	 relationship	 was	moderated	 by	 ethnicity	 and	 relationship	 status	
(McMahon,	Winkel,	 Suchman	 &	 Luthar,	 2002).	 However,	 among	 incarcerated	
women,	child-welfare	 involvement	has	been	associated	with	higher	motivation	
to	 enter	 treatment,	 suggesting	 that	 treatment	 participation	 may	 be	 critical	 to	
reunification	with	their	children	(Grella	&	Rodriguez,	2011).
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	 Logistical	 issues	 and	 access	 to	 resources	 also	 facilitate	 or	 inhibit	
treatment	 participation	 among	 women.	 In	 a	 study	 of	 cocaine-dependent,	
criminally	 involved	women	 both	 in	 and	 not	 in	 treatment,	 Saum,	Hiller,	 Leigey,	
Inciardi,	 &	Surratt	 (2007)	 showed	 that	 enabling	 factors,	 such	 as	 being	 legally	
employed,	 having	 health	 insurance,	 having	 custody	 of	 children,	 and	 knowing	
where	to	go	to	get	treatment,	appeared	to	be	the	most	 influential	predictors	of	
treatment	participation	(as	compared	with	predisposing	and	service	need	factors).	
In	a	study	of	individuals	seeking	publicly	funded	treatment	in	Washington	State,	
women	were	 found	to	spend	 longer	on	a	wait	 list	 for	 treatment	and	 to	be	 less	
likely	 to	 eventually	 enter	 treatment	 compared	with	men	 (Downey,	Rosengren,	
&	Donovan,	 2003).	The	authors	noted	 that	 pregnant	women,	who	were	given	
priority	 for	 admission	 to	 treatment,	 were	 excluded	 from	 the	 analyses;	 hence,	
women	who	were	not	pregnant	may	have	had	longer	wait	times	stemming	from	
the	remaining	limited	capacity	of	inpatient	and	residential	beds	for	women.	They	
further	surmised	that	women	postpone	treatment	entry	due	to	lack	of	childcare	
arrangements,	thus	prolonging	their	time	on	the	wait	list.
	 A	qualitative	study	conducted	in	Australia	examined	barriers	to	treatment	
participation	among	32	women	who	sustained	recovery	for	more	than	one	year	
without	 participation	 in	 either	 treatment	 or	 self-help	 groups	 (Copeland,	 1997).	
The	 sample	 identified	 the	 following	 barriers	 to	 treatment:	 social	 stigma	 and	
labeling,	 lack	of	awareness	of	 the	 range	of	 treatment	options,	concerns	about	
childcare,	the	economic	and	time	costs	of	residential	treatment,	concerns	about	
the	 confrontational	 approaches	 that	 were	 pervasive	 in	 traditional	 substance	
abuse	 treatment,	 as	 well	 as	 stereotyped	 perceptions	 of	 treatment	 services	
(e.g.,	the	“religious”	nature	of	12-step	groups).	Moreover,	several	studies	have	
shown	that	women	with	co-occurring	mental	disorders	and/or	who	are	homeless	
may	be	 reluctant	 to	enter	 into	 treatment	because	of	 their	greater	vulnerability,	
which	is	often	related	to	histories	of	trauma	and	victimization	(Padgett,	Hawkins,	
Abrams,	 &	 Davis,	 2006;	 Watkins,	 Shaner,	 &	 Sullivan,	 1999).	 A	 recent	 study	
conducted	with	national	survey	data	showed	that	among	individuals	with	alcohol	
or	 drug	 dependence	 disorders,	 women	 were	 less	 likely	 to	 seek	 treatment	 or	
other	services	for	 their	disorders	 than	men.	However,	women	who	had	sought	
help	 were	 more	 likely	 to	 have	 multiple	 substance	 dependencies,	 comorbid	
mental	health	problems,	and	lower	rates	of	employment	compared	with	female	
substance	 users	who	 had	 not	 sought	 treatment	 (Grella	&	Stein,	 2013).	Thus,	
although	generally	women	are	 less	 likely	 to	seek	 treatment	 for	substance	use	
problems,	and	they	often	encounter	several	barriers	in	doing	so,	those	who	do	
enter	treatment	tend	to	have	greater	problem	severity.
Treatment needs of women with substance use 
disorders
	 Research	 from	 epidemiological	 and	 clinical	 studies	 has	 consistently	
shown	that	women	progress	from	alcohol	or	drug	use	initiation	to	dependence	
more	quickly	 than	men	do,	a	phenomenon	that	may	arise	from	underlying	sex	
differences	 in	 the	neurobiology	of	addiction	(Elton	&	Kilts,	2009).	Women	also	
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tend	to	enter	substance	use	disorder	treatment	after	fewer	years	of	substance	
use,	but	arrive	to	treatment	with	a	more	severe	clinical	profile	compared	to	men.	
In	 particular,	 women	 report	 greater	 psychological	 distress	 and	 mental	 health	
problems,	most	often	mood	and	anxiety	disorders;	more	interpersonal	conflicts	
with	 family	 and	 family-related	 needs,	 particularly	 issues	 related	 to	 parenting;	
greater	exposure	to	childhood	and	adult	trauma	and	victimization	and	associated	
trauma	symptoms;	and	more	problems	related	to	lack	of	employment	vocational	
skills,	and	economic	resources	(Wechsberg,	Craddock	&	Hubbard	1998;	Stewart	
et	al.	2003;	McKay	et	al.	2003;	Chatham	et	al.	1999;	Brady	et	al.	1993).
	 Consistent	with	this	clinical	profile,	women	in	substance	abuse	treatment	
have	 lower	quality	of	 life	as	compared	with	women	 in	 the	general	 population,	
particularly	related	to	their	history	of	trauma	and	lack	of	recovery	support	from	
friends	and	others	 (Tracy	et	 al.,	 2012).	Women	substance	abusers	also	have	
higher	rates	of	sexual	risk	behaviors	than	men,	particularly	among	women	with	
greater	alcohol	use	and	psychiatric	severity,	which	puts	 them	at	higher	 risk	of	
contracting	 HIV	 (Brooks	 et	 al.,	 2010).	As	 previously	 noted,	 women	 are	more	
likely	 to	 be	 adversely	 affected	 by	 their	 spouse	 or	 partner’s	 substance	 use,	
including	a	greater	likelihood	of	victimization,	injury,	mood	and	anxiety	disorders,	
physical	health	problems,	and	overall	poorer	quality	of	life	(Dawson	et	al.	2007).	
Thus,	relationship	issues,	and	the	role	of	substance	use	within	the	relationship	
dynamic,	are	central	issues	for	women’s	treatment	and	recovery.
	 Moreover,	 there	 are	 significant	 differences	 in	 the	 treatment	 needs	 of	
women	by	age,	ethnicity,	sexual	orientation,	culture	and	religious	orientation,	and	
parental	status.	In	one	study	of	women	opiate	users	who	were	seeking	methadone	
treatment,	four	clusters	were	identified	that	were	characterized	by	different	areas	of	
problem	severity:	unemployment,	medical	illness,	psychiatric	distress,	and	higher	
social	functioning	(McMahon	&	Luthar,	2000).	African	American	women	were	over	
represented	 in	 the	group	defined	primarily	by	poor	vocational-education	history,	
whereas	white	women	were	over	represented	in	the	group	that	had	high	psychiatric	
distress	as	well	as	 in	 the	higher-functioning	group.	Among	a	study	of	women	in	
the	criminal	 justice	system,	white	women	reported	the	highest	needs	for	 family-	
and	psychological-related	services,	whereas	African	American	women	expressed	
higher	needs	for	health-related	services	(Grella	&	Greenwell,	2007).	Other	studies	
have	 shown	 that	 experiences	 of	 socio-economic	 disadvantage,	 exposure	 to	
community	violence,	criminal	justice	system	interactions,	and	access	to	resources	
among	women	vary	by	ethnicity	and	influence	perceptions	of	treatment	needs	and	
coping	behaviors	(Amaro	et	al.,	2005,	2007).
	 Older	women	are	particularly	at	risk	of	depression	and	misuse	of	alcohol	
and/or	prescription	medications	given	their	generally	higher	rates	of	prescription	
medication	use	and	their	risks	of	social	 isolation	and	chronic	health	problems	
(Simoni-Wastila,	Ritter,	&	Strickler,	2004;	Simoni-Wastila	&	Yang,	2006).	Among	
older	adults	with	a	history	of	heroin	dependence,	women	 report	more	mental	
and	physical	health	problems	compared	to	 their	male	counterparts,	and	more	
severe	mental	health	problems	than	women	of	comparable	age	in	the	general	
population	 (Grella	&	Lovinger,	2011).	Thus,	 treatment	approaches	 for	women	
need	to	be	tailored	to	address	heterogeneity	among	women,	particularly	related	
to	age,	parenting	status,	cultural	background,	and	socio-economic	resources.
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Substance abuse treatment processes and 
outcomes for women
	 Treatment	processes	and	outcomes	appear	 to	be	 influenced	by	gender	
in	complex	ways	(Green,	2006).	Among	patients	treated	in	a	health	maintenance	
setting,	Green	et	al.	(2002)	found	that	although	time	spent	in	treatment	and	rates	of	
treatment	completion	did	not	differ	by	gender,	treatment	retention	and	completion	
for	both	men	and	women	were	associated	with	different	participant	characteristics.	
An	extensive	review	of	the	literature	by	Greenfield	and	colleagues	(2007)	found	
that	gender	itself	is	not	a	significant	predictor	of	treatment	retention,	completion,	
or	 outcomes,	 but	 different	 factors	may	 predict	 outcomes	 for	 men	 and	 women.	
The	 authors	 concluded	 that	 psychological	 distress	 and	 psychiatric	 symptoms;	
socioeconomic	 status,	 such	 as	 higher	 income,	 employment,	 and	 educational	
attainment;	social	support;	and	personal	and	social	stability	are	all	associated	with	
treatment	retention	and	substance	use	outcomes,	although	relationships	vary	by	
gender.
	 Similarly,	 in	 an	 experimental	 study	 of	 participants	 in	 therapeutic	
community	programs,	Messina,	Wish,	and	Nemes	(2000)	found	that	for	both	men	
and	women	 treatment	completion	was	 the	strongest	predictor	of	 improved	drug	
use,	employment,	and	criminal	justice	outcomes,	although	women	benefited	from	
longer	time	in	treatment.	Access	to	services	also	appears	to	differentially	influence	
outcomes	 for	men	and	women.	 In	a	multi-site	national	study	 that	examined	 the	
relationship	of	services	received	to	outcomes,	the	receipt	of	educational,	housing,	
and	 income	support	 services	was	 related	 to	 reduced	post	 treatment	 substance	
abuse	for	both	women	and	men;	however,	receipt	of	mental	health	services	was	
more	closely	related	to	reductions	in	post	treatment	substance	use	for	women	than	
for	men	(Marsh,	Cao,	&	D’Aunno,	2004).
	 Studies	 have	 shown	 few	 gender	 differences	 in	 rates	 of	 post	 treatment	
relapse	 to	 alcohol	 use,	 although	 the	 evidence	 is	mixed	 in	 regard	 to	 relapse	 to	
drug	use.	There	are	gender	differences,	however,	 in	the	situations	or	conditions	
that	are	associated	with	relapse	to	substance	use.	For	males,	these	include	living	
alone,	positive	affect,	and	social	pressures,	whereas	for	females,	relapse	has	been	
associated	with	not	living	with	one’s	children,	being	depressed,	having	a	stressful	
marriage,	and	being	pressured	to	use	by	their	sexual	partners	(Zywiak	et	al.,	2006;	
Walitzer	 &	Dearing,	 2006;	 Saunders	 et	 al.,	 1993;	Rubin,	 Stout	 &	 Longabaugh,	
1996).	 In	addition,	some	research	has	shown	that	women	tend	to	engage	more	
than	 men	 in	 self-help	 participation	 following	 treatment	 (Humphreys,	 Mavis	 &	
Stofflemayr,	1991)	and	in	successive	treatment	episodes	(Hser	et	al.,	2004),	both	
of	which	may	influence	the	course	of	recovery	following	treatment.
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Gender differences in longitudinal recovery 
outcomes
	 More	in-depth	information	on	how	gender	influences	the	dynamic	course	
of	substance	use,	treatment	participation,	and	recovery	outcomes	is	obtained	from	
longitudinal	studies.	In	one	longitudinal	study	of	a	Chicago-based	treatment	sample,	
men	and	women	did	not	differ	 in	the	prevalence	of	substance	use	reported	at	a	
24-month	follow-up,	but	there	was	more	persistent	use	of	alcohol	and	marijuana	
among	men	and	use	of	cocaine	among	women	(Grella	et	al.,	2003).	Moreover,	
women	 were	 more	 likely	 to	 return	 to	 treatment	 over	 time,	 whereas	 men	 were	
more	likely	to	return	to	prison.	For	women,	living	with	a	substance	user	following	
treatment	predicted	a	greater	likelihood	of	their	own	substance	use	at	24	months,	
but	this	relationship	was	not	significant	among	men.
	 According	 to	 a	 36-month	 assessment	 conducted	 with	 this	 same	 study	
cohort,	there	were	no	differences	between	men	and	women	in	the	proportion	who	
reported	any	alcohol	or	drug	use;	however,	there	were	persistent	gender	differences	
in	several	areas	of	psychosocial	functioning,	including	greater	psychological	distress	
among	women	and	greater	criminal	justice	involvement	among	men	(Grella,	Scott	
&	Foss,	2005).	Women	continued	to	have	lower	rates	of	employment	and	to	report	
more	interpersonal	problems	than	men,	but	they	had	greater	increases	in	self-help	
participation.	Another	study	conducted	with	this	cohort	examined	transitions	across	
various	 recovery	statuses	 (e.g.,	abstinent,	using,	 treatment)	 for	up	 to	6	years.	 In	
multivariate	models	controlling	for	other	characteristics,	women	were	one-third	less	
likely	than	men	to	transition	from	recovery	to	using	over	this	time.	Moreover,	self-
help	participation	was	a	stronger	predictor	of	 transitioning	 from	using	 to	 recovery	
(or,	conversely,	of	remaining	in	recovery)	for	women	(Grella	et	al.,2008).	In	contrast,	
having	an	external	mandate	was	a	much	more	powerful	factor	influencing	treatment	
re-entry	among	men;	there	was	a	12-fold	greater	likelihood	of	moving	from	using	to	
treatment	for	men	who	were	mandated	to	treatment	compared	with	women.	Another	
transition-based	 analysis,	 conducted	 with	 a	 sample	 of	 individuals	 who	 received	
treatment	for	cocaine	use	over	a	6-month	period,	showed	that	men	were	twice	as	
likely	as	women	to	transition	across	statuses,	either	from	using	to	abstinent	or	vice	
versa,	controlling	for	level	of	treatment	received	over	the	interval	(Gallop	et	al.,	2007).
	 Similar	findings	have	been	obtained	in	a	longitudinal	study	of	individuals	
who	sought	help	for	alcohol	problems.	This	study	found	that	women	were	more	
likely	than	men	to	participate	in	self-help	groups	and	to	have	greater	reductions	in	
drinking	associated	with	their	self-help	participation	over	an	8-year	follow-up	period	
(Timko,	Finney	&	Moos,	2005;	Timko	et	al.,	2002).	Moreover,	these	findings	have	
endured	over	a	16-year	 follow-up	period	 (Moos,	Moos	&	Timko,	2006).	Another	
longitudinal	follow-up	study	compared	outcomes	following	treatment	among	older	
adults	(aged	55	and	over)	sampled	from	a	managed	care	provider.	At	the	5-year	
follow-up	point,	women	had	higher	rates	of	abstinence	compared	with	men,	and	
older	women	had	better	outcomes	compared	with	younger	women	(Satre	et	al.,	
2004).	At	 the	7-year	 follow-up	point,	older	women	were	about	 twice	as	 likely	as	
older	men	to	be	abstinent;	however,	duration	in	the	index	treatment	episode	was	
the	strongest	predictor	of	outcomes	for	both	(Satre	et	al.,	2007).
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	 Taken	together,	these	studies	suggest	that	the	course	of	recovery	for	men	
and	women	may	be	mediated	through	their	differential	interactions	with	treatment,	
criminal	justice,	and	12-step	groups,	and	the	social	influences	on	their	substance	
use.	Women	appear	to	sustain	better	outcomes	over	time,	related	to	their	 initial	
treatment	 participation	 and	 ongoing	 12-step	 participation.	 Continuing	 care	
interventions	for	substance	use	disorders	can	build	upon	these	findings	regarding	
gender	 dynamics	 that	 influence	 recovery	 trajectories	 in	 order	 to	 develop	more	
tailored	interventions	for	both	men	and	women.
Gender-specific treatment programs for women 
with substance use disorders
	 Gender-specific	 treatment	 services	 for	 women	 have	 increased	 in	 the	
past	several	decades,	but	still	 remain	 far	 from	universal	 (Grella	&	Greenwell,	
2004).	 Data	 from	 the	 2011	 National	 Survey	 of	 Substance	 Abuse	 Treatment	
Services	(N-SSATS),	an	annual	census	of	facilities	providing	substance	abuse	
treatment	in	the	United	States,	shows	that	close	to	one-third	(31.5%)	of	facilities	
that	provide	substance	abuse	treatment	in	the	United	States	provide	treatment	
programs	 or	 groups	 specifically	 designed	 for	 women	 (Substance	Abuse	 and	
Mental	Health	Services	Administration	 [SAMHSA],	2012).	Moreover,	 the	rates	
are	 somewhat	 higher	 when	 examined	 only	 for	 specialty	 addiction	 providers	
(34.7%),	 as	 compared	 with	 providers	 of	 mental	 health	 services,	 combined	
mental	health	and	substance	abuse	treatment	services,	or	general	health	care	
services.	Facilities	that	are	funded	by	local,	county,	or	community	government	
or	state	also	have	higher	rates	of	offering	special	programs	or	groups	for	women	
39.9%	and	42.5%	respectively	(SAMHSA,	2012).
	 Studies	 have	 shown	 that	 treatment	 facilities	 that	 provide	 services	 to	
women	 only,	 or	 in	 which	 there	 is	 a	 higher	 concentration	 of	 women,	 typically	
provide	a	wider	range	of	services	designed	to	meet	women’s	specific	treatment	
needs	 (Uziel-Miller	&	Lyons,	 2000;	Grella	 et	 al.,	 1999).	Similar	 findings	have	
been	 shown	 for	 treatment	 programs	 that	 receive	 a	 majority	 of	 their	 funding	
from	private	(i.e.	non-governmental)	sources.	Private-sector	programs	in	which	
women	were	the	majority	of	patients	were	more	likely	than	programs	with	fewer	
women	 to	 provide	 child	 care,	 have	 family	 involvement	 in	 treatment,	 provide	
treatment	 for	 psychiatric	 disorders,	 employ	 counselors	 with	 master’s	 level	
degrees,	 receive	 referrals	 from	 mental	 health	 sources	 and	 fewer	 workplace	
referrals,	and	accept	payment	through	public	insurance	(Tinney	et	al.,	2004).
	 Another	 survey	 of	 outpatient	 substance	 abuse	 treatment	 programs	
examined	the	organizational	factors	related	to	the	provision	of	women’s	health	
services,	 such	 as	 gynecological	 exams,	 reproductive	 services,	 and	 prenatal	
services.	Programs	providing	these	services	were	more	likely	to	receive	funding	
earmarked	for	women’s	treatment,	to	be	methadone	providers,	to	have	a	greater	
proportion	of	staff	who	were	specifically	 trained	 in	women’s	 treatment	 issues,	
and	to	be	private	not-for-profit	and	public	units,	rather	than	for-profit	(Campbell	&	
Alexander,	2005).	A	study	using	data	from	the	National	Treatment	Center	Study,	
a	 national	 survey	 of	 public	 and	 privately	 funded	 treatment	 programs,	 found	
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that	 fewer	 than	half	of	 the	publicly	 funded	programs	screened	for	or	provided	
referrals	 for	 eating	 disorders,	 and	 few	 programs	 actually	 provided	 on-site	
treatment	for	these	disorders	(Gordon	et	al.,	2008).	About	one-fifth	of	privately	
funded	programs	provided	treatment	for	eating	disorders	(Killeen	et	al.,	2011).	
Overall,	rates	of	screening,	referral,	and	treatment	for	these	disorders	were	low,	
given	 the	 prevalence	 of	 eating	 disorders	 among	 women	 with	 substance	 use	
disorders.
	 A	 study	 using	 N-SSATS	 data	 from	 2000	 showed	 that	 programs	
providing	“special	services”	for	women	(e.g.,	a	women-specific	program,	group,	
or	 treatment	 track)	 were	 more	 likely	 to	 provide	 other	 services	 that	 address	
women’s	treatment	needs	(e.g.,	child	care,	transportation	assistance,	housing	
assistance,	domestic	violence	counseling,	employment	counseling),	and	 that	
units	that	were	primarily	publicly	financed	or	not-for-profit	were	more	likely	to	
provide	 these	 services	 than	 those	 that	were	 for-profit	 (Olmstead	&	Sindelar,	
2004).	Moreover,	a	panel	study	compared	the	provision	of	services	relevant	to	
women’s	treatment	needs	(e.g.,	prenatal	care,	child	care,	single-sex	therapy,	
same-sex	therapists,	staff	trained	in	women’s	treatment)	in	outpatient	treatment	
programs	in	1995	and	2005	(Campbell	et	al.,	2007).	The	study	found	that	there	
were	significant	declines	over	this	period	in	the	provision	of	single-sex	therapy	
and	the	percentage	of	staff	trained	to	work	with	women	in	outpatient	programs.	
Furthermore,	 private	 for-profit	 treatment	 units	 became	 more	 prevalent	 over	
the	study	period,	and	these	programs	were	 less	 likely	 than	others	 to	provide	
the	 range	 of	 services	 defined	 by	 women’s	 treatment	 needs.	 There	 were	
also	 significant	 declines	 in	 the	 provision	 of	 same-gender	 group	 therapy	 in	
methadone	programs	from	1995	to	2000,	as	well	as	declines	in	same-gender	
individual	and	group	therapy	in	non-methadone	outpatient	programs	from	1995	
to	2005.	However,	despite	these	decreases,	same-gender	group	therapy	was	
more	prevalent	among	methadone	than	drug-free	(non-methadone)	outpatient	
programs	(Alexander	et	al.,	2008).
	 Overall,	 the	 availability	 of	 services	 targeted	 to	 women’s	 needs	 have	
become	more	 prevalent	within	 the	 treatment	 system	over	 the	 past	 25	 years,	
largely	due	to	increases	in	funding	for	these	services	and	the	development	of	
women-specific	 programs.	 However,	 the	 availability	 of	 these	 services	 often	
depends	on	other	organizational	characteristics,	including	the	type	of	treatment	
modality	and	the	source	of	program	revenue.	Moreover,	 there	remain	gaps	 in	
the	provision	of	 needed	services	 to	women.	As	 seen	 in	 one	 study	of	women	
who	were	referred	into	a	women-specific	program	by	the	child	welfare	system,	
fewer	than	half	of	the	women	who	indicated	they	had	specific	treatment	needs	
for	child	care,	family	counseling,	job	training,	housing	assistance,	and	benefits	
assistance	actually	received	these	services	while	in	treatment	(Smith	&	Marsh,	
2002).	Thus,	the	provision	of	services	dedicated	to	women	is	neither	universal	
nor	comprehensive	throughout	the	broader	treatment	system.
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Characteristics and outcomes of women treated 
in gender-specific programs
	 Table	 1	 provides	 a	 summary	 of	 published	 studies	 that	 examine	 the	
characteristics	 and	 outcomes	 of	 women	 who	 receive	 treatment	 in	 women-only	
substance	use	treatment	programs,	including	some	studies	that	compare	women	in	
mixed-gender	and	women-only	programmes.	As	seen	in	this	table,	several	studies	
suggest	that	women	who	receive	treatment	in	women-only	programs	have	a	more	
severe	profile	of	treatment	needs	at	admission,	but	have	better	treatment	retention,	
compared	 to	women	 in	mixed-gender	 programs.	 In	 an	 early	 study	 conducted	 in	
Australia,	 women	 treated	 in	 women-only	 residential	 programs	 were	 more	 likely	
to	have	been	sexually	abused	as	children,	 to	be	 lesbian,	and	to	have	dependent	
children,	compared	 to	women	 in	mixed-gender	residential	programs	(Copeland	&	
Hall,	1992b).	Yet	these	women	were	also	less	likely	to	drop	out	of	the	women-only	
program	compared	with	a	mixed-gender	program	(Copeland	&	Hall,	1992a).
	 In	another	study	conducted	 in	Los	Angeles,	women	who	were	 treated	 in	
women-only	 residential	 programs	 had	 more	 severe	 problems	 before	 treatment	
entry,	but	were	 twice	as	 likely	as	women	 in	mixed-gender	programs	 to	complete	
treatment	 (Grella	 1999).	Another	 multi-site	 study	 in	 California	 compared	 women	
treated	in	women-only	and	mixed-gender	programs,	including	both	residential	and	
outpatient	programs.	Women	in	women-only	programs	had	greater	problem	severity	
in	a	number	of	domains	including	alcohol,	drug,	family,	medical,	and	psychiatric	(Niv	
&	Hser,	2007).	Moreover,	they	utilized	more	treatment	services	and	had	better	drug	
and	legal	outcomes	at	follow-up	compared	to	women	in	mixed-gender	programs.
	 A	study	that	used	national	data	from	a	multi-site	treatment	outcome	study	
in	the	United	States	found	that	pregnant	and	parenting	women	who	were	treated	
in	residential	programmes	with	higher	proportions	of	other	such	women	had	longer	
stays	in	treatment,	which	were	positively	associated	with	post-treatment	abstinence	
(Grella,	Joshi,	&	Hser,	2000).	These	programmes	also	provided	more	comprehensive	
services,	 including	 services	 that	 addressed	 family,	 parenting,	 and	mental	 health	
needs.	Using	national	multi-site	data,	Brady	and	Ashley	(2005)	showed	that	women	
in	 women-only	 residential	 programs	 stayed	 in	 treatment	 an	 average	 of	 83	 days	
compared	 to	 22	 days	 for	 those	 in	mixed-gender	 programs.	 Similarly,	 Greenfield	
and	colleagues	(2004)	 found	that	women	were	retained	 longer	 in	gender-specific	
residential	 programs	 in	 three	national	 treatment	outcome	studies.	With	 regard	 to	
post-treatment	 outcomes	 of	women	 treated	 in	women-only	 versus	mixed-gender	
programs,	 findings	 have	 been	mixed.	 In	 a	 non-experimental	 study	 conducted	 in	
Australia,	 there	were	no	outcome	differences	 in	drug	use,	severity	of	depression,	
self-esteem,	or	social	support	network	between	women	in	women-only	and	mixed-
gender	 programs	 (Copeland	 et	 al.,	 1993).	 Prendergast	 and	 colleagues	 (2011)	
compared	women	treated	in	women-only	versus	mixed-gender	outpatient	programs;	
at	one	year	follow-up,	women	who	participated	in	the	women-only	treatment	reported	
significantly	less	substance	use	and	criminal	activity	than	women	in	the	mixed-gender	
treatment,	but	there	were	no	differences	in	arrest	or	employment	status	at	follow-up.	
Claus	and	colleagues	(2007)	showed	that	women	who	were	treated	in	specialized	
residential	treatment	programs	for	women	in	Washington	State	were	more	likely	than	
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those	in	standard	mixed-gender	programs	to	participate	in	continuing	care	following	
their	discharge.
	 Another	 study	 used	 administrative	 records	 to	 examine	 post-treatment	
outcomes	for	up	to	8	years	among	500	mothers	treated	in	women-only	programs	
(across	modalities)	and	a	matched	sample	of	500	mothers	treated	in	mixed-gender	
programs	 in	 California	 (Hser,	 Evans,	 Huang	 &	Messina,	 2011).	 They	 found	 that	
women	treated	in	women-only	programs	had	lower	levels	of	arrest,	mental	health	
services	utilization	rates,	and	drug	treatment	participation	during	the	first	year	after	
drug	treatment.	No	differences	were	found,	however,	between	the	two	groups	in	the	
long-term	trajectories	except	that	the	women-only	program	participants	had	lower	
incarceration	rates	during	the	third	year	after	treatment.	In	the	same	study,	outcomes	
were	examined	specifically	for	Hispanic	women.	Hispanic	women	treated	in	women-
only	 programs	were	 underrepresented	 (relative	 to	mixed-gender	 programs),	 and	
also	had	more	severe	 treatment	needs,	 indicated	by	greater	severity	 in	drug	and	
alcohol	 use,	 health	 and	 mental	 health	 problems,	 economic	 status,	 and	 criminal	
justice	involvement	at	admission.	Hispanic	women	treated	in	women-only	programs	
had	higher	mental	health	service	utilization	over	8	years	post-treatment	admission,	
although	no	differences	were	found	in	trajectories	of	arrests	and	incarceration	(Hser,	
Hunt,	Evans,	Chang	&	Messina,2012).
	 As	shown	in	Table	1,	most	evaluations	of	women-only	programs	have	used	
observational	 designs	 that	 capitalize	 on	 samples	 from	 women-only	 and	 mixed-
gender	programmes.	There	have	been	only	a	few	experimental	studies	that	compare	
the	outcomes	of	treatment	in	women-only	versus	mixed-gender	treatment	programs.	
An	 experimental	 study	 of	 women	 in	 the	 “early	 stages”	 of	 alcohol	 dependence	
conducted	 in	Sweden	 found	 that	women	 treated	 in	women-only	programs	had	a	
greater	reduction	in	alcohol	use	and	better	social	adjustment	compared	to	women	
who	were	 treated	 in	mixed-gender	 programs	 (Dahlgren	 &	Willander,	 1989).	 The	
authors	surmised	that	women	may	be	more	likely	to	enter	into	women-only	programs	
at	an	earlier	stage	of	their	addiction	careers.	In	contrast,	Kaskutas	and	colleagues	
found	no	beneficial	effects	of	women-specific	 treatment	 in	an	experimental	study	
that	randomly	assigned	participants	to	a	community-based	women-only,	community	
mixed-gender	day	treatment,	or	a	hospital-based	program	(Kaskutas	et	al.,	2005).
	 Overall,	a	large	body	of	research	has	demonstrated	that	women	have	higher	
rates	of	 treatment	completion	and	better	outcomes	under	 the	following	conditions:	
(1)	in	residential	treatment	programs	that	have	live-in	accommodations	for	children	
(Wobie	et	al.,	1997;	Szuster	et	al.,	1996;	Stevens	&	Patton,	1998;	Hughes	et	al.,	1995);	
(2)	in	outpatient	treatment	that	includes	the	provision	of	family	therapy	(Zlotnick	et	al.,	
1996),	 individual	counseling	(Volpicelli	et	al.,	2000),	and	family	services	(Wingfield	
&	 Klempner,	 2000);	 and	 (3)	 when	 treatment	 includes	 comprehensive	 supportive	
services,	such	as	case	management,	pregnancy-related	services,	parenting	training/
classes,	childcare,	vocational	training,	and	aftercare	(Weisdorf	et	al.,	1999;	Strantz	
&	Welch,	1995;	Lanehart	et	al.,	1996;	Howell,	Heiser	&	Harrington,	1999;	Camp	&	
Finkelstein,	1997).	 In	addition,	women	 in	substance	abuse	 treatment	who	 receive	
a	 wider	 range	 of	 health	 and	 social	 services,	 or	 enhanced	 services,	 report	 better	
outcomes	and	greater	satisfaction	with	treatment	(Sanders,	Trinh	&	Sherman,	1998),	
particularly	 when	 services	 are	 matched	 with	 their	 needs	 (Smith	 &	 Marsh,	 2002;	
Marsh,	D’Aunno	&	Smith,	2000).
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	 In	a	systematic	review	of	program	factors	related	to	successful	 treatment	
outcomes	 among	women	 in	 35	 studies,	 five	 factors	 were	 identified:	 (1)	 single-	
versus	mixed-gender	programs;	(2)	treatment	intensity;	(3)	provision	of	child	care;	
(4)	 case	 management;	 and	 (5)	 supportive	 staff	 and	 the	 provision	 of	 individual	
counseling	(Sun,	2006).	Similarly,	a	systematic	review	of	38	studies	of	substance	
abuse	 treatment	 for	 women,	 most	 of	 which	 were	 non-experimental	 designs,	
identified	 six	 elements	 associated	 with	 better	 outcomes	 regarding	 treatment	
completion,	length	of	stay,	decreased	use	of	substances,	reduced	mental	health	
symptoms,	improved	birth	outcomes,	employment,	self-reported	health	status,	and	
HIV	risk	reduction	(Ashley,	Marsden	&	Brady,	2003).	These	elements	are:	(1)	child	
care;	 (2)	prenatal	care;	 (3)	women-only	program	composition;	 (4)	supplemental	
services	and	workshops	 that	 address	women-focused	 topics;	 (5)	mental	 health	
services;	and	(6)	comprehensive	programming.
	 These	 comprehensive	 reviews	 also	 identified	 several	 methodological	
shortcomings	to	the	extant	body	of	research	on	women’s	treatment	programs.	These	
included	 a	 limited	 range	 of	 treatment	 outcomes	 examined,	 lack	 of	 experimental	
studies	with	randomized	assignment	to	conditions,	lack	of	standardized	measures,	
lack	of	consistent	definitions	for	treatment	factors	and	outcomes,	small	sample	sizes,	
lack	of	 thorough	program	description,	 lack	of	 thorough	statistical	 analyses,	 small	
effect	sizes	for	observed	outcomes,	and	limited	follow-up	periods.	Further,	although	
it	 is	assumed	 that	 the	 therapeutic	process	within	women-specific	programs	differ	
from	those	in	mixed-gender	programs	(Hodgins,	el-Guebaly	&	Addington,	1997),	few	
studies	have	measured	the	dynamic	aspects	of	treatment	provided	in	women-only	
as	compared	with	mixed-gender	programs.	Some	have	noted	that	merely	changing	
the	program	composition	from	mixed-gender	to	women-only	may	not	substantially	
change	the	treatment	process	 in	order	 to	fully	address	women’s	treatment	needs	
(Bride,	 2001).	 Others	 have	 noted	 that	 traditional	 therapeutic	 community	 (TC)	
programs,	even	if	gender-specific,	may	be	clinically	inappropriate	if	their	emphasis	
on	confrontation	 is	not	modified	to	accommodate	the	greater	 likelihood	of	 trauma	
and	abuse	history	among	women,	particularly	among	women	in	the	criminal	justice	
system	where	TC	programs	have	been	widely	adopted	(Eliason,	2006).
	 One	recent	study	validated	three	scales	that	measured	different	domains	
of	“gender-sensitive”	treatment	(Grella,	2008),	using	data	from	site	visits	and	semi-
structured	interviews	with	program	directors,	clinical	directors,	and	counselors	in	
13	mixed-gender	 outpatient	 treatment	 programs	 from	Washington	 State	 (Tang,	
Claus,	Orwin,	Kissin	&	Arieira,	2012).	The	unique	domains	included:	(1)	treatment	
orientation	 and	 staff	 training	 (i.e.,	 program	orientation	 toward	 behavioral	 health	
services	and	staff	training	related	to	women’s	treatment,	such	as	trauma,	parenting,	
cultural	issues,	domestic	violence),	(2)	general	and	women-specific	services	(i.e.,	
treatment	assessment	and	services	related	to	vocational	counseling,	trauma,	life	
skills,	parenting	needs,	medical	needs)	and	(3)	program	physical	environment	(i.e.,	
safety,	privacy,	livability	of	the	program	and	surrounding	area,	such	as	cleanliness,	
recreational	 areas,	 number	 of	 clients	 per	 bedroom/bathroom).	 However,	 the	
relationship	 of	 these	 specific	 domains	with	 treatment	 outcomes	 among	women	
treated	in	women-specific	programs	has	not	been	examined.
	 An	important	consideration	with	regard	to	the	adoption	of	gender-specific	
services	is	the	generally	higher	cost	of	these	services,	due	to	the	longer	duration	of	
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treatment	and	inclusion	of	services	such	as	medical	services,	services	for	children,	
mental	health	services,	housing,	etc.	that	 increase	costs	(Burgdorf	et	al.,	2004).	
One	study	found	that	a	mixed-gender	aftercare	treatment	program	was	less	cost-
effective	for	women	compared	with	men	because	of	the	higher	costs	associated	
with	women’s	more	severe	baseline	characteristics	(e.g.,	more	employment	needs;	
Yeom	&	Shepard,	2007).	Yet	several	studies	have	shown	that	despite	the	generally	
higher	 costs	 of	 gender-specific	 treatment	 for	women,	 these	 costs	 are	 offset	 by	
the	 improved	outcomes	they	yield.	Cost-benefit	analyses	have	shown	favorable	
results	in	residential	versus	outpatient	treatment	for	women	(Daley	et	al.,	2000);	
in	 specialized	 versus	 standard	 residential	 programs	 for	 women	 (French	 et	 al.,	
2002);	and	in	a	multidisciplinary,	comprehensive	treatment	program	for	pregnant	
women	 versus	 standard	 care	 (Svikis	 et	 al.	 1997).	 Moreover,	 a	 cost-outcome	
study	 of	 SAMHSA’s	 multi-site	 Women,	 Co-Occurring	 Disorders	 and	 Violence	
Study	showed	that	there	was	no	added	cost	for	trauma-integrated	treatment	over	
standard	treatment	(Domino	et	al.,	2005).
 Study Research Design Sample Site / Findings
   Location
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Substance abuse treatment for criminal justice 
involved women
	 Given	 their	 higher	 rates	 of	 arrest	 and	 incarceration	 in	 recent	 years,	
particularly	 for	drug-related	crime,	women	substance	abusers	are	 increasingly	
being	 referred	 to	 treatment	 under	 court	 supervision	 (Grella,	 2008).	 As	 with	
substance-abusing	 women	 in	 community	 treatment,	 criminal	 justice-involved	
women	with	substance	use	problems	typically	report	a	more	severe	clinical	profile	
compared	to	justice-involved	men	(Belenko	&	Houser,	2012),	and	are	in	need	of	
a	wider	range	of	services	(Adams,	Leukefeld	&	Peden,	2008;	Messina,	Burdon,	&	
Prendergast,	2003).	Yet	women	offenders	often	face	barriers	to	accessing	health	
care,	 treatment	 and	 other	 services	 in	 the	 community	 if	 they	 lack	 employment	
and/or	health	 insurance	coverage	(Fearn	&	Parker,	2005;	Staton,	Leukefeld,	&	
Webster,	 2003).	They	may	 feel	 intimidated	 or	 stigmatized	 in	 their	 interactions	
with	health	care	providers	(Staton,	Leukefeld,	&	Logan,	2001;	Plugge,	Douglas,	
&	Fitzpatrick,	2011),	which	further	limits	their	use	of	health	care	and	prevention-
oriented	services.
	 Studies	 have	 shown	 that	 incarcerated	 women	 have	 significantly	 higher	
rates	 of	 psychiatric	 disorders	 than	 incarcerated	men	 (Binswanger	 et	 al.,	 2010;	
Sacks,	2004;	Teplin	et	al.,	1996).	About	one	half	of	women	on	probation	or	parole	
have	a	past-year	mental	disorder,	which	is	approximately	twice	the	rate	of	women	
in	the	general	population	(National	Survey	on	Drug	Use	and	Health,	2012).	Women	
offenders	are	2	-	4	times	more	likely	to	have	a	history	of	various	types	of	trauma	
and	abuse	compared	 to	women	 in	 the	general	population	of	comparable	socio-
demographics	(Grella,	Lovinger,	&	Warda,	2013;	Messina	&	Grella,	2006).	Further,	
because	of	their	high	rates	of	trauma	exposure,	women	offenders	are	at	high	risk	
of	PTSD.	Rates	of	 lifetime	PTSD	among	women	offenders	 typically	 range	 from	
Table 1. Summary	of	Research	on	Women-Only	vs.	Mixed-Gender	Treatment	Programs
WO	=	women-only;	MG	=	mixed-gender
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one	quarter	to	one	third	(Hutton	et	al.,	2001).	Incarcerated	women	are	especially	
at	 risk	 for	 trauma	 re-exposure	 and	 PTSD	 if	 they	 engage	 in	 prostitution	 (Millay	
et	al.,	2009).	Addressing	 their	 treatment	needs	 related	 to	 trauma	exposure	and	
associated	 trauma-related	symptoms	 is	paramount,	as	studies	have	shown	that	
offenders	with	mental	 health	 problems	 are	more	 likely	 than	 others	 to	 return	 to	
prison	(Messina,	Burdon,	Hagopian,	&	Prendergast,	2004).
	 Women	 offenders	 typically	 have	 limited	 employment	 skills	 and	 work	
history,	and	repeated	prior	interactions	with	the	criminal	justice	system	(Langan	&	
Pelissier,	2001;	Pelissier	&	Jones,	2005;	Grella	&	Greenwell,	2007).	Many	women	
substance	abusers	thatenter	into	the	criminal	justice	system	have	been	separated	
from	their	children	and	are	involved	with	the	child	welfare	system.	They	often	lack	
basic	parenting	skills	and	display	poor	parental	attitudes	that	are	 indicative	of	a	
higher	risk	for	child	abuse	(Grella	&	Greenwell,	2006).
	 In	 addition,	 women	 offenders	 often	 have	 physical	 health	 problems	
that	 stem	 from	 the	 effects	 of	 their	 substance	 abuse	 and	 associated	 unhealthy	
behaviors,	which	are	exacerbated	by	their	lack	of	access	to	or	utilization	of	health	
care	 services	 (Staton,	 Leukefeld,	 &	 Logan,	 2001).	 Research	 has	 shown	 that	
substance-abusing	women	 offenders	 are	 at	 risk	 of	 a	 range	 of	 chronic	 physical	
health	 problems;	 these	 include	 TB,	 hepatitis,	 toxemia,	 anemia,	 hypertension,	
diabetes,	and	obesity	 (Langan	&	Pelissier,	2001).	Women	offenders	often	have	
reproductive	health	problems,	including	unplanned	pregnancies,	inconsistent	use	
of	birth	control,	and	high	rates	of	STDs	(Clarke	et	al.,	2006;	Fogel,	1993).
	 Several	studies	have	shown	high	 rates	of	sexual	 risk	behaviors	among	
women	offenders,	which	make	them	vulnerable	to	HIV	and	other	STDs	(Guydish	
et	al.,	2011;	Scott	&	Dennis,	2012).	Female	offenders	have	high	rates	of	infectious	
diseases,	 STDs,	 and	 high-risk	 behaviors	 for	 HIV/AIDS	 stemming	 from	 their	
involvement	in	prostitution	and	sexual	contact	with	high-risk	sex	partners	(Schilling	
et	al.,	1994;	Vlahov	et	al.,	1991;	Guyon	et	al.,	1999;	Magura	et	al.,	1993).	Studies	
have	also	 shown	 that	women	 inmates	have	 limited	access	 to	medical	 services	
(Plugge	&	Fitzpatrick,	2005;	Plugge,	Douglas	&	Fitzpatrick,	2008;	Douglas,	Plugge,	
&	 Fitzpatrick,	 2009)	 and	 receive	 poor	 health	 care,	 especially	 gynaecological	
services	(Stoller,	2000)	while	incarcerated.	Without	adequate	intervention,	these	
women	are	at	high	risk	for	chronic	health	problems	that	could	have	been	averted	
with	improved	health	behaviors.	For	example,	one	study	in	England	found	that	over	
85%	of	a	sample	of	incarcerated	women	smoked	cigarettes,	were	inactive,	and	did	
not	 eat	 adequate	 amounts	 of	 fruits	 and	 vegetables,	 and	 30%	were	 overweight	
or	 obese	 (Plugge	 et	 al.,	 2009).	Unemployment	 and	 lower	 education	were	 both	
associated	with	higher	 levels	of	health	risk	behaviors,	 in	particular	hypertension	
(Shah,	Plugge	&	Douglas,	2011).	The	 rate	of	smoking	among	 female	offenders	
far	exceeds	that	of	women	in	the	general	population,	and	there	is	an	urgent	need	
for	smoking	cessation	interventions	for	this	population	–	both	for	their	own	health	
status	and	that	of	their	children	who	are	exposed	to	second-hand	smoke	(Cropsey	
et	al.,	2004,	2008).
	 Because	 women	 in	 the	 criminal	 justice	 system	 have	 more	 severe	
problems	related	to	their	drug	use	and	background,	they	are	more	likely	to	need	
higher	 intensity	treatment,	 including	residential	 treatment,	 treatment	for	a	 longer	
duration,	 and	 continuing	 care	 (Belenko	 &	 Peugh,	 2005).	 One	 study	 showed	
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that	 women	 in	 prison	 were	 more	 likely	 than	 men	 of	 comparable	 drug-related	
problems	 to	 participate	 in	 treatment,	 particularly	 among	women	with	 a	 history	
of	 opiate,	 cocaine,	 or	 methamphetamine	 use	 (Belenko	 &	 Houser,	 2012).	 Yet	
some	 research	 has	 shown	 that	 women	 in	 prison	 receive	 fewer	 services	 than	
their	male	counterparts	(Oser	et	al.,	2009)	and	that	they	face	additional	barriers	
to	accessing	services	in	the	community	(Jordan	et	al.,	2002;	Staton,	Leukefeld	
&	Logan,	2001).	Moreover,	women	released	from	jail	have	high	rates	of	relapse	
and	need	for	treatment;	one	study	of	female	arrestees	shows	that	approximately	
three	quarters	of	women	relapsing	 to	drug	use	within	90	days	of	 their	 release	
(Scott	&	Dennis,	2012).
	 Several	 randomized	 controlled	 studies	 have	 found	 better	 outcomes	 for	
women	 offenders	 who	 are	 treated	 in	 “gender-responsive”	 programs	 designed	
specifically	for	women	(Covington	&	Bloom,	2006).	In	one	study,	women	in	drug	
court	who	received	gender-responsive	outpatient	treatment,	compared	to	women	
who	 received	 usual	 care,	 had	 better	 in-treatment	 performance,	 more	 positive	
perceptions	of	treatment,	and	a	trend	for	greater	reductions	in	symptoms	of	PTSD	
(Messina,	Calhoun	&	Warda,	2012).	Another	study	of	women	 in	prison	showed	
that	those	who	received	a	manual-guided	gender-responsive	treatment	program	
had	 significantly	 lower	 re-incarceration	 rates	 12	months	 after	 parole	 compared	
to	 participants	 in	 a	 standard,	 therapeutic	 community	 program	 (31%	 vs.	 45%,	
respectively).	They	were	also	more	likely	to	participate	in	aftercare	following	parole	
(Messina,	Grella,	Cartier	&	Torres,	2010).	Lastly,	women	in	prison	who	participated	
in	 a	 “gender-sensitive”	 modified	 therapeutic	 community	 had	 better	 outcomes	
regarding	drug	use,	mental	health	functioning,	criminal	activity,	trauma	exposure,	
and	recidivism,	compared	to	women	who	received	usual	care	outpatient	substance	
abuse	treatment	(Sacks,	McKendrick	&	Hamilton,	2012).
	 In	 sum,	 women	 offenders	 with	 substance	 use	 problems	 share	 similar	
characteristics	 to	 women	 in	 community-based	 substance	 abuse	 treatment,	
although	their	problems	are	typically	more	severe.	They	generally	present	a	more	
severe	clinical	profile	in	relation	to	men,	particularly	regarding	mental	and	physical	
health,	 history	 of	 trauma	and	 abuse,	 parenting,	 and	 employment	 needs.	Given	
their	high	need	for	services,	both	in	correctional	and	community	settings,	and	the	
effects	 of	 their	 incarceration	 on	 themselves	 and	 their	 families,	 a	 priority	 should	
be	placed	on	developing	gender-responsive	interventions	for	substance-abusing	
women	who	are	involved	in	the	criminal	justice	system.
Evidence-based treatment approaches for 
women substance abusers
	 In	the	past,	studies	of	the	effectiveness	of	substance	abuse	treatment	often	
failed	to	take	into	consideration	either	gender	differences	or	specific	approaches	
developed	 for	women	 (Greenfield	et	 al.,	 2011).	Yet	 recently,	 there	 is	 a	growing	
literature	based	on	the	findings	of	comparative	effectiveness	studies	that	examine	
treatment	protocols	that	have	been	developed,	or	modified,	specifically	for	women.	
In	Table	1	we	briefly	review	findings	from	research	on	the	predominant	evidence-
based	treatment	approaches	that	have	been	examined	for	women.
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Pharmacotherapy
	 Several	studies	have	examined	the	use	of	opiate-substitution	therapies	in	
the	treatment	of	pregnant	women,	examining	outcomes	related	to	prenatal	exposure	
and	 birth	 outcomes,	 and	 the	 relationship	 with	 dosing	 (Kaltenbach,	 Berghella	 &	
Finnegan	 1998;	 Johnson	 et	 al.,	 2001;	 Fischer	 et	 al.,	 2000).	 Pharmacological	
treatment	of	opiate-dependent	pregnant	and	post-partum	women	requires	careful	
consideration	 of	 the	 assessment	 and	 selection	 of	 appropriate	 maintenance	
medication;	 induction	and	stabilization;	and	medication	management	 in	relation	to	
the	various	stages	of	pregnancy,	delivery,	post-partum,	and	aftercare.	A	large,	multi-
site	double-blind	study	recently	showed	that	opiate-dependent	pregnant	women	who	
receive	buprenorphine	have	similar	or	improved	outcomes	(with	regard	to	treatment	
adherence,	 birth	 outcomes,	 neonatal	 status)	 as	 pregnant	 women	 who	 receive	
methadone	maintenance	treatment	(Jones	et	al.,	2012;	Gaalema	et	al.,	2012).
	 Apart	 from	 issues	 related	 to	 pregnancy,	 few	 clinically	 significant	 gender	
differences	have	been	identified	in	the	use	of	buprenorphine	(a	medication	with	both	
opioid-agonist	and	antagonist	properties)	and	methadone	(an	opioid	agonist).	There	
is	some	evidence	suggesting	gender	differences	in	dose-response	to	medications	
used	 to	 treat	 substance	 abuse	 (Pettinati	 et	 al.	 2007;	 Pettinati,	 Dundon	 &	 Lipkin	
2004),	 with	 poorer	 outcomes	 regarding	 side	 effects,	 retention,	 and	 abstinence	
observed	among	women	than	men.	Other	studies	have	identified	gender	differences	
in	response	to	different	dosing	schedules	(Marsch	et	al.	2005).	However,	a	recent	
study	found	no	significant	gender	differences	among	individuals	 in	a	 large	clinical	
trial	for	prescription	opioid	dependence	in	medication	dose,	treatment	retention,	or	
opioid	outcomes	(McHugo	et	al.,	2013).	There	were	differences,	however,	in	baseline	
characteristics,	 with	 women	 reporting	 significantly	 greater	 functional	 impairment,	
greater	psychiatric	severity,	and	more	use	of	opioids	to	cope	with	negative	emotions	
and	pain	than	men,	and	men	reporting	more	alcohol	problems	than	women.
	 There	is	some	evidence	suggesting	that,	among	patients	with	cocaine	and	
alcohol	dependence	being	treated	with	naltrexone	(an	opioid	receptor	antagonist),	
women	have	more	side	effects,	less	treatment	adherence,	more	treatment	attrition,	
and	lower	rates	of	abstinence	in	response	to	the	same	dose,	compared	to	men.	
Gender	differences	in	pharmacokinetics	(e.g.,	processes	related	to	the	absorption,	
distribution,	 metabolism,	 and	 elimination	 of	 a	 drug)	 may	 underlie	 differential	
responses	 to	 medications	 and	 their	 effectiveness	 in	 treating	 alcohol	 or	 drug	
dependence;	however,	research	in	this	area	is	still	limited.
Cognitive behavioral therapy/relapse prevention
	 Cognitive	behavioral	therapies	use	structured	protocols	to	teach	patients	
skills	for	managing	their	symptoms	and	avoiding	relapse	(i.e.,	relapse	prevention).	
Patients	are	 taught	how	 to	 recognize	 “cues”	or	 “triggers”	of	 substance	use	and	
to	 use	 strategies	 for	 avoiding	 relapse	 in	 those	 situations.	As	 noted	 previously,	
research	has	shown	that	different	factors	are	associated	with	relapse	to	substance	
use	following	treatment	for	men	and	women,	particularly	related	to	social	situations	
and	 relationships.	 Several	 small	 pilot	 studies	 have	 tested	 cognitive	 behavioral	
therapy	approaches	delivered	to	women	in	group	settings.
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	 A	 behavioral	 therapy	 trial	 conducted	 by	 Greenfield	 and	 colleagues	
(Greenfield	et	al.	2007b)	aims	to	parcel	out	the	effects	of	a	women-specific	group	
therapy	that	uses	cognitive	behavioral	techniques.	The	trial	compares	the	outcomes	
of	women	who	participate	in	an	all-women’s	group	that	focuses	on	the	factors	that	
precipitate	and	consequences	of	women’s	alcohol	 and	drug	use.	Results	 from	a	
pilot	 study	 show	 promising	 outcomes	 for	 the	 all-women	 group	 compared	 with	
standard	 group	 therapy,	 but	 at	 present	 it	 is	 unclear	 if	 the	 group	 dynamics,	 such	
as	 the	 level	 of	 comfort	 and	 support	 and	 nature	 of	 interaction	 in	 the	 all-women’s	
group,	 versus	 the	 content	 of	 discussion	 regarding	 women’s	 specific	 cues	 and	
triggers,	or	both	processes,	underlie	the	superior	outcomes.	In	addition,	there	are	
significant	reductions	in	psychiatric	symptoms	up	to	6-months	post-treatment	among	
participants	 in	both	 treatment	groups,	and	 these	are	greater	among	women	with	
higher	degrees	of	severity	(McHugh	&	Greenfield,	2010).	Another	pilot	study	testing	
a	women-specific	group	counseling	intervention,	using	a	workbook-based	psycho-
education	approach,	shows	promising	results	regarding	retention	and	satisfaction,	
but	has	not	yet	been	tested	in	an	experimental	trial	(Najavits	et	al.,	2007b).
Motivational enhancement interventions
	 Motivational	 enhancement	 interventions	 use	 therapeutic	 strategies	 to	
increase	 the	 individual’s	 awareness	 of	 their	 substance	 abuse	 problems	 and	
to	engage	 their	commitment	 to	behavior	change.	These	approaches	can	build	
upon	the	issues	that	are	central	to	motivating	women	to	address	their	substance	
abuse	 problems,	 particularly	 related	 to	 their	 identity,	 self-esteem,	 health,	 and	
relationships	 with	 children,	 other	 family	 members,	 and	 friends.	 Motivational	
interventions	 can	 also	 build	 upon	 the	 specific	 coping	 styles	 used	 by	 women,	
which	may	be	more	emotionally	 focused	 than	 those	of	men	 (Cook,	Epperson	
&	Gariti,	2005)	as	well	as	more	reliant	on	religious	or	spiritual	coping	methods	
(Fallot	&	Heckman,	2005).
	 Few	studies	have	actually	looked	at	gender	differences	in	the	effectiveness	
of	motivational	approaches	(Vasilaki,	Hosier	&	Cox,	2006).	Most	of	these	studies	
have	focused	on	pregnant	substance-abusing	women,	since	pregnant	women	may	
decline	to	enter	 into	 treatment	 if	 they	fear	doing	so	will	 jeopardize	their	custody	
of	 their	children	(Jessup	et	al.,	2003;	Haller,	Miles	&	Dawson,	2003).	Moreover,	
pregnancy	may	be	a	“window	of	opportunity”	during	which	women	are	potentially	
more	receptive	to	motivational	interventions	that	can	be	delivered	within	prenatal	
care	visits	(Jessup	&	Brindis,	2005;	DiClemente,	Dolan-Millun	&	Windsor,	2000).	
In	one	study,	a	brief	motivational	 intervention	was	used	 to	address	alcohol	use	
among	pregnant	women	in	primary	health	care	settings;	information	on	the	health	
effects	of	alcohol	use	during	pregnancy	was	provided,	with	the	aim	of	motivating	
women	based	on	their	desire	to	protect	the	health	of	their	child	(Handmaker,	Miller	
&	Manicke,	1999).	Participants	who	had	 the	highest	blood	alcohol	 levels	during	
early	pregnancy	had	greater	 reductions	 in	alcohol	use	at	a	2-month	 follow-up	 if	
they	 received	 the	 motivational	 interview,	 compared	 to	 participants	 that	 merely	
received	 an	 informational	 pamphlet.	 Similarly,	 in	 another	 experimental	 study,	
pregnant	women	with	the	highest	levels	of	alcohol	consumption	had	significantly	
greater	reductions	in	use	after	a	single-session	brief	intervention	compared	with	a	
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usual	care	group;	furthermore,	the	effect	was	enhanced	when	the	woman’s	partner	
participated	in	the	session	(Chang	et	al.,	2005).
	 An	experimental	 study	conducted	 in	 the	NIDA-sponsored	Clinical	Trials	
network	 examined	 the	 effectiveness	 of	 the	Motivational	 Enhancement	 Therapy	
for	Pregnant	Substance	Users	(three	sessions)	versus	treatment	as	usual	(three	
individual	 counseling	 sessions)	 among	 pregnant	 women	 recruited	 from	 four	
programs.	Although	 there	were	 no	 overall	 beneficial	 effects	 of	 the	motivational	
intervention	for	the	study	sample	as	a	whole,	minority	women	who	received	the	
intervention	 tended	 to	 have	 better	 substance	 use	 outcomes	 at	 the	 one-month	
follow-up	(Ondersma	et	al.,	2009).
Contingency management
	 Contingency	management	approaches	employ	a	schedule	of	rewards	to	
strengthen	 the	 practice	 of	 desired	 behaviors	 (e.g.,	 abstinence).	These	 rewards	
are	 small	 gifts,	 cash,	 or	 vouchers	 that	 can	 be	 accumulated	 according	 to	 the	
duration	of	abstinence	attained,	and	they	can	be	reversed	upon	a	relapse.	These	
approaches	 have	 been	 successfully	 used	 in	 smoking	 reduction	 programs	 for	
pregnant	women	who	 are	 in	 treatment	 for	 drug	 abuse	 (Donatelle	 et	 al.,	 2004),	
most	commonly	in	methadone	maintenance	treatment	(Svikis	et	al.,	1997b;	Jones	
et	al.,	2001;	Jones	et	al.,	2000;	Tuten,	Fitzsimons,	Chisolm,	Nuzzo	&	Jones,	2012).	
Use	of	contingency-based	 incentives	has	also	been	combined	with	motivational	
interventions	 to	 increase	 participation	 in	 counseling	 sessions	 among	 pregnant	
women	seeking	prenatal	care	(Jones	et	al.,	2004).
Trauma-specific interventions
	 As	noted	previously,	women	in	substance	abuse	treatment,	either	community-	
or	 correctional-based,	 have	 higher	 rates	 of	 co-occurring	 post-traumatic	 stress	
disorder	(PTSD)	compared	to	men	and	to	women	in	the	general	population.	Women	
with	both	substance	use	disorders	and	PTSD	are	more	 impaired	at	admission	 to	
treatment	and	show	less	improvement	over	time	in	measures	of	substance	use	and	
psychosocial	 functioning	 (Najavits	et	al.,	2007a).	Similarly,	exposure	 to	childhood	
abuse	 and	 trauma	 among	 women	 has	 been	 associated	 with	 less	 improvement	
in	 substance	 use	 severity	 and	 mental	 health	 status	 following	 substance	 abuse	
treatment	(Sacks,	McKendrick	&	Banks,	2007)	and	with	higher	rates	of	relapse.
	 Several	 interventions	 have	 been	 developed	 to	 integrate	 treatment	 for	
trauma	 exposure	 and	 PTSD	 within	 the	 context	 of	 substance	 abuse	 treatment	
(McHugo	et	al.	2005).	SAMHSA’s	Women,	Co-Occurring	Disorders	and	Violence	
Study	has	provided	a	rich	basis	of	empirical	support	for	the	inclusion	of	trauma-
specific	 services	 within	 the	 context	 of	 substance	 abuse	 treatment	 for	 women.	
This	multi-site,	quasi-experimental	initiative	tested	the	effectiveness	of	a	menu	of	
trauma-related	interventions	that	were	integrated	into	substance	abuse	treatment,	
in	 comparison	with	 substance	 abuse	 treatment-as-usual.	The	 outcome	 showed	
that	women	who	received	trauma-informed	treatment	had	greater	improvements	in	
trauma	and	mental	health-related	symptoms	at	12-month	follow-up,	compared	with	
those	in	the	usual-care	comparison	condition,	although	there	were	no	differences	
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between	groups	in	substance	use	outcomes	(Morrissey	et	al.,	2005).	The	strongest	
effects	were	found	in	sites	where	counseling	sessions	(either	individual	or	group)	
integrated	 trauma-related,	 substance	abuse,	 and	mental	 health	 issues,	 yielding	
greater	reductions	in	mental	health	symptoms	and	alcohol	and	drug	use	problem	
severity	(Cocozza	et	al.,	2005).
	 Several	 trauma-specific	 interventions	 have	 been	 developed.	 These	
include:	Seeking	Safety,	which	integrates	cognitive	behavioral	strategies	with	group	
psychotherapy	to	address	both	PTSD	and	substance	abuse	disorders	(Najavits	et	
al.,	1998;	Najavits,	2002);	Beyond	Trauma,	which	employs	“relational	theory”	to	build	
upon	the	 importance	of	relationships	 in	women’s	emotional	well-being	(Covington,	
2003);	 and	 the	Trauma	Recovery	and	Empowerment	Model	 (TREM),	which	uses	
group	therapy	to	promote	recovery	skills	and	social	functioning	(Fallot	&	Harris,	2002).
	 Many	of	 these	protocols	are	currently	undergoing	clinical	studies	 in	 the	
field	to	test	their	effectiveness	with	different	populations.	One	experimental	study	
conducted	as	part	of	 the	NIDA-sponsored	Clinical	Trials	Network	examined	 the	
effectiveness	of	Seeking	Safety	 (12	sessions)	 relative	 to	a	control	 condition	 for	
women	in	7	outpatient	treatment	programs.	Both	treatment	groups	reduced	their	
PTSD	 symptoms,	 with	 marginally	 greater	 improvements	 among	 participants	 in	
Seeking	Safety	who	attended	more	sessions,	although	there	were	no	differences	in	
substance	use	outcomes	(Hien	et	al.,	2009).	Further,	individuals	who	participated	
in	Seeking	Safety,	and	who	had	more	severe	substance	use	disorders	at	baseline,	
had	 better	 improvements	 in	 substance	 use	 outcomes	 contingent	 upon	 prior	
reductions	in	PTSD	symptoms	(Hein	et	al.,	2010).
Conclusion
	 There	have	been	tremendous	gains	in	recent	years	in	our	understanding	of	
the	influence	of	gender	on	the	differential	pathways	into	treatment,	the	clinical	and	
service	need	profiles	of	women	who	enter	into	treatment,	and	the	factors	related	
to	their	treatment	retention	and	outcomes.	Moreover,	there	is	a	growing	body	of	
research	on	 the	organizational	characteristics	of	 the	programs	 in	which	women	
receive	 substance	 abuse	 treatment,	 the	 types	 of	 services	 that	 are	 provided	 in	
these	programs,	and	the	relationship	of	services	received	to	treatment	outcomes,	
including	the	cost	effectiveness	of	“specialized”	treatment	for	women.	The	growing	
emphasis	on	evidence-based	 treatment	approaches	within	 the	field	of	addiction	
treatment	provides	 further	opportunities	 to	 tailor	 treatment	protocols	 to	 increase	
their	 effectiveness	 with	 women,	 particularly	 cognitive	 behavioral	 therapies,	
motivational	enhancement	interventions,	contingency	management,	and	trauma-
specific	 interventions.	At	 the	same	 time,	 the	emerging	emphasis	on	developing	
treatment	 protocols	 that	 are	 “gender	 responsive”	 provides	 a	 framework	 for	
treatment	services	that	are	based	in	an	understanding	of	how	gender	influences	the	
development	and	progression	of	substance	use	disorders	and	treatment	processes	
and	outcomes.	 It	 is	critical	 to	continue	 to	develop,	 implement,	disseminate,	and	
sustain	effective	treatment	approaches	that	are	specifically	tailored	to	addressing	
women’s	treatment	needs.
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Background
Barriers to accessing substance abuse treatment
	 In	Spain,	one	of	the	key	objectives	of	the	National	Strategy	on	Drugs	2009-
2016	and	the	Action	Plan	on	Drugs	2009-2012	is	to	improve	access	to	substance	
abuse	treatment	and	to	increase	gender-specific	care	programmes	for	clients.	In	
order	to	do	this,	understanding	the	barriers	that	limit	access	to	treatment	for	both	
male	and	female	substance	users	was	very	important.
	 Reported	 barriers	 include:	 lack	 of	 motivation,	 belief	 that	 the	 quality	
of	 treatment	 is	 poor	 or	 ineffective,	 location	 of	 services,	 stigma,	 negative	 staff	
attitudes,	poor	health,	and	concerns	about	 treatment	access	-	e.g.	assessment,	
appointments,	referrals	etc.	-	(Neale	et	al.,	2008).
	 A	 recent	 study	 (Improvement	 of	 Access	 to	 Treatment	 for	 People	 with	
Alcohol	 and	 Drug	 Related	 Problems,	 IATPAD	 Project)	 on	 patients	 who	 were	
receiving	 treatment	 for	 substance	abuse	 in	 two	 care	 centres	 for	 drug	addiction	
(CAS)	 in	 Barcelona	 reported	 that	 the	 barriers	 to	 accessing	 treatment	 may	 be	
personal	 (acceptance	of	 the	problem,	motivation	 to	seek	 treatment,	etc.)	and/or	
systemic	(opening	hours,	waiting	lists,	length	of	consultation	with	the	professional,	
location,	 etc.).	Participants	 described	 the	 importance	 of	 recommendations	 from	
other	users	of	the	service,	previous	experiences	of	treatment,	and	the	visibility	of	
services	in	contributing	to	their	decision	to	seek	treatment	(Gilchrist	et	al.,	2011;	
Fonseca	et	al.,	2012).
	 However,	 this	 study	 did	 not	 consider	 users	 who	 were	 not	 seeking	 or	
receiving	treatment	at	CAS,	nor	did	it	analyze	the	results	by	gender.	Furthermore,	
the	study	included	only	service	users	from	Barcelona	and	therefore,	the	opinions	
and	experiences	of	users	from	outside	of	Barcelona	remain	unknown.
177
Objectives
1	 	To	determine	the	barriers	to	accessing	substance	abuse	treatment	among	
substance	 users	 who	 were	 not	 receiving	 or	 seeking	 treatment	 in	 care	
centres	for	drug	addictions	(CAS).
2	 To	examine	sex	differences	in	the	barriers	reported.
Methodology
Design
In-depth	qualitative	interviews	were	conducted.
Methods
	 A	“purposive	sample”	(Pope	and	Mays,	1995)	in	which	effort	was	made	to	
include	“atypical	values”	was	generated,	stratified	by	factors	of	influence	including	
sex,	the	substances	that	were	object	of	abuse,	age,	history	of	treatment,	and	the	
referral	source	to	generate	the	maximum	range	of	perspectives	and	experiences,	
and	to	reach	saturation	(or	the	point	at	which	no	new	information/matter	is	observed	
in	the	data),	which	usually	occurs	with	12-15	interviews	(Guest	et	al.,	2006).
Participants
	 Users	of	both	 licit	and	 illicit	substances	were	eligible	 to	enter	 the	study.	
Patients	were	eligible	if	they	had	been	referred	to	a	CAS	by	mental	health	centres,	
primary	healthcare	centres,	psychiatric	liaison	services,	emergency	units	or	harm	
reduction	 centres,	but	who	had	not	attended	 their	 appointment	or	had	 failed	 to	
engage	 with	 the	 CAS	 or	 who	 were	 in	 treatment	 for	 the	 use	 of	 one	 substance	
but	 who	 continued	 to	 use	 another	 substance	 for	 whichthey	were	 not	 receiving	
treatment	were	invited	to	participate,	or	who	were	in	treatment	for	the	use	of	one	
substance	but	who	continued	to	use	another	substance	for	which	they	were	not	
receiving	treatment.
	 It	was	proposed	 to	 recruit	a	convenience	sample	of	40	participants	 (20	
men	and	20	women)	from	a	total	of	39	centres	in	Catalonia,	Spain	(table	1).
The	selected	centres	were	informed	of	the	objectives	of	the	study.
Analysis
	 The	qualitative	 interviews	were	 recorded	and	 transcribed	verbatim.	The	
data	were	organized	and	coded	using	NVivo	8	software	by	GG	and	AB.
	 A	 qualitative	 research	 framework	 approach	 was	 used	 for	 the	 analysis:	
familiarisation,	identifying	a	thematic	framework,	indexing,	charting	and	mapping	
and	interpretation	(Pope	et	al.,	2000).	Attention	was	paid	to	analysis	of	“deviant”	
cases	(i.e.	those	that	contradicted	“the	emerging	explanation	of	the	phenomenon	
being	studied”	 (Pope	et	al.,	2000)	 to	 “refine	 the	analysis	 to	 the	point	 that	 it	can	
explain	all	or	the	vast	majority	of	the	cases	under	scrutiny”	(Pope	et	al.,	2000)).
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Table 1. Centres	Number	of	participants	sought	and	recruited	by	centre	and	sex
Results
	 Twenty	 seven	 participants	 were	 recruited	 from	 25	 of	 the	 39	 centres	
included	in	the	study.	In	the	remaining	14	centres,	participants	did	not	present	for	
interview	on	the	date	arranged	in	7	centres	and	the	remaining	7	centres	reported	
that	they	did	not	have	any	eligible	patients	(Table	1).
	 Of	 the	27	participants	 interviewed,	6	had	been	 referred	 to	 the	CAS	but	
had	 never	 attended;	 9	 had	 been	 referred	 to	 the	CAS	 but	 had	 not	 been	 linked	
to	 treatment	 (despite	 having	 attended	 at	 least	 one	 appointment),	 and	 12	 were	
receiving	treatment	for	one	of	the	substances	they	were	using	but	not	for	another/
others	(Table	2).
Barriers to entering treatment
	 Both	individual	and	service	barriers	to	entering	treatment	were	identified	
(see	Table	3,	below).	The	main	barriers	included	lack	of	motivation	and	denial	of	
having	a	substance	abuse	problem	that	requires	treatment,	waiting	time	to	enter	
treatment,	negative	staff	attitudes,	stigma	and	fear	of	treatment	failure	based	on	
previous	treatment	attempts.
Individual barriers
Lack of recognition of problem
	 Participants	identified	that	a	lack	of	recognition	of	the	problem	“it’s not that 
serious” or “I don’t need it so much”	(ID	16,	Male,	35	years	old,	Emergency	Unit)	
resulted	 in	 not	 seeking	 treatment.	 “Because I hadn’t looked for (treatment), I’d 
never worried about my habit, I didn’t care, if I’ve got some, then I’ll have a smoke” 
(ID	9,	Female,	19	years	old,	PHC)
Motivation and willpower
	 Many	commented	that	there	were	no	barriers	to	accessing	treatment	other	
than	the	substance	abuser	themselves,	who	often	lacked	motivation	to	enter	and	
remain	in	treatment.	“Whenever I’ve asked for treatment they’ve given it to me... 
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Table 2.	Participant	information
1.	Referred	to	CAS	but	had	never	attended.
2.	Referred	to	CAS	but	had	not	been	linked	to/	engaged	in	treatment.
3.	In	treatment	for	one	of	the	substances	they	were	using,	but	not	receiving	treatment	for	the	use	of	an	
additional	substance
the thing is, they don’t want to, I reckon they don’t want to, because if they wanted 
to they’d do it, so if someone has the will power...” (ID	21,	Female,	40	years	old,	
PHC). “There aren’t any barriers, the barrier is each person’s will power, if they 
want to do the treatment or not” (ID	8,	Male,	36	years	old,	PHC).
	 Despite	the	availability	of	help,	it	was	recognised	that	it	was	the	individual’s	
responsibility	to	stop	using	it	“(methadone) doesn’t get you off the habit, in the end 
I was taking methadone and using, because the taking that stuff doesn’t get you 
off it....that’s up to you” (ID	6,	Female,	25	years	old,	Harm	Reduction	Centre).	“You 
have to put in the will power... I reckon there are enough tools”	(ID	10,	Male,	37	
years	old,	Emergency	Unit).
	 Furthermore,	this	lack	of	motivation	or	“will	power”	to	stop	using	substances,	
often	 resulted	 in	 giving	 up	 treatment	 and	 a	 return	 to	 substance	 use.	 “I’ve tried 
Psychiatric	liaison
Psychiatric	liaison
Psychiatric	liaison
Psychiatric	liaison
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(treatment) but the truth is it’s got so much control of my head, I start lots of times 
but I’ve never finished, I leave in a hurry, I don’t go, I only think about getting drugs 
whatever way I can ”	(ID	2,	Male,	48	years	old,	Harm	Reduction	Centre).
	 Willpower	was	often	 tested	 further	 as	drugs	were	 readily	 available	 and	
many	continued	to	have	drug	using	friends/	partners,	which	often	“tempted”	them	
to	continue	using.	“Having drugs on hand” (ID	9,	Female,	19	years	old,	PHC); “For 
me the people who are.... let’s say, close to me, right? Well lots of times I saw them 
with the mentality that most users have, their mind’s only on taking drugs, once I’m 
with them the mentalities join together, accumulate, become one, and then you just 
think about the same thing, let’s go and find this, let’s go and do that”	(ID	20,	Male,	
40	years	old,	Emergency	Unit).	One	woman	talked	about	her	lack	of	self-esteem	
affecting	her	ability	to	seek	treatment,	believing	that	she	was	a	“nuisance”	to	staff.	
(ID	1,	Female,	27	years	old,	Harm	Reduction	Centre).
Previous experience
	 Some	had	previous	experience	of	substance	abuse	 treatment,	which	 in	
many	cases,	influenced	their	decisions	to	return	to	treatment.	One	woman	spoke	
about	a	previous	treatment	experience	where	as	a	result	of	her	involvement	with	
the	CAS,	 her	 children	had	been	 taken	 into	 care.	 “Because I didn’t feel good, I 
needed more because I had more cravings, I was explaining, you told me you can’t 
do that, I was pregnant, I started using again and in the end they took my child 
away, and I don’t want to go to the CAS because I don’t like the CAS, things don’t 
go well for me there “	(ID	7,	Female,	27	years	old,	Harm	Reduction	Centre).
Stigma
	 Some	participants	were	reluctant	to	enter	treatment	due	to	the	stigma	of	
having	to	attend	a	CAS.	Some	users	“Thought that I wasn’t like them (other drug 
users)”	(ID	25,	Male,	40	years	old,	Psychiatric	Liaison)	who	were	using	the	same	
services,	which	may	act	as	a	barrier	to	accessing	treatment	in	a	CAS.
“And the shame you feel when you go, you know? It affects you a lot, I don’t know, you 
feel bad... you say, “Hell, look where I’ve ended up”, you know? Here I am and it’s... 
you know? In the place where people come to get methadone, you know? You think, 
“What am I doing here? I’m not like them! The thing is, if someone who doesn’t smoke 
joints sees me the same way as them, I mean, if I see them that way, the people who 
don’t smoke joints, how do they see me? ”	(ID	9,	Female,	19	years	old,	PHC).
Service barriers
Negative staff attitudes
	 Experiencing	stigma	and	negative	attitudes	or	“treatment”	from	staff	was	
highlighted	as	a	barrier	to	treatment.	“I don’t like the way they treat you (in the CAS), 
besides, they don’t treat you properly, they treat you like that, like a drug addict, not 
like a person, they de-value you... they don’t make you feel like a person... they 
make you feel like a drug addict instead of a sick person. Really, we are sick, we’re 
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like any other person, we have a problem but that doesn’t make us a piece of shit. 
What do they do to make you feel that they treat you like that? The way that they 
talk to you, they look down on you. No, and anything that you do, they’re always 
picking you up on it, “don’t do that, you can’t do that, whatever…” I don’t know, 
they get on your back, but it’s the way they talk to you, looking down on you”.	(ID	
1,	Female,	27	years	old,	Harm	Reduction	Centre).
Waiting times
	 While	some	reported	they	were	treated	“very quickly”	(ID	11,	Female,	43	
years	old,	Harm	Reduction	Centre),	many	participants	reported	long	waiting	times	
to	enter	treatment	which	often	resulted	in	their	loss	of	motivation.	“Because they 
give you an appointment, you say ‘I’m going’, you’ve made up your mind, today 
I got up and I said, ‘I don’t want any more, my life is a disaster, I can’t take any 
more’, they give me an appointment in three months time but that day you want 
to take some, just on that day you don’t want to give up the drug... you go back 
to ask for an appointment, they tell you they won’t give you one because you 
always do the same thing, but it’s obvious, give it to me now, let me go now. As if 
it wasn’t hard enough to say ‘I’m going to give up’, help us at that moment that we 
decide we need it” (ID	11,	Female,	43	years	old,	Harm	Reduction	Centre). “No, if 
somebody wants to get better I think it’s easy for them to come here, ask for help 
…when you’re hooked and you’re on the street you come here, they give you an 
appointment in two weeks’ time. Man, you’re on the street, you’re hooked, they 
ought to see you there and then… but you come in off the street, on two grams a 
day and they tell you “wait three weeks or two weeks” and you go to shit, you fall 
to pieces”	(ID	16,	Male,	35	years	old,	Emergency	Unit).
Lack of flexibility
	 Several	 participants	 commented	 that	 in	 CAS	 there	 were	 “lots of rules” 
(ID	20,	Male,	40	years	old,	Emergency	Unit)	which	often	served	as	a	barrier	 to	
remaining	 in	 treatment.	 One	 man	 described	 having	 his	 methadone	 treatment	
discontinued	in	the	CAS	because	of	a	positive	urine	result.	While	one	man	who	
was	working	reported	organising	his	work	around	treatment	appointments	“I chose 
a morning or afternoon that I had time off work” (ID	22,	Male,	56	years	old,	PHC);	
several	male	participants	stated	that	treatment	or	treatment	opening	hours	were	
not	always	suitable	for	those	in	employment.
	 Indeed,	one	participant	described	leaving	treatment	in	the	CAS	“Because 
I got a job and I can’t always be leaving people, leave and say every week I 
have to go to the doctor, I have to go to the doctor, and in the end they find out 
where I go and I’m out.… It wasn’t compatible, it wasn’t compatible with my work 
hours, and that’s the reason, that’s the only fault, the only reason, the reason I 
gave up” (ID	25,	Male,	40	years	old,	Psychiatric	Liaison). “Well, out of laziness, 
because I can’t be bothered. At the start you say ‘OK, go on then,’ you start keen 
enough but then you think about it and you say ‘What for, they’re going to have 
me going there every day to have a drink (methadone), they don’t give it to you 
for the whole week, you have to go every day, and then in the end it’s the same 
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as using because if you have to go every day, what about work?’ In what job are 
they going to let you go every day for half an hour to have a drink? None” (ID	
6,	 Female,	 25	 years	 old,	Harm	Reduction	Centre). One man complained that 
he needed to be registered on the electoral roll in the area where he wanted to 
seek treatment in the CAS “If you’re not registered you can’t, well…. Traps of 
bureaucracy.” (ID	20,	Male,	40years	old,	Emergency	Unit).
Offer of treatment limited
	 Several	 participants	 complained	 that	 the	 offer	 of	 treatment	 for	 their	
substance	use	was	limited,	which	contributed	to	their	decision	to	enter	or	drop	out	
of	treatment.	“Methadone makes me panic… because it’s one more drug for me 
and the craving is worse”	(ID	1,	Female,	27	years	old,	Harm	Reduction	Centre).
One	participant	described	stopping	methadone	maintenance	 treatment	 “all of a 
sudden and that made me use more, because the craving was pretty strong… 
because I was fed up of going to the CAS”	(ID	24,	Male,	40	years	old,	Psychiatric	
Liaison).	One	man	did	not	want	to	take	medication	for	his	alcohol	problem	“Because 
I don’t want the medication, I don’t know what harm it can do”(ID	25,	Male,	40	
years	old,	Psychiatric	Liaison)	and	another	did	not	want	to	be	detoxified	“Because 
I was afraid of going into a hospital” (ID	22,	Male,	56	years	old,	PHC),	and	another	
believed	their	was	no	treatment	for	cocaine	addiction	(ID	23,	Male,	42	years	old,	
Harm	Reduction	Centre).
Cost of treatment
	 While	 treatment	 in	 a	CAS	 is	 offered	 free	of	 charge	 to	 patients,	 several	
highlighted	that	a	barrier	to	accessing	therapeutic	communities	was	the	cost.	Also	
those	with	mental	health	problems	highlighted	the	cost	of	medications.	“We don’t 
have any money to buy the medication... because it’s expensive too, because 
the pills are expensive, so sometimes it’s not that we don’t want to work, we’re 
having treatment and we can’t work, so they should make it easier for us to make it 
more affordable for… the medication, just for the users or the ones with psychotic 
problems like me, my pills cost me nearly 19 euros, you see? And… that’s what 
they should do, because it’s a problem, this is an illness, it’s not seen. I think it’s 
an illness, because when you’re depressed, you turn to the drugs, then from the 
drugs you go into psychosis, it’s an illness because it disconnects a nerve in your 
brain to take so much and you can’t find a solution and so I think they should 
provide with the medication”	(ID	21,	Female,	40	years	old,	PHC).	“The treatments 
are expensive, they’re very expensive and there are people who can’t afford them” 
(ID	24,	Male,	40	years	old,	Psychiatric	Liaison).
Location
	 The	location	and	distance	required	to	travel	to	treatment	centres	was	also	
seen	as	a	potential	barrier	due	to	the	expense	and	time	required.	“I had to walk five 
kilometres, get on the train… and they don’t pay for anything at all for you, I asked 
for something… a payment, they didn’t give me anything so in the end I decided 
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not to go”	(ID	6,	Female,	25,	Harm	Reduction	Centre).	“I don’t have the means to 
come every day, I can’t. How am I going to come? I don’t have a car, I don’t have 
a motorbike, I don’t have money for the bus, either. What do I do? I can’t”	(ID	8,	
Male,	60	years	old,	PHC).
	 However,	one	male	participant	did	not	want	to	be	near	where	he	lived	as	
a	result	of	the	temptation	to	use	drugs	and	the	proximity	of	drug	using	friends	in	
their	local	area	and	would	prefer	to	attend “some centre where they did know my 
old friends or anything” (ID	23,	Male,	42	years	old,	Harm	Reduction	Centre).
Facilitators to entering treatment
	 Most	participants	had	previous	treatment	experience	for	substance	abuse,	
mainly	 from	CAS.	 Individual	and	service	 facilitators	 for	entering	 treatment	were	
identified,	reflecting	the	previously	identified	barriers	(Table	3).
Individual facilitators
Family support/friends
	 Two	 females	 highlighted	 the	 “need for lots of help from the family that 
supports you …these are professionals, they’re not your family, and if your family 
doesn’t help you after this it doesn’t matter how much you come here if they don’t 
help you at home you won’t get anywhere, you get home and you get depressed 
and carry on using, however much you take the medication” (ID	21,	Female,	40	
years	old,	PHC).	“I’m not receiving professional help, or moral help, or help from 
friends, from family, nothing... The ones who help you are your family, not the 
doctors. If the doctors help you, you have to go for visits and all that, but it’s your 
family that are by your bedside, giving you the pills, giving you food and seeing that 
you want to give up the drugs and they’re the ones who value what you’re doing” 
(ID	11,	Female,	43	years	old,	Harm	Reduction	Centre).
Reputation of service
	 Participants	had	heard	about	CAS	through	word	of	mouth	from	family	and	
friends	who	had	attended.	Recommendations	from	others	and	what	to	expect	from	
services	also	contributed	to	decisions	on	entering	treatment	“My friends who have 
been through the same situation, that I see that they’re well, I ask them, they tell 
me where they I have to go, pum , pam, pam” (ID	2,	Male,	48	years	old,	Harm	
Reduction	Centre).
	 Knowing	what	to	expect	from	treatment	may	facilitate	treatment	access	as	
several	participants	described	not	knowing	what	 to	expect	 from	treatment	“Let’s 
see, I wasn’t expecting it at all, because it was the first time (treatment	 at	 the	
CAS)… So I didn’t know how it went”(ID	3,	Female,	48	years	old,	AMHC).	One	
suggestion	that	may	help	users	join	or	access	treatment	was	“To find out a bit… 
get ready for it” (ID	17,	Male,	48	years	old,	AMHC).	Indeed,	one	male	described	
being	prepared	 for	what	 to	expect	at	his	visit	 to	 the	CAS	by	a	worker	 from	 the	
Harm	Reduction	Centre	stating	 “They told me where I had to go, who I had to 
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talk to, so that when I went in I was talking in an interview with Tony, I had a good 
interview with him and he suggested I should go to the doctor, he explained to 
me how it works, what times I could go, everything”	 (ID	8,	Male,	60	years	old,	
PHC).	Another	reported	dropping	out	of	treatment	as	it	was	not	what	he	expected	
“Because basically when you don’t know something it’s always interesting to get to 
know it, to know …what treatment you’re going to have or what’s going to happen, 
and then you realize that it’s not what you were expecting… you’re not keen, you 
don’t like it”	(ID	24,	Male,	40	years	old,	Psychiatric	Liaison).
Awareness of services
	 While	 one	 male	 participant	 believed	 there	 was	 no	 need	 for	 “more 
information, no, what more information are they going to tell you, I don’t know, it’s 
all been said”	(ID	15,	Male,	36	years	old,	PHC).
	 Others	felt	 that	better	awareness	of	the	types	of	services	available	may	
facilitate	treatment	seeking.	“Lack of information, but information of all kinds, about 
the centre, and about ourselves. It’s not all one person’s fault, it has to be shared 
around” (ID	26,	Male,	60	years	old,	Psychiatric	Liaison).
Service facilitators
Referrals
	 Being	referred	to	a	CAS	by	another	health	professional	(e.g.	GP,	AMHC,	
harm	reduction	centre,	liver	specialist	etc.)	facilitated	access.	“So if you are referred 
by someone it’s easy. I mean, if someone, through psychiatric emergencies, or 
whatever, refers you immediately... things move and you get in, you’re here and 
you have a visit”	(ID	15,	Male,	36	years	old,	PHC).
	 Two	men	interviewed	described	how	staff	from	the	CAS	came	to	visit	them	
when	they	were	inpatients	to “ask me if I was interested (in attending the CAS)… 
they recommended it if I want, it’s not obligatory, there’s no obligation, if I want 
to come to this centre... I said yes but I have to think about it properly, let’s see, 
at the moment I don’t feel well, I’ve got pancreatitis and it’s pretty complicated 
and I don’t know, let’s see what the doctor says in the end when I get out, when 
I’m discharged. Let’s see, it depends, now it depends”	 (ID	 25,	Male,	 40	 years	
old,	Psychiatric	Liaison).	Participants	were	often	referred	to	CAS	from	AMHC	or	
psychiatric	inpatient	units,	following	a	specific	incident.
Several	participants	had	been	 “sent by the courts” (ID 3, Female, 48 years old, 
AMHC) to	the	CAS,	which	facilitated	retention	in	treatment	as	“until 2014, I think it 
is, I have to be (in treatment in the CAS)… because if not I’m going to prison” (ID	15,	
Male,	36	years	old,	PHC).	“Well, through an episode in Accident and Emergency, 
with violence… arrest by the police, then everything was forced through so that 
I would come so I came and that’s it. If you come because you’re referred by 
someone it’s easy”	(ID	10,	Male,	37	years	old,	Emergency	Unit).
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Coordination between services
	 Coordination	of	care	between	services,	especially	for	mental	health	and	
substance	abuse,	 facilitated	access	 to	 treatment	and	ensured	 that	 “they sorted 
everything out between… because this is a consortium and the Harm Reduction 
Centre and the other one sorted the whole thing out. You have to come on such 
and such a day... They coordinate everything. Everything is controlled between the 
three of them they’ve got everything under control, here everyone knows the same 
as everyone else (between	the	Harm	Reduction	Centre,	the	AMHC	and	the	CAS)” 
(ID	12,	Female,	33	years	old,	AMHC).	
	 Moreover,	 one	man	 believed	 the	 co-location	 of	 the	AMHC	and	CAS	 in	
the	same	building	assisted	him	with	accessing	psychological	services	“Well here 
(the CAS) they leave me alone a bit more because I’ve got the one from above 
(AMHC) and the one from above is with the one who works below (CAS)”	(ID	17,	
Male,	48	years	old,	AMHC).	This	was	considered	important	as	several	participants	
described	their	GP	as	not	prepared	to	treat	their	substance	abuse:	“No because 
my doctors told me that because I was using it was something really expensive for 
the practice, because I was hooked on this and I didn’t… she didn’t worry about 
me very much.” (ID	4,	Female,	45	years	old,	Psychiatric	Liaison).	“The GP told me 
if I was here (CAS) I didn’t need to go to him (PHC) for these things (treatment 
for substance use), because he gives me stuff for if I have some illness, if I’ve got 
something, but being here he knows there are doctors who… it’s not necessary for 
him to give me things for this (substance use)”	ID	8,	Male,	60	years	old,	PHC.
	 In	 addition,	 continuity	 of	 care	was	 important	 for	 one	 female	 participant	
who	did	not	wish	to	disclose	her	history	of	childhood	abuse	to	an	additional	staff	
member.	Her	usual	psychologist	was	on	maternity	leave	and	she	was	reluctant	to	
see	another	member	of	staff	because	“the thing is I don’t want to explain my life to 
anybody… Well, it’s an abuse that I suffered when I was little…” (ID	11,	Female,	
43	years	old,	Harm	Reduction	Centre).
Quick response
	 Many	stressed	the	importance	of	a	quick	response	when	seeking	treatment	
to	sustain	motivation	to	accessing	treatment.
“Of course, you can’t wait a month, you can’t because you don’t know what you’re 
going to do in a month or how you’re going to be, when you really decide to start 
treatment they should give it to you at that moment because we’re like that… well, 
maybe it’s our problem, we’re very immediate and we want everything, but as soon as 
you’ve decided, they should give it to you, damn it! Because if they make you wait a 
month, in a month’s time probably you don’t want it”	(ID	6,	Female,	25	years	old,	Harm	
Reduction	Centre).	“They gave me (an appointment) in a month, two months and so I 
forget things, but normally, I need… urgent help. When I have to wait the mind goes… 
but if I have to wait things change” (ID	2,	Male,	48	years	old,	Harm	Reduction	Centre).
	 Several	women	believed	there	was	a	need	for	a	support	service	to	maintain	
motivation	while	patients	were	awaiting	their	appointment.	One	woman	explained	
that	after	waiting	a	month	for	an	appointment,	she	did	not	go	“because I didn’t feel 
like it, I mean, what was I going to go there for?”	She	believed	that	having	someone	
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to	encourage	her	may	have	helped	sustain	her	original	motivation	“Someone to tell 
me ‘OK, come on, I’ll go with you, let’s go, I’ll take you,’ then probably I’d have gone, 
it would have been tough but with a bit of pushing I’d have gone, but just me on 
my own, since I didn’t say anything, I didn’t tell anyone I had the visit or anything, 
just my big sister, I said ‘Right, I’m not going, I’m not going, and that’s that”	(ID	9,	
Female,	19	years	old,	PHC).	“Some type of network of accompaniment, until the day 
of the visit arrives, to have someone you can visit, until the appointment, you’re not 
going to give up the drug until the day of the appointment, but someone to remind 
you that you have that day… I don’t know, if the specialist doctor can’t see you for 
three months, some kind of auxiliary who can see you before, so that you end up 
going on that day. Someone, that is, other visits that at least you don’t lose the idea 
of giving up that you had”	(ID	11,	Female,	43,	Harm	Reduction	Centre).	“Well, you 
said it before, it’s you know, the time you have to wait, you have to go on, you have 
to… there are lots of… it’s a lot of time that you waste because if you have to wait a 
week for the first visit, to go in, then you have to wait one week, two weeks or three 
weeks longer to start the treatment, I mean, and in that time what are you doing? 
For example it’s a month, a month you’re not going to use because you’re waiting, 
could be you end up, like I said, having an overdose, you could end up in jail. What 
will happen to you? What will happen in your life? You waste time. We’re wasting 
enough time when we use, I don’t mean you have to go the first day and they give it 
(treatment) to you, no, but come on, a week, three weeks, that’s a long time because 
we change quickly, and when you ask for help it’s because you don’t feel well, you 
can’t take any more” (ID	7,	Female,	27	years	old,	Harm	Reduction	Centre).
Positive staff encounters
	 Many	commented	that	a	positive	relationship	with	staff	facilitated	treatment	
access	and	retention.	“The first time you go to a CAS you should feel ok, you should 
feel good, not feel like… a leper or something like that”	(ID	21,	Female,	40	years	
old,	PHC).	“The relationship with the professionals is pretty good, they help you all 
they can but that’s it, it doesn’t go any further”	(ID	24,	Male,	40	years	old,	Psychiatric	
Liaison).	“They give you a warm welcome, they’re polite, they’re friendly, they don’t 
look down on you for the way you’re dressed or how clean you are and so on”	(ID	18,	
Male,	36	years	old,	AMHC).	“I see very human treatment with the people here, you 
know? At no time do you feel like a… I don’t know, the people treat you well, I don’t 
know, I don’t see a treatment… I don’t know of…, professional to patient, you know? 
I see a very, very human treatment and, I don’t know, we’re very apprehensive 
people, you know? Straight away we’d see that mistake and it’s... and I don’t see 
that mistake, you know? I see the people very… I don’t know.. very willing to help 
the people who come, so if sometimes it doesn’t work I think that it’s something 
more personal, it works as far as you want it to work, I don’t know, we haven’t… it’s 
(treatment) always worked for me whenever I’ve wanted it to, when I didn’t want it to 
it didn’t work… I see that the people make an effort from the first moment until… you 
always get on better with some than with others, right? But all of them… yes, they 
make an effort, people who make an effort, you know? You see it and you notice it, 
from your position you notice it and that’s why… you keep coming, right? If not, you 
wouldn’t come” (ID	16,	Male,	35	years	old,	Emergency	Unit).
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Post-treatment
	 The	 need	 for	 support	 after	 treatment	 to	 facilitate	 reintegration	 to	 a	
substance-free	lifestyle	was	also	highlighted	by	females,	“That’s it, keeping busy, 
working, keeping myself occupied”	(ID	11,	Female,	43	years	old,	Harm	Reduction	
Centre).
Location
	 The	 proximity	 of	 the	 treatment	 centre	 to	 the	 participants’	 home	 was	
important	when	deciding	what	treatment	to	enter	“It	was	close	to	my	home”	(ID	22,	
Male,	56	years	old,	PHC).
Reasons for refusing or leaving treatment
	 In	addition	to	the	barriers	previously	identified,	participants	who	had	been	
referred	to	treatment	but	had	not	attended	or	were	not	engaged	in	treatment	for	
substance	use	were	asked	to	describe	why.
Characteristics of the patient
	 Due	 to	 having	 to	wait	 for	 an	 appointment,	 and	 therefore,	 continuing	 to	
use,	several	participants	described	forgetting	about	their	appointments	or	reduced	
motivation	to	address	their	substance	abuse.	“And the fact that you’re with your 
friends, using, when you’re using you don’t remember if you have an appointment, 
if you have to, you don’t remember, because you’re using, you don’t remember 
anything else, just about using”	 (ID	 5,	 Female,	 42	 years	 old,	 Harm	Reduction	
Centre).	“Here in the CAS, yes. Well, they try to get you to go every x amount of 
time for an appointment, what happens is that I don’t go, I forget the appointments, 
I don’t know what day it is and… I go, and I don’t remember, that’s the truth… 
today when they give me the treatment again I go a bit crazy and don’t pay much 
attention… I don’t remember the dates, I lose consciousness and come back in 2 
months… I was going for a while but I didn’t continue… because I don’t follow the 
rules anywhere”(ID	8,	Male,	60	years	old,	PHC).
Denial of problem
	 Several	 dropped	 out	 or	 did	 not	 attend	 treatment	 because	 they	 did	 not	
believe	they	had	a	problem.	“I’m not an alcoholic, I don’t drink every day… I didn’t 
go (to treatment), why do I want to waste my time there? No, I’m in my right mind 
and the best thing, I can give it up alone without any help, just me with my priority, 
it can be done, sure it can, I went the first time, the second and the third I didn’t go” 
(ID	25,	Male,	40	years	old,	Psychiatric	Liaison).	“Because I thought I didn’t have a 
problem with drugs, I saw it as something normal. It’s true that I saw it was eating 
up all my money…” (ID	12,	Female,	33	years	old,	AMHC).
	 Some	who	were	receiving	treatment	for	their	main	substance	of	abuse	but	
were	also	consuming	other	substances	believed	they	did	not	require	treatment	for	
the	other	substances	they	consumed.	Although	referred	to	the	CAS	from	the	AMHC	
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where	 one	 participant	 received	 treatment	 for	 depression	 she	 had	 not	 attended	
“Because my alcohol consumption is zero, or practically zero... that they should fill 
a place that could be used for someone who really needs it… I went so they could 
give me an appointment and they said that it wasn’t necessary, if I wasn’t drinking 
alcohol every day or anything, it wasn’t necessary… the thing is the doctor told me 
that they wanted to throw me out, when they see problems everyone goes for the 
CAS” (ID	3,	Female,	48	years	old,	AMHC).
Previous treatment attempts
	 Some	talked	about	previous	failed	treatment	attempts	and	that	they	had	
dropped	out	of	treatment	following	a	relapse.	One	woman	referred	to	the	CAS,	but	
who	did	not	engage	in	treatment	said	that	it	was	“out of laziness, what I told you, 
because I didn’t…I get tired, I get tired and then it doesn’t work at all, it’s a double 
frustration, that’s why I prefer not to know, because you get your hopes up when 
you start to feel well and then you get frustrated and you have a bad time of it until 
you end up accepting that you’re hooked again, so I prefer…”	(ID	6,	Female,	25	
years	old,	Harm	Reduction	Centre).	“(name of worker) always (name) stops and 
‘come here and we’ll give you something’, she’s always there, she values me a lot, 
I’m happy with her but I’m the crazy one, I’m the one who’s not all there, I’m OK for 
a little while and then… I go back (into relapse)… but then she loses me and… I 
don’t come any more”	(ID	8,	Male,	60	years	old,	PHC).
	 For	 some,	 there	was	a	 lack	of	 understanding	of	 addiction	as	a	 chronic	
relapsing	condition	that	may	require	several	treatment	attempts.	This	fear	of	failure	
based	 on	 previous	 treatment	 attempts,	 may	 prevent	 substance	 abusers	 from	
accessing	treatment.	“When you start feeling anxious, you start to get down, you 
start… I don’t want to give up smoking, because I feel bad” (ID	9,	Female,	19years	
old,	PHC).
Service factors
Waiting time
	 One	of	the	main	reasons	cited	for	not	attending	the	CAS	following	referral	
was	because	of	the	length	of	time	they	had	to	wait	for	an	appointment.	“Yes, I went 
there, they gave me information and there they gave me an appointment for 2 or 3 
weeks later but because I didn’t write it down properly in my diary so I didn’t… I didn’t 
turn up and then when they gave me an appointment I don’t remember well but I was 
already in the Hospital de San Pablo” (ID	10,Male,	38	years	old,	Emergency	Unit).
Type of centre
	 Many	had	chosen	to	attend	a	Harm	Reduction	Centre	instead	of	a	CAS	
as	 they	were	admitted	 to	 the	 former	 quicker	 and	 considered	 their	 relationships	
with	 the	staff	very	positive.	 “Here (Harm Reduction Centre) it’s easier to get in, 
I mean you just have to sign a contract that they prepare for you in two minutes 
and that’s it, and what’s more… I mean you don’t have to ask for an appointment, 
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it’s more direct, more immediate... so they don’t register you, you get some, you 
take it, you go out clean… and you get hot toasted sandwiches, which you don’t 
get anywhere… only here... They don’t tell me I need help, they give me the help 
I need and tell me it’s there for me, whether I take it or not is up to me... They 
guide you…”	(ID	6,	Female,	25	years	old,	Harm	Reduction	Centre).	“I go to the 
Harm Reduction Centre because unfortunately I’m a prostitute and there they… 
(do) tests and I can ask for condoms… You connect really well with them, it’s true, 
they’re people who make it easy for you. They’re like friends, not like professionals. 
So they make things easy for you. You go to a hospital, you see doctors and there 
you see friends”	(ID	11,	Female,	43	years	old,	Harm	Reduction	Centre).	“I saw that 
it was easy, I was living nearby, it was easy that, that they can help me quickly and 
better” (ID	2,	Male,	48	years	old,	Harm	Reduction	Centre).
Offer of treatment
	 Some	refused	treatment	or	had	not	engaged	in	treatment	because	of	the	
type	of	treatment	they	were	offered.	“With the CAS, you wouldn’t lose the craving, 
right?...It’s a day centre, isn’t it?... Well that’s not the way, if you’re not shut in it 
doesn’t go, you stay hooked”	 (ID	4,	Female,	45	years	old,	Psychiatric	Liaison).	
“I explained to them that I wanted to do things my way like trying to find myself 
some kind of hobby, trying to find myself different friends, trying I don’t know, to 
do something else that… for example, I used to do, I used to go hang-gliding. The 
thing is now I’m receiving a pension for life and that sport is pretty expensive. So 
I don’t know, I’ll see… I don’t want to do treatment. I’ve done treatment five times 
and I don’t have any reason to do it again… Because I’ve done five treatments, I 
don’t want to do any more, I know how they work and they’re no use to me…” (ID	
24,	Male,	40	years	old,	Psychiatric	Liaison).
	 Several	 participants	 described	 stopping	 methadone	 maintenance	
treatment	or	not	wanting	to	begin	methadone	treatment	due	to	the	length	of	time	
that	 they	 would	 be	 required	 to	 remain	 on	 treatment.	 “I gave up (methadone) 
because the withdrawal symptoms were pretty strong… because I was fed up of 
going to the CAS” (ID	24,	Male,	40	years	old,	Psychiatric	Liaison).
	 Another	stated	that	“I stopped going because I wanted to shoot up, I mean, 
I wasn’t even happy with the methadone, OK, it took away the pain, but I needed 
drugs, I had to,… you know? No, I couldn’t and it was getting up in the morning 
and having that in your head, I mean, it’s a fucking shit, you’re in a fucking prison 
because you say ,’OK, tomorrow I won’t shoot up, because I’ve got methadone, 
and it’s true, with methadone you don’t need it. But as you take methadone you 
take more cocaine and you leave the heroin to get the cocaine down, but you have 
to take something, I don’t know what it is, if it’s the whole business of the ritual of 
preparing it or seeing the guys, it could also be psychologically that role of going 
to look for some, to score, I don’t know, it could be that. Now, what you also hope 
for is the pleasure. I don’t know, I was really hooked, I mean, I liked it, yes”	(ID	
14,	Male,	38	years	old,	PHC).	Many	described	a	fear	of	methadone	“I didn’t go 
(to treatment)... I gave it up (treatment) because I saw that (methadone) was a 
double addiction” (ID 6, Female, 25years old, Harm Reduction Centre). “I’ve never 
wanted to (take methadone)… because I think that, the way I am, I don’t know, it’s 
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like admitting defeat, you know? So since I’m a person that if they can do the work 
for me, then it’s like… I know that I’d get comfortable, so this little… I don’t know, 
this little rage that I have would drive me to carry on, I suppose that if I was taking 
methadone, maybe I’m mistaken, it’s not my… my point of view, right? But until 
now I’ve always been a bit reluctant” (ID	16,	Male,	35	years	old,	Emergency	Unit).
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Frequency of care
	 Several	participants	highlighted	the	need	for	more	frequent	visits.	“Let’s 
see, normally the psychologist is once a month… and man, you’d think it would be 
better if it was once a week or every two weeks, but you also have to bear in mind 
that there are a lot of people that have this problem and it’s not like there are so 
many professionals and with the system now with the cutbacks there are fewer…” 
(ID	10,	Male,	38	years	old,	Emergency	Unit).	“I would like it to be something more 
constant… for me, coming once a month doesn’t take away the problem, you 
know?” (ID	13,	Female,	24	years	old,	Harm	Reduction	Centre). “I think it was too 
long, you know, between one appointment and the next, I mean”(ID	24,	Male,	40	
years	old,	Psychiatric	Liaison).
Conclusion
	 Few	 differences	 were	 reported	 between	 male	 and	 female	 participants.	
Table	3	summarises	the	main	barriers	and	facilitators	to	not	seeking	nor	engaging	
with	substance	abuse	treatment	by	sex	of	the	participants.
	 Individual	barriers	 identified	 included	denial	 of	 the	problem	or	a	 lack	of	
motivation	or	willpower	to	address	their	addiction	problem.	Several	also	described	
the	stigma	of	having	to	seek	treatment	for	their	substance	use.	The	importance	of	
a	rapid	response	when	treatment	was	sought	was	crucial	to	sustaining	motivation	
to	address	problem	substance	use;	with	several	women	highlighting	the	need	for	
professional	support	during	the	waiting	period.	Previous	experience	of	treatment	
including	 negative	 staff	 attitudes	 or	 treatment	 contributed	 to	 their	 decisions	 to	
access	treatment	or	not,	with	many	reporting	choosing	Harm	Reduction	Centres	
rather	than	CAS	due	to	a	perceived	greater	kindness	and	understanding	from	staff	
and	greater	flexibility	with	regards	to	the	treatment	regime.
	 Extended	 opening	 hours	 were	 required	 to	 facilitate	 treatment	 entry	
for	 men	 in	 employment.	 Participants	 were	 often	 informed	 about	 services	 and	
service	reputation	by	‘word	of	mouth’	from	other	service	users,	and	family	support	
(especially	for	females)	was	considered	important.
	 Males	 highlighted	 the	 need	 for	 information	 about	 available	 services.	
Several	 (mostly	male)	 participants	described	 the	difficulty	 in	 trying	 to	address	
their	substance	abuse	due	to	their	continued	association	with	substance	abusing	
friends	or	partners	 (one	woman	described	 this,	data	not	presented).	The	offer	
of	 treatment	was	also	 important,	with	many	highlighting	 that	 they	did	not	want	
to	have	methadone	maintenance	treatment,	mainly	due	to	it	being	perceived	as	
highly	addictive	and	 that	 they	were	 required	 to	 stay	on	methadone	 for	 a	 long	
period	of	time	(males	only).
	 The	cost	and	waiting	time	to	enter	therapeutic	communities	was	stressed.	
Moreover,	several	 identified	 that	 fear	of	 treatment	 failure	stopped	 them	seeking	
treatment.	This	may	be	linked	to	their	potential	lack	of	understanding	that	addiction	
is	 a	 chronic	 relapsing	 condition,	 often	 requiring	 several	 treatment	 attempts.	
Overall,	proximity	 to	 the	services	was	considered	 to	 facilitate	 treatment	access,	
although	 one	male	 described	 wanting	 a	 service	 out	 with	 his	 local	 area	 due	 to	
the	temptation	of	the	readily	available	drugs	for	sale.	It	is	valued	positively	being	
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referred	for	addiction	treatment	by	another	health	professional,	as	having	‘what	to	
expect’	explained	to	 them	prior	 to	attending	treatment.	The	coordination	of	care	
between	services	especially	AMHC	and	CAS	where	the	patient	had	co-occurring	
mental	health	and	substance	use	problems	was	valued.	One	woman	stressed	the	
importance	of	continuity	of	care	provider	as	she	had	established	trust	to	disclose	
her	childhood	history	of	abuse	to	one	staff	member.
The	findings	are	similar	to	a	recent	study	conducted	in	Catalonia	among	alcohol	
and	drug	users	attending	two	CAS	(Fonseca	et	al.,	2012)	and	are	compared	to	this	
study	in	Table	3.
Recommendations for improving access to 
treatment
	 As	many	reported	hearing	about	available	treatment	through	other	service	
users,	using	outreach	or	peer	educators	may	be	a	useful	way	to	inform	substance	
users	about	available	services	and	to	encourage	them	to	attend	treatment.	This	
would	also	prepare	service	users	about	what	 to	expect	 from	treatment.	Several	
service	users	described	being	 introduced	 to	 treatment	at	 the	CAS	by	staff	 from	
Harm	Reduction	Centres	as	helpful	 to	 understanding	what	 treatment	 at	 a	CAS	
entails.
	 One	of	the	largest	barriers	 identified	was	waiting	for	treatment	once	the	
decision	 to	 seek	 treatment	 had	 been	 made,	 often	 resulting	 in	 participants	 not	
attending	 their	first	appointment	due	to	 forgetting	 they	had	an	appointment	or	a	
decrease	in	their	initial	motivation	to	seek	treatment.	CAS	should	consider	using	
text	messages	or	 telephone	calls	or	a	drop-in	service	 to	 remain	 in	contact	with	
potential	service	users	while	they	wait	for	their	appointment	to	sustain	or	encourage	
motivation	and	 remind	 them	of	 their	 appointment	dates	and	 times.	Motivational	
interviewing	is	also	required	to	move	patients	from	‘pre-contemplation’	who	attend	
a	Harm	Reduction	Centre	to	‘action’	to	address	their	addiction	problem.	Service	
users	should	also	be	 informed	that	addiction	 is	a	chronic	relapsing	condition	so	
that	if	they	lapse	they	will	not	drop	out	of	treatment.	Furthermore,	services	should	
be	more	flexible	to	incorporate	lapses	without	excluding	those	who	(re)lapse	from	
treatment.	Several	participants	also	highlighted	that	they	would	prefer	more	regular	
visits	to	address	their	mental	health	and	addiction	problems.
	 The	 importance	of	non-stigmatising	staff	who	understand	addiction	was	
described.	 Workforce	 development	 is	 required	 across	 all	 sectors	 that	 come	
into	 contact	with	 alcohol	 and	 drug	 users	 to	 increase	 their	 understanding	 about	
addiction,	 their	competency	 in	working	with	 this	client	group	and	also	 to	reduce	
negative	attitudes.	If	potential	service	users	were	treated	compassionately	by	staff,	
they	may	be	more	likely	to	seek	treatment.
	 While	 methadone	 is	 an	 effective	 evidenced-based	 approach	 to	 heroin	
addiction,	many	stated	that	they	would	prefer	other	types	of	treatment.	Consideration	
should	 be	 given	 to	 widening	 the	 availability	 of	 other	 treatment	 approaches	 for	
heroin	addiction.
	 Opening	hours	should	be	extended	to	accommodate	service	users	who	
are	in	employment	or	may	wish	to	return	to	employment.	Furthermore,	educating	
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employers	about	addiction	may	reduce	the	stigma	when	patients	need	to	inform	
their	employers	that	they	need	to	attend	treatment.
	 Several	 participants	 described	 the	need	 for	 reintegration	 services	post-
treatment	 to	 enable	 them	 to	 have	 a	 successful	 substance-free	 lifestyle	 and	 be	
gainfully	employed	or	manage	their	leisure.
	 While	no	substantial	differences	in	barriers	and	facilitators	were	reported	
between	males	and	females,	 it	 is	still	 important	 to	consider	 issues	such	as	 fear	
of	 loosing	care	of	 children	and	histories	of	 childhood	abuse	or	 intimate	partner	
violence,	which	although	also	occur	 frequently	among	male	substance	abusers,	
they	 occur	 at	 a	 higher	 rate	 among	 female	 substance	 abusers.	 Staff	 should	 be	
trained	in	how	to	identify	and	respond	to	these	issues	among	substance	abusers.
Note
	 This	chapter	 is	a	summary	of	 the	report:	Gilchrist G, Blazquez A., Pons 
Rabasa A., Coronado M, Colom J i Torrens M. Barreres per a l’accés al tractament, 
segons el gènere, entre consumidors i consumidores de substàncies que no 
busquen ni reben tractament.
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Gender differences in heroin 
addiction and treatment in the 
Italian "VEdeTTE" Cohort Study
Paola Burroni (1), Federica Vigna-Taglianti (2) 
(1) Drug Addiction Local Service, ASL 1, Torino, Italy
(2) Department of Clinical and Biological Sciences, University of Torino, Italy, Piedmont Centre for Drug 
Addiction Epidemiology, ASL TO3, Torino, Italy
	 Gender	 differences	 in	 substance	 use	 are	 marked,	 in	 risk	 factors,	
prevalence	of	use,	treatment	access	and	outcomes.
According	to	the	Annual	National	Report	on	Drug	Addiction,	in	Italy	the	proportion	
of	female	addicts	treated	each	year	at	National	Health	System	(NHS)	treatment	
centres	is	around	14%:	one	female	patient	is	treated	every	six	male	patients.	This	
male/female	ratio	has	been	constant	for	many	years,	as	well	as	the	observation	
that	the	prevalence	of	females	treated	at	NHS	centres	is	very	low	in	South	Italy	
regions,	suggesting	differences	in	both	risk	and	protective	factors	between	the	
population	of	North	and	South.
	 Despite	gender	differences	have	been	manifest	and	well-known	for	many	
years,	only	few	studies	investigated	the	reasons	of	such	differences	especially	
in	the	field	of	substance	addiction,	as	the	European	Monitoring	Centre	for	Drugs	
and	Drug	Addiction	pointed	out	(EMCDDA	2005).
	 The	 VEdeTTE	 study	 collected	 a	 large	 amount	 of	 data	 on	 more	 than	
10,500	heroin	addicts	 treated	between	1998	and	2001	 in	 Italian	NHS	centres,	
allowing	 the	 investigation	 of	 gender	 differences	 including	 risk	 and	 protective	
factors,	substance	use	patterns,	treatments,	outcomes,	and	even	mortality.
	 The	analysis	of	gender	differences	in	the	VEdeTTE	study	was	addressed	
in	 a	 specific	monograph	 (Burroni	 2007)	 written	 and	 published	 by	 a	 group	 of	
experts	from	different	research	and	clinical	fields.	In	this	chapter	we	summarize	
the	main	results	and	conclusions	of	that	work	to	which	we	refer	for	further	details.
	 In	 the	 study,	 we	 used	 the	 sociological	 definition	 of	 gender	 differences:	
systems	 of	 factors	 influencing	 the	 development	 of	 the	 social	 constructs	 of	 male	
and	female,	which	are	not	limited	to	sexual	contents	but	deeply	related	to	symbols,	
values	and	health.	These	differences	 include	characteristics	which	make	up	male	
and	 female	 identity,	 and	 their	 representation	 which	 changes	 across	 time	 and	
generations.	According	to	sociologists,	examples	of	women	protective	factors	towards	
drug	addiction	include	a	better	integration	in	the	family	model,	a	lower	inclination	to	
transgression,	and	a	lower	and	different	tendency	to	aggressive	behaviours.
	 From	a	 psychological	 point	 of	 view,	 gender	 differences	 in	 drug	 addiction	
originate	 during	 the	 early	 stages	 of	 child	 development,	 e.g.	 during	 the	 primary	
dependence	phase	(“mother-child”	phase),	the	following	separation	of	the	child	from	
the	mother,	and	the	approach	and	comparison	with	the	father.	Psycho-pathological	
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disturbances	in	these	early	phases	favour	the	development	of	drug	addiction	among	
males,	 and	 of	 eating	 disorders	 among	 females.	However,	when	women	develop	
addiction	 they	 are	 concurrently	 affected	 by	 several	 psychopathological	 disorders	
and	symptoms.	Our	analysis	confirms	that	these	psychopathological	disorders	and	
symptoms	occur	much	more	frequently	in	women	than	in	men.
	 Despite	 the	 large	sample	and	 the	amount	of	 information	collected,	 the	
VEdeTTE	study	was	not	able	to	answer	all	the	questions	related	to	the	observed	
gender	 differences.	 Several	 differences	 were	 highlighted,	 but	 the	 disciplines	
involved	 in	 the	 research	 could	 not	 fully	 explain	 the	 results.	 Therefore,	 many	
questions	 remain	 unexplained	 and	 open.	 The	 need	 of	 further	 studies	 and	
knowledge	in	this	field	is	still	a	priority	for	research.
The VEdeTTE Study
	 VEdeTTE	is	a	multi-centre	cohort	study	of	heroin	addicts	admitted	to	NHS	
treatment	centres	throughout	Italy	between	September	1998	and	March	2001.	The	
study	was	funded	by	the	Italian	Ministry	of	Health	to	evaluate	the	effectiveness	of	the	
treatments	in	reducing	mortality	and	improving	retention	in	treatment.
	 Upon	enrolment,	clinical	history	and	personal	information	were	collected	by	
centre	personnel	through	a	structured	interview,	whilst	information	on	treatment	was	
registered	during	the	18	months	following	the	start	of	the	study	(for	more	details	on	
the	study	design	and	population,	see	Bargagli	2000	and	Bargagli	2006).
	 All	 treatments	 were	 provided	 on	 an	 outpatient	 basis	 by	 the	 centres’	
personnel,	except	for	residential	and	semi-residential	treatments	and	in	some	cases	
of	inpatient	detoxification.
	 The	large	and	representative	sample	of	patients	enrolled	in	the	study	(8,953	
males	and	1,501	females)	gave	us	the	possibility	to	explore	the	patterns	of	gender	
differences	at	intake	and	at	follow-up.
	 For	this	analysis,	the	enrolled	population	was	described	according	to	gender	
with	regard	to	socio-demographic	characteristics,	drug-addiction	related	issues,	risk	
behaviours	at	intake,	and	psychiatric	symptoms	before	and	after	the	first	heroin	use.
	 In	order	to	study	treatment	retention	and	its	determinants,	the	analysis	was	
conducted	on	the	first	Methadone	Maintenance	treatment	and	the	first	Therapeutic	
Community	episodes.	For	 the	purposes	of	 the	survival	analysis,	 treatments	were	
considered	abandoned	according	to	the	classification	given	by	the	clinician.	Kaplan-
Meier	product-limit	estimator	was	calculated	overall	and	for	each	group	stratification.	
A	Cox	Proportional	Hazard	model	was	built	for	the	maximum	likelihood	estimation	
of	the	risk	of	drop-out	including	all	possible	determinants	of	drop-out,	separately	for	
males	and	females.
	 At	the	end	of	the	study	period	(1th	April	2001)	vital	status	was	ascertained	at	
the	treatment	centre,	and	at	the	Registry	Office	of	the	last	municipality	of	residence.	
Vital	status	data	were	retrieved	for	96.3%	of	the	enrolled	subjects.	Cause	of	death	
was	 coded	 according	 to	 the	 International	 Classification	 of	 Diseases	 (ICD)	 IX	
revision.	Person-years	at	risk	were	calculated	from	the	start	of	treatment	to	the	end	
of	the	18-month	study	period	in	each	centre	or	until	the	date	of	death.	Standardized	
mortality	rates	(SMR)	were	calculated	based	on	death	rates	of	the	Italian	population	
aged	15	to	65	years	(year	1998).
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Results
Socio-demographic characteristics
	 Women	 enrolled	 in	 the	 VEdeTTE	 cohort	 were	 married,	 divorced	 or	
widowed	more	 frequently	 than	men:	12.1%	of	women	were	divorced	and	3.8%	
were	 widowed	 vs	 7.8%	 and	 0.5%	 of	 men	 (Table	 1).	 This	 pattern	 had	 already	
been	observed	by	other	authors	(Marsh,	1985;	Schottenfeld,	1998;	Grella,	1999;	
Wechsberg,	11998;	Acharyya,	2003).
	 A	 lower	 proportion	 of	 women	 lived	 with	 their	 family	 of	 origin	 (38.2%	
vs	57.9%	of	men),	whilst	a	 larger	proportion	 lived	with	 their	partner	(23.7%	vs	
9.6%	of	men)	or	their	children	(without	the	partner)	(3.5%	vs	only	0.3%	of	men),	
consistently	 with	 the	 literature	 (Hser,	 1987b;	 Grella,	 1999;	Wechsberg,	 1998;	
Chatham,	1999;	Freeman,	1994;	Rowan-Szal,	2000;	Green,	2002;	Hser,	2003;	
Stewart,	 2003;	 EMCDDA,	 2005).	A	 higher	 proportion	 of	 women	 had	 no	 fixed	
abode.
	 Women	showed	a	higher	education	level,	but	they	had	a	stable	job	less	
frequently	than	men,	they	were	unemployed	more	often	(42.9%	vs	34.3%)	or	in	a	
“non	professional	condition”	including	prostitution	and	housekeeping,	consistently	
with	 several	 previous	 studies	 (Stocco,	 2000;	 Hser,	 1987b;	 Grella,	 1999;	
Wechsberg,	 1998;	 Chatham,	 1999;	 Schottenfeld,	 1998:	 Petry,	 2000;	 Riehman,	
2003;	Puigdollers,	2004;	Freeman,	1994;	Brady,	1993;	Marsh,	1985;	Marsh,	1986;	
Rowan-Szal,	2000;	Green,	2002;	Callaghan,	2002;	Hser,	2004;	Winhusen,	2003;	
Acharyya,	2003;	Grella,	2003;	EMCDDA,	2005;	Kelly,	2009).
	 Women	 had	 recent	 legal	 problems	 or	 were	 serving	 a	 sentence	 less	
frequently	 than	 men,	 a	 common	 finding	 in	 the	 literature	 (Hser,	 1987a;	Anglin,	
1987;	Grella,	1999;	Wechsberg,	1998;	Chatham,	1999;	Marsh,	1985;	Marsh,	1986;	
Powis,	1996;	Hser,	2003;	Grella,	2003;	Hser,	2004;	Stewart,	2003;	Rowan-Szal,	
2000;	Joe,	1995;	Mino,	1998).
Drug use
	 Women	were	 younger	 than	men	 at	 first	 access	 to	 treatment,	 and	 they	
had	 been	 addicted	 for	 a	 shorter	 period	 of	 time,	 a	 finding	 already	 observed	 in	
other	 studies	 (Haseltine,	 2000;	 Hser,	 1987a,b;	Avila,	 1996;	 Rosenbaum,	 1981;	
Wechsberg,	1998;	Chatham,	1999;	Grella,	1999;	El-Guebaly,	1995;	Marsh,	1986;	
Rowan-Szal,	2000;	Green,	2002;	Hser,	2004;	Brady,	1999;	Greenfield,	2007).
	 Men	accessed	to	the	treatment	as	a	consequence	of	judicial	proceedings	
more	frequently	than	women,	whilst	women	were	more	frequently	referred	by	the	
Health	System	or	by	their	family.
	 With	 regard	 to	 substance	 use	 associated	 to	 heroin,	 women	 used	
amphetamines	 (3.0%	 vs	 1.7%	 of	 men)	 or	 benzodiazepines	 (25.2%	 vs	 16.2%	
of	 men)	 more	 frequently.	 By	 contrast,	 men	 used	 alcohol	 (54.6%	 vs	 44.0%	 of	
women).	These	results	were	consistent	with	previous	studies	(Chambers,	1970;	
Suffet,	1976;	Anglin,	1987;	Hser,	1987b;	Marsh,	1985;	Brady,	1993;	Darke,	1994;	
Freeman,	1994;	Wechsberg,	1998;	Bretteville-Jensen,	1999;	Rowan-Szal,	2000;	
Green,	2002;	Hser,	2003;	Grella,	2003).
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	 Women	shared	needles	or	 injection	 instruments	more	than	men	(22.1%	
vs	17.2%),	but	they	had	unprotected	intercourses	less	frequently	than	men	(9.6%	
vs	14.9%).	Previous	studies	observed	a	higher	rate	of	needles	or	other	injection	
instruments	exchange	among	women	(Bennett,	2000;	Chatham,	1999;	Sherman,	
2001;	Evans,	2003;	Puigdollers,	2004),	a	risk	behaviour	often	acted	together	with	
their	partner	(Freeman,	1994;	Evans,	2003).
Comorbidity
	 As	reported	by	the	patients	or	registered	in	the	clinical	records,	HIV/AIDS	
and	hepatitis	C	affected	women	more	than	men,	respectively	17,8%	vs	11%	and	
74%	vs	70%.	Also	psychiatric	comorbidity	was	more	 frequent	among	women.	
Women	reported	they	had	already	experienced	bad	mood	or	depression	before	
the	first	heroin	use	in	a	higher	proportion	than	men	(65.9%	vs	46.4%).	They	also	
reported	self-damaging	behaviours	and	suicide	attempts	more	often	than	men,	
respectively	29.0%	vs	11.6%	and	20.9%	vs	4.3%.	Aggressive	behaviours	were	
more	frequent	among	women	(31.8%)	compared	with	men	(26.7%).	Psychotic	
thinking	and	hallucinations	were	reported	by	7.4%	of	women	compared	to	4.9%	
of	men,	and	10.6%	of	women	had	psychiatric	hospitalizations	as	compared	to	
4.4%	 of	 men.	According	 to	 the	 literature,	 psycho-pathologic	 problems,	 such	
as	anxiety-depressive	syndrome	and	personality	disorders,	are	more	frequent	
and	more	severe	among	females	heroin	addicts	(Haseltine,	2000;	Petry,	2000;	
Wechsberg,	 1998;	 El-Guebaly,	 1995;	 Chatham,	 1999;	 Grella,	 1999;	 Brady,	
1993;	Green,	2002;	Stewart,	2003;	Rowan-Szal,	2000;	Zilberman,	2003;	Grella,	
2003;	Darke,	2009;	Brady,	1999),	as	well	as	suicide	attempts	and	self-damaging	
behaviours	(Luthar,	1996;	Darke,	2004;	Haseltine,	2000;	Wechsberg,	1998).
	 After	starting	heroin	use,	 the	 rate	of	psychiatric	symptoms	 increased,	
but	 differences	 generally	 decreased:	 bad	 mood/depression	 was	 reported	 by	
90.0%	of	women	versus	85.6%	of	men.	All	other	variables	showed	 the	same	
pattern,	 but	 the	 differences	 between	 genders	 were	 still	 considerable:	 self-
damaging	behaviours	were	reported	by	39.2%	of	women	vs	25.8%	of	men,	and	
suicide	attempts	by	21.1%	of	women	vs	11.3%	of	men.	Aggressive	behaviours	
were	still	more	 frequent	among	women	(44.0%)	 than	men	(38.2%).	Psychotic	
thinking	and	hallucinations	were	reported	by	18.5%	of	women	as	compared	to	
15.0%	of	men,	and	13.4%	of	women	had	psychiatric	hospitalizations	compared	
to	8.6%	of	men.
	 The	 observed	 differences	 between	 genders	 were	 confirmed	 by	 a	
multivariate	adjusted	analysis	(data	not	shown,	for	further	details	see	the	original	
publication:	Burroni,	2007).
Treatments
	 Detoxification	with	methadone	 and	 residential	 community	were	 the	 first	
treatments	upon	enrolment	for	a	similar	proportion	of	men	and	women	(Table	2).	
Methadone	maintenance	was	the	first	treatment	for	a	slightly	higher	proportion	of	
women,	whereas	psychotherapy	was	more	frequently	administered	to	women	than	
men,	alone	or	concurrent	with	other	treatments	(14.3%	vs	9%).	Also	the	proportion	
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of	 counselling	 interventions	 was	 significantly	 higher	 among	 women	 (38.7%	 vs	
33.1%),	as	well	as	the	job	guidance	(6.1%	vs	4.5%).
	 Both	 for	 men	 and	 women,	 the	 most	 frequent	 sequence	 of	 treatment	
was	 methadone	 maintenance	 followed	 by	 methadone	 at	 tapering	 doses.	After	
that,	substitution	 treatments	were	used	mostly	 for	men,	while	psychotherapy	or	
psychosocial	treatment	for	women.
	 Women	tend	to	come	to	an	agreement	about	the	treatment	outcome	with	
the	clinical	staff	more	than	men,	and	they	remain	in	contact	with	the	NHS	centre	
longer,	asking	for	new	and	different	treatments,	especially	psychosocial	treatments,	
counselling,	job	advices	and	psychotherapy.	Similar	patterns	were	observed	in	the	
study	by	Rowan-Szal.
	 In	the	first	six	months	of	the	study,	1,727	men	and	257	women	received	
methadone	maintenance	as	their	first	treatment.	Among	them,	28.3%	of	men	and	
21.8%	of	women	left	the	treatment	in	the	following	12	months.	The	difference	in	
the	abandon	rate	is	statistically	significant	in	favour	of	women;	Figure	1	shows	that	
the	outdistance	begun	after	 the	first	6	months.	Afterwards,	women	 remained	 in	
treatment,	whilst	another	10%	of	men	dropped-out.
	 In	 the	first	six	months	of	 the	study,	433	men	and	81	women	received	a	
community	 treatment	as	 their	first	 treatment.	 In	 the	 following	12	months,	51.0%	
of	men	and	55.6%	of	women	left	the	treatment.	The	difference	is	not	statistically	
significant,	 but	 after	 the	 third	month	 the	 two	populations	diverged	with	a	better	
retention	among	men	(Figure	2).
	 Table	3	shows	the	results	of	Cox	multivariate	models	investigating	factors	
influencing	abandon	of	Methadone	and	Therapeutic	Community	treatment	among	
men	and	women.	No	fixed	abode	and	an	unstable	job	were	risk	factors	for	abandon	
of	methadone	maintenance	in	both	genders.	A	short	duration	of	addiction,	heroin	
use	at	the	time	of	the	interview	and	recent	legal	problems	or	imprisonment	were	
predictive	 of	 abandon	 of	 methadone	maintenance	 among	men	 but	 not	 among	
women.	On	the	contrary,	sharing	needles	was	a	risk	factor	for	women	for	leaving	
the	 treatment.	 High	methadone	 dosages	were	 protective	 towards	 the	 abandon	
both	in	men	and	in	women,	but	the	effect	was	even	more	evident	among	women.	
Also	the	association	of	treatments	was	protective	towards	the	abandon,	and	when	
psychotherapy	was	associated	the	protective	effect	was	even	more	evident	in	both	
genders.
	 Higher	 education	 level	 acted	 as	 a	 risk	 factor	 for	 the	 abandon	 of	 the	
community	 in	 both	 genders,	 as	well	 as	 sharing	 needles.	A	 younger	 age	was	 a	
predictor	of	abandon	among	men,	as	well	as	being	in	psychotherapy	and	having	
had	previous	episodes	of	therapeutic	community	in	the	last	12	months.
	 The	 findings	 of	 previous	 studies	 that	 examined	 gender	 differences	 in	
substance	abuse	treatment	retention	and	completion	were	inconsistent	(Greenfield,	
2007).	According	to	some	studies,	women	abandoned	substance	abuse	treatment	
more	 frequently	 than	men	 (Mino,	1998;	Petry,	 2000;	Simpson,	1997);	 however,	
others	did	not	find	differences	(Gerstein,	2000;	Stewart,	2003;	Schottenfeld,	1998;	
Del	Rio,	1997;	Green,	2002).	Low	socio-economic	status,	low	education	level	and	
frequent	 legal	problems	among	women,	young	age	among	men	and	severity	of	
dependence	 in	 both	 genders	 seemed	 to	 be	 associated	 with	 a	 lower	 treatment	
retention	(Knight,	2001;	Messina,	2000;	Green,	2002).
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Figure 2. Retention	in	Residential	Community	by	gender
Table 2. First	treatments	received	by	patients	in	the	study	period,	by	gender
Figure 1. Retention	in	Methadone	Maintenance	Treatment	by	gender
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Table 3. Risk	factors	for	treatment	abandon:	results	from	adjusted	Cox	model*
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Mortality
	 Among	 the	 10,454	 subjects	 eligible	 for	 the	 analyses,	 190	 (1.8%)	 died	
during	the	study	period	(by	1st	April	2001):	153	men	and	37	women,	1.7%	of	the	
male	cohort	and	2.5%	of	the	female	cohort.	397	(3.8%)	were	lost	to	follow-up.
	 Death	causes	are	shown	in	table	4.	A	higher	proportion	of	deaths	caused	
by	infectious	diseases,	AIDS,	overdoses,	respiratory	diseases,	and	violent	causes	
were	 observed	 among	 women,	 while	 deaths	 due	 to	 cardiovascular	 system	 or	
digestive	diseases	were	more	 frequent	among	men.	For	both	men	and	women	
overdose	was	 the	most	 frequent	 cause	of	 death,	 followed	by	AIDS	and	 violent	
causes.
	 AIDS	and	overdose	standardized	mortality	rates,	stratified	by	gender,	are	
shown	 in	 table	 5.	 They	were	 estimated	 for	 10,057	 subjects	 whose	 information	
on	vital	 status	on	31st	March	2001	was	 retrieved,	 for	a	 total	of	21,612	person-
years	at	risk.	A	higher	overdose	mortality	rate	was	observed	among	women:	4.0	
vs	2.6/1,000	person-years	of	men,	whilst	a	higher	AIDS	mortality	rate	was	found	
among	males:	2.6	vs	1.8/1,000	person-years	of	women.	Also	the	overall	mortality	
rate	was	higher	among	men:	12.7	vs	8.4/1,000	person-years	of	women
Men Women
Cause of death n nRate RateCI 95% CI 95%
	 AIDS	 30	 2.6	 0.6-4,6	 8	 1.8	 0.4-3,1
	 Overdose	 56	 2.6	 0.8-4,5	 14	 4.0	 0.9-7,2
	 Other	causes*	 49	 6.7	 0.0-14,0	 12	 2.3	 0.9-3,6
 All causes 153	 12.7	 4.9-20,5	 37	 8.4	 4.7-12,2
Table 5. Standardized	mortality	rate/1,000	person-years	
Men Women Total
Table 4. Deaths	among	men	and	women	in	the	study	period
204
Summary and discussion
	 The	analysis	of	gender	differences	in	the	Italian	VEdeTTE	cohort	of	heroin	
addicts	confirms	the	findings	of	previous	studies,	at	 least	on	socio-demographic	
characteristics	and	drug-related	patterns:
	 ●		at	intake	in	the	VEdeTTE	cohort,	women	had	a	higher	education	level,	
but	 they	 had	 a	 stable	 job	 less	 frequently	 than	men,	 and	 were	 more	
frequently	unemployed;
	 ●		compared	 to	men,	women	 lived	with	 their	 partner,	 or	 alone	with	 their	
children	more	frequently,	and	were	more	frequently	divorced	or	widowed;
	 ●		age	of	first	heroin	use	was	younger	among	women,	as	well	as	the	age	of	
first	treatment,	with	a	shorter	addiction	career	at	intake;
	 ●		psychiatric	 symptoms	 were	 more	 frequent	 and	 more	 severe	 among	
women,	 including	 depression,	 self-damaging	 behaviours	 and	 suicide	
attempts;	 furthermore,	 female	 heroin	 users	 were	 far	 more	 likely	 to	
attempt	suicide	prior	to	the	initiation	of	heroin	use;
	 ●		women	engaged	in	risk	behaviours	(needle	exchange)	more	frequently	
than	 men,	 but	 they	 experienced	 crimes	 and	 imprisonment	 less	
frequently;
	 ●		heroin	addicted	women	used	amphetamines	and	benzodiazepines	as	
secondary	drugs,	whilst	men	used	alcohol	more	frequently.
	 With	regard	to	treatments,	women	were	more	willing	to	ask	and	receive	
psychosocial	 treatments	and	psychotherapy	 than	men.	They	retained	better	 in	
Methadone	Maintenance,	and	worst	in	Therapeutic	Community.	Indicators	of	poor	
socio-economic	situation	and	severe	addiction,	such	as	bad	housing	conditions,	
an	unstable	 job	and	sharing	needles,	were	 risk	 factors	 for	 leaving	methadone	
treatment	among	women.	By	contrast,	a	recent	addiction,	heroin	use	at	the	time	
of	the	interview	and	recent	legal	problems	or	imprisonment	acted	as	risk	factors	
among	men.	 High	methadone	 dosages	were	more	 protective	 among	women,	
whilst	the	protection	given	by	associated	treatments	was	similar	for	males	and	
females.	Lower	education	and	sharing	needles	were	risk	factors	for	the	abandon	
of	 the	 therapeutic	 community	 in	 both	 genders,	whilst	 the	 young	age,	 to	 be	 in	
psychotherapy	 treatment,	 and	 to	 have	 had	 a	 previous	 episode	 of	 therapeutic	
community	 in	 the	 last	 12	 months	 were	 statistically	 significant	 predictors	 of	
abandon	among	men	only.
	 Over	the	18	months	of	the	study,	1.7%	of	the	enrolled	males	and	2.5%	of	
the	females	died,	with	a	higher	overall	mortality	rate	among	men	and	an	overdose	
mortality	rate	higher	among	women.
	 From	 our	 study,	 some	 clear	 indications	 on	 the	 differences	 in	 risk	 and	
protective	factors	for	heroin	addiction	between	genders	emerged.
	 It	is	confirmed	that	drug	addicted	women	experience	a	worst	socio-economic	
condition.	In	all	pre-treatment	variables	analysed,	they	are	disadvantaged	towards	
men.	Bad	socio-economic	factors	are	an	indicator	of	severity	of	the	condition	and	
therefore	they	need	to	be	taken	into	account	in	treatment	choices	and	associations.
	 From	 the	 pharmacological	 side,	 high	 methadone	 dosages	 are	 highly	
recommended,	due	to	their	protective	effect	(Faggiano,	2003).
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	 The	high	prevalence	of	psychiatric	disorders	show	the	importance	of	taking	
into	account	co-morbidity,	when	patients	first	access	treatment	(Zilberman,	2003).	
Despite	this	higher	prevalence	of	psychiatric	symptoms	and	disorders,	which	might	
increase	the	risk	of	negative	outcomes,	in	the	VEdeTTE	cohort	methadone	retention	
was	 better	 for	 women	 than	 for	 men,	 and	 high	 methadone	 dosages	 were	 more	
protective	among	women.	The	two	findings	could	be	related	to	one	another.	In	fact,	
the	higher	protection	of	high	methadone	dosages	for	women	could	be	due	to	the	
contribution	of	methadone	in	lowering	psychiatric	symptoms.
	 When	 choosing	 a	 therapeutic	 community	 treatment,	 particular	 attention	
has	to	be	paid	to	the	education	level	of	the	subject	(both	male	and	female):	this	can	
be	a	difficult	treatment	for	some	subjects,	with	high	risk	of	abandon	and	all	related	
risky	outcomes.	However,	adding	child	and	family	components	favours	retention	
and	 completion	 of	 therapeutic	 community	 program	 among	women	 (McComish,	
2000;	Grella,	2000;	Szuster,	1996).
	 From	a	general	point	of	view,	since	many	features	both	of	the	patient	and	
of	the	treatment	can	influence	treatment	outcomes	differently	in	men	and	women,	a	
gender	specific	approach	to	treatment	of	heroin	addiction	and	to	relapse	prevention	
should	always	be	applied.	A	2003	 review	 found	 that	gender	sensitive	programs	
improve	treatment	completion,	 length	of	stay,	birth	outcomes,	employment,	self-
reported	health	status,	HIV	and	decrease	use	of	substance,	as	well	as	HIV	risk	
(Ashley,	 2003).	 Furthermore,	 a	 study	 on	 cost-effectiveness	 of	 mixed-gender	
programs	for	substance	abuse	found	that	when	the	program	is	standardized	for	
both	genders	it	is	less	cost-effective	for	women:	they	show	less	improvement	than	
men	in	the	outcomes	and	the	program	is	more	costly	(Yeom,	2007).
Conclusions
	 Results	of	our	analysis	suggest	the	need	of	a	gender-oriented	approach	in	
the	treatment	of	drug	addiction.
We	recommend	particular	care	in	the	treatment	of	addicted	women:
1	 investigate	psychiatric	comorbidity	and	self-damaging	acts	in	the	past;
2	 investigate	infectious	diseases	comorbidity;
3	 investigate	risk	factors	and	traumatic	events	of	the	early	stages	of	life;
4	 in	the	strategy	of	treatment,	take	into	account	traumatic	events	and	related	
psychopathological	comorbidity;
5	 consider	 that	 women	 more	 frequently	 need	 and	 better	 adhere	 to	
psychosocial	 treatment,	 advice,	 counselling,	 job	 guidance	 and	
psychotherapy;
6	 remember	that	stable	outcomes	are	more	easily	obtained	among	women	
by	using	adequate	methadone	dosages;
7	 remember	 that	 psychotherapy	 associated	 to	 methadone	 maintenance	
increases	treatment	retention.
	 Finally,	 the	 specific	 characteristics	 of	 the	 psychological	 and	 social	
development	of	women,	as	well	as	the	cultural	context	must	be	taken	into	account.	
Today,	 the	design	of	gender-oriented	pathways	of	care	 is	a	priority	 for	 the	drug	
addiction	field.
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Introduction
U.S. Government commitments to gender equality and 
women’s empowerment
	 In	recent	years,	the	United	States	government	has	brought	unprecedented	
attention	 to	 the	growing	body	of	evidence	 that	 supports	a	 relationship	between	
gender	equality	and	the	successful	pursuit	of	nations’	security	as	well	as	foreign	
policy	objectives.	Investments	in	women’s	health,	education,	and	employment,	for	
example,	correlate	with	more	positive	development	outcomes	and	greater	economic	
growth.	Women’s	political	and	social	participation	strengthens	institutions,	making	
them	more	 representative	 and	better	 performing.	Data	 also	 shows	 that	women	
bring	 a	 range	 of	 unique	 experiences	 and	 contributions	 to	making	 and	 keeping	
peace	that	lead	to	improved	security	for	entire	societies.
	 The	 United	 States	 has	 promulgated	 new	 policies	 and	 approaches	 that	
reflect	 and	 promote	 gender	 equality	 and	 advancement	 of	 the	 status	 of	women	
and	 girls	 as	 key	means	 for	 achieving	U.S.	National	 security	 and	 foreign	 policy	
objectives.	The	U.S.	National	Security	Strategy	(2010)	specifically	recognizes	that	
countries	are	more	peaceful	and	prosperous	when	women	are	accorded	full	and	
equal	 rights	and	opportunity,	 and	 that,	when	 those	 rights	and	opportunities	are	
denied,	countries	often	lag	behind.	In	addition,	the	2010	Quadrennial	Diplomacy	
and	Development	Review	 (QDDR)	 identifies	women	as	an	 integral	part	of	U.S.	
diplomacy	and	development	-	not	simply	as	beneficiaries,	but	as	agents	of	peace,	
reconciliation,	 development,	 growth,	 and	 stability.	 The	 QDDR	 directs	 the	 U.S.	
Department	of	State	and	U.S.	Agency	for	International	Development	(USAID)	to	
apply	a	focus	on	gender	equality	across	U.S.	diplomatic	and	development	efforts.	
To	accomplish	the	vision	outlined	in	the	National	Security	Strategy	and	the	QDDR,	
the	U.S.	Department	of	State	and	USAID	have	issued	policy	guidance	to	require	
that	gender	equality	be	incorporated	into	policy	development,	strategic	and	budget	
planning,	implementation	of	policies	and	programs,	management	and	training,	and	
monitoring	and	evaluation	of	results.
	 The	United	States’	commitment	to	the	promotion	of	gender	equality	aligns	
with	those	of	many	bilateral	and	multilateral	partners,	including	the	United	Nations	
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(UN).	UN	General	Assembly	and	Security	Council	resolutions	commit	the	UN	and	
member	 states	 to	 advance	 the	 status	 of	 women	 and	 girls	 around	 the	world	 in	
order	to	advance	global	stability,	prosperity,	and	peace.	In	2000,	the	UN	Security	
Council	 recognized	 the	 significant	 role	 women	 must	 play	 in	 peacebuilding,	
adopting	UN	Security	Council	Resolution	1325.	Resolution	1325	and	subsequent	
resolutions	(1820,	1888,	1889,	and	1960)	stress	the	importance	of	women’s	equal	
participationand	full	involvement	in	all	efforts	for	the	maintenance	and	promotion	
of	peace	and	security	and	their	protection	from	violence.	These	resolutions	urge	all	
actors	to	incorporate	gender	perspectives	in	the	pursuit	of	sustainable	peace	and	
security	for	all.
	 These	 goals	 can	 only	 be	 realized	 through	 international	 partnership	
and	 collaboration.	A	 vital	 investment	 in	 women’s	 social,	 political,	 and	 economic	
participation	is	essential	to	address	virtually	every	challenge	we	face	as	nations	and	
as	a	global	community.	In	recognition	of	this	fact,	President	Obama,	joining	regional	
organizations	 and	 countries	 of	 the	 Global	 North	 and	 South,	 in	 December	 2011,	
released	the	U.S.	National	Action	Plan	on	Women,	Peace	and	Security,	describing	
the	United	States’	course	to	accelerate	and	better	coordinate	our	efforts	to	advance	
women’s	inclusion	in	peacebuilding	and	their	protection	from	violence.
Addressing an important barrier to women’s 
social, political, and economic participation-
substance abuse and dependence
	 In	 the	 past	 thirty	 years,	 the	 number	 of	 women	 addicted	 to	 drugs	 and	
alcohol	 has	 increased	 dramatically.	 Studies	 suggest	 that	 female	 substance	
abusers	 experience	 a	 particular	 social	 stigma	 that	 often	 prevents	 them	 from	
accessing	treatment.	Drug	abuse	inhibits	the	participation	of	women	in	all	aspects	
of	society.
	 In	 response	 to	 the	growing	number	of	drug-addicted	women	worldwide,	
the	 U.S.	 Department	 of	 State’s	 Bureau	 of	 International	 Narcotics	 and	 Law	
Enforcement	Affairs	 (INL)	 is	 increasingly	 focused	 on	 improving	 and	 expanding	
gender-responsive	 drug	 rehabilitation	 services	 to	 serve	 women.	 Specialized	
programming	 that	 addresses	 the	 unique	 needs	 of	 addicted	 women	 is	 typically	
offered	 in	 tandem	with	 services	 to	 support	 children	 who	 are	 impacted	 by	 their	
parents’	or	other	family	members’	addiction	or	may	be	addicts	themselves.	INL’s	
ongoing	 expansion	 of	 women’s	 services,	 including	 gender-responsive	 training	
curricula,	 treatment	 protocols,	 and	 family-focused	 programs,	 fully	 incorporates	
evidence-based	approaches	and	best	practices,	with	the	ultimate	goal	of	helping	
these	women	to	achieve	sustainable,	drug-free	lifestyles.
	 Through	this	expansion,	INL	has	seen	an	improvement	in	women’s	social	
functioning	 and	 mental	 health	 status,	 including	 a	 decrease	 in	 suicide	 ideation	
and	suicide	attempts.	 In	addition,	 the	 increase	 in	number	of	days	worked	post-
treatment	helped	improve	women’s	income	generation	for	the	family.	The	effects	
illustrate	that	these	programs	assist	in	providing	women	with	increased	social	and	
economic	opportunities.
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INL-funded training: guiding the recovery of 
women (GROW)
	 A	growing	body	of	research	demonstrates	that	female	substance	abusers	
differ	 substantially	 from	 substance-abusing	men	 in	 their	 patterns	 of	 abuse	 and	
related	 issues.	 Case	 studies	 from	 around	 the	 world	 have	 documented	 that	
women	with	substance	use	problems	experience	significant	barriers	to	accessing	
treatment,	and	are	significantly	underrepresented	 in	 treatment	settings.	Barriers	
to	treatment	are	often	rooted	in	societal	norms	and	attitudes,	cultural	taboos,	and	
stigma	towards	women	with	substance	abuse	problems.	Many	addicted	women	
suffer	paralyzing	guilt	for	“failing”	to	meet	societal	expectations	and	to	fulfill	their	
role	as	 “mother”	or	 “nurturer,”	making	 it	especially	difficult	 to	acknowledge	 their	
drug	 dependency	 and	 seek	 help.	Others	 are	 unable	 to	 overcome	deep	 shame	
associated	 with	 effects	 of	 domestic	 violence,	 sexual	 abuse,	 and	 other	 trauma.	
Finally,	for	women	experiencing	sustained	conditions	of	extreme	distress,	such	as	
in	the	case	of	war-torn	Afghanistan,	substance	use	may	appear	as	the	solution	to	
a	problem	from	which	there	seems	no	escape.
	 In	the	past	decade,	an	increasing	number	of	countries	have	promoted	
gender-responsive	 services	 for	women	 through:	 policy	 statements;	 inclusion	
in	 national	 drug	 strategies;	 the	 development	 of	 treatment	 best-practices,	
guidelines	and	standards,	symposiums,	and	reports;	and	the	dissemination	of	
information	 on	model	 programs.	As	 international	 awareness	 of	 the	 need	 for	
gender-responsive	 services	 has	 grown,	 drug	 treatment	 professionals	 have	
sought	 information	 on	 proven	 approaches	 that	 address	 complex	 conditions	
faced	by	addicted	women.
	 In	2007,	armed	with	research	evidence	showing	that	women,	especially	
addicted	women	with	children,	 face	a	unique	set	of	psychological,	 social,	and	
logistical	 barriers	 to	 treatment	 and	 recovery,	 and	 in	 response	 to	 the	 growing	
number	of	 substance-abusing	women	worldwide,	 INL	began	 leading	a	 charge	
for	 excellence	 in	 women’s	 treatment	 by	 convening	 a	 panel	 of	 dedicated	 and	
experienced	experts	on	women’s	substance	abuse	treatment	issues.	The	panel	
was	 asked	 to	 develop	 a	 comprehensive	 training	 curriculum	 that	 would	 meet	
the	 special	 needs	 of	 women,	 educate	 treatment	 providers	 and	 professionals,	
and	promote	gender-responsive	addiction	treatment	as	a	global	“best	practice.”	
This	effort	resulted	in	the	Guiding	the	Recovery	of	Women	(GROW)	Curriculum,	
which	 postulates	 that	 “women	 grow	 and/or	 develop	 in,	 through,	 and	 toward	
relationships.”	Additionally,	 an	 extensive	 body	 of	 research	 shows	 that	women	
with	addiction	 issues	benefit	 from	 improved	 recovery	when	services:	 (1)	 build	
on	strengths;	 (2)	avoid	confrontational	approaches;	 (3)	 teach	coping	skills;	 (4)	
arrange	for	special	needs	such	as	childcare;	(5)	address	and	provide	interventions	
for	 trauma	 and	 abuse;	 (6)	 foster	 family	 reintegration;	 (7)	 build	 health	 support	
networks	 with	 shared	 family	 goals;	 and	 (8)	 make	 prevention	 and	 emotional	
support	available	for	children.
	 GROW	is	designed	to	train	treatment	professionals	to	address	the	many	
underlying	 issues	 that	 cause	 women	 to	 be	 a	 vulnerable	 group	 for	 substance	
abuse,	including	structural	issues	such	as	child	care,	housing,	employment,	and	
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marital	status	as	well	as	social,	cultural	and	personal	beliefs,	and	behaviors	that	
often	punish	and	stigmatize	parenting	and	pregnant	women	who	abuse	drugs.	At	
its	core,	the	GROW	curriculum	provides	a	practical	research-based	approach	to	
the	theory	and	practice	of	gender-responsive	drug	treatment	that	covers	topics	in	
theories	of	addiction,	models	of	treatment,	psychology	of	women,	and	how	to	apply	
theoretical	 knowledge	 in	everyday	situations.	The	basic	GROW	curriculum	 is	a	
five-day	training	that	covers	the	philosophy	of	gender-based	treatment	and	a	range	
of	topics	specific	to	treatment	and	recovery	for	substance	abusing	women,	such	as	
the	psycho-social	development	of	women,	impact	of	trauma	and	post-	traumatic	
stress	disorder	on	recovery,	issues	of	co-occurring	disorders,	and	barriers	to	the	
treatment	process	that	both	women	and	treatment	practitioners	often	experience.	
The	curriculum	combines	lecture	presentations,	practical	applications/small-group	
exercises,	journal	writing	and	discussions,	and	provides	participants	with	tools	to	
create	their	own	action	plans	for	improving	treatment	services	for	women	in	their	
respective	countries	and	organizations.
	 Since	INL	first	piloted	the	basic	GROW	curriculum	in	2008,	the	program	
has	expanded	under	 the	guidance	of	 the	expert	 panel.	 In	addition	 to	 the	basic	
GROW,	 the	 curriculum	 includes	 eight	 GROW-specific	 topics	 that	 have	 been	
designed	to	train	treatment	professionals	to	address	many	underlying	issues	that	
can	affect	women’s	substance	abuse	 treatment	and	 recovery,	and	contribute	 to	
cycles	of	relapse.	The	GROW	special	topic	areas	at	this	time	include:	(1)	Pregnant	
Addicted	Women,	(2)	Women	and	Children,	(3)	Domestic	Violence,	(4)	Trauma,	
(5)	Co-occurring	Disorders,	(6)	Adolescent	Girls,	(7)	Relapse	Prevention,	and	(8)	
Aftercare/Continuing	Care.	A	ninth	special	 topic	on	Substance	Abuse	Treatment	
and	Family	Therapy	is	planned	for	completion	in	early	2013.
Worldwide dissemination of the grow curriculum
	 The	basic	GROW	curriculum	was	first	piloted	in	Georgetown,	Guyana.	Since	
2008,	INL	has	sponsored	the	basic	GROW	training,	along	with	GROW	special	topic	
curriculum	 in	 Brazil,	 Ecuador,	 Guyana,	 Kenya,	 Mexico,	 Nigeria,	 Peru,	 and	 South	
Africa.	 In	 the	 fall	of	2012,	a	group	of	women	treatment	providers	 from	Afghanistan	
attended	training	in	Italy.	From	the	outset,	GROW	trainings	have	sparked	interest	in	the	
broader	needs	of	substance-abusing	women	and	attracted	increasingly	wider	circles	
of	professionals,	including	general	medical	doctors,	psychiatrists,	neuropsychologists,	
mental	 health	 psychologists,	 mental	 health	 managers,	 psychotherapists,	 social	
workers,	counselors,	nurses,	university	professors,	health	clinic	managers,	hospital	
administrators,	 anthropologists,	 governmental	 and	 non-governmental	 agency	
personnel,	and	policymakers.
	 Through	the	GROW	curriculum,	INL	has	established	a	foundation	of	quality	
service	delivery	standards	for	substance	abuse	treatment	and	recovery	services	for	
women	around	the	world.	INL	intends	to	continue	supporting	and	promoting	GROW	
training	in	the	coming	years	as	part	of	its	commitment	to	address	social,	cultural,	and	
economic	barriers	 that	 have	previously	blocked	women’s	access	 to	 treatment	and	
contributed	to	the	cycle	of	addiction.
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Quick facts
	 ●		A	growing	body	of	research	found	that	addiction	treatment	is	most	successful	
when	it	is	gender-responsive.
	 ●		As	 international	 awareness	 of	 the	 need	 for	 gender-responsive	 services	
has	grown,	drug	treatment	professionals	increasingly	seek	information	on	
proven	approaches	to	help	women	recover	from	drug	addiction.
	 ●		The	INL-funded	GROW	curriculum	was	developed	by	a	panel	of	experts	on	
women’s	substance	abuse	treatment	issues	to	educate	treatment	providers	
and	other	professionals	on	the	special	needs	of	women.
	 ●		GROW	 curriculum	 includes:	 Basic	 GROW,	 and	 eight	 special	 topics,	
including:	 Pregnant	 Addicted	 Women,	 Women	 and	 Children,	 Domestic	
Violence,	 Trauma,	 Co-occurring	 Disorders,	 Adolescent	 Girls,	 Relapse	
Prevention,	and	Aftercare/Continuing	Care.
INL-funded treatment facilitating recovery for 
women
	 Recognizing	 that	 gender-responsive	 treatment	 is	 key	 to	 successful	 drug	
demand	reduction,	INL	funds	programs	that	bring	quality	substance	abuse	treatment	
to	women	across	 the	globe.	 In	addition	 to	providing	a	host	of	 training	programs	 to	
currently	 existing	 treatment	 facilities,	 INL’s	 efforts	 also	 include	 the	 creation	 and	
sponsorship	of	residential	treatment	facilities	for	women.	Research	demonstrates	that	
longer	stays	 in	residential	 treatment	programs	 increase	the	chances	 for	successful	
recovery,	especially	for	female	addicts.	In	keeping	with	these	findings,	INL	has	funded	
treatment	centers	that	provide	long-term	residential	care	for	women,	also	in	Brazil.
Brazil: all female treatment
	 In	October	2007,	 INL	and	the	Associação	Promocional	Oração	e	Trabalho	
(APOT)	–	the	Prayer	and	Work	Outreach	Association	–	created	an	all-female	substance	
abuse	treatment	program	on	its	campus	in	Campinas,	Brazil.	The	facility,	Our	Lady	
of	Guadalupe	Prevention	and	Assistance	Center,	complements	Brazil’s	many	male	
substance	abuse	treatment	facilities.	With	a	20-bed	capacity,	Our	Lady	of	Guadalupe	
provides	 long-term	 treatment	with	average	patient	stays	of	 five	 to	six	months.	The	
program	is	designed	not	only	to	treat	drug	addiction,	but	also	to	reintegrate	women	
into	 their	 families	 and	 communities,	 breaking	 the	 cycle	 of	 addictive	 behavior.	 The	
program	is	a	12-step	recovery	process,	including	norms	of	living,	spiritual	exercise,	
physical	education,	 individual	and	group	counseling,	 trauma-informed	therapy,	self-
help,	crafts,	relapse	prevention,	disciplinary	and	maternity	meetings,	and	work	therapy.	
Additionally,	 to	 facilitate	 their	 recovery,	 the	women	maintain	daily	contact	with	 their	
children	and	weekly	family	visits	are	strongly	encouraged.	When	visiting,	the	entire	
family	participates	in	recovery	support	group	sessions	to	strengthen	bonds	and	forge	
new	psychological	partners	in	recovery.	
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INL-funded outcome evaluations on women’s drug 
treatment
Thailand
	 In	 response	 to	 Thailand’s	 drug	 problem,	 where	 methamphetamine	 has	
replaced	opium	as	the	primary	drug	of	abuse,	INL	conducted	trainings	for	Thailand’s	
drug	treatment	facilities	in	the	Therapeutic	Community	(TC)	model	of	drug	treatment.	
A	recent	evaluation	of	those	facilities	revealed	that	Thai	TCs	are	extremely	successful	
at	 reducing	drug-use	and	 its	consequences,	especially	among	women.	Of	 the	105	
females	that	were	part	of	the	evaluation,	92	percent	reported	using	any	drug	(excluding	
alcohol)	before	treatment	.	A	small	percentage	of	clients	participating	in	the	evaluation	
entered	the	treatment	directly	from	hospital	settings	run	by	the	Ministry	of	Public	Health.	
As	such,	their	opportunity	to	use	drugs	in	that	30-	day	period	prior	to	entering	treatment	
was	severely	limited.	This	evaluation	found	that	six	months	after	treatment,	only	10	
percent	reported	using	any	drug	(Figure	1).	This	89-percent	reduction	in	female	drug	
use	is	exemplary,	as	six-month	recovery	rates	exceeding	80	percent	are	rare.	Females	
in	the	study	had	similar	decreases	for	all	drug	types,	most	notably	methamphetamine,	
marijuana,	opiates,	and	inhalants.
Figure 1: Percent	of	Female	Clients’	Drug	Use	Before	and	Six	Months	After	Treatment
Percent of Female Clients Drug Use Before
and Six Months After Treatment
Thailand Study, 2007
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Colombia
	 TC	 facilities	 in	Colombia	 that	have	 received	 INL-funded	 training	have	also	
demonstrated	empirical	 success	of	 treating	women.	A	completed	evaluation	of	TC	
treatment	 provider	 trainings	 in	 Medellin,	 Cali,	 and	 Bogota	 demonstrates	 that	 the	
programs	have	successfully	yielded	impressive	outcomes	for	women	in	treatment.	The	
Colombian	evaluation	shows	that	55	percent	of	females	entering	inpatient	treatment	
in	Colombia	used	drugs	prior	 to	 treatment.	Pre-treatment	drug	use	was	calculated	
by	measuring	usage	with	in	the	past	30	days.	51	percent	of	the	female	clients	in	the	
treatment	 programs	 participating	 in	 the	 evaluation	 entered	 treatment	 directly	 from	
prisons	and	 their	opportunity	 to	use	drugs	30	days	prior	 to	entering	 treatment	was	
severely	limited.	This	study	found	that	after	these	women	participated	in	the	treatment	
program	only	36	percent	of	women	 reported	using	any	drugs	six	months	after	 the	
program–	a	reduction	of	35	percent	(Figure	2).
	 Arrests	and	criminal	activities	among	women	were	 reduced	by	93	percent	
pre-	and	post-	treatment.	With	the	introduction	of	GROW	in	Colombia,	INL	anticipates	
improving	these	numbers	further.
	 Responding	to	evidence	that	female	substance	abusers	face	unique	barriers	
to	treatment	and	require	gender-responsive	treatment,	INL	has	sponsored	programs	
in	 countries	 throughout	 the	 world	 aimed	 at	 providing	 efficient	 and	 effective	 drug	
treatment	to	this	special	population.	INL	supported	trainings	for	programs	in	Thailand	
Figure 2: Overall	Changes	in	Substance	Abuse	in	Women	Before	and	90	Days	After	Treatment
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and	Colombia	have	already	shown	empirical	success	when	treating	female	addicts	
and	 INL	 continues	 to	 enhance	 service	 provider	 training	 by	 creating	 and	 piloting	 a	
training	curriculum	catering	specifically	to	the	treatment	of	women.
Quick facts
	 ●		Science-based	outcome	evaluation	revealed	that	overall	drug	use	among	
women	was	reduced	from	92	percent	to	10	percent	and	methamphetamine	
abuse	was	reduced	from	90	percent	to	10	percent	(pre-	and	post-treatment)	
in	target	treatment	programs	in	Thailand	(Figure	1).
	 ●		A	science-based	outcome	evaluation	revealed	that	overall	drug	use	among	
women	was	reduced	from	56	percent	to	37	percent	and	cocaine	abuse	was	
reduced	from	28	percent	to	15	percent	(pre-	and	post-treatment)	in	target	
treatment	programs	in	Colombia	(Figure	2).
	 ●		Arrests	 and	 criminal	 activities	 among	women	were	 reduced	 by	 over	 93	
percent	 each	 (pre-	 and	 post-treatment)	 in	 target	 treatment	 programs	 in	
Colombia.
	 ●		In	Afghanistan,	 INL’s	 residential,	 outpatient,	 and	 home-based	 treatment	
programs	reach	over	3,804	substance	abusing	women	per	year.
	 ●		With	INL	assistance,	Brazil	created	a	long-term	residential	treatment	center	
that	specializes	in	women’s	treatment.	In	2009,	the	program	was	expanded	
to	include	children	of	substance	abusing	mothers	and	pregnant	and	post-
partum	women.
	 ●		INL	 developed	 the	 GROW	 curriculum	 to	 train	 drug	 treatment	 providers	
on	the	latest	theories	and	practices	in	gender-responsive	treatment	in	the	
United	States	and	abroad.
INL’s efforts to curb drug demand in Afghanistan
INL treatment centers in Afghanistan1
	 INL	 has	 supported	 the	 expansion	 of	 treatment	 programs	 throughout	
Afghanistan	with	special	focus	on	women.	In	2007,	INL	created	the	Sanga	Amaj	
Center,	the	first	and	only	women’s	residential	substance	abuse	treatment	center	
in	Afghanistan.	With	bed	space	 for	25	women,	 the	Center	provides	residential	
substance	 abuse	 treatment	 to	 200	 women	 a	 year.	 In	 addition,	 the	 program	
provides	 home-based	 treatment	 to	 80	 women	 per	 year,	 thereby	 supplying	
services	 to	a	 total	of	280	women	on	an	annual	basis.	Of	particular	concern	 in	
Afghanistan	 is	 the	ability	 of	women	 to	overcome	 the	 stigma	of	 drug	addiction	
and	 successfully	 obtain	 work.	 To	 supplement	 treatment	 and	 fulfill	 this	 need,	
the	 Sanja	Amaj	 Center	 also	 provides	 vocational	 skills	 training	 to	 100	women	
annually.	Further,	to	assist	drug-addicted	mothers	seeking	treatment,	the	Center	
provides	educational,	social	and	recreational	services	to	200	dependent	children	
of	women	in	treatment	each	year.
1 This section includes additional Figures 1 and 2, which are separate and distinct from the aforementioned 
Figures 1 and 2.
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	 Since	2007,	 INL	has	 funded	seven	additional	 residential	 treatment	centers	
for	women,	for	a	total	of	eight	centers	as	of	November	2012.	Each	of	these	residential	
women’s	centers	has	a	corresponding	facility	for	children.	Altogether,	these	16	centers	
treat	1,520	women	and	1,720	children	on	an	annual	basis.	INL	also	funds	33	home-
based	and	outpatient	treatment	centers	that	provide	services	to	an	additional	2,284	
women	per	year.	Three	specialized	residential	facilities	for	female	adolescents	treat	
150	clients	per	year.
	 In	summary,	as	of	November	2012,	INL-funded	services	in	Afghanistan	deliver	
treatment	to	3,804	women	per	year	through	a	combination	of	home-based,	outpatient,	
and	 residential	 programs,	 as	 well	 as	 provide	 therapeutic,	 educational,	 social,	 and	
recreational	services	 to	1,720	dependent	children	of	women	 in	 treatment	per	year.	
Finally,	an	additional	2,000	children	will	be	treated	via	the	creation	of	eight	specialized,	
outpatient	clinics.	INL	is	confident	that	the	success	of	these	programs	will	encourage	
more	Afghan	women	to	seek	much	needed	treatment.
INL training in Afghanistan
	 Since	2008,	INL	has	worked	in	Afghanistan	to	help	manage	the	consequences	
of	 its	 vast	 opium	 production.	 Through	 a	 partnership	 with	 the	 Colombo	 Plan	 Drug	
Advisory	Program	(CPDAP),	 INL	has	supported	trainings	of	Afghan	drug	treatment	
center	staff	and	has	funded	the	centers	themselves.	These	trainings	center	around	the	
CPDAP	model,	which	helps	staff	develop	a	variety	of	skills	related	to	the	full	continuum	
of	 substance	 abuse	 treatment,	 from	 identification	 of	 substance	misuse	 to	 relapse	
prevention.	This	summary	details	an	evaluation	of	the	CPDAP	trainings	and	examines	
short-term	 outcomes	 of	 patients	 treated	 at	 seven	 trained	 centers	 in	 Afghanistan.	
The	evaluation	indicates	that	the	CPDAP-trained	programs	had	a	positive	effect	on	
program	participants,	particularly	with	regard	to	reduced	illegal	drug	use,	opiate	use,	
and	criminal	behavior.
	 In	 2009,	 INL	 funded	 an	 evaluation	 of	 seven	 residential	 drug	 treatment	
programs	that	 received	CPDAP	training	and	 implemented	 the	CPDAP	model.	This	
evaluation	aimed	 to	examine	 treatment	center	patients’	change	 in	 illegal	drug	use,	
alcohol	use,	and	criminal	behavior	from	before	entering	the	treatment	program	to	after	
treatment	was	completed.	It	also	reviewed	the	level	of	implementation	of	the	CPDAP	
treatment	model	within	 the	 drug	 treatment	 centers.	These	 programs	were	 located	
in	Balkh,	Bamyan,	Herat,	Kabul,	Paktia,	and	Wardak.	Three	of	the	programs	serve	
women	and	children	and	four	of	the	programs	serve	men	only.
	 The	 programs	 have	 the	 capacity	 to	 serve	 1,452	 patients	 each	 year	 via	 a	
45-day	residential	 treatment	program	and	a	365-day	outpatient	program.The	study	
sample	consisted	of	504	patients	who	received	services	at	the	seven	drug	treatment	
centers.	 These	 patients	 participated	 in	 a	 baseline	 interview	 one	 to	 five	 days	 after	
completing	detoxification	and	a	follow-up	interview	12	months	after	inpatient	treatment	
was	completed	or	approximately	13.5	months	after	the	baseline	interview.	There	were	
353	patients	that	participated	in	the	post-treatment	interviews,	yielding	a	70-percent	
retention	rate.	To	corroborate	the	post-treatment	interviews,	97	percent	of	interviewed	
patients	completed	a	urinalysis	test.
	 Treatment	 in	 the	 seven	programs	 that	 received	CPDAP	 training	 positively	
impacted	 the	 patients	 involved	 in	 the	 study.	 Baseline	 to	 post-treatment	 interviews	
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observed	statistically	significant	decreases	in	the	use	of	any	illegal	drug	in	the	past	30	
days,	including	opiates.	While	the	overall	use	of	illegal	drugs	went	down,	the	increase	
in	marijuana	 and	 pharmaceuticals	 pre/post-	 treatment	 was	 noted.	 Figure	 1	 below	
shows	 these	statistically	significant	changes	 for	all	patients	and	by	gender	 for	any	
illegal	drug	and	for	opiates	during	the	baseline	to	post-treatment	interview	period.	At	
the	baseline	interviews,	85	percent	of	the	patients	reported	using	at	least	one	illegal	
drug	in	the	past	30	days.	Only	75	percent	reported	using	illegal	drugs	at	the	time	of	
the	post-treatment	interview,	representing	a	12-percent	decrease	from	the	baseline.	
Additionally,	84	percent	of	the	patients	reported	using	opiates	in	the	30	days	before	
treatment,	while	 only	 58	 percent	 used	 at	 the	 time	 of	 the	 post-treatment	 interview,	
representing	a	31	percent	decrease	from	the	baseline.	All	prevalence	reductions	are	
statistically	significant	(p	<	.05).
	 The	study	also	examined	if	there	were	any	gender	differences	in	illegal	drug	
use	among	 treatment	center	patients.	Of	 the	504	patients	 interviewed	at	baseline,	
175	(35	percent)	were	female	and	329	(65	percent)	were	male.	Likewise,	at	the	post-
treatment	 follow	 up,	 121	 of	 353	 patients	 (34	 percent)	 were	 female	 while	 232	 (66	
percent)	were	male,	making	the	before/after	groups	comparable.	For	past	30-day	use	
of	any	 illegal	drugs,	 female	patients	realized	a	20-	percent	decrease	from	baseline	
to	the	post-treatment	interview,	while	males	experienced	an	eight	percent	decrease	
during	 this	 timeframe.	Further,	 for	 past	 30-day	use	of	 opiates,	 the	 female	patients	
had	a	45-percent	decrease	from	baseline	to	the	post-treatment	interview,	while	male	
patients	experienced	a	23-percent	decrease.	The	difference	in	the	decreases	of	opiate	
use	between	the	male	and	female	patients	was	statistically	significant,	as	indicated	
here	in	Figure	1.
Figure 1: Significant Changes in illegal Drug Use Before Treatment and After Treatment by Gender
(Afganistan, 2012)
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	 Criminal	behavior	as	an	outcome	is	often	examined	in	substance	abuse	
treatment	studies	as	drugs	and	crime	are	undeniably	linked.	In	the	current	study,	
there	 were	 significant	 reductions	 in	 criminal	 behavior	 among	 the	 participating	
patients	 from	 baseline	 to	 the	 post-treatment	 interviews.	 Among	 self-reported	
serious	 crimes	 (e.g.	 robbery,	 arson,	 and	 violence	 against	 others)	 committed	 in	
the	past	month,	there	was	a	40	percent	reduction	from	13	percent	at	baseline	to	
eight	percent	at	the	post-treatment	interview	(Figure	2).	Likewise,	there	was	a	48	
percent	reduction	in	the	frequency	of	self-reported	non-serious	crimes	(e.g.	forgery,	
buying	and	selling	stolen	property,	and	theft)	committed	in	the	past	month,	from	
25	percent	at	baseline	to	13	percent	at	the	post-treatment	interview.	The	number	
of	 self-reported	arrests	 in	 the	past	 six	months	also	decreased	 from	baseline	 to	
post-treatment	interviews	by	46	percent,	as	did	the	number	of	arrests	in	the	past	
30	days,	from	five	percent	to	one	percent	(73	percent	decrease).	All	of	the	above	
decreases	were	statistically	significant.
	 The	study	also	provided	a	descriptive	analysis	of	 the	 implementation	of	
the	CPDAP	model	at	each	of	the	seven	treatment	centers.	The	analysis	reviewed	
treatment	participation,	patient	 length	of	stay,	patient	satisfaction,	and	 interviews	
with	each	of	the	seven	treatment	center	directors	concerning	implementation	fidelity.	
Among	the	503	patients,	95	percent	completed	inpatient	treatment	and	85	percent	
of	patients	completed	outpatient	 treatment.	These	observations	are	 important	 to	
note	as	the	study	also	found	that	patients	who	complete	outpatient	treatment	were	
six	times	more	likely	to	have	a	reduction	in	any	illegal	drug	use	in	the	past	30	days	
and	five	times	more	likely	to	experience	a	decrease	in	past	30-day	opiate	use.
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	 Overall,	 the	 seven	 INL-funded	 drug	 treatment	 programs	 in	Afghanistan	
are	positively	impacting	the	lives	of	participants.	The	evaluation	revealed	positive	
outcomes	 for	a	sample	of	patients	over	a	13.5-month	period.	From	baseline	 to	
post-treatment	 interviews,	 the	sample	had	significantly	 less	 illegal	drug	use	and	
less	self-reported	criminal	behavior.
Conclusion
	 These	programs	demonstrate	that	investments	targeting	specialized	treatment	
to	women’s	health	 can	yield	 significant	 results	 for	 curbing	drug	demand	 in	 female	
addicts.	Substance	abuse	addiction	is	an	important	barrier	to	women’s	social,	political,	
and	economic	participation.	Addiction	prevents	women	from	achieving	more	effective	
social	 and	 political	 roles	 in	 their	 societies,	 andgiven	 women’sunique	 perspective	
on	creating	and	maintaining	peace,	 this	 lack	of	 female	participation	can	weaken	a	
country’s	national	security.	For	this	reason,	it	is	imperative	that	actors	consider	gender	
perspectives,	such	as	the	ones	described	above,	when	designing	and	implementing	
drug	treatment	programs.
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Introduction
	 The	 present	 chapter	 is	 aimed	 at	 sharing	 the	 European	 experience	 in	
monitoring	 and	 analysing	 information	 on	 the	 drug	 situation	 and	 in	 sharing	 best	
practices	to	respond	to	the	problems	of	all	the	people	directly	or	indirectly	affected	
by	drug	use.	More	details	can	be	found	mainly	in	two	publications	by	the	European	
Monitoring	Centre	for	Drugs	and	Drug	Addiction	(EMCDDA)	devoted	respectively	
to	gender	perspective	on	drug	use	(EMCDDA,	2006)	and	to	pregnancy,	childcare	
and	the	family	(EMCDDA,	2012a)2.
	 This	 publication	 is	 part	 of	 the	 contribution	 that	 the	 	 EMCDDA	provided	
to	 the	 promotion	 of	 best	 prectices	within	 the	Project	DAWN	 (Drug	 and	Alcohol	
Women	Network).	Under	the	header	of	“gender	mainstreaming”	the	focus	of	this	
chapter	 is	mainly	on	 the	special	needs	and	requirements	of	 female	drug	users.	
This	restriction	is	in	line	with	the	general	gender	debate	of	the	last	decades.
	 The	 first	 chapter	 offers	 a	 broad	prospective	 on	 the	existing	 information	
on	epidemiology	of	drug	use	and	gender	differences	in	Europe.	The	gender	ratio	
among	patients	in	treatment	is	illustrated	in	chapter	two	by	specific	primary	drug	of	
use	accompanied	by	a	brief	discussion	on	the	effect	modification	that	gender	has	
in	treatment	access,	completion,	and	outcome.	In	the	second	and	third	chapters	
we	also	devote	some	thoughts	to	pregnancy	and	motherhood	in	drug	users	with	
2 The present chapter is based on many publications of EMCDDA and some extracts have been maintained 
unaltered from the original. The authors are indebt with the Scientific Staff, the data managers, the editors 
and the scientific writers of EMCDDA.
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particular	 attention	 to	 the	 specific	 risks	 of	 drug	use	during	 pregnancy	 and	how	
responses	to	this	specific	condition	are	provided	across	the	European	countries.
	 Policy	and	legal	 framework	for	pregnant	drug	users,	drug	using	parents	
and	 their	 children	at	 the	European	and	national	 level	are	also	described	 in	 the	
conclusion	of	each	sub-section	and	in	a	devoted	section	to	describe	the	frameworks	
concerning	drug	using	parents	and	their	children.
	 The	 sixth	 section	 is	 aimed	 to	 identify	 the	 guidelines	 and	 other	 quality	
assurance	 tools	which	are	 in	place	 in	Europe	 to	provide	effective	 responses	 to	
drug	users	in	pregnancy	and	when	they	have	family	responsibility.
The EMCDDA and its monitoring activities
	 The	European	Monitoring	Centre	for	Drugs	and	Drug	Addiction	(EMCDDA)	
was	 established	 in	 1993.	 Inaugurated	 in	 Lisbon	 in	 1995,	 it	 is	 one	 of	 the	 EU’s	
decentralised	agencies.	
	 The	 EMCDDA	 provides	 the	 EU	 and	 its	 Member	 States	 with	 a	 factual	
overview	of	European	drug	problems	and	a	solid	evidence	base	to	support	the	drugs	
debate.	Today	 it	offers	policymakers	 the	data	 they	need	 for	drawing	up	 informed	
drug	laws	and	strategies.	It	also	helps	professionals	and	practitioners	working	in	the	
field	to	pinpoint	best	practices	and	new	areas	of	research.	The	agency	underpins	the	
work	undertaken	at	EU	and	Member	State	level	to	tackle	drug	use.	It	does	this	by	
improving	the	quality	of	data	available	to	monitor	progress	and	benchmark	different	
initiatives.	It	operates	an	early	warning	system	to	facilitate	rapid	responses	to	new	
threats.	It	also	makes	evidence	about	good	practice	widely	available.
	 The	EMCDDA	uses	five	key	epidemiological	indicators	to	achieve	its	goal.	
These	indicators	have	been	developed	by	the	Centre	in	close	collaboration	with	the	
Reitox	network,	experts	across	Europe,	and	with	other	international	organisations	
competent	in	the	field	of	drugs	and	drug	addiction.	The	five	key	epidemiological	
indicators	underpin	the	EMCDDA’s	reporting	on	trends	and	developments	in	the	
EU	drug	situation.	They	are	also	a	necessary	component	of	any	analysis	of	the	
coverage	of	responses	or	the	assessment	of	the	impact	of	policies	and	actions.	
Each	 indicator	 collects,	 among	 others,	 information	 on	 the	 gender	 of	 the	 target	
population	 and	 EMCDDA	 main	 annual	 publication,	 the	Annual	 Report,	 include	
statistics	 on	 the	 gender	 ratio	 of	 drug	 users.	 Furthermore	 periodically,	 specific	
publications	have	been	devoted	to	gender	issues	in	drug	use.
An overview on gender specific aspects of drug 
treatment
Evidence of effectiveness for drug treatment
	 The	number	of	studies	on	the	effectiveness	of	drug	related	interventions	has	
multiplied	over	the	last	decades.	
Today	a	good	body	of	evidence	exists	for	some	treatment	interventions.	Nevertheless,	
studies	providing	 information	on	gender	specific	aspects	of	drug-use	 treatment	are	
rare.	Usually	women	are	less	recruited	in	clinical	trials	than	men,	for	a	number	of	well	
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studied	reasons	(Meinert	and	Gilpin,	2001).	Potential	pregnancies,	and	having	more	
often	than	men	the	responsibility	of	taking	care	of	others,	are	some	of	the	factors	that	
can	reduce	the	availability	of	women	to	participate	in	clinical	studies.	Other	specifically	
epidemiological	 characteristics	 of	 the	 feminine	 gender,	 such	 as	 having	 lower	 age	
specific	mortality	rates,	make	women	a	more	expensive	target	population	for	clinical	
trials.	 In	 fact,	 larger	sample	size	and	 longer	 term	studies	are	needed	 to	detect	an	
impact	in	a	population	made	of	women.
	 Nevertheless,	some	recent	studies	have	included	opioid	pregnant	women	in	
order	to	identify	the	best	substitution	treatment	to	maintain	the	mother	stable	without	
causing	harm	to	the	new	born	baby	(Jones	et	al.,	2009;	Minozzi	et	al.,	2008).	The	
studies	proved	that	Methadone	and	Buprenorphine	resulted	to	be	feasible	options	to	
help	pregnant	women	without	causing	harm	to	their	offspring.
Treatment in Europe
	 Treatment	facilities	are	usually	organised	around	the	needs	of	opioid	addicts,	
who	are	mainly	men.	Also	amongst	the	second	biggest	client	group	–	cannabis	users	
–	males	are	much	more	 frequent.	On	 the	other	side	 those	 treatment	 interventions	
that	 do	have	a	gender-specific	 component	 are	mainly	 targeted	 to	women’s	 needs	
and,	in	particular,	to	pregnant	drug	users	or	women	with	children	(EMCDDA,	2006).	
Thus,	in	practice,	gender-specific	treatment	often	means	treatment	targeted	towards	
women	drug	users.	Most	European	countries	report	having	at	least	one	treatment	unit	
or	programme	exclusively	for	women	or	for	women	with	children.	In	recent	years,	the	
introduction	of	high-quality	management	at	drugs	agencies	seems	to	have	played	a	
role	 in	several	countries	 in	achieving	a	higher	 target	group	specialisation,	although	
coverage	of	gender-specific	service	provision	appears	to	be	low	and	is	often	limited	to	
major	urban	centres.	The	most	common	types	of	gender-specific	intervention	include	
case	management	approaches	that	facilitate	the	mediation	of	care	for	pregnant	drug	
users,	services	that	specifically	address	the	mothers	and	fathers	of	small	children,	and	
specially	designed	outreach	projects	targeted	at	sex	workers.
	 Males	 by	 far	 outnumber	 females	 among	 drug	 treatment	 clients.	As	 some	
research	 studies	 have	 suggested	 that	 there	may	 be	 barriers	 to	 service	 uptake	 by	
women.	An	 important	 question,	 but	 one	 that	 is	 difficult	 to	 answer,	 is	 the	 extent	 to	
which	women	are	underrepresented	in	the	treatment	population	compared	with	the	
population	of	those	who	could	be	considered	in	need	of	treatment	(EMCDDA,	2006).
	 All	2011	data	available	from	different	types	of	treatment	suggest	that,	among	
drug	clients	asking	for	treatment	for	the	first	time,	males	outnumber	females	by	a	ratio	
of	4	to	1.	Gender	ratios	among	drug	clients	vary	greatly	between	countries	but	are	
generally	higher	 in	 the	southern	European	countries	 than	 in	northern	countries.	 In	
2011,	the	highest	proportions	of	female	clients	were	in,	Finland,	Czech	Republic	and	
United	Kingdom,	and	the	lowest	were	in	Italy,	Cyprus	and	Turkey.
Gender difference in treatment access, completion and 
outcome
	 The	structural,	social,	cultural	and	personal	barriers	to	treatment	that	women	
can	face	are	multiple	(EMCDDA,	2006).	A	report	by	the	United	Nations	Office	on	
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Drugs	and	Crime	(UNODC,	2004)	shows	that,	among	individuals	with	substance	use	
problems,	women	are	more	likely	than	men	to:	a)	have	a	partner	with	a	substance	
use	 problem;	 b)	 childcare	 responsibilities;	 c)	 severe	 problems	 at	 the	 beginning	
of	 treatment;	 d)	 trauma	 related	 to	physical	 and	 sexual	 abuse;	 and	e)	 concurrent	
psychiatric	 disorders.	 Research	 on	 gender	 differences	 in	 the	 access,	 duration,	
completion,	 and	 outcome	 of	 treatment	 suggests	 that	 generalisations	 on	 gender	
cannot	easily	be	made.	In	some	analyses,	women	are	reported	to	be	more	 likely	
than	men	to	access	treatment;	the	reasons	for	this	may	be	related	to	the	existence	
of	specific	services	offered	to	women	or	to	the	fact	that	women	need	treatment	more	
than	men	if	they	are	pregnant	or	if	they	have	children	(see	next	section).	In	other	
studies,	women	are	reported	to	seek	treatment	proportionately	less	often	than	men	
because	of	the	associated	social	stigma.
	 There	is	not	enough	information	about	gender	differences	in	treatment	duration,	
completion,	 and	 outcome	 in	 Europe	 to	 draw	 any	 firm	 conclusions.	 For	 example,	 a	
German	analysis	of	outpatient	treatment	data	reports	that	men	require	shorter	treatment	
duration	and	have	a	better	outcome,	whereas,	in	Slovakia,	among	clients	of	a	methadone	
programme,	the	success	rate	was	higher	for	women	than	for	men.	More	research	is	
needed	to	better	understand	gender	differences	in	all	treatment	processes;	the	analysis	
should	take	into	account	differences	in	the	clients’	characteristics,	their	patterns	of	drug	
use,	and	the	differences	between	the	types	of	treatment	offered	(for	example	outpatient/
inpatient;	medical/counselling).
Pregnant women
	 The	risks	of	using	drugs	during	pregnancy	have	been	well	documented,	and	
the	harms	related	to	drug	use	in	families	with	children	are	well	known.	However,	not	
all	pregnant	women	who	use	drugs	have	problems	during	or	after	their	pregnancies,	
and	not	all	parents	with	drug	problems	have	difficulty	caring	 for	 their	children.	Still,	
a	 common	 and	 often	well-founded	 concern	 of	 drug-using	 parents	 is	 that	 they	 are	
inevitably	viewed	as	neglectful	and	face	the	risk	of	having	their	children	taken	away	
from	them.	There	are,	however,	an	array	of	programmes	to	help	both	pregnant	drug	
Table 2: Gender	ratio	by	primary	drug	of	clients	entering	treatment,	(2011	or	most	recent	year	available.	
new	outpatient	clients,	ratio	of	males	to	females	by	country	and	primary	drug
Statistical	Bullettin	table	TDI	21	part	(i)	http://www.emcdda.europa.eu/stats12#display:/stats12/tditab21a
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users	and	drug-using	parents.	To	date,	 though,	no	comprehensive	 information	has	
been	available	on	the	extent	of	these	problems	in	Europe,	and	how	they	are	responded	
to	at	European	level.
	 The	true	prevalence	of	drug	use	among	pregnant	women,	however,	is	difficult	
to	 ascertain,	 and	 differences	 across	 countries	 or	 in	 certain	 areas	may	 also	 exist.	
Ireland,	for	example,	reported	that	the	proportion	of	urine	samples	that	tested	positive	
for	 drug	metabolites	 was	 higher	 among	women	 admitted	 for	 labour,	 compared	 to	
Table 3: Health	harms	associated	with	substance	use	during	pregnancy.
NB:	The	effect	of	these	drugs	may	be	confounded	by	polydrug	use	and/or	other	health	and	lifestyle	factors	
associated	with	drug	use.
Source:	A	summary	of	the	health	harms	of	drugs.	The	Centre	for	Public	Health,	Faculty	of	Health	&	Applied	
Social	Science,	Liverpool	John	Moore’s	University,	on	behalf	of	 the	Department	of	Health	and	National	
Treatment	Agency	for	Substance	Misuse	(2011)..
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women	attending	scheduled	antenatal	visits.	One	reason	for	this	may	be	that	women	
who	use	drugs	are	less	likely	to	receive	antenatal	care	than	women	who	are	drug	free.	
In	Latvia,	for	example,	antenatal	care	is	received	before	the	12th	week	of	pregnancy	
by	90%	of	expectant	women	in	the	general	population,	compared	to	70%	those	who	
had	ever	used	drugs	(EMCDDA,	2012a).
Risks of drug use during pregnancy
	 All	 psychoactive	 drugs,	 including	 alcohol,	 tobacco,	 and	 some	 prescribed	
medications,	may	have	adverse	effects	on	the	pregnancy,	the	unborn	child	and	the	
newborn.	Different	drugs,	however,	may	act	differently	(Table	3).	This	may	be	due	not	
only	to	the	drug	itself,	but	also	to	the	poor	overall	health	and	the	nutritional	status	of	the	
drug-using	expectant	mother.	The	degree	of	the	impact	of	drug	use	during	pregnancy	
largely	depends	on	the	intensity	of	drug	use.
	 Several	studies	in	the	Netherlands	have	assessed	the	short	and	long-term	
effects	of	cannabis	use	during	pregnancy.	Short-term	effects	included	reduced	foetal	
growth,	smaller	foetal	head	size,	reductions	in	the	foetal	placental	and	cardiac	blood	
flow,	and	low	birth	weight	(El	Marroun	et	al.,	2009).	The	effect	of	cannabis	(usually	
of	combined	use	with	tobacco)	on	intrauterine	growth	seemed	stronger	than	that	of	
antenatal	 tobacco	exposure	alone,	and	heavier	use	was	associated	with	 increased	
harm	(El	Marroun	et	al.,	2010).	At	the	age	of	18	months,	girls	-	but	not	boys	-	who	
were	exposed	to	cannabis	or	tobacco	in	the	womb	showed	increased	aggression	and	
attention	problems,	although	the	 latter	association	disappeared	when	controlled	for	
confounders	(El	Marroun	et	al.,	2011).	As	the	child	grows	older,	however,	these	effects	
may	disappear.
	 The	vasoconstrictive	effect	of	cocaine	and	amphetamines,	as	described	by	
studies	in	Belgium	and	Germany,	decreases	the	blood	supply	in	the	area	of	the	placenta	
in	pregnant	women	using	these	drugs.	This	may	result	in	miscarriage	during	the	first	
trimester	of	pregnancy,	and	placental	abruption,	intrauterine	death,	or	premature	birth	
in	the	third	quarter.	In	addition,	retarded	foetal	growth	and	reduced	head	circumference	
were	also	observed.	While	during	the	first	two	years	of	the	child	no	further	teratogenic	
effects3	were	described,	some	studies	found	an	increased	incidence	of	sudden	infant	
deaths	and	certain	behavioural	disorders.
	 Results	 of	 research	 conducted	 in	 Germany	 and	Austria	 indicate	 that	 the	
teratogenic	 effects	 of	 opioids	 are	 fewer	 than,	 for	 example,	 of	 alcohol	 or	 tobacco.	
Anomalies	 during	 pregnancy	 and	 at	 birth	 include	 insufficient	 foetal	 growth	 and	
intrauterine	development	of	the	bones,	intrauterine	death,	premature	birth,	anomalies	
in	 spontaneous	 movements,	 and	 neonatal	 withdrawal	 syndrome.	 One	 study	 in	
Vienna	found	prenatal	dystrophy	and	microcephaly	in	21%	and	14%,	respectively,	of	
newborns	of	women	who	used	heroin	during	their	pregnancies.	During	the	first	year	
of	life,	elevated	risks	of	sudden	infant	death	and	delayed	statomotoric	development	
have	been	observed.	In	some	children,	microcephaly	at	birth	remained	later	on	in	life,	
resulting	in	mild	cognitive	impairment.	A	range	of	eye	problems,	including	strabismus,	
has	been	reported	by	studies	in	the	United	Kingdom	among	children	who	had	been	
exposed	to	opioids	in	the	womb.
3 Effects that cause developmental malformations in the foetus or later on in the life of the newborn.
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	 Injecting	drug	users	have	a	higher	than	average	prevalence	of	blood-borne	
infectious	diseases,	and	 these	can	be	 transmitted	 to	 the	 foetus	 (Gyarmathy	et	al.,	
2009).	The	most	common	blood-borne	infection	among	injecting	drug	users	is	hepatitis	
C,	the	level	of	transmission	of	which	during	birth	varies	depending	on	a	number	of	
factors.	Available	evidence	suggests	that	mother-to-child	transmission	of	the	hepatitis	
C	virus	(HCV)	occurs	only	during	pregnancy	and	birth,	but	not	through	breastfeeding.	
A	systematic	review	of	worldwide	transmission	rates	found	that	transmission	of	HCV	
from	mother	to	child	depends	largely	on	the	presence	of	viral	RNA	in	the	mother’s	
blood	and	whether	the	mother	is	co-infected	with	HIV	(Thomas	et	al.,	1998).	Among	
those	who	are	uninfected	with	HIV,	 the	probability	of	 transmission	 is	1–3%	among	
HCV	RNA-negative	women,	and	4–6%	among	HCV	RNA-positive	women.	Among	
those	infected	with	both	HCV	and	HIV,	the	probability	of	HCV	transmission	can	be	as	
high	as	41%,	and	that	of	HIV	is	also	high.
Responses to drug use among pregnant women: 
best practices in Europe
	 Interventions	involving	pregnant	drug	users	include	substance	use	treatment	
and	antenatal	and	postnatal	programmes.	Substitution	treatment	for	drug	use	during	
pregnancy,	however,	 is	available	only	 for	opioid	users,	with	 the	aim	to	stabilise	the	
users’	lifestyle	and	encourage	them	to	use	antenatal	and	obstetric	services.	Antenatal	
care	reduces	the	complications	of	pregnancy	and	birth	—	especially	those	related	to	
neonatal	withdrawal	—	and	decreases	the	probability	of	birth	defects.	The	following	
chapters	give	some	examples	of	programmes	that	provide	treatment	in	a	more	narrow	
and	wider	sense	to	pregnant	women.	These	data	have	been	collected	through	the	
EMCDDA	National	Focal	Points	as	part	of	 their	contribution	 to	an	EMCDDA	report	
(EMCDDA,	2006).
Drug treatment
	 Many	 opioid	 users	want	 to	 cease	 using	when	 they	 find	 out	 that	 they	 are	
pregnant,	but	opioid	withdrawal	is	a	high-risk	option	because	a	return	to	heroin	use	
during	pregnancy	can	result	in	poorer	obstetric	outcomes,	and	severe	opioid	withdrawal	
symptoms	may	 induce	spontaneous	abortion	 in	 the	 first	 trimester	of	pregnancy,	or	
premature	 labour	 in	 the	 third	 trimester	 (WHO,	 2009).	Therefore,	 opioid-dependent	
pregnant	women	are	encouraged	to	start	opioid	substitution	treatment	and	those	who	
are	already	receiving	this	treatment	are	advised	to	continue.
	 An	example	of	this	kind	of	treatment	is	a	drug	liaison	midwife	service	that	was	
initiated	in	1999	in	each	of	Dublin’s	three	maternity	hospitals	to	ensure	that	pregnant	
opioid	users	engage	in	both	antenatal	and	drug	services,	and	that	they	are	stabilised	
on	methadone.	A	preliminary	assessment	allows	immediate	admission	to	treatment.	
The	 mainstay	 of	 treatment	 is	 opioid	 substitution	 with	 methadone:	 stabilisation	 of	
drug	use	is	emphasised,	and	women	are	encouraged	to	remain	on	oral	methadone	
throughout	their	pregnancy.	The	option	to	detoxify	after	the	first	trimester	exists,	but	
women	are	not	pressured	to	reduce	dose	or	to	detoxify.	Those	who	had	difficulties	
stabilising	 are	 offered	 inpatient	 admission	 to	 a	 specialist	 drug	 dependency	 unit.	A	
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fast-track	system	to	admit	pregnant	women	into	treatment	is	provided	in	the	United	
Kingdom,	where	substitute	prescribing	can	‘occur	at	any	time	in	pregnancy’	as	it	is	less	
risky	than	continued	drug	use.
Multidisciplinary comprehensive antenatal and postnatal 
programmes
	 Several	countries	reported	provision	of	multidisciplinary	comprehensive	care	
programmes4.	Doctors,	psychologists	and	social	workers	follow	up	drug-using	women	
and	their	children	from	early	pregnancy	into	childhood	to	ensure	the	well-being	and	
healthy	 development	 of	 the	mother	 and	 the	 child.	 The	 family	 outpatient	 centre	 of	
Hvidovre	Hospital	in	Denmark	is	a	specialised	unit	for	pregnant	women	who	are	or	
have	used	drugs,	or	for	families	with	drug	problems	(where,	for	example,	the	father	or	
family	members	other	than	the	mother	use	drugs).	
	 Children	born	to	these	mothers	are	followed	up	with	comprehensive	medical	
and	psychological	care	until	they	reach	school	age.	Based	on	this	model,	the	Danish	
government	has	established	and	 financed	 family	outpatient	centres	 throughout	 the	
country	 to	 help	 pregnant	 drug	 users	 and	 children	 who	were	 exposed	 to	 drugs	 in	
the	womb	from	birth	until	they	start	school.	The	Danish	focal	point	reported	that	the	
occurrence	of	pregnancy	and	birth	complications	and	birth	defects	among	drug-using	
pregnant	clients	decreased	considerably	in	the	country	as	a	result	of	comprehensive	
antenatal	and	postnatal	care	programmes.
	 Some	of	 these	care	services,	 like	Benniena	 in	Malta,	grew	over	a	decade	
from	a	counselling	 service	 for	pregnant	drug	users	 to	a	 comprehensive	 centre	 for	
families	affected	by	drug	use.	Malta	responded	to	the	increasing	number	of	pregnant	
drug	users	by	creating	a	working	committee	on	‘substance	abuse	mothers’,	composed	
of	a	multidisciplinary	panel	including	social	workers,	paediatricians,	midwives	from	all	
obstetrics	wards,	paediatric	nursing	officers,	antenatal	midwives,	and	medical	doctors.	
The	remit	of	the	working	committee	is	to	follow	mothers-to-be	who	have	substance	
use	problems	and	to	ensure	that	drastic	measures,	such	as	care/court	orders,	can	be	
avoided,	and	that	the	child	is	placed	within	the	family	of	birth	if	possible.
	 The	HAL	(‘drugs,	alcohol	and	pharmaceuticals’)	services	in	Finland	form	
a	 multi-professional	 treatment	 model	 where	 a	 network	 of	 maternity	 outpatient	
clinics	—	covering	the	entire	country	—	provides	psychosocial	interventions	with	
comprehensive	medical	care.	Two-thirds	of	HAL	clients	are	referred	from	maternity	
clinics	 and	 the	 rest	 from	 substance-use	 or	 other	 services,	 such	 as	 emergency	
outpatient	clinics.	All	university	hospitals	have	HAL	services,	which	treat	a	total	of	
about	400	substance-using	mothers	each	year,	providing	pregnancy	monitoring	
(including	repeated	alcohol	and	drug	tests	and	laboratory	tests	relevant	for	at-risk	
groups,	such	as	hepatitis	B,	hepatitis	C	and	HIV),	psychiatric	and	psychological	
assistance,	and	paediatric	assistance.	Children	born	in	the	HAL	system	are	followed	
up	regularly	with	health	appointments	and	visits	and	by	child	welfare	services	until	
they	reach	school	age.	Low-threshold	agencies	called	‘family	ambulatories’	have	
been	established	in	Norway	based	on	a	Danish	model,	and	which	in	collaboration	
4  In addition to the examples presented in this section, the provision of multidisciplinary comprehensive care 
was also reported by Belgium, Luxembourg and the United Kingdom.
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with	postnatal	wards,	mental	healthcare	services	and	various	municipal	agencies,	
provide	preventive	health	assistance	to	pregnant	substance	users	and	follow-ups	
of	their	children	until	they	reach	school	age.
	 The	‘addictology	mobile	team’	of	the	Port	Royal-Cochin	hospital	group	in	Paris,	
France	aims	to	help	pregnant	drug	users	to	gain	or	regain	parenting	abilities.	The	team,	
which	provides	assistance	during	pregnancy,	child	birth,	and	in	the	post-partum	period,	
consists	of	five	professionals:	a	psychiatrist	and	a	general	practitioner	(both	specialised	
in	drug	addiction),	a	social	worker,	a	nurse,	and	a	midwife.	Further,	another	35	projects	
have	been	implemented	in	France	since	2010,	in	order	to	preserve	the	health	of	drug-
using	mothers,	mothers-to-be,	and	 their	young	or	unborn	children.	All	of	 them	exist	
within	specialised	drug	treatment	centres,	mainstreamed	housing	and	social	reinsertion	
facilities,	and	low-threshold	services,	in	collaboration	with	maternity	clinics,	emergency	
wards,	and	the	infant	early	sociomedical	welfare	system	(including	psychiatry).
	 Several	 hospitals	 in	 Austria	 (especially	 in	 Vienna	 and	 Innsbruck)	 offer	 a	
combination	of	antenatal	and	postnatal	medical,	psychosocial,	and	welfare	services	for	
this	population.	After	a	one-year	pilot	project,	a	programme	at	the	University	Hospital	
of	Psychiatry	 in	 Innsbruck	was	 initiated,	consisting	of	scheduled	examinations	and	
assistance	by	a	midwife	available	to	pregnant	women	who	receive	opioid	substitution	
treatment	and	additional	services	by	the	addiction	clinic.	Many	hospitals	in	Vienna	offer	
comprehensive	care,	including	outreach	activities	to	contact	women	at	an	early	stage	
of	their	pregnancy.	For	example,	the	Comprehensive	Care	Project	at	the	University	
Hospital	 in	Vienna	offers	a	multi-professional	approach	 including	physicians,	social	
workers,	pharmacists,	nurses,	and	psychotherapists,	providing	both	antenatal	care	and	
aftercare	of	the	children.	Expectant	mothers	receive	psychiatric	and	psychosocial	care,	
and	maintenance	 therapy	with	methadone,	morphine	or	buprenorphine.	Newborns	
with	withdrawal	syndrome	receive	immediate	treatment,	and	all	children	are	followed	
up	on	with	regular	check-ups	until	age	six,	and	receive	therapy	(e.g.	physiotherapy	or	
speech	therapy)	when	needed.	The	project	has	also	generated	a	wealth	of	longitudinal	
scientific	information	on	pregnant	drug	users	and	their	developing	children.
	 In	 the	Netherlands,	 the	Precaution	 (Voorzorg)	 programme	was	developed	
based	 on	 the	American	Nurse	 Family	 Partnership,	 a	 project	 that	 had	 been	 found	
effective	in	several	randomised	controlled	trials,	and	adapted	to	the	Dutch	situation.	
The	project	follows	a	standardised	protocol,	and	targets	drug-using	women	under	the	
age	of	25,	who	are	at	most	28	weeks	pregnant	and	who	have	no	other	children,	and	
follows	them	up	until	the	child	is	two	years	old.	During	this	period,	participating	families	
receive	60	home	visits	lasting	60-90	minutes,	with	a	decreasing	frequency	of	once	a	
week	after	birth	to	once	a	month	at	the	end	of	the	project.	In	Spain,	the	Red	Cross	
Assistance	runs	a	follow-up	programme	for	high-risk	pregnant	women,	with	the	goal	
of	reducing	the	harmful	effect	of	their	drug	consumption	on	their	lives	and	on	the	lives	
of	their	newborns.	In	this	project,	pregnancy	is	considered	an	opportunity	to	initiate	
medical	 follow	 up	 and	 addiction	 treatment,	 including	 substitution	 therapy,	 infection	
control,	or	psychiatric	care,	if	needed.
	 A	 large	 variety	 of	 multidisciplinary	 comprehensive	 programmes	 are	
available	in	Germany	at	local,	regional	and	national	levels.	The	WIGWAM	outreach	
programme	 in	 Berlin,	 for	 example,	 is	 an	 interdisciplinary	 cooperation	 available	 for	
pregnant	drug	users	since	1987.	In	addition	to	antenatal	care,	medical	help	related	
to	birthing,	and	addiction	treatment	(including	inpatient	treatment	for	newborns	with	
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neonatal	abstinence	syndrome),	women	are	offered	referrals	to	substitution	treatment,	
psychosocial	 assistance,	home	visits,	and	welfare	services.	The	Early	 Intervention	
for	Pregnant	Women	with	Substance	Addictions	(Fruehintervention	fuer	sucht¬mittel-
abhaengige	Schwangere,	KIDS)	was	 initiated	 in	Kassel	 in	2007	with	 the	objective	
of	 reaching	 pregnant	 women	 with	 substance	 addictions	 as	 early	 as	 possible	 in	
pregnancy	in	order	to	provide	referrals	to	medical	and	social	services.	In	Portugal,	the	
Integrated	Project	of	Maternal	Support	provides	integrated	and	global	care	to	pregnant	
and	postpartum	addicted	woman	and	their	children,	following	outpatient	therapeutic	
modalities	best	suited	to	each	situation	regarding	the	treatment,	harm-reduction,	and	
reintegration	needs	of	these	patients.
Special concerns and populations
	 One	particular	concern	is	the	disappearance	of	drug-using	new	mothers	who	
leave	their	newborns	in	the	hospital	soon	after	giving	birth,	often	without	even	naming	
them.	The	Bulgarian	focal	point,	for	example,	reported	this	practice	—	especially	among	
young	Roma	drug-using	women.	As	a	 response,	a	non-governmental	organisation	
‘For	Our	Children’	visits	the	Plovdiv	General	Hospital	for	Active	Treatment	—	where	
many	of	these	abandonment	cases	have	been	reported	—	and	provides	emotional,	
psychological	and	social	support,	and	counselling	to	birthing	women	who	may	be	at	
such	risk.	The	organisation	aims	to	promote	reintegration	of	babies	into	their	biological	
families,	or	 if	 that	 is	not	possible,	support	alternative	families,	especially	those	next	
of	kin.	Additional	assistance	to	pregnant	or	birthing	drug-using	women	includes	the	
provision	of	food	and	items	for	the	baby,	such	as	nappies,	bath	lotions,	and	clothes.
	 A	 special	 population	 among	 pregnant	 drug	 users	 is	 those	 in	 prison.	
Comprehensive	antenatal	services	exist,	for	example,	in	Dublin,	Ireland	in	Mountjoy	
Prison,	 where	 antenatal	 care	 including	 HIV	 testing	 and,	 if	 infected,	 treatment	 is	
offered	 to	 expecting	 mothers.	 These	 services	 collaborate	 closely	 with	 community	
organisations	to	prepare	the	mother	and	her	newborn	for	their	eventual	 life	outside	
prison.	Another	special	population	 is	women	with	HIV,	an	 infection	often	 related	 to	
drug	injection.	In	Estonia,	to	prevent	transmission	through	breast	feeding,	infants	of	
HIV-infected	women	have	the	opportunity	to	obtain	formula	milk	for	free	until	the	child	
reaches	the	age	of	12	months.
European policy and legal frameworks concerning 
pregnant drug users
	 Regarding	 legislation	 concerning	 pregnant	 users	 or	 children	 before	 birth,	
in	 some	 Member	 States,	 pregnancy	 is	 one	 criterion	 that	 may	 trigger	 eligibility	 or	
facilitate	an	application	for	opioid	substitution	treatment5.	Treatment	is	based	on	the	
mother’s	consent;	Finland	and	Sweden	reported	that	it	was	difficult	legally	to	protect	a	
foetus.	For	example,	to	protect	the	health	of	the	foetus,	the	drug	using	mother	might	
be	compelled	 to	submit	 to	care.	Nevertheless	because	 the	 rights	start	at	birth,	 the	
protection	 of	 foetus	 cannot	 violate	 the	 right	 of	 the	mother	 to	 self-determination.	 In	
5  In addition to the examples presented in this section, the provision of multidisciplinary comprehensive care 
was also reported by Belgium, Luxembourg and the United Kingdom.
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both	countries	there	have	recently	been	proposals	to	change	this.	In	the	Netherlands,	
coercive	treatment	in	the	form	of	a	prenatal	supervision	order	is	legally	possible	once	
a	pregnancy	has	reached	24	weeks.	It	is	also	possible	to	enforce	psychiatric	hospital	
admission	for	pregnant	drug	users,	but	this	is	seldom	applied	since	this	particular	law	
was	designed	to	address	mental	health	issues.	However,	one	of	the	key	legal	issues	
facing	this	topic	is	the	inconsistency	between	certain	laws	and/or	perceptions	of	them.	
For	instance,	protecting	the	well-being	of	the	child	may	conflict	with	the	right	of	a	parent	
to	raise	children.	While	a	mother	may	have	the	right	to	protection	or	assistance,	and	
the	examples	mentioned	above	show	how	she	may	be	encouraged	 to	 take	 it,	she	
may	also	fear	applying	for	it	if	there	is	a	risk	that	her	child	would	be	taken	away,	and	
may	even	hide	or	deny	her	pregnancy	because	of	this;	this	concern	was	reported	by	
Germany,	Hungary,	Netherlands	and	Sweden.
	 While	various	countries	establish	obligations	to	report	matters	that	concern	
child	 welfare,	 the	 extension	 of	 this	 obligation	 to	 unborn	 children	 remains	 unclear.	
Sweden	 reported	 that	 the	 obligation	 did	 not	 apply	 to	 unborn	 children,	 whereas	 in	
Finland,	since	March	2010,	an	anticipatory	child	welfare	notification	must	be	submitted	
when	there	is	reasonable	cause	to	suspect	that	an	unborn	child	will	need	child	welfare	
support	measures	 immediately	after	birth.	 In	Denmark,	concerns	about	 the	welfare	
of	unborn	children	must	also	be	 reported,	and	 the	obligation	 to	 report	 child	abuse	
applies	to	all	citizens	regardless	of	their	relationship	to	the	child.	In	the	United	Kingdom	
(England	and	Wales),	there	are	no	mandatory	reporting	obligations,	but	professionals	
and	local	authorities	have	a	duty	to	report	 if	an	unborn	baby	or	a	child	 is	at	risk	of	
significant	harm.	In	most	countries,	obligations	to	report	(or	act	on)	suspicions	of	a	
child	 ‘in	 trouble’	 are	 placed	mainly	 on	 professionals,	 for	 example	members	 of	 the	
social	service	system	(Slovenia),	members	of	the	child	risk	warning	system	(Hungary),	
and	those	who	work	with	children	(Sweden).	Sweden	also	reported	that	members	of	
the	Prisons	and	Probation	Service	are	obliged	to	report	 if	 they	suspect	that	a	child	
is	being	mistreated.	 In	Germany,	 such	an	obligation	has	been	noted	 to	clash	with	
physicians’	 and	 social	workers’	 confidentiality	 obligations,	 though	a	new	 law	 -	The	
‘Bundeskinderschutzgesetz’,	which	came	into	effect	on	1	January	2012	-	aims	to	lay	
down	a	standard	to	address	this.	In	Poland,	if	the	behaviour	of	the	drug-dependent	
parent	results	in	harm	to	the	child’s	health,	the	child	has	a	right	to	compensation	under	
the	Civil	Code,	even	if	the	actions	occurred	during	the	mother’s	pregnancy.
Drug using mothers and child care
	 No	precise	information	is	available	on	how	many	drug	users	live	with	children	
in	Europe.	The	only	data	that	are	available	concern	drug	users	entering	treatment.	
This	population,	however,	is	only	a	partial	representation	of	all	drug	users	who	live	with	
children,	and	not	all	countries	in	Europe	collect	this	information.	The	latest	available	
data	on	 those	entering	 treatment	 for	drug	use	problems	 in	26	European	countries	
show	that	about	one	in	ten	drug	use	clients	(ranging	between	3%	and	17%)	entering	
treatment	in	2010	lived	with	children	(alone	or	with	a	partner,	see	Figure	2).	Overall,	
5%	of	all	treatment	entrants	(or	40%	of	those	who	reported	living	with	children)	were	
single	parents;	on	average,	–	women	were	four	times	more	likely	to	be	single	parents	
than	men	(OR=4.1,	95%	C.I.	4.0	–	4.3).
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The role of the family in treating drug addiction
	 Evidence	 shows	 that	 involving	 family	 members	 in	 treatment	 for	 relatives	
affected	 by	 drug	 addiction	 is	 important	 for	 at	 least	 two	 reasons:	 to	 alleviate	 the	
symptoms	 of	 stress	 and	 their	 consequences	 on	 family	members,	 and	 to	 improve	
the	effectiveness	of	 treatment	 (Orford	et	al.,	2010).	Copello	and	colleagues	(2005)	
identified	 three	main	 types	 of	 family-based	 interventions,	 and	 presented	 evidence	
to	 support	 the	effectiveness	of	 all	 three	 types:	 a)	 interventions	 in	which	 the	 family	
encourages	the	substance	user	to	enter	into	treatment;	b)	interventions	which	involve	
the	family	in	the	treatment	itself,	and	c)	interventions	aimed	at	supporting	the	family	
members.	Other	reviews	have	shown	that	family-oriented	interventions	also	decrease	
behaviours	and	situations	 that	 facilitate	substance	use,	by	modifying	 the	emotional	
environment	 linked	 to	 substance	 use.	A	 review	 study	 in	 Germany	 that	 assessed	
Figure 1:	Percentage	of	all	reported	clients	entering	treatment	living	with	children
NB:	Data	are	for	2010	or	most	recent	year	available.	Data	for	Poland	refer	to	data	from	a	pilot	study;	data	for	
the	United	Kingdom	come	from	their	2011	National	report	and	refer	only	to	England.	For	more	information,	
see	Table	TDI-14	in	the	2012	statistical	bulletin.
Sources:	Reitox	national	focal	points.
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services	aimed	at	drug-using	parents	identified	systematic	family-oriented	approach	as	
an	important	conceptual	element	in	work	with	families	with	addiction	problems.	Group	
services	(support	groups,	individual	counselling,	case	counselling,	weekend	seminars,	
crisis	 intervention	and	parent	training	courses),	public-relations	work	(awareness	of	
services),	administration	(planning	of	resources),	and	supporting	services	(child-care	
while	parents	 take	part	 in	activities	or	 family	seminars)	are	also	key	elements	 that	
contribute	to	the	success	of	the	programmes.	Initiating	contact	with	help	agencies	is	
often	difficult	for	drug-using	parents:	feelings	of	embarrassment	and	shame,	and	fear	
of	losing	their	children	were	identified	as	major	barriers	to	seeking	care.	Outreach	and	
referral	by	other	-	often	non-drug	related	services	-	may	help	parents	overcome	these	
barriers.
Integration of children in their biological families
	 Many	drug-using	parents,	and	mothers	in	particular,	shy	away	from	seeking	
treatment	or	care,	because	they	fear	that	their	children	may	be	taken	away	from	them.	
While	at	times	these	fears	may	be	well-founded,	in	the	majority	of	cases,	authorities	
support	drug-using	parents	 in	 their	efforts	 to	seek	care	and	 treatment	 in	order	 that	
children	can	stay	with	their	biological	parents	in	an	improved,	healthier	environment.	
However,	 even	 when	 children	 are	 taken	 from	 their	 drug-using	 parents,	 they	 are	
often	placed	in	families	next	of	kin.	For	example,	the	wide	range	of	social	services	
provided	by	the	Bulgarian	foundation	‘For	Our	Children’	includes	services	promoting	
the	reintegration	of	babies	and	children	into	their	biological	families,	and	there	is	an	
emphasis	on	extended	families	when	placement	in	foster	families	or	care	is	necessary.	
One	of	the	founding	principles	of	the	Lichtblick	project	in	Frankfurt,	Germany	is	that	
it	 is	 in	the	best	 interest	of	the	children	to	avoid	being	removed	from	the	custody	of	
their	biological	parents.	The	comprehensive	services	provided	by	the	project	aim	to	
empower	drug-using	parents	to	create	a	healthy	physical	and	mental	environment	for	
their	children.
	 In	January	2008,	a	pilot	 family	drug	and	alcohol	court	 (FDAC)	was	set	up	
in	 London	 to	 address	 the	 specific	 needs	 of	 drug-using	 parents	 and	 thus	 improve	
outcomes	for	 their	children	(Harwin	et	al.,	2011).	 It	was	 the	 first	court	of	 its	kind	 in	
England	 and	 Wales,	 and	 consisted	 of	 a	 rehabilitation	 programme	 for	 drug-using	
parents	whose	children	are	subject	to	care	proceedings,	and	was	led	by	a	judge.	In	
the	final	evaluation	report,	it	was	shown	that	39%	of	children	in	areas	that	were	served	
by	the	FDAC	stayed	with	the	family,	in	comparison	to	21%	of	children	in	families	who	
were	subject	to	normal	care	proceedings.	There	was	also	a	positive	difference	reported	
in	the	proportion	of	mothers	who	had	stopped	substance	misuse	(48%	compared	to	
39%).	A	greater	reduction	in	substance	use	was	also	reported	among	fathers	in	the	
evaluation	(39%	of	those	in	the	FDAC	group	compared	to	one	of	the	19	fathers	in	the	
other	group).
	 The	Health	Service	Executive	(HSE)	in	Ireland	has	developed	a	pilot	project	
with	a	family-oriented	approach	that	is	expected	to	reduce	the	number	of	children	who	
need	to	leave	their	families	to	be	cared	for	in	alternative	forms	of	care.	In	addition,	the	
HSE	provides	a	full	range	of	support	services	to	both	parents	and	children,	including	
therapeutic	 work,	 parent	 education	 programmes,	 home-based	 parent	 and	 family	
support	 programmes,	 child	 development	 and	 education	 interventions,	 youth	 work,	
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and	community	development.	An	evaluation	of	the	Families	First	project	in	north-east	
England	shows	that	parents	at	risk	of	losing	their	children	can	successfully	change	their	
lives	such	that	the	children	can	remain	safely	in	the	family	home.	The	availability	of	
kinship	care,	usually	provided	by	grandparents,	was	an	important	factor	in	preventing	
children	from	being	taken	into	care	(Templeton,	2011).
Family-based residential treatment programmes
	 Inpatient	 residential	 treatment	 programmes	 that	 specifically	 cater	 to	 the	
needs	 of	 families	 exist	 in	 some	 Member	 States.	 For	 example,	 the	 therapeutic	
community	ofSananim	in	the	city	of	Karlov	(Czech	Republic)	has	provided	treatment	
to	altogether	115	drug	dependent	mothers	and	 their	117	children	since	2001.	The	
Belgian	organisation	Trempoline	developed	the	Kangaroo	project	with	the	objective	
of	supporting	women	in	their	role	as	mothers.	During	the	daytime,	while	mothers	in	
this	 therapeutic	 programme	 are	 engaged	 in	 activities	 (e.g.	 therapeutic	 community	
and	social	reintegration),	their	children	attend	nursery	school,	kindergarten,	or	school	
classes,	depending	on	their	ages.	The	inpatient	treatment	clinic	De	Lage	Kamp	in	the	
Netherlands	has	been	serving	addicted	parents	and	their	children	(up	to	age	12)	for	
more	than	15	years.	Treatment	is	offered	to	up	to	nine	families	at	a	time	for	the	duration	
of	 12	months	 on	 average,	 with	 detoxification	 during	 the	 first	 four	 weeks.	 Parents	
participate	in	group	sessions	and	receive	individual	counselling,	and	children	are	in	
day	care	engaged	in	educational	activities	and	games.	A	high-threshold	programme	
in	Slovenia	called	Projekt	Človek	Society	houses	three	families	(mothers	or	fathers	
and	their	children)	at	a	time.	This	inpatient	social	rehabilitation	and	addiction	treatment	
programme	teaches	parents	skills	related	to	parenting	and	improving	the	relationship	
with	their	children.	A	nationwide	network	of	inpatient	facilities	in	Finland	(the	Federation	
of	Mother	and	Child	Homes	and	Shelters)	has	been	offering	treatment	and	care	to	
drug-using	mothers	(and,	to	a	lesser	extent,	fathers)	and	their	children	since	the	late	
1990s.	Several	family	inpatient	institutions	exist	in	Norway	as	well:	a	national	study	
from	2005	showed	that	93%	of	the	children	were	under	the	age	of	three	years,	and	
25%	of	them	were	born	while	the	mother	was	already	staying	at	the	institution.
	 The	Coolmine	Therapeutic	Community	 in	 Ireland	 is	 the	 only	 residential	
service	 in	 the	 country	 where	 children	 of	 primary	 school	 age	 can	 live	 on-site	
with	 their	mother,	allowing	mothers	 to	 receive	 the	support	 they	need	while	 their	
children’s	 personal	 development	 is	 strengthened	 through	 specialist	 counselling	
and	 child	 welfare	 initiatives.	 The	 Federation	 of	 Mother	 and	 Child	 Homes	 and	
Shelters	in	Finland	runs	a	national	specialised	treatment	system	known	as	Pidä	
kiinni	(Hold	tight),	consisting	of	seven	mother	and	child	homes	around	the	country.	
To	date,	 the	Pidä	kiinni	homes	and	service	units	have	rehabilitated	about	1,500	
families.	The	service	reaches	some	250	families	annually,	of	which	about	100	are	
referred	to	mother	and	child	shelters	and	about	150	to	outpatient	services.	In	the	
Lithuanian	 public	 institution	TC–Laisva	 valia,	 up	 to	 10	 substance-using	women	
may	get	 long-term	psychological	care	and	social	rehabilitation	services	together	
with	their	little	children.	The	‘Eltern-Kind-Haus’	(‘parent-child	house’)	in	Boeddiger	
Berg,	Germany,	 is	a	special	service	where	drug-using	parents	live	together	with	
their	children	and	receive	advice	and	help	regarding	child-raising	questions	and	
support	in	organising	everyday	family	life.
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Provision of or referral to care services
	 Parents	 with	 drug	 problems	 and	 their	 children	 need	 on-going	 care.	 This	
includes	regular	follow-ups	by	case	managers	of	prevention	programme	participants,	
with	the	aim	of	providing	on-going	counselling	to	prevent	drug	use	and	to	encourage	
a	healthy	 life	style.	Some	may	require	clients	to	return	to	the	programme	that	they	
participated	in,	while	others	provide	home	visits.	Specific	help	offered	to	clients	may	
include	crisis	intervention,	legal	help	with	issues	related	to	drug	use,	and	child-care	
while	they	participate	in	programme	activities.	Obviously,	not	all	programmes	may	be	
comprehensive	enough	to	offer	all	services.	Therefore,	they	often	provide	referrals	to	
other	services	or	encourage	service	utilisation.
	 The	 Kiddo	 Project	 in	 Belgium	 helps	 parents	 become	 aware	 of	 how	 their	
current	or	past	drug	problems	may	affect	their	children,	it	informs	them	about	other	
services	available,	and	it	encourages	them	to	make	use	of	those	services.	In	addition	
to	referring	mothers	to	facilities	 in	the	area	of	child	and	youth	welfare	services,	the	
‘Liliput	–	Mutter	+	Kind’	service	in	Nürnberg,	Germany	offers	individual	counselling	to	
mothers	and	children,	child-care,	and	leisure	time	activities.	In	Kassel,	Germany,	KIDS	
reaches	out	to	expecting	drug	users	and	mothers	with	drug	problems	and	connects	
them	with	social	and	health	services.	Päiväperho	(Butterfly)	in	Finland	links	substance-
using	 pregnant	 women	 and	mothers	 of	 small	 children	with	 child	 welfare	 services,	
substance	use	services,	maternity	clinics	and	family	counselling	clinics,	in	addition	to	
providing	low-threshold	services.
	 Since	2000,	a	crisis	 intervention	service	called	Option	2	has	been	running	
in	Cardiff	and	the	Vale	of	Glamorgan,	Wales.	Staff	work	intensively	with	two	or	three	
families	for	up	to	30	hours	a	week	over	a	four-week	period,	with	follow-up	visits	at	one,	
six,	and	twelve	months	post	intervention.	Booster	sessions	are	available	to	respond	
to	a	crisis	or	to	help	parents	reinforce	their	coping	skills.	Parents	are	asked	to	develop	
goals	 to	 reduce	 risks	 to	 their	children	and	 to	 identify	behavioural	changes	 that	will	
prevent	their	children	from	being	taken	into	care	by	social	services.	Examples	of	goals	
include:	drug	or	alcohol	abstinence;	improved	family	relations;	developing	improved	
routines	 for	 children;	 dealing	 with	 domestic	 violence;	 and	 managing	 children’s	
behaviour.	 Several	 similar	 interventions	 which	 target	 families	 with	 substance	 use	
problems	using	the	Option	2	model	have	been	developed	across	the	United	Kingdom,	
but	provision	is	not	provided	on	a	national	basis.
	 A	 multi-disciplinary	 social	 work	 team,	 including	 community	 care	 and	
probation	professionals,	 is	available	at	the	Drug	Treatment	Centre	Board	in	Dublin,	
Ireland,	 focusing	on	 family	support	 (including	child	welfare),	advocacy,	group	work,	
writing	reports,	and	attending	inter-agency	meetings.	A	children’s	playroom	provides	
stimulation	and	a	safe	and	supportive	child-centred	setting	for	children	aged	between	
1	and	14	years,	who	accompany	their	parents	or	guardians	to	the	clinic.	They	also	offer	
advice	and	support	to	parents	who	may	have	child-care	concerns.	The	Ballyfermot	
Advance	Project	in	Ireland	subsidises	child-care	costs	in	order	to	facilitate	treatment	
access	to	drug-using	parents.
	 Social	work	at	police	stations	is	an	important	element	of	responses	in	Finland.	
It	involves	responding	to	situations	that	emerge	in	the	course	of	police	work	involving	
children,	young	offenders,	family	and	domestic	violence,	mental	health	patients,	drug	
users,	and	other	people	undergoing	acute	crises.
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Psychosocial support
	 Several	activities	provide	psychosocial	support	for	recovering	drug-using	
parents.	Psychotherapy,	psychosocial	care,	and	support	groups	with	activities	to	
learn	healthy	expression	of	emotions	are	aimed	at	minimising	the	complications	
related	 to	 drug	 use.	 Several	 programmes	 offer	 services	 that	 facilitate	 social	
reintegration	and	rehabilitation.
	 The	Welsh	programme	Integrated	Family	Support	Services	 is	a	multi-
agency	 service	 which	 provides	 targeted	 support	 to	 families	 where	 there	 are	
concerns	 regarding	 child	 welfare	 and	 parental	 substance	 misuse	 (drugs,	
alcohol	 or	 both).	 It	 is	 a	 family-centred	 approach	 to	 services	 that	 offers	 early	
intervention	 in	addition	 to	crisis	management.	 It	provides	 intensive	support	 to	
improve	parenting	capacity	as	well	as	social	service	 intervention	and	aims	 to	
help	bridge	the	gaps	between	child	and	adult	services	by	protecting	vulnerable	
children,	while	 at	 the	 same	 time	 helping	 parents	 to	 develop	 new	 skills.	 Four	
‘pioneer’	areas	 in	Wales	adopted	 the	scheme	 in	 late	2010,	and	 it	 is	 reported	
that	 some	early	 successes	 in	preventing	 children	being	 taken	 into	 care	have	
been	observed.	These	areas	were	to	be	evaluated	in	2011,	and	following	this	
it	 is	 expected	 that	 the	 programme	will	 be	 applied	 nationally.	 The	 evaluation,	
published	in	May	2013,	suggest	that	generally,	broadly	positive	trajectories	are	
still	being	achieved	by	the	majority	of	the	participating	families	(albeit	based	on	
relatively	small	numbers)6.
	 An	array	of	services	in	Germany	provides	psychosocial	support	to	drug-
using	parents	and	their	children.	‘Regenbogen’,	an	inpatient	aftercare	programme	
in	 Germany	 provides	 abstinence-based	 support,	 counselling,	 and	 assistance	
to	 parents	 with	 substance	 use	 problems.	 The	 HiKiDra	 project	 in	 Kiel	 offers	
comprehensive	 social	 counselling	 for	 parents,	 and	 support	 groups	 not	 only	 for	
mothers,	but	also	for	pregnant	women,	children	and	adolescents.	The	‘Bella	Donna’	
drug	counselling	office	has	been	offering	services	 to	women	and	girls	 in	Essen	
since	1992.	Their	training	programme	MUT!	helps	mothers	who	use	drugs	or	are	
in	substitution	treatment,	and	their	children,	by	providing	support,	suggestions,	and	
practical	help	 in	 the	everyday	chores	of	 raising	children.	Child-care	 is	available	
while	mothers	attend	group	meetings.
Empowerment and skills building
	 Parents	who	are	seeking	to	recover	from	drug	addiction	benefit	substantially	
from	acquiring	and	strengthening	skills	that	enable	them	to	forge	a	strong	family.	
Building	 parenting	 skills	 -	 such	as	 setting	 limits	 for	 their	 children,	 planning	 and	
organising	 the	household,	 planning	 the	 children’s	 education	 -	 is	 one	main	 goal	
of	therapeutic	programmes.	These	include	being	aware	of	the	parent’s	addiction,	
learning	how	to	deal	with	real-life	family	situations,	and	acquiring	practical	everyday	
skills.	A	key	aspect	 is	building	 family	coherence	by	planning	 family	 leisure	 time	
and	 fostering	 the	 parent-child	 relationship.	 Skills-building	 activities	 related	 to	
6  Evaluation of the Integrated Family Support Service (IFSS) . Accessed June 2013 at: http://wales.gov.uk/
about/aboutresearch/social/latestresearch/integratedfamily/?lang=en
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interpersonal	skills,	communication,	coping,	problem	solving,	and	decision-making	
are	also	often	part	of	therapeutic	work	for	parents	with	drug	problems.
	 The	Ana	Liffey	Drug	Project	in	Ireland	aims	to	promote	and	support	high	
quality	parenting	and	to	enhance	the	quality	of	life	for	children	whose	parents	use	
drugs.	SAOL	is	a	community-based	educational	and	rehabilitation	day	programme	
for	women	in	treatment	for	drug	addiction.	It	provides	a	full-time	child-care	facility	
and	 early	 education	 programme	 for	 their	 children	 called	 the	SAOL	Beag	 (Little	
SAOL)	Children’s	Centre.	Using	an	individualised	curriculum	and	approach	to	work	
with	the	children,	the	programme	seeks	to	identify	each	child’s	interests,	strengths,	
and	learning	goals	and	to	plan	activities	and	learning	experiences	for	the	child.	An	
integral	part	of	this	service	is	to	work	in	partnership	with	the	parents.	Another	key	
element	is	the	relationship	the	children	have	with	the	adults	who	work	with	them:	
the	staff	are	qualified	and	experienced	 in	dealing	with	children	and	aim	 to	 form	
strong,	caring	relationships	with	the	children.
	 A	special	programme	in	Denmark	called	‘Dag	og	Døgncenteret’	(the	Day	
Care	and	Inpatient	Centre)	is	an	inpatient	programme	that	places	the	mother	(or	
parents)	and	the	child	together	in	a	foster	family	under	special	terms	and	conditions.	
In	 this	 system,	 the	 parents	 are	 not	 allowed	 to	 take	 the	 child	 with	 them	 if	 they	
unexpectedly	leave	the	foster	family	or	experience	recurrence	of	their	drug	use.	In	
Denmark,	other	inpatient	institutions	exist	that	do	not	specifically	target	drug-using	
parents	with	children,	but	are	aimed	to	help	families	with	any	psychosocial	problem	
or	a	 risk	of	neglect.	The	 ‘1-2-3	Lass!’	 (1-2-3	Go)	project	 in	Luxembourg	 targets	
pregnant	women	and	mothers	with	children	under	two	years	of	age.	It	began	as	
a	pilot	project	in	2007	as	a	collaboration	between	the	‘service	parentalité’	and	the	
National	Drug	Addiction	Prevention	Centre,	with	the	aim	to	strengthen	and	improve	
the	parenting	skills	of	participants.
	 The	 Polish	 government	 sponsored	 a	 prevention	 programme	 in	 2010	
entitled	‘New	Beginning’	targeting	drug-dependent	mothers	and	pregnant	women.	
The	programme	featured	support	groups	and	parenting	classes.	The	aim	was	to	
improve	the	participants’	knowledge	and	skills	regarding	conflict	solving,	coping,	
positive	 thinking,	 leisure	 time	 activities;	 to	manage	 the	 child’s	 development;	 to	
improve	the	parent-child	relationship;	and	to	promote	parenting	skills.	Apart	from	
psychological	and	health	matters,	some	classes	were	devoted	to	legal	issues.
Policy and legal frameworks concerning drug-
using parents and their children
Legal framework at international level
	 The	main	international	laws	governing	illicit	drugs	are	the	UN	Conventions	of	
1961,	1971	and	1988.	The	first	two	make	no	mention	of	young	people.	The	preamble	
of	 the	1988	Convention	Against	 Illicit	Traffic	 in	Drugs	expresses	deep	 concern	 for	
the	 fact	 that	 children	are	used	as	a	 consumer	market	 for	 drug	distribution,	 and	 in	
Article	3	(5)	it	mentions	the	victimisation	of	minors	and	the	distribution	of	drugs	near	
schoolchildren,	for	example,	as	aggravating	supply	offences.	Nevertheless,	there	is	no	
explicit	mention	of	children	of	drug	users.
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	 However,	the	following	year	the	UN	Convention	on	the	Rights	of	the	Child	was	
signed	in	November	1989,	where	Article	33,	states:
 “States Parties shall take all appropriate measures, including legislative, 
administrative, social and educational measures, to protect children from the illicit 
use of narcotic drugs and psychotropic substances as defined in the relevant 
international treaties, and to prevent the use of children in the illicit production 
and trafficking of such substances”.
	 The	 preamble	 states	 that	 the	 child	 ‘needs special safeguards and care, 
including appropriate legal protection before as well as after birth’.	As	there	is	no	mention	
of	from	whose	illicit	drug	use	the	child	should	be	protected,	this	has	been	interpreted	
as	meaning	that	states	should	protect	children	from	drug	use	within	the	family	(Barrett	
and	Veerman,	2012).	 It	may	be	 read	 together	with	Article	24,	which	gives	 the	 right	
to	antenatal	and	postnatal	care,	and	therefore	may	include	substitution	treatment	for	
opioid-dependents,	and	may	also	be	considered	as	supporting	parenting	skills.
Legal framework at European level
	 At	 the	 European	 level,	 there	 is	 again	 no	 specific	 law	 applying	 to	 the	
children	of	drug	users.	Nevertheless,	the	issue	of	removing	children	from	families	
may	be	governed	by	the	‘right	to	family	life’.	Article	8	of	the	European	Convention	
on	Human	Rights	states:
	 ●		Everyone	 has	 the	 right	 to	 respect	 for	 his	 private	 and	 family	 life,	 his	
home	and	his	correspondence.
	 ●		There	shall	be	no	interference	by	a	public	authority	with	the	exercise	of	
this	right	except	such	as	is	in	accordance	with	the	law	and	is	necessary	
in	 a	 democratic	 society	 in	 the	 interests	 of	 national	 security,	 public	
safety	 or	 the	 economic	well-being	 of	 the	 country,	 for	 the	 prevention	
of	disorder	or	crime,	for	the	protection	of	health	or	morals,	or	for	the	
protection	of	the	rights	and	freedoms	of	others.
	 States	are	allowed	some	discretion	–	known	as	the	margin	of	appreciation	
–	 in	 their	 interpretation	 of	 this	 law.	 This	 will	 differ	 according	 to	 context	 but	 is	
particularly	wide	in	the	area	of	child	protection	(Kilkelly,	2003).	Nevertheless,	it	has	
been	established	by	the	court	that	a	family	life	will	always	include	the	relationship	
between	a	mother	and	child,	even	when	there	is	no	marriage,	no	cohabitation,	or	
only	the	potential	for	family	life	even	if	it	has	not	yet	been	established	(for	example,	
a	child	was	 removed	 from	a	parent	at	birth)	 (Kilkelly,	2003).	As	 the	well-being	of	
the	child	 is	paramount,	returning	the	child	to	his	or	her	parents	should	always	be	
considered;	without	measures	to	prepare	for	the	child’s	return	to	his	or	her	parents,	
the	 implementation	of	a	custody	order	may	be	damaging	 to	 the	child	 (Conrod	et	
al.,	2010).	This	was	reported	as	a	basic	principle	in	Belgium,	Latvia,	Slovenia,	and	
Slovakia.	In	the	Czech	Republic,	one	of	the	objectives	of	the	national	action	plan	on	
caring	for	vulnerable	children	is	to	reduce	the	number	of	children	in	institutional	care,	
while	the	Irish	Child	Care	Act	of,	1991	aims	to	avoid	the	use	of	care.	If	disagreements	
between	 parents	 or	 authorities	 occur,	 the	 child	 has	 a	 right	 to	 be	 informed	 of	
proceedings	and	to	express	its	opinion,	according	to	the	European	Convention	on	
the	Exercise	of	Children’s	Rights	1996.
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Guidelines and recommendations
	 Substitution	 treatment	 combined	 with	 social	 work	 and	 addiction	
counselling	 is	 the	 standard	 practice	 for	 treatment	 of	 heroin	 use	 during	
pregnancy	 (Mactier,	 2011).	 Methadone	 is	 the	 most	 commonly	 available	 and	
prescribed	 opioid	 substitution	 medication	 in	 Europe,	 although	 in	 countries	
where	it	 is	available,	buprenorphine	and	slow-release	oral	morphine	may	also	
be	prescribed.	In	a	number	of	countries,	methadone	is	reported	as	the	primary	
substitution	 medication	 (e.g.	 Germany,	 Ireland,	 Latvia,	 Netherlands,	 United	
Kingdom),	whereas	in	some	others	buprenorphine	is	the	first	choice	medication	
(e.g.	Estonia,	Norway).	In	Germany,	treatment	with	diamorphine	is	also	available	
in	 addition	 to	 the	 substitution	 medications	 commonly	 prescribed	 for	 opioid-
using	pregnant	women,	though	it	is	only	for	high-risk	individuals,	under	strictly	
controlled	circumstances.
	 Recommendations	follow	international	standards,	and	in	some	countries	
pregnant	 women	 receive	 priority	 in	 treatment	 entry.	 Treatment	 protocols	 for	
opioid-using	pregnant	women,	however,	may	vary	by	country.	In	many	countries,	
substitution	 treatment	 is	 encouraged	 at	 any	 time	 during	 the	 pregnancy,	 while	
detoxification	 is	 strongly	 discouraged;	 especially	 during	 the	 first	 trimester,	 to	
prevent	birth	defects	and	miscarriage,	and	the	third	trimester	to	prevent	premature	
birth.
	 Eight	countries	reported	guidelines	for	services	for	pregnant	drug	users	
and	their	newborn,	and	one	country	(Portugal)	reported	that	guidelines	are	being	
developed.	The	majority	of	 these	guidelines	address	substitution	 treatment.	 In	
Germany,	Ireland,	Romania	and	the	United	Kingdom,	guidance	is	provided	within	
the	 general	 framework	 for	 substitution	 treatment,	 with	 pregnant	 women	 as	 a	
specific	subgroup,	while	Hungary,	Norway	and	Sweden	have	developed	special	
guidelines.
	 Three	 countries	 (Ireland,	 Netherlands,	 Romania)	 reported	 quality	
assurance	 documents	 addressing	 neonatal	 abstinence	 syndrome.	 In	 the	
Netherlands,	 two	 specific	 protocols	 are	 available	 concerning	 diagnostics,	
medical	treatment,	support	and	multidisciplinary	treatment	and	care	of	both	child	
and	parents.	In	Ireland,	the	Irish	Prison	Service’s	healthcare	standards	provide	
guidance	 on	 medical	 treatment,	 breastfeeding,	 and	 psychosocial	 support.	
Finally,	in	Romania,	within	the	general	framework	of	clinical	guidelines	for	opioid	
substitution	treatment,	recommendations	are	provided	on	treatment	choices	and	
on	breastfeeding	for	infants	with	neonatal	abstinence	syndrome.
Conclusions
	 In	 Europe	 a	 lower	 number	 of	 women	 than	men	 consume	 drugs,	 with	
wide	 variations	 between	 specific	 drugs.	 Nevertheless	 the	 women	 affected	 by	
drug	 use	 problems	 experience	 a	 higher	 excess	 risk	 of	 mortality	 and	 related	
problems.	Furthermore,	as	the	problems	associated	with	drug	use	are	not	limited	
to	the	individual,	but	they	affect	the	family	as	a	whole,	women	are	those	more	
intensively	involved	in	the	care	of	a	drug	user	relative.
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	 Female	drug	users	may	have	children	and	when	this	 is	 the	case,	 they	
are	more	likely	than	their	male	counterparts	to	live	alone	with	their	children.	Drug	
users	who	have	children	constitute	a	special	 subgroup	because	 in	addition	 to	
their	concerns	related	to	drug	use	in	general,	they	also	have	additional	needs,	
such	as	child-care	while	they	are	in	treatment	and	assistance	with	issues	related	
to	parenting.	Furthermore,	the	legal	protection	and	the	right	of	the	child	to	grow	
up	in	his	or	her	own	family	may	be	threatened	with	the	possibility	that	children	can	
be	removed	from	the	family	if	child	protection	services	consider	their	environment	
dangerous	to	their	well-being.	On	the	other	hand,	however,	living	with	drug	using	
parents	might	not	always	guarantee	adequate	living	conditions	and	safety	for	the	
children.
	 Legislations	 in	 Europe	 strive	 to	 keep	 the	 family	 united	 rather	 than	
separating	 children	 from	 their	 families.	 Legislation	 specifically	 applying	 to	
pregnant	drug	users	or	 to	unborn	children	 facilitates	eligibility	 for	 treatment	 in	
many	countries.
	 In	addition	to	legislation,	a	variety	of	interventions	-	many	of	them	evidence-
based	-	have	been	developed	in	European	countries	to	help	pregnant	drug	users,	
addicted	 parents,	 and	 their	 children.	 For	 example,	 the	 majority	 of	 treatment	
interventions	 for	pregnant	women	follow	the	evidence	of	providing	substitution	
treatment	to	those	dependent	on	opioids.	Furthermore,	to	ensure	that	pregnant	
drug	users	 receive	proper	and	 timely	care,	 some	countries	organise	outreach	
services	and	referral	systems,	offer	multidisciplinary	comprehensive	programmes	
during	 and	 after	 pregnancy	 and	 therapeutic	 communities	 where	 recovering	
parents	and	their	children	can	remain	together.	Interventions	responding	to	the	
needs	of	drug-using	parents	and	 their	children	 include	measures	enabling	 the	
children	to	stay	with	their	biological	families,	family-based	interventions,	provision	
of	or	 referral	 to	care	services,	psychosocial	support,	empowerment,	and	skills	
building.	 Internet-based	 prevention	 programmes	are	 also	 available,	 especially	
for	adolescents	and	young	adults	with	drug-using	parents,	a	group	that	continues	
to	lack	appropriate	attention.
	 Data	 on	 the	 prevalence	 of	 drug	 use	 among	 pregnant	 women	 is	 not	
available	for	most	European	countries,	so	programmes	aimed	to	help	pregnant	
drug	users	may	not	be	aware	of	the	size	of	the	target	group.	Likewise,	the	extent	
to	which	families	affected	by	drug	use	have	been	reached	by	existing	programmes	
remains	 unknown.	 National	 reports,	 however,	 indicate	 that	 coverage	 may	 be	
small	 or	 vary	 substantially	 by	 country,	 and	 that	 the	 viability	 of	 some	 of	 these	
programmes	may	be	questionable.	There	are	several	factors	that	may	contribute	
to	 this.	First,	 there	 is	 a	 shortage	of	 appropriate	and	available	 interventions	at	
organisations	that	cater	to	problem	drug	users	and	their	families,	often	combined	
with	a	lack	of	policy	support.	Second,	reaching	the	target	group	may	be	difficult.	
Treatment	services	that	exist	may	have	several	impediments	that	prevent	them	
from	increasing	their	coverage.	For	example,	a	potentially	general	issue	relates	
to	public	funding:	as	drug	treatment	services	are	often	dependent	on	funding	from	
local	or	government	authorities,	budget	cuts	resulting	from	the	recent	financial	
crisis	 may	 have	 negatively	 affected,	 among	 other	 things,	 the	 functioning	 of	
interventions	and	services	targeting	drug	users	with	children.	Diminished	funding	
may	have	 led	 to	a	 loss	of	 treatment	places,	an	 insufficiency	of	medications,	a	
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decrease	in	the	variety	and	diversity	of	services,	and	the	eventual	closure	of	such	
services	-	just	to	name	a	few.	As	recovering	from	substance	use	and	problems	
related	to	it	may	be	a	lifelong	process,	securing	long-term	government	or	other	
funding	is	an	essential	part	of	prevention	efforts.
	 Regular	monitoring	and	evaluation,	and	particularly,	identifying	the	size	
of	the	target	population,	will	facilitate	a	better	understanding	of	the	issues,	needs,	
and	potential	solutions	related	to	drug-using	pregnant	women,	and	female	drug	
users	in	general.
	 Removing	the	barriers	to	seeking	treatment,	such	as	the	lack	of	child-care	
and	fear	of	legal	consequences,	will	allow	women	who	are	directly	using	drugs	or	
who	are	relatives	of	a	drug	user	to	seek	help.	Whether	a	woman	is	a	drug	use	or	
only	the	relative	of	one,	addressing	her	needs	is	central	to	appropriate	treatment.	
Women	 who	 use	 drugs	 tremendously	 suffer	 physically	 and	 psychologically.	
Female	 relatives	 of	 drug	 users	 can	 suffer	 violence	 and	 enormous	 emotional	
distress.	 In	any	case	women	ought	 to	be	empowered	 to	help	 themselves	and	
their	relatives	to	seek	help	and	to	achieve	good	outcomes.
243
Bargagli, A. M., Hickman, M., Davoli, M., Perucci, C. A., Schifano, P. et al. (2006), 
‘Drug-related mortality and its impact on adult mortality in eight European countries’, 
Eur J Public Health 16(2), pp. 198-202 (available at: PM:16157612).
Barrett, D. and Veerman, P. E. (2012), A commentary on the United Nations convention 
on the rights of the child, Article 33: Protection from narcotic drugs and psychotropic 
substances, Martinus Nijhoff, Leiden.
Conrod, P. J., Castellanos-Ryan, N. and Strang, J. (2010), ‘Brief, personality-targeted 
coping skills interventions and survival as a non-drug user over a 2-year period during 
adolescence’, ARCH. GEN. PSYCHIATRY 67(1), pp. 85-93 (available at: PM:20048226).
El Marroun, H., Tiemeier, H., Steegers, E. A., Jaddoe, V. W., Hofman, A. et al. (2009), 
‘Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R 
Study’, J. Am. Acad. Child Adolesc. Psychiatry 48(12), pp. 1173-81.
El Marroun, H., Tiemeier, H., Steegers, E. A., Roos-Hesselink, J. W., Jaddoe, V. W. et 
al. (2010), ‘A prospective study on intrauterine cannabis exposure and fetal blood flow’, 
Early Hum. Dev. 86(4), pp. 231-6 (available at: PM:20451334).
El Marroun, H., Hudziak, J. J., Tiemeier, H., Creemers, H., Steegers, E. A. et al. (2011), 
‘Intrauterine cannabis exposure leads to more aggressive behavior and attention 
problems in 18-month-old girls’, Drug Alcohol Depend. 118(2-3), pp. 470-4 (available 
at: PM:21470799).
EMCDDA (2006), ‘Gender perspective on drug use and responding to drug problems’, 
Publications Office of the European Union , Luxembourgh.
EMCDDA (2012a), ‘Pregnancy, childcare and the family: key issues for Europe’s 
response to drugs’, Publications Office of the European Union , Luxembourgh.
EMCDDA (2012b), ‘2012 Annual report on the state of the drugs problem in Europe’, 
Publications Office of the European Union , Luxembourgh.
Gyarmathy, V. A., Giraudon, I., Hedrich, D., Montanari, L., Guarita, B. and Wiessing, 
L. (2009), ‘Drug use and pregnancy - challenges for public health’, Euro. Surveill 14(9), 
pp. 33-6 (available at: PM:19317968).
Harwin, J., Ryan, M., Tunnard, J., Alrouh, B., Matias, C. et al. (2011), ‘The family drug 
& alcohol court (FDAC) evaluation project’.
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G. et al. (2009), ‘RCT 
Comparing Methadone and Buprenorphine in Pregnant Women’, (available at: http://
clinicaltrials.gov/ct2/show/NCT00271219).
Kilkelly, U. (2003), The right to respect for private and family life: A guide to the 
implementation of Article 8 of the European Convention on Human Rights, Council of 
Europe, Strasbourg.
Meinert, C. L. and Gilpin, A. K. (2001), ‘Estimation of gender bias in clinical trials’, 
Stat. Med. 20(8), pp. 1153-64 (available at: PM:11304732).
References
244
Minozzi, S., Amato, L., Vecchi, S. and Davoli, M. (2008), ‘Maintenance agonist 
treatments for opiate dependent pregnant women’, Cochrane Database Syst. Rev. (2), 
p. CD006318 (available at: PM:18425946).
Templeton, L. (2011), ‘Dilemmas facing grandparents with grandchildren affected by 
parental substance misuse’, Drugs: education, prevention and policy (0), pp. 1-8.
Thomas, S. L., Newell, M. L., Peckham, C. S., Ades, A. E. and Hall, A. J. (1998), ‘A 
review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants 
born to mothers with and without HCV viraemia or human immunodeficiency virus 
infection’, Int. J. Epidemiol. 27(1), pp. 108-17 (available at: PM:9563703).
WHO (2009), ‘Guidelines for the psychosocially assisted pharmacological treatment of 
opioid dependence’, World Health Organisation, Geneva.
245
Treatment of alcohol use disorders 
(AUDs): a sex-gender approach
Flavia Franconi (1), Gian Luigi Gessa (2), Roberta Agabio (3)
(1) Department of Biomedical Sciences, University of Sassari, Sassari, Italy
(2) Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology; Center of 
Excellence on Neurobiology of Dependence, University of Cagliari, Italy; Neuroscience Institute, National 
Research Council of Italy, Section of Cagliari, Italy
(3) Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology; Center of 
Excellence on Neurobiology of Dependence, University of Cagliari, Italy
Introduction
	 Alcohol	 use	 disorders	 (AUDs)	 involve	 serious	 health	 problems	 with	
enormous	social	and	individual	costs.	As	in	many	other	medical	fields,	the	majority	
of	 investigations	 of	AUDs	 have	 been	 focused	 on	male	 animals	 and	men,	 with	
these	 findings	 mainly	 obtained	 in	 males	 being	 translated	 in	 women	 (Franconi	
et	 al.,	 2007;	 Legato	 et	 al.,	 2009).	Nevertheless,	 several	 differences	 have	 been	
identified	 between	men	and	women	 regarding	 alcohol	 consumption	 and	AUDs,	
from	epidemiology,	pharmacokinetics,	and	patterns	of	drinking	 to	 the	amount	of	
alcohol	and	medical	complications	(Ceylan-Isik	2010;	Cyr,	McGarry,	2002;	Epstein	
et	al.,	2007;	Heading,	2008;	Hensing,	Spak,	2009;	Koechl	et	al.,	2012;	Schuckit	et	
al.,	1998;	Schulte	et	al.,	2009;	Weinberg	et	al.,	2009;	and	literature	therein).	For	
instance,	the	consumption	of	alcohol	is	more	prevalent	among	men	than	women	
(Hasin	et	al.,	2007),	but	women	are	more	vulnerable	to	alcohol-related	morbidity	
and	mortality	 (Shipton	et	al.,	2011).	 In	addition,	women	develop	specific	effects	
to	alcohol	such	as	alterations	of	the	menstrual	cycle	(Emanuele	et	al.,	2002),	an	
increased	risk	of	breast	cancer	(Vachon	et	al.,	2001;	Nelson	et	al.,	2002;	Liu	et	
al.,	2013)	and,	during	pregnancy,	the	risk	of	foetal	alcohol	syndrome	(Sokol	et	al.,	
2003).	Finally,	evidence	suggests	that	women	with	AUDs	are	more	likely	than	men	
to	meet	numerous	barriers	to	access	and	entry	into	treatment	for	AUDs	(Greenfield	
et	al.,	2010a;	Tuchman,	2010).
	 Biological	 (e.g.	 acetylator	 phenotypes)	 and	 environmental	 factors	 (e.g.	
care	 provider-patient	 relationship)	 influence	 the	 response	 to	 treatment.	Women	
and	men	differ	very	much	 in	biological	 (sex)	and	psychosocial-cultural	 (gender)	
factors	that	they	may	be	considered	as	two	different	categories	of	subjects	in	the	
response	to	medical	treatment	(Legato,	2009;	Campesi	et	al.,	2013).	Hippocrates	
had	already	observed	a	gender	difference	in	the	susceptibility	to	developing	certain	
diseases	and	correlated	it	to	the	menstrual	cycle	writing	that	“A	woman	does	not	
take	 the	gout	unless	her	menses	has	stopped”	 (Enomoto	and	Endou,	2005).	 In	
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recent	years,	gender	differences	have	been	described	 in	 the	context	of	several	
drug	abuse	treatments	(Anderson,	2005;	Anderson,	Walton,	2005;	Campesi	et	al.,	
2013;	El-Maarri	et	al.,	2007;	Franconi	et	al.,	2007,	2011a,	2011b;	Gandhi	et	al.,	
2004;	Kaminsky	et	al.,	2006;	Legato,	2009;	Marino	et	al.,	2011;	Regitz-Zagrosek,	
2012;	Soldin	and	Mattison,	2009;	Zhang	et	al.,	2011a)	and	it	is	highly	probable	that	
women	and	men	also	differ	with	regard	to	specific	treatments	for	AUDs.	However,	
relatively	few	studies	have	examined	gender	differences	in	this	field.	Reviewing	the	
literature,	we	mainly	focused	on	women	because	they	are	less	studied	and	thus	
receive	less	evidence-based	treatment,	underlining	evidence	of	the	effectiveness	
of	treatment	for	AUDs	in	women,	in	women	during	pregnancy	and	possible	sex-
gender	differences	in	response	to	it.
Pharmacokinetic of alcohol
	 After	oral	administration,	alcohol	is	absorbed	rapidly	into	the	bloodstream	
from	the	gastrointestinal	system	and	is	distributed	into	total-body	water	(Schuckit,	
2011).	Alcohol	 is	 submitted	 to	 a	 first-pass	metabolism	 by	 the	 gastric	 and	 liver	
enzyme	alcohol	dehydrogenase,	first	to	acetaldehyde,	and	then	to	acetic	acid.	A	
constant	amount	of	alcohol	is	metabolised	per	unit	of	time	(approximately	8	g	per	
hour,	in	a	70-kg	adult).	Small	amounts	of	alcohol	are	excreted	in	urine,	sweat,	and	
breath,	but	metabolism	to	acetate	accounts	for	90-98%	of	ingested	alcohol,	mostly	
via	 hepatic	metabolism.	A	 hepatic	 cytochrome	P450	 (CYP),	CYP2E1,	 also	 can	
contribute	to	this,	especially	at	higher	concentrations	and	under	conditions	such	
as	AUDs,	where	its	activity	may	be	induced.
Sex-Gender differences
	 Women	achieve	higher	blood	alcohol	levels	than	men	after	drinking	equivalent	
amounts	of	alcohol.	In	general,	women	have	less	body	water,	a	higher	proportion	of	
body	 fat	and	a	smaller	volume	of	distribution	 than	men	of	similar	body	weight.	 In	
addition,	women	have	a	smaller	first-pass	metabolism	of	alcohol	than	men	(Baraona	
et	al.,	2001),	having	lower	levels	of	the	gastric	alcohol	metabolising	enzyme	alcohol	
dehydrogenase,	at	least	in	young	age	(Parlesak	et	al.,	2002).	It	is	not	clear	whether	
alcohol	absorption	also	changes	during	menstrual	cycle	(Pizon	et	al.,	2007).
Complications of AUDs
	 Excessive	 alcohol	 consumption	 is	 causally	 related	 to	 more	 than	 60	
different	medical	conditions,	in	most	cases	detrimentally	(Room	et	al.,	2005).	For	
most	of	 these	conditions,	 the	 risk	of	 the	disease	 is	 related	 to	 the	blood	alcohol	
levels	achieved.
Sex-Gender differences
	 Despite	 lower	 levels	 of	 consumption,	 women	 experience	 a	more	 rapid	
progression	to	alcohol-related	medical	conditions	than	men	(McGarry,	Cyr,	2005).	
Compared	to	men,	women	develop	alcohol-induced	liver	disease	over	a	shorter	
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period	 of	 time	 and	 after	 consuming	 less	 alcohol	 (Johnson	 et	 al.,	 2005;	Eagon,	
2010).	In	addition,	women	are	more	likely	than	men	to	develop	alcoholic	hepatitis	
and	to	die	from	cirrhosis	(Rehm	et	al.,	2010).	There	is	also	evidence	for	greater	
effects	on	skeletal	and	cardiac	muscle,	hypertension,	accelerated	brain	atrophy,	
and	an	earlier	onset	of	cognitive	deficits	 in	women	affected	by	AUDs	compared	
to	men	(McGarry,	Cyr,	2005;	Nanchahal	et	al.,	2000).	Notably,	women	with	AUDs	
have	a	higher	risk	of	developing	drug	interactions	and	physical	injuries	from	falls	
and	accidents	(Epstein	et	al.,	2007).	In	particular,	it	has	been	calculated	that	AUDs	
increase	mortality	risk	by	about	160%	and	40%	in	women	and	in	men,	respectively	
(Wilsnack	et	al.,	2009).	A	recent	study	showed	a	decrease	 in	mortality	 risk	 in	a	
Scottish	 population,	with	 the	exception	of	 young	women,	where	alcohol-related	
deaths	were	increased	(Shipton	et	al.,	2013).
Neurobiology of AUDs
	 Alcohol	 affects	 almost	 all	 brain	 neurotransmitter	 systems	 in	 different	
ways	depending	on	the	dose	and	frequency	of	consumption.	For	example,	when	
acutely	 assumed,	 alcohol	 induces	 sedative	 effects,	 mainly	 through	 stimulation	
of	 the	 inhibitory	 gamma-aminobutyric	 acid	 GABAA	 receptors	 and	 the	 inhibition	
of	 the	 excitatory	 N-methyl-D-aspartate	 (NMDA)	 glutamate	 receptors.	When	 it	 is	
chronically	 consumed,	 the	 intensity	 of	 the	 perceived	 effects	 decreases	 because	
of	the	appearance	of	tolerance.	Tolerance	is	due	to	the	development	of	opposite,	
maladaptive	 changes	 in	 most	 neurotransmitter	 systems	 and	 requires	 increased	
doses	of	alcohol	to	achieve	effects	of	the	same	intensity.	After	a	prolonged	heavy	
use	 of	 alcohol,	 if	 alcohol	 use	 is	 reduced	 or	 interrupted,	 a	 withdrawal	 syndrome	
occurs	(APA,	2013).
	 Alcohol,	as	well	as	all	other	drugs	that	are	taken	in	excess,	have	in	common	
the	direct	activation	of	the	mesolimbic	dopaminergic	system	(the	“reward”	system),	
the	 neuronal	 system	 that	 is	 believed	 to	 mediate	 the	 reinforcing,	 motivational,	
stimulating,	and	rewarding	properties	of	 these	substances	(Koob,	Volkow,	2010).	
Briefly,	alcohol	increases	extracellular	fluid	dopamine	levels	in	the	ventral	striatum,	
specifically	the	nucleus	accumbens	region.	The	impact	of	alcohol	on	dopaminergic	
pathways	is	mediated	by	 its	 interaction	with	other	neurotransmitter	systems	such	
as	the	opioid,	GABAergic,	serotonergic,	glutamatergic,	purinergic,	cholinergic	and	
cannabinoid	systems	(Gianoulakis,	2009;	Heinz	et	al.,	2009;	Leishman	et	al.,	2013;	
Nam	et	 al.,	 2012;	Rahman	et	 al.,	 2012).	As	an	example,	 dopaminergic	 neurons	
of	 the	“reward”	system	receive	GABAergic	 inputs.	The	activation	of	metabotropic	
GABAB	receptors	has	an	inhibitory	effect	on	dopaminergic	tone	that	is	thought	to	
reduce	the	reinforcing	effects	of	substances	of	abuse	(Kumar	et	al.,	2013).
	 There	 is	 also	 a	 complex	 relationship	 between	 alcohol	 consumption	 and	
brain	 stress	 systems	 (Belujon,	 Grace,	 2011;	 Roberto	 et	 al.,	 2012;	 Uhart,	Wand,	
2009).	Acute	alcohol	consumption	induces	anti-anxiety	effects,	while	chronic	alcohol	
consumption	can	profoundly	disturb	 the	 response	 to	 stress,	 changing	 the	activity	
of	 several	 factors	 related	 to	 stress	 such	 as	 corticotropin-releasing	 factor	 (CRF)	
and	corticosteroids	released	by	the	adrenal	glands,	increasing	the	susceptibility	to	
relapse.
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Sex-Gender differences
	 Increasing	evidence	from	human	and	animal	research	indicates	the	presence	
of	 sex-gender	 differences	 in	many	 aspects	 of	 the	 neurobiology	 of	 substance	 use	
disorders	(Carroll,	Anker,	2010;	Devaud	et	al.,	2004;	Greenfield	et	al.,	2010b;	Leishman	
et	al.,	2013;	Wiren	et	al.,	2006).	Some	of	these	differences	appear	to	be	genetically	
sustained	and	influenced	by	ovarian	hormones	and	their	metabolites,	as	well	as	by	
the	hypothalamic	pituitary	adrenal	(HPA)	axis,	dopamine,	and	GABA	(Carroll,	Anker,	
2010).	Namely,	the	relationship	between	neurosteroids	(i.e.	steroid	hormones	that	also	
act	in	the	CNS)	and	alcohol	has	been	largely	investigated.	Acute	alcohol	increases	
neurosteroid	 production,	 and	 the	 increase	 in	 neurosteroidogenesis	 after	 alcohol	
consumption	correlates	with	subjective	reports	of	“liking”	or	“wanting	to	consume	more”	
in	humans	(Helms	et	al.,	2012).	Although	little	is	known	about	the	relationship	between	
neurosteroids	and	alcohol	 interactions	at	GABAA	 receptors,	 it	 has	been	proposed	
that	they	have	a	synergistic	effect	on	increasing	inhibition.	Saliently,	allopregnanolone	
(a	metabolite	of	progesterone)	is	the	most	potent	endogenous	modulator	of	GABAA	
receptors	(Finn	et	al.,	2010).	Alcohol	consumption	increases	allopregnanolone	brain	
levels	in	male	rats;	similar	increases	are	achieved	in	female	rats	at	oestrous	and	during	
pregnancy	(Chisari	et	al.,	2010).	Also,	the	activation	of	GABAB	receptors	is	different	
between	 the	 sexes	 and	 changes	 in	 a	 dynamic	manner	 across	 the	 oestrous	 cycle	
(Liu,	Herbison	2011).	These	findings	suggest	that	fluctuations	in	neurosteroids	levels	
could	modify	the	functioning	of	central	GABAA	and	GABAB	receptors	and	induce	sex-
gender	differences	in	the	sensitivity	to	alcohol	and	other	substances	of	abuse.	There	
are	also	sex-gender	differences	in	the	ability	of	alcohol	to	enhance	dopamine	release	
in	the	mesolimbic	pathway.	For	example,	a	PET	study	has	revealed	that	men	show	
twice	as	much	dopamine	release	 in	 the	ventral	striatum	compared	 to	women	after	
acute	alcohol	intake	(Boileau	et	al.,	2003).	In	preclinical	models	of	AUDs,	females	had	
a	higher	alcohol	intake	than	males	and	this	difference	suggests	a	higher	sensitivity	of	
females	to	the	reward	effects	value	of	alcohol	than	males	(Finn	et	al.,	2010,	Colombo	
et	al.,	2012).	In	women	of	child-bearing	age,	the	luteal	phase	of	the	menstrual	cycle	
is	associated	with	a	reduced	ability	of	alcohol	to	activate	reward	circuitry,	which	could	
account	for	increased	alcohol	consumption	during	this	phase	(Lenz	et	al.,	2012).	Sex	
hormone	activity	 can	mediate	 the	acute	 rewarding	effects	 of	 alcohol	 by	 regulating	
the	HPA	axis	and	endogenous	opioid	systems,	both	of	which	contribute	to	dopamine	
release	in	the	nucleus	accumbens	(Lenz	et	al.,	2012).	Globally,	these	data	suggest	that	
not	only	may	women	require	specific	treatment	for	AUDs,	but	also	that	their	response	
to	treatment	may	change	across	the	different	phases	of	their	lives,	as	well	as	during	
the	oestrous	cycle.
Diagnostic criteria of AUDs
	 According	to	the	Fourth	Edition	of	the	Diagnostic	and	Statistical	Manual	
of	 Mental	 Disorders	 (DSM-IV-TR),	AUDs	 include	 two	 severe	 mental	 disorders,	
alcohol	dependence	and	abuse,	both	of	which	are	characterised	by	maladaptive	
patterns	of	alcohol	consumption,	 leading	to	clinically	significant	 impairment,	and	
are	associated	with	devastating	consequences	 (APA,	2000).	Even	 if	abuse	and	
dependence	have	been	classified	by	DSM-IV-TR	as	independent	disorders,	they	
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are	often	considered	a	single	disorder	with	different	grades	of	severity.	Accordingly,	
in	the	last	edition	of	DSM	(DSM-5),	abuse	and	dependence	have	been	combined	
into	a	single	mental	disorder,	defined	as	alcohol	use	disorder	AUD	(APA,	2013).
Sex-Gender differences
	 There	are	no	sex-gender	differences	among	the	diagnostic	criteria	of	AUDs	
and	AUD	(APA,	2000;	APA,	2013).	The	paragraph	entitled	“Gender-related	diagnostic	
issues”	of	DSM-5	describes	gender-differences	in	rates	of	drinking	(higher	in	men	
than	women),	 alcohol	 levels	 achieved	after	 drinking	 (higher	 in	women	 than	men	
per	drink),	and	alcohol-related	vulnerability	to	some	of	the	physical	consequences	
associated	with	alcohol	higher	in	women	than	men	(APA,	2013).
Prevalence of AUDs
	 AUDs	are	common	disorders,	with	well-known	sex-gender	differences	(APA,	
2013;	The	ESEMeD⁄MHEDEA	2000	 Investigators,	 2004;	Wittchen	 et	 al.,	 2011).	 In	
the	United	States,	a	large	study	found	that	approximately	8%	and	30%	of	the	adult	
population	suffered	from	current	and	lifetime	AUDs,	respectively	(Hasin	et	al.,	2007).
Sex-Gender differences
	 In	the	1980s,	the	prevalence	of	AUDs	was	approximately	five	times	more	
in	 men	 than	 in	 women	 (Robins,	 Regier,	 1991);	 however,	 over	 the	 past	 three	
decades,	 this	difference	 in	 the	United	States	has	narrowed	such	that	AUDs	are	
now	only	twice	as	prevalent	in	men	than	in	women	(Hasin	et	al.,	2007),	because	
the	number	of	women	affected	by	AUDs	is	raising	and	the	disparity	between	men	
and	women	 is	rapidly	diminishing	(Epstein	et	al.,	2007).	One	of	 the	reasons	 for	
this	change	is	related	to	the	increase	of	the	subgroup	of	population	comprised	by	
very	old	people,	in	which	women	are	prevalent	(Culberson,	Ziska,	2008;	Koechl	et	
al.,	2012;	Simoni-Wastila,	Yang,	2006).	Moreover,	male	and	female	adolescents	
do	 not	 exhibit	 the	 same	 disparity	 in	 the	 prevalence	 of	AUDs.	 For	 instance,	 a	
community-based	sample	of	3,072	adolescents	revealed	that	rates	of	AUDs	were	
not	statistically	different	for	girls	and	boys	aged	12	to	17	(Schulte	et	al.,	2009).
Comorbidity
	 Patients	 affected	 by	 AUDs	 often	 suffer	 from	 other	 mental	 disorders,	
such	as	other	substance	use	disorders,	mood	disorders,	anxiety	disorders,	and	
personality	disorders	(Hasin	et	al.,	2007).	The	co-occurrence	of	 these	disorders	
worsens	the	prognosis	of	both	disorders	and	requires	specific	interventions.
Gender differences
	 The	prevalence	of	specific	comorbid	disorders	differs	between	men	and	
women:	for	example,	women	affected	by	AUDs	are	more	likely	to	suffer	from	mood	
and	anxiety	disorders	than	men,	whereas	men	with	AUDs	are	more	likely	to	suffer	
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from	personality	disorders	and	additional	 substance	use	disorders	 than	women	
(Compton	et	al.,	2000).	However,	recently,	after	adjustment	for	sociodemographic	
characteristics	 and	 additional	 co-occurring	 psychiatric	 diagnosis,	 most	 of	 the	
prevalence	of	comorbid	disorders	did	not	differ	significantly	by	sex	(Goldstein	et	
al.,	2012).	Only	mood	disorders	were	more	prevalent	among	women	affected	by	
AUDs	than	in	men	(Goldstein	et	al.,	2012).
	 More	 than	 150	 prescription	 and	 over-the-counter	 medications	 interact	
negatively	with	alcohol	(National	Institute	on	Alcohol	Abuse	and	Alcoholism,	2003).	
Thus,	sex	and	gender	differences	in	comorbidity	appear	to	be	also	relevant	for	the	
possible	drug	interactions	with	alcohol	and	among	drugs	used	to	treat	comorbid	
disorders	and	those	to	treat	AUDs.	Furthermore,	older	women	prevail	over	men	
and	the	elderly	(>65	years)	consume	more	drugs;	thus,	interactions	could	be	more	
frequent	in	older	women	(Gomberg,	1990).
Treatment of AUDs
	 The	 treatment	of	AUDs	 is	aimed	at	 reducing	 the	severity	of	 intoxication	
and	withdrawal	symptoms	if	needed,	and	achieving	long-term	sobriety	(or	at	least	
a	reduction	in	alcohol	consumption),	and	preventing	relapses	(Kleber	et	al.,	2007).
Intoxication
	 The	diagnosis	of	alcohol	intoxication	requires	the	occurrence	of	at	least	one	
of	the	following	criteria:	slurred	speech,	incoordination,	unsteady	gait,	nystagmus,	
impairment	in	attention	or	memory,	and	stupor	or	coma	(APA,	2013).	It	can	be	a	
medical	emergency,	and	a	number	of	people	die	every	year	 from	 this	disorder.	
The	 treatment	 of	 acute	 alcohol	 intoxication	 is	 based	 on	 its	 severity	 (Schuckit,	
2011).	 Mild	 intoxications	 require	 reassurance	 and	 maintenance	 in	 a	 safe	 and	
monitored	 environment,	 adequate	 hydration	 and	 nutrition,	 while	 hospitalisation	
is	 recommended	 for	 severe	 acute	 alcohol	 intoxication	 (e.g.	 comatose	 patients	
or	those	with	evidence	of	respiratory	depression	that	may	require	intubation	and	
ventilator	assistance)	(Kleber	et	al.,	2007;	Schuckit,	2011).	Medical	and	psychiatric	
problems	should	also	be	investigated	to	establish	whether	hospitalisation	may	be	
required.	In	some	European	countries	(including	Italy),	metadoxine,	a	pyridoxine-
pyrrolidone	carboxylate,	is	approved	for	the	treatment	of	acute	alcohol	intoxication	
(Leggio	et	al.,	2011).	Two	clinical	trials,	with	a	total	of	110	intoxicated	subjects	of	
both	sexes,	found	that	its	administration	was	able	to	accelerate	alcohol	elimination	
(Shpilenia	et	al.,	2002;	Diaz	Martinez	et	al.,	2002).
Sex-gender differences and pregnancy
	 The	 total	 number	 of	 patients	 treated	 with	 metadoxine	 is	 insufficient	 to	
evaluate	its	efficacy	in	the	treatment	of	alcohol	intoxication	for	men	(87	subjects)	
and	women	(23	subjects),	and	it	also	does	not	permit	the	evaluation	of	possible	
sex-gender	differences	in	response	to	it.	Furthermore,	metadoxine	is	not	suitable	
for	 patients	 who	 are	 pregnant	 or	 breastfeeding	 (www.unitedpharmacies.com/
customer/product.php?productid=1366).
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Alcohol withdrawal syndrome
	 The	essential	feature	of	alcohol	withdrawal	syndrome	is	the	development	
of	symptoms	reflecting	autonomic	hyperactivity	and	anxiety	within	several	hours	to	
a	few	days	after	the	cessation	of,	or	reduction	in,	heavy	and	prolonged	alcohol	use	
(APA,	2013).	Its	diagnosis	requires	the	occurrence	of	at	least	two	of	the	following	
symptoms	 and	 signs:	 sweating	 or	 pulse	 rate	 greater	 than	 100	 bpm,	 increased	
hand	 tremor,	 insomnia,	nausea	or	vomiting,	 transient	hallucinations	or	 illusions,	
psychomotor	agitation,	anxiety	and	generalised	 tonic-clonic	seizures.	Generally,	
these	symptoms	and	signs	are	minor	but	can	develop	into	a	severe,	even	fatal,	
condition.	 It	 has	 been	 suggested	 that	 approximately	 10%	 of	 the	 subjects	 with	
alcohol	withdrawal	syndrome	develop	dramatic	symptoms	such	as	delirium	and	
generalised	tonic-clonic	seizures	(APA,	2013).	
	 The	treatment	of	alcohol	withdrawal	syndrome	is	based	on	its	severity:	mild	
syndromes	 require	 generalised	 support,	 reassurance,	monitoring	 and	 thiamine,	
while	severe	syndromes	necessitate	pharmacological	treatments	to	(1)	reduce	the	
severity	of	symptoms,	and	(2)	prevent	the	incidence	of	seizures	and	delirium	(Kleber	
et	al.,	2007).	Because	different	medications	have	been	used	in	the	treatment	of	
alcohol	withdrawal	syndrome	(such	as	benzodiazepines,	anticonvulsants,	alpha-
2-adrenergic	agonists,	beta-adrenergic	antagonists,	and	gamma-hydroxybutyrate	
(GHB),	several	studies	evaluated	their	safety	and	effectiveness	in	achieving	these	
two	aims.
 Benzodiazepines (e.g.	 lorazepam,	 chlordiazepoxide,	 and	 diazepam)	
are	 the	 drugs	 of	 choice	 in	 the	 management	 of	 alcohol	 withdrawal	 syndrome	
(Amato	et	al.,	2011;	Hall,	Zador,	1997;	Kosten,	O’Connor,	2003;	Mayo-Smith	et	
al.,	1997).	A	meta-analysis,	evaluating	the	results	obtained	from	134	clinical	trials	
conducted	 from	1966	 to	1995,	 found	 that,	among	 the	different	pharmacological	
agents	used,	benzodiazepines	 (1)	 reduced	 the	severity	of	symptoms	of	alcohol	
withdrawal	syndromes	and	(2)	prevented	the	 incidence	of	seizures	and	delirium	
(Mayo-Smith	et	al.,	1997).	A	more	recent	study,	which	evaluated	5	 reviews	and	
114	studies	including	a	total	of	7,333	participants,	also	found	that	benzodiazepines	
performed	better	 than	placebo	and	other	drugs	 in	preventing	 the	occurrence	of	
seizures	(Amato	et	al.,	2011).	All	benzodiazepines	are	effective	in	treating	alcohol	
withdrawal	 syndrome	 and	 the	 choice	 of	 a	 specific	 one	 is	 influenced	 by	 patient	
features	(Chang,	Steinberg,	2000;	Schuckit,	2006).	Shorter	acting	benzodiazepines,	
such	as	 lorazepam	and	oxazepam,	are	 indicated	 in	elderly	patients,	 in	subjects	
with	hepatic	impairment,	and	postoperative	patients,	 in	order	to	avoid	excessive	
sedation.	 Longer	 acting	 drugs,	 such	 as	 chlordiazepoxide	 and	 diazepam,	 may	
cause	excessive	sedation	but	are	useful	in	the	prevention	of	seizures.	Agents	with	
a	rapid	onset	of	action,	such	as	lorazepam,	alprazolam,	and	diazepam,	generate	
additional	concerns	regarding	abuse.	However,	the	clinical	use	of	benzodiazepines	
is	limited	by	potential	for	abuse,	psychomotor	sedation,	cognitive	impairment,	and	
the	possibility	of	pharmacological	interaction	with	alcohol.
 Anticonvulsants	(e.g.	carbamazepine,	valproic	acid,	and	phenytoin)	were	
studied	as	alternatives	to	benzodiazepines	for	the	treatment	of	alcohol	withdrawal	
syndromes	 (Erstad,	 Cotugno,	 1995).	A	 meta-analysis	 found	 that	 they	 reduced	
the	 severity	 of	 alcohol	 withdrawal	 syndrome	 but	 did	 not	 prevent	 complications	
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(Mayo-Smith	 et	 al.,	 1997).	 A	 more	 recent	 review	 article,	 which	 evaluated	 56	
studies	 including	 a	 total	 of	 4,076	 participants,	 concluded	 that	 there	 are	 limited	
data	to	determine	the	effectiveness	of	anticonvulsants	in	the	treatment	for	alcohol	
withdrawal	syndrome	(Minozzi	et	al.,	2010).
 Alpha-2-adrenergic agonists	 (e.g.	 clonidine)	 and	 beta-adrenergic 
antagonists	(e.g.	propranolol	and	atenolol)	may	be	useful	as	adjuvant	treatments,	
but	are	unsuitable	for	use	alone	in	the	treatment	of	alcohol	withdrawal	syndromes	
(Kosten,	O’Connor,	2003).	As	anticonvulsants,	a	meta-analysis	study	found	that	
these	 drugs	 also	 reduced	 the	 severity	 of	 alcohol	 withdrawal	 syndrome	 (e.g.	
autonomic	 manifestations)	 but	 have	 not	 been	 proven	 to	 prevent	 complications	
(Mayo-Smith	et	al.,	1997).
 Ghb,	 an	 endogenous	 constituent	 of	 the	 mammalian	 brain,	 has	 been	
approved	for	 the	treatment	of	alcohol	withdrawal	syndromes	in	Italy	and	Austria	
(Agabio	 et	 al.,	 2010).	 However,	 a	 recent	 study	 found	 that	 benzodiazepines	
performed	better	than	placebo	and	other	drugs,	including	GHB,	in	preventing	the	
occurrence	of	seizures,	finding	insufficient	evidence	for	effectiveness	and	safety	for	
the	use	of	other	drugs	anticonvulsants,	baclofen,	GHB	and	psychotropic	analgesic	
nitrous	oxide	(Amato	et	al.,	2011).	Another	review	article	evaluated	6	trials,	with	a	
total	of	286	subjects,	and	concluded	that	there	are	limited	data	to	determine	the	
effectiveness	of	GHB	in	the	treatment	of	alcohol	withdrawal	syndrome	(Leone	et	
al.,	2010).
Sex-gender differences and pregnancy
	 It	 has	been	 reported	 that	males	and	 females	differ	 in	 the	 symptoms	of	
alcohol	withdrawal	(Leishman	et	al.,	2013).	A	clinical	study	found	that	women	(62	
subjects)	developed	 less	severe	symptoms	of	alcohol	withdrawal	 than	men	 (66	
subjects);	however,	the	Authors	reported	that	men	could	have	experienced	more	
severe	withdrawal	than	women	because	they	were	older	and	had	longer	histories	of	
AUDs	than	women	(Deshmukh	et	al.,	2003).	Also,	female	rats	are	less	susceptible	
to	seizures	during	acute	withdrawal	than	male	rats	(Wiren	et	al.,	2006).	Sex-gender	
differences	in	the	time	course	for	the	development	of,	and	recovery	from,	alcohol	
withdrawal	syndrome	may	be	due	to	differences	in	neurochemical	and	molecular	
adaptations	related	 to	circulating	steroid	 levels,	 including	sex	steroids	(Wiren	et	
al.,	2006).	Because	allopregnanolone	has	shown	anticonvulsant	effects	in	some	
preclinical	models,	 the	current	hypothesis	 is	 that	males	and	 females	may	have	
different	GABAA	sensitivity	due	to	 the	effects	of	neurosteroids	(Leishman	et	al.,	
2013).
	 To	date,	no	 randomised	clinical	 trials	have	been	conducted	 to	evaluate	
the	effectiveness	of	pharmacological	treatments	of	alcohol	withdrawal	syndrome	
in	women	and	in	pregnancy,	or	to	evaluate	possible	sex-gender	differences	in	the	
response	to	treatment	(Heberlein	et	al.,	2012).	However,	sex-gender	differences	
already	 observed	 in	 some	 properties	 of	 certain	 drugs	may	 be	 useful	 to	 select	
the	 more	 appropriate	 agent	 to	 treat	 alcohol	 withdrawal	 syndrome	 in	 women.	
Accordingly,	these	differences	will	be	briefly	described.
 Benzodiazepines	are	metabolised	extensively	by	CYPs,	particularly	by	
CYP3A4	 and	 2C19	 (Ketter	 et	 al.,	 1995).	 CYP3A4	 and	 2C19	 (at	 least	 in	 some	
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populations)	are	more	active	in	women	than	in	men	(Franconi	et	al.,	2007;	Tamminga	
et	al.,	1999;	 Inomata	et	al.,	2005);	moreover,	CYP3A4	activity	decreases	 in	 the	
elderly,	with	a	probable	higher	reduction	in	men	than	in	women	(Schwartz,	2003).	
Accordingly,	 gender	differences	have	been	described	 in	 the	 clearance	of	 some	
benzodiazepines	and	 in	 the	severity	of	certain	side	effects	 (Chetty	et	al.,	2012;	
Verster	et	al.,	2012).	These	data	suggest	that	the	response	to	benzodiazepines	in	
the	treatment	of	alcohol	withdrawal	syndrome	may	also	differ	between	men	and	
women.
	 Further	 differences	 may	 be	 found	 in	 the	 response	 to	 drugs	 between	
women	who	are	 taking	oral	 contraceptives	and	 those	who	are	not	 taking	 these	
drugs.	Women	taking	oral	contraceptives	eliminate	valproic	acid	more	rapidly	than	
women	who	are	not	taking	them	(Galimberti	et	al.,	2006).	This	result	suggests	that	
valproic acid	may	be	less	effective	in	the	treatment	of	alcohol	withdrawal	syndrome	
if	 women	 are	 taking	 oral	 contraceptives.	Carbamazepine, phenytoin	 and	 oral	
contraceptives	are	mainly	metabolised	by	CYP3A4	and	are	also	 inducers	of	 its	
activity	(Crawford	et	al.,	1990;	Crawford,	2002).	Accordingly,	the	administration	of	
carbamazepine	or	phenytoin	reduces	the	effectiveness	of	oral	contraceptives.	It	is	
highly	probable	that	carbamazepine	and	phenytoin	may	also	be	less	effective	in	the	
treatment	of	alcohol	withdrawal	syndrome	if	women	are	taking	oral	contraceptives.	
These	 data	 suggest	 that	 it	 is	 necessary	 to	 properly	 investigate	 the	 use	 of	 oral	
contraceptives	to	“adjust”	the	dose	of	drugs	to	treat	alcohol	withdrawal	syndrome	
in	women.
	 Some	beta-blockers	(such	as	propranolol and metoprolol)	are	substrates	
of	another	CYP,	CYP2D6,	and	this	enzyme	is	more	active	in	men	than	in	women.	
This	 difference	 is	 considered	 to	 be	 the	 basis	 of	 gender	 differences	 seen	 in	
certain	drugs	metabolised	by	CYP2D6	(Franconi	et	al.,	2007).	For	example,	peak	
concentrations	of	propranolol	are	70%	higher	in	women	than	in	men	(Fletcher	et	
al.,	1994),	while	concentrations	of	other	beta-blockers	(which	are	not	substrates	
of	CYP2D6,	such	as	atenolol)	do	not	present	sex-gender	differences	(Franconi	
et	al.,	2007).	These	data	suggest	that	doses	of	pharmacological	treatments	may	
vary	greatly	between	men	and	women.	The	choice	of	drugs	should	be	also	made	
considering	 the	 high	 vulnerability	 of	 women	 to	 develop	 alcohol-induced	 liver	
disease.
	 Finally,	clinical	studies	where	benzodiazepines	and	other	medications	used	
to	 treat	 alcohol	 withdrawal	 syndrome	 (e.g.	 anticonvulsants)	 were	 administered	
during	pregnancy	for	reasons	other	than	alcohol	withdrawal	syndrome	showed	that	
these	drugs	were	related	to	the	risk	of	foetal	malformations	and	perinatal	problems,	
suggesting	that	their	use	should	be	avoided	during	pregnancy	(Marinucci	et	al.,	2011).
Treatment to achieve sobriety and prevent 
relapses or reduce alcohol consumption
	 AUDs	 have	 a	 variable	 course	 characterised	 by	 periods	 of	 remission	
and	 relapse	 (see	Schuckit,	2009).	Although	some	 individuals	achieve	 long-term	
sobriety	without	treatment,	others	need	treatment	to	stop	the	cycles	of	remission	
and	relapse.	Treatment	includes	psychosocial	treatments	and	pharmacotherapy.
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Psychosocial treatments
	 Several	psychosocial	 treatments,	as	well	as	attending	self-help	groups,	
have	been	proven	to	be	useful	in	the	treatment	of	AUDs	(Kleber	et	al.,	2007).	As	
an	example,	brief	interventions	are	recommended	to	reduce	alcohol	consumption	
of	heavy	drinkers	 (NIAAA,	2005),	while	other	psychosocial	 treatments	 (such	as	
cognitive	behavioural	therapies,	motivational	enhancement	therapies,	and	12-step	
facilitation	counselling)	to	treat	AUDs	(Project	Match	Research	Group,	1998).
 Brief interventions	are	short	(5-20	minutes)	focused	counselling	sessions	
(Fleming	et	al.,	2002)	that	may	be	delivered	by	healthcare	workers	during	routine	
office	 visits	 (NIAAA,	 2005).	A	meta-analysis	 study,	 of	 21	 randomised-controlled	
trials,	 including	a	 total	of	7,286	subjects	 (Kaner	et	al.,	2007),	showed	 that	brief	
interventions	 promote	 significant	 lasting	 reductions	 in	 drinking	 levels	 in	 heavy	
drinkers.
Sex - gender differences and pregnancy
	 A	meta-analysis	of	subjects	divided	by	gender	(including	less	than	6%	of	
women)	did	not	find	any	significant	benefit	of	brief	interventions	in	reducing	drinking	
in	women	(Kaner	et	al.,	2007).	On	the	other	hand,	another	meta-analysis	evaluated	
the	results	obtained	by	a	higher	number	of	female	heavy	drinkers	(33%)	and	found	
that	brief	interventions	induce	a	similar	reduction	in	alcohol	consumption	in	men	
and	women	 (Ballesteros	et	 al.,	 2004).	Thus,	 setting	up	new	studies	 is	 urgently	
needed	in	order	to	understand	the	therapeutic	relevance	of	brief	interventions	in	
female	heavy	drinkers.
	 A	 recent	 review	 study	 evaluated	 the	 effectiveness	 of	 psychological	
interventions	-	ranging	from	a	10-minute	education	session	and	the	provision	of	a	
self-help	manual	through	to	an	hour-long	motivational	interview	with	reinforcement	
at	each	prenatal	visit	 -	 in	 reducing	alcohol	consumption	of	a	 total	of	715	heavy	
drinker,	 pregnant	 women	 (Stade	 et	 al.,	 2009).	 This	 review	 concluded	 that	
psychosocial	 interventions	 may	 increase	 abstinence	 from	 alcohol,	 and	 reduce	
alcohol	 consumption	 among	 pregnant	 women;	 however,	 the	 results	 were	 not	
consistent.	Another	 review	article	 found	 that	pregnant	heavy	drinkers	are	highly	
motivated	 to	 reduce	 their	alcohol	 intake	and	 that	brief	 interventions	and	control	
treatments	 were	 equally	 effective	 in	 reducing	 alcohol	 consumption	 without	
significant	differences	between	groups	(Nilsen,	2009).
	 Project	Match	Research	Group	(1998)	showed	that	cognitive behavioural 
therapy	and	12-step	facilitation	counselling	(focused	to	“facilitate”	a	commitment	
to	self-help	groups	of	the	association	“Alcoholics	Anonymous”)	gave	better	results	
than motivational enhancement therapy	 in	reducing	alcohol	consumption	and	
alcohol-related	negative	 consequences	 (Project	Match	Research	Group,	1998).	
Another	large,	randomised,	controlled	trial	evaluated	the	efficacy	of	medications	
(naltrexone,	 acamprosate,	 or	 placebo),	 behavioural	 therapies	 (combining	 some	
aspects	 of	 behavioural	 intervention,	 cognitive	 behavioural	 therapy,	 12-step	
facilitation,	 and	 motivational	 interviewing),	 medical	 management,	 and	 their	
combinations	 in	a	16-week	 treatment	period	 in	1,383	patients	 (482	women	and	
955	men)	affected	by	AUDs	(Anton	et	al.,	2006).	The	results	of	this	study	showed	a	
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substantial	reduction	in	drinking	in	all	groups,	with	better	results	achieved	in	patients	
who	received	naltrexone	and	medical	management,	or	behavioural	therapies	and	
medical	management;	no	other	combination	produced	better	efficacy	than	these	
two	combinations.	This	study	concluded	that	naltrexone	and	medical	management	
should	be	therefore	recommended	to	all	patients	affected	by	AUDs	as	it	may	be	
delivered	by	primary	care	physicians	(Anton	et	al.,	2006).	Agosti	and	colleagues	
(2012)	also	suggested	that	the	benefit	of	the	addition	of	a	psychosocial	intervention	
to	medication	in	treating	AUDs	may	be	limited.
	 The	 Project	 Match	 Research	 Group	 (1998)	 found	 better	 outcomes	 in	
women	than	in	men	although	this	difference	was	no	longer	noticeable	after	a	3	year	
follow-up	period	(Project	Match	Research	Group,	1998).	Conversely,	other	studies	
found	no	difference	between	men	and	women	in	the	response	to	psychotherapy	
[378	women	and	848	men	 in	 response	 to	naltrexone	and	medical	management	
(Greenfield	 et	 al.,	 2010a);	 106	 women	 and	 106	men	 affected	 by	AUDs	 in	 the	
response	to	psychotherapies	(Diehl	et	al.	2007)].	Globally,	these	results	suggest	
that	the	small	differences	observed	in	previous	studies	may	be	due,	at	least	in	part,	
to	the	heterogeneous	samples	evaluated	and	that	the	combination	of	naltrexone	
and	medical	management	 should	be	also	 recommended	 to	women	affected	by	
AUDs	(Greenfield	et	al.,	2010a).
	 No	 clinical	 trial	 has	 been	 conducted	 to	 evaluate	 the	 effectiveness	 of	
psychosocial	 interventions	 in	 pregnant	 women	 affected	 by	 AUDs	 (Lui	 et	 al.,	
2008),	and	there	is	insufficient	evidence	to	recommend	the	routine	use	of	home	
visits	during	pregnancy	 in	 these	patients	 (Doggett	 et	 al.,	 2005).	Globally,	 these	
data	indicate	that	it	is	necessary	to	investigate	the	effectiveness	of	psychosocial	
interventions	in	pregnancy	in	consideration	to	the	fact	that	effectiveness	of	these	
interventions	 could	 reduce	 the	 risk	 of	 foetal	malformations	 that	may	occur	with	
medications.
	 The	effectiveness	of	attending self-help groups	has	not	been	evaluated	
in	 randomised	 studies	 (Kleber	 et	 al.,	 2007).	 However,	 it	 has	 been	 found	 that	
subjects	 who	 attend	Alcoholics	Anonymous	 achieve	 better	 rates	 of	 abstinence	
(about	 twice	as	high	as	 those	who	do	not	attend	 this	 self-help	group)	and	 that	
higher	 levels	of	attendance	are	related	to	higher	rates	of	abstinence	(Kaskutas,	
2009).
	 Two	 recent	 studies	 found	 that	 men	 and	 women	 use	 and	 attend	 self-
help	groups	differently,	but	 that	 there	was	no	difference	 in	 the	beneficial	effects	
achieved	 (Kelly,	Hoeppner,	2013;	Witbrod,	Delucchi,	 2011).	No	clinical	 trial	 has	
been	 conducted	 to	 evaluate	 the	 effectiveness	 of	 attending	 self-help	 groups	 in	
pregnant	women	affected	by	AUDs	(Lui	et	al.,	2008).
Pharmacotherapy
	 The	 existing	 landscape	 of	 pharmacological	 treatments	 for	 AUDs	 is	
limited.	At	 present,	 in	 the	US,	 four	medications	–	 disulfiram,	 acamprosate,	 oral	
and	 extended-release	 naltrexone	 –	 have	 been	 approved	 by	 the	 US	 Food	 and	
Drug	Administration	to	treat	AUDs;	in	Europe,	extended-release	naltrexone	is	not	
available,	whereas	nalmefene	has	 recently	 received	marketing	authorisation.	 In	
Italy	and	Austria,	GHB	is	also	available	(Leone	et	al.,	2010).	All	of	these	agents	
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have	demonstrated	some	ability	to	reduce	drinking	and/or	increase	the	abstinence	
time,	but	results	have	not	always	been	consistent.	 In	general,	 the	magnitude	of	
effect	of	the	available	pharmacotherapies	for	AUDs	is	modest,	with	no	treatment	
adequately	 suiting	 all	 patients	 (van	 de	 Brink,	 2012).	 Among	 these	 agents,	
acamprosate	has	been	estimated	to	be	the	most	widely	prescribed	drug	for	AUDs	
in	the	US	(Mark	et	al.,	2009).
 Disulfiram	has	been	approved	by	the	US	Food	and	Drug	Administration	
for	 the	 treatment	of	AUDs	since	1951	 (Suh	et	al.,	2006).	 It	 inhibits	 the	enzyme	
responsible	 for	 converting	 acetaldehyde	 to	 acetate	 in	metabolising	 alcohol	 and	
increases	the	concentration	of	acetaldehyde.
	 The	 accumulation	 of	 acetaldehyde	 produces	 unpleasant	 signs	 and	
symptoms	such	as	facial	flushing,	sweating,	and	mild	headache.	At	a	moderate	
level	of	 intensity,	the	reaction	may	also	include	nausea,	tachycardia,	palpitation,	
hyperventilation,	hypotension,	and	dyspnoea.	In	more	severe	reactions,	vomiting,	
respiratory	depression,	cardiovascular	collapse,	arrhythmias,	myocardial	infarction,	
acute	 congestive	 heart	 failure,	 unconsciousness,	 convulsions,	 and	 death	 may	
occur	(Jørgensen	et	al.,	2011).	Disulfiram	should	therefore	prevent	patients	from	
drinking	to	avoid	the	occurrence	of	these	unpleasant	signs	and	symptoms	when	
they	are	treated	with	this	medication	(Kleber	et	al.,	2007).	However,	 its	use	has	
been	 limited	 because	 there	 are	 difficulties	 in	 getting	 patients	 to	 take	 disulfiram	
on	a	regular	basis	and,	despite	the	fact	it	has	been	used	for	more	than	60	years	
for	the	treatment	of	AUDs,	its	effectiveness	has	not	yet	been	proven	(Garbutt	et	
al.,	 1999).	The	evaluation	of	effectiveness	and	 tolerability	of	disulfiram	was	 the	
aim	of	a	 recent	 review	article	 (Jørgensen	et	al.,	2011).	Namely,	11	 randomised	
clinical	 trials	 were	 selected	 (published	 from	 1979	 to	 2010),	 including	 a	 total	 of	
1,527	patients.	This	study	found	that,	when	compared	with	placebo,	none,	or	other	
treatments,	 supervised	 treatment	with	disulfiram	had	some	effect	on	short-term	
abstinence	but	its	long-term	effect	had	not	yet	been	evaluated.
	 Disulfiram also	 inhibits	 dopamine	 β-hydroxylase,	 an	 enzyme	 involved	
in	 catecholamine	 synthesis	 (Faiman,	 1979;	Haley,	 1979;	Wright,	Moore,	 1990),	
catalysing	 the	 hydroxylation	 of	 dopamine	 to	 norepinephrine,	 thus	 changing	 the	
ratios	of	dopamine	to	norepinephrine	(Stanley	et	al.,	1997).	This	last	effect	induced	
a	new	interest	in	disulfiram	for	treatment	in	cocaine	use	disorder	and	pathological	
gambling	(Charpeaud	et	al.,	2011).
Sex-gender differences and pregnancy
	 The	number	of	women	recruited	in	randomised	clinical	trials	was	too	low	
to	evaluate	the	effectiveness	and	safety	of	disulfiram	in	 the	treatment	of	 female	
patients	affected	by	AUDs	or	possible	sex-gender	differences	in	the	response	to	
it	 (Jørgensen	et	al.,	2011).	However,	 it	has	been	 found	 that	oral	contraceptives	
increased	the	activity	of	dopamine	β-hydroxylase	in	women	(Rockson	et	al.,	1975)	
and	 in	 rodents	 (Serova	 et	 al.,	 2002),	 indicating	 the	 importance	 of	 hormones	 in	
controlling	the	activity	of	this	enzyme.	Importantly,	women	show	significantly	lower	
activity	than	men	of	another	enzyme	involved	in	catabolism	of	dopamine,	catechol-
O-methyltransferase	(COMT)	(Boudikova	et	al.,	1990;	Chen	et	al.,	2004;	Jiang	et	
al.,	2003).	Therefore,	the	effects	of	disulfiram	may	be	attenuated	in	women.
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Regarding	its	possible	use	in	pregnancy,	a	recent	review	article	concluded	that,	to	
date,	no	randomised	clinical	trial	has	been	conducted	to	evaluate	the	effectiveness,	
safety	or	tolerability	of	disulfiram	in	pregnant	women	affected	by	AUDs	(Smith	et	
al.,	2009).	 In	 the	US,	disulfiram	is	 included	 in	 the	“class	C	pregnancy	category”	
which	means	that	there	is	evidence	of	adverse	effects	 in	animal	studies,	but	no	
adequate	or	well-controlled	human	studies.
 Acamprosate is	a	drug	with	a	chemical	structure	that	is	similar	to	that	of	
the	endogenous	amino	acid	N-acetyl	homotaurine	(Littleton,	2007).	Its	mechanism	
of	action	is	not	completely	known;	however,	it	is	thought	to	work	at	brain	glutamate	
receptor	 sites,	 stabilising	 glutamatergic	 function:	 during	 alcohol	 withdrawal,	 the	
increased	calcium	 influx	 through	NMDA	glutamate	 receptors	 induces	a	 state	of	
neuronal	 hyperexcitability	 associated	 with	 physical	 symptoms	 of	 withdrawal	
and	 an	 increased	 desire	 to	 start	 drinking	 again.	 By	 inhibiting	 calcium	 influx,	
acamprosate	is	claimed	to	restore	the	balance	between	inhibitory	and	excitatory	
neurotransmitters,	attenuating	alcohol	craving	(Littleton,	2007).	In	animal	models	
of	 AUDs,	 acamprosate	 a)	 attenuated	 self-administration	 of	 alcohol	 under	 free	
choice	 conditions,	 b)	 diminished	 the	 temporary	 increase	 in	 voluntary	 alcohol	
intake	observed	during	a	reinstated	access	to	alcohol	after	a	period	of	deprivation	
(the	 “alcohol	 deprivation	 effect”,	 used	 as	 a	model	 of	 relapse),	 and	 c)	 inhibited	
development	of	the	conditioned	place	preference	(Littleton,	2007).
	 A	recent	meta-analysis	evaluted	the	results	obtained	by	6,915	participants	
affected	 by	AUDs	 and	 enrolled	 in	 24	 randomised	 controlled	 trials	 finding	 that,	
compared	to	placebo,	acamprosate	significantly	reduced	the	risk	of	any	drinking	
and	 increased	 the	 cumulative	 abstinence	 duration,	 inducing	 the	 occurrence	 of	
diarrhoea	as	the	only	significant	side	effect	(Rösner	et	al.,	2010a).
Sex-gender differences and pregnancy
	 Acamprosate	 seems	 to	 have	 the	 same	 pharmacokinetics	 in	 men	 and	
women	(Saivin	et	al.,	1998).	A	meta-analysis	showed	that	4,794	men	and	1,317	
women	affected	by	AUDs	(recruited	in	22	out	of	the	24	trials	already	evaluated	in	
a	previous	meta-analysis	by	Rosner	et	al.,	2010)	did	not	differ	in	any	measure	of	
acamprosate	efficacy,	safety	or	tolerability	(Mason,	Lehert,	2012).	However,	some	
recent	studies	have	suggested	that	men	and	women	may	differ	in	their	response	
to	drugs	interacting	with	the	glutamatergic	system	(Micevych,	Mermelstein,	2008;	
Parkash,	et	al.,	2010).	To	date,	no	randomised	clinical	 trial	has	been	conducted	
to	 evaluate	 the	 effectiveness,	 safety	 or	 tolerability	 of	 acamprosate	 in	 pregnant	
women	affected	by	AUDs	(Smith	et	al.,	2009).	In	the	United	States,	acamprosate	
is	included	in	pregnancy	category	C.
 Naltrexone	 is	 a	 competitive	antagonist	 at	 μ,	 δ,	 and	 κ-opioid	 receptors,	
which	was	approved	for	the	treatment	of	AUDs	in	1994	by	the	US	Food	and	Drug	
Administration	 (Swift,	 2013).	 It	 is	 also	 approved	 for	 the	 treatment	 of	 AUDs	 in	
much	of	the	world,	including	Europe,	Asia,	and	Australia.	Naltrexone	is	thought	to	
act	by	diminishing	part	of	the	rewarding	effects	induced	by	alcohol	consumption	
and,	 subsequently,	blunting	alcohol	 cravings.	The	endogenous	opioid	 receptors	
are	 assumed	 to	mediate,	 at	 least	 in	 part,	 the	 pleasant	 and	 euphoric	 effects	 of	
drinking.	 As	 naltrexone	 binds	 to	 these	 receptors,	 the	 pleasant	 and	 euphoric	
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effects	of	drinking	diminish	and	subjects	experience	a	reduced	“high”	after	alcohol	
consumption	 compared	 to	 former	 drinking	 (Volpicelli,	 1995).	 In	 animal	 models	
of	AUDs,	naltrexone	decreases	alcohol	 intake	under	 free-choice	conditions	and	
prevents	the	development	of	conditioned	place	preference	for	alcohol;	however,	it	
fails	to	consistently	reduce	the	“alcohol	deprivation	effect”.
	 A	 recent	meta-analysis	evaluated	 the	 results	obtained	 in	7,793	patients	
affected	by	AUDs	enrolled	in	50	double-blind	randomised	controlled	trials,	which	
compared	the	effects	of	oral	naltrexone	with	placebo	or	active	control	on	drinking-
related	outcomes	(Rösner	et	al.,	2010b).	According	to	this	study,	oral	naltrexone	
effectively	 reduced	 the	 risk	 of	 heavy	 drinking	 and	 decreased	 drinking	 days,	
inducing	gastrointestinal	problems	(e.g.	nausea)	and	sedative	effects	(e.g.	daytime	
sleepiness)	as	the	main	side	effects.	Globally,	meta-analyses	of	controlled	clinical	
trials	 of	 naltrexone	 in	AUDs	 treatment	 show	modest	 effect	 sizes	 for	 efficacy	 in	
reducing	heavy	drinking	(Swift,	2013).	The	main	 limitations	 in	the	clinical	use	of	
naltrexone	are	the	risk	of	hepatotoxicity	and	the	low	compliance	shown	by	patients	
(Kranzler	 et	 al.,	 2008).	 Concerns	 about	 low	 adherence	 with	 oral	 formulations	
induced	 the	 development	 of	 slow	 release	 formulations	 of	 naltrexone	 and	 now	
depot	injectable	formulations	are	available	that	only	require	monthly	intramuscular	
administration	(Garbutt	et	al.,	2005;	Kranzler	et	al.,	2004;	Lobmaier	et	al.,	2011).
Sex-gender differences and pregnancy
	 The	 literature	 on	 oral	 naltrexone	 has	 not	 clearly	 identified	 sex-gender	
differences	 in	 the	 response	 to	 it	 (Baros	et	 al.,	 2008;	Gastfriend,	 2011;	O’Malley,	 et	
al.,	2007;	Pettinati	et	al.,	2008).	However,	the	majority	of	data	suggests	that	women	
report	smaller	drug	effects	 than	men	 (Franck,	Jayaram-Lindström,	2013;	Garbutt	et	
al.,	2005;	Krishnan-Sarin	et	al.,	2007;	Ray	et	al.,	2008).	When	evaluating	naltrexone	
effects	during	the	descending	limb	of	the	blood	alcohol	concentration,	it	was	seen	that	
men	had	greater	alcohol-induced	stimulation	and	greater	naltrexone-induced	decrease	
of	this	stimulation	than	women	(Ray	et	al.,	2008).	Numerous	gender	differences	have	
been	found	in	the	opioidergic	system,	at	least	with	agonists,	especially	in	the	field	of	
analgesia.	Women	show	higher	μ-	and	κ-opioid	receptor	sensitivity	than	men	(Fillingim	
et	al.,	2004;	Gear	et	al.,	1996a,	1996b,	1999,	2003;	Sarton	et	al.,	2000).	In	addition,	sex-
gender	differences	were	observed	in	the	relationship	between	opioid	system	and	the	
HPA	axis	(Kudielka	et	al.,	2009;	Uhart	et	al.,	2006;	Zubieta	et	al.,	1999,	2002).	Opioids	
inhibit	the	HPA	axis	through	μ-opioid	receptors	(Valentino,	Van	Bockstaele	2001),	and	
naltrexone,	which	is	a	primarily	μ-opioid	receptor	antagonist,	acutely	disinhibits	the	HPA	
axis.	This	effect	seems	to	occur	in	a	sex-gender	specific	way.	Accordingly,	naltrexone	
induces	a	higher	cortisol	release	in	women	than	in	men	(Lovallo	et	al.,	2012).
	 When	 taken	 orally,	 naltrexone	 is	 quickly	 absorbed	 and	 undergoes	 first-
pass	metabolism	in	the	liver.	Conversely,	the	extended	release	formulations	(which	
are	 intramuscularly	 injected)	 have	 lower	 risks	 of	 hepatotoxicity	 compared	 to	 the	
oral	 formulation	 since	 naltrexone	 does	 not	 undergo	 first	 pass	 metabolism	 in	 the	
liver	 (Franck,	Jayaram-Lindström,	2013).	Because	of	 the	 frequent	alcohol-induced	
liver	disease	developed	by	women,	extended	release	formulations	should	be	more	
suitable	than	oral	ones	to	women	affected	by	AUDs,	even	if	oral	naltrexone	is	more	
efficacious	 in	 women	 than	 in	 men	 (Kiefer	 et	 al.,	 2005).	 Three	 extended	 release	
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formulations	were	evaluated	for	the	therapy	of	AUDs;	although	patients	of	both	sexes	
were	recruited,	the	sex	analysis	was	performed	for	only	one	formulation.	The	results	
of	this	analysis	indicate	that	naltrexone	administration	was	effective	in	men	but	not	in	
women	(Johnson,	2007).	A	treatment-by-gender	interaction	was	found	in	one	study	
in	which	the	treatment	effect	was	found	to	be	significant	in	men	but	not	in	women	
even	if	they	represented	only	a	minority	of	subjects	-	201	out	of	624	-	equal	to	32.2%	
(Garbutt	et	al.,	2005).	One	study	suggested	a	 larger	 response	 in	women,	but	 the	
study	measured	 the	 immediate	 effects	 after	 isolated	 drinking	 events,	 rather	 than	
effects	on	drinking	behaviour	over	an	extended	period	of	time	(Tidey	et	al.,	2008).
	 To	date,	no	randomised	clinical	trial	has	been	conducted	to	evaluate	the	
effectiveness	or	safety	of	naltrexone	in	pregnant	women	affected	by	AUDs	(Smith	
et	al.,	2009).	In	the	United	States,	naltrexone	is	included	in	pregnancy	category	C.	
However,	some	studies	suggest	good	tolerability	of	naltrexone	during	pregnancy	in	
patients	affected	by	opioid	use	disorders	as	well	as	strong	interest	among	pregnant	
women	in	its	use	to	reduce	alcohol	consumption	(Jones	et	al.,	2012).
 Nalmefene,	 a	 μ-opioid	 antagonist	 like	 naltrexone,	 received	 marketing	
authorisation	for	the	reduction	of	alcohol	consumption	in	adults	affected	by	AUDs	
by	 the	European	Committee	 for	Medicinal	Products	 for	Human	Use	 (Aubin	and	
Daeppen,	2013).	Like	naltrexone,	the	proposed	mechanism	of	action	of	nalmefene	
is	to	reduce	the	reinforcing	effects	of	alcohol,	helping	patients	to	reduce	drinking	
by	blocking	 the	 rewarding	effects	of	alcohol.	However,	nalmefene	has	a	 longer	
plasma	half-life,	shows	more	effective	binding	to	central	opioid	receptors,	and	has	
higher	 bioavailability	 and	 lower	 liver	 toxicity	 than	 naltrexone	 (Franck,	 Jayaram-
Lindström,	2013;	Swift,	2013).
	 Two	 recent,	 large,	 randomised,	 double-blind,	 placebo-controlled,	
multicentre	 trials	 including	 1,322	 patients	 affected	 by	 AUDs	 demonstrated	 its	
effectiveness	 and	 safety	 in	 the	 treatment	 of	AUDs	 compared	 to	 placebo	 (Gual	
et	 al.,	 2013;	Mann	 et	 al.,	 2013).	 Both	 of	 the	 studies	 found	 that	 patients	 taking	
nalmefene	significantly	reduced	the	number	of	heavy	drinking	days	compared	to	
placebo.	Nausea,	dizziness,	and	fatigue	were	the	more	frequent	side	effects.
Sex-gender differences and pregnancy
	 Despite	394	out	of	1,322	recruited	patients	being	women	(equal	to	29.8%),	
two	 recent	 large,	 randomised	 controlled	 trials	 did	 not	 report	 any	 sex-gender	
differences	in	the	effectiveness,	safety	or	tolerability	of	nalmefene	(Gual	et	al.,	2013;	
Mann	et	al.,	2013).	To	date,	no	randomised	controlled	trial	has	been	conducted	to	
evaluate	the	effectiveness,	safety	or	tolerability	of	nalmefene	in	pregnant	women	
affected	by	AUDs	(Smith	et	al.,	2009).
 GHB,	 an	 endogenous	 constituent	 of	 the	 mammalian	 brain,	 is	 a	
pharmacological	agent	 for	 the	 treatment	of	narcolepsy	and	AUDs,	as	well	 as	a	
drug	of	abuse,	which	is	illicitly	used	due	to	some	of	its	psychotropic	effects	(Agabio	
et	al.,	2010).	These	apparently	opposite	effects	of	GHB	are	thought	to	be	due	to	
its	actions	 in	 the	mesocorticolimbic	dopamine	system	and	on	GABAB	receptors	
located	in	the	ventral	tegmental	area.	In	this	area,	low	doses	of	GHB	(corresponding	
to	those	reached	after	recreational	use)	activate	the	GABAB	receptors	in	GABAB	
neurons,	decreasing	GABA	release,	and,	in	turn,	disinhibiting	dopamine	neurons.	
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Conversely,	higher	doses	of	GHB	activate	the	GABAB	receptors	in	dopaminergic	
neurons,	causing	their	hyperpolarisation	and	inducing	anti-craving	effects	(Agabio	
et	 al.,	 2010).	Accordingly	 with	 this	 latter	 effect,	 preclinical	 studies	 showed	 that	
GHB	administration	significantly	reduced	voluntary	alcohol	consumption	and	the	
motivational	properties	of	alcohol	(Gessa	et	al.,	2000).
	 Evaluation	 of	 the	 clinical	 effectiveness	 and	 tolerability	 of	 GHB	 in	 the	
treatment	of	AUDs	was	the	aim	of	a	recent	meta-analysis	(Leone	et	al.,	2010).	This	
study	selected	7	trials	(all	conducted	in	Italy),	including	362	participants	affected	
by	AUDs,	and	found	that	patients	who	received	GHB	obtained	better	results	than	
those	who	 received	naltrexone,	disulfiram	or	placebo	 in	maintaining	abstinence	
and	 in	 reducing	 the	 severity	 of	 alcohol	 craving.	The	most	 frequent	 side	 effects	
induced	by	GHB	were	dizziness	and	vertigo.	However,	sample	sizes	in	individual	
trials	were	generally	small,	ranging	from	17	to	86	participants.
Gender differences and pregnancy
	 The	number	 of	 female	patients	 recruited	 in	 the	 randomised	 clinical	 trials	
conducted	to	evaluate	the	effectiveness	and	safety	of	GHB	in	the	treatment	of	AUDs	
was	 too	 low	 to	 evaluate	 its	 efficacy,	 safety	 or	 tolerability	 in	women.	To	 date,	 no	
randomised	clinical	trial	has	been	conducted	to	evaluate	the	effectiveness,	safety	or	
tolerability	of	GHB	in	pregnant	women	affected	by	AUDs	(Smith	et	al.,	2009).
Utilisation of service
	 The	majority	of	subjects	affected	by	AUDs	never	receive	treatment.	Using	
data	from	a	large	epidemiological	study	conducted	in	the	US,	it	has	been	evaluated	
that	less	than	15%	of	these	individuals	have	received	alcohol	treatment,	including	
self-help	group	participation	(Cohen	et	al.,	2007).	At	most,	approximately	9%	of	the	
population	 needing	 treatment	 for	AUDs	have	 received	 the	 equivalent	 of	 a	 single	
prescription	of	a	medication	approved	to	treat	the	disorder	(Mark	et	al.,	2009).
Sex-gender differences
	 Women	are	less	likely	than	men	to	seek	treatment	and	pregnant	women	
are	less	likely	to	receive	alcohol	treatment	than	non-pregnant	women	(Greenfield	
et	al.,	2007;	Terplan	et	al.,	2012).	Various	factors	have	been	analysed	to	explain	
this	finding,	such	as	childcare	responsibilities,	transportation,	financial	status,	and	
social	stigma	(Greenfield	et	al.,	2007;	2010a).	Interestingly,	it	has	been	found	that	
childcare,	women	only	 treatment,	and	programs	 focused	on	pregnant	and	non-
pregnant	women	enhance	treatment	seeking	and	retention	by	women	affected	by	
AUDs	(Dahlgre,	Willander,	1989;	Niv,	Hser,	2007).
Conclusions and take home messages
	 AUDs	 are	 associated	 with	 a	 huge	 health	 burden	 in	 most	 countries	
worldwide.	Actually,	 the	 epidemiology	 and	 natural	 history	 of	AUDs	 are	 strongly	
dependent	on	sex-gender	and	relatively	few	studies	have	investigated	sex-gender	
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differences	in	the	effectiveness	and	safety	of	specific	behavioural	or	pharmacologic	
therapy	 of	AUDs	 in	 non-pregnant	 as	 well	 as	 pregnant	 women.	 Therefore,	 it	 is	
necessary	 to	 investigate	 sex-gender	 differences	 in	 all	 steps	 of	 drug	 discovery	
and	 the	development	of	 treatments	 for	 these	disorders.	Specific	 information	on	
female	patients	should	always	be	collected.	Namely,	for	women	of	child-bearing	
age,	 the	phase	of	menstrual	cycle,	use	of	contraceptive	methods	(oral	or	depot	
contraceptives,	 barrier	 methods	 such	 as	 the	 diaphragm	 or	 condom),	 state	 of	
pregnancy,	or	breast-feeding;	for	women	in	menopause,	data	of	last	menstruation	
and	 the	 possible	 use	 of	 substitutive	 treatment.	 The	 influences	 of	 exogenous	
hormones	is	relevant	in	view	of	the	possible	bidirectional	relationship	between	sex	
hormones	and	drugs	and	the	effect	of	sexual	steroids	on	rewarding	system.
	 Men	are	usually	overrepresented	in	comparison	with	women;	as	a	result,	
the	 female	 samples	 are	 too	 small	 and	 do	 no	 permit	 a	 fair	 statistical	 analysis	
for	 women.	 Thus,	 the	 results	 obtained	 in	 men	 are	 translatable	 to	 women;	
consequentially	women	receive	a	therapy	that	is	less	based	on	the	principles	of	
evidence-based	medicine	 than	men.	 Pharmacological	 agents	 should	 be	 tested	
in	 sufficient	 numbers	 of	 different	 subgroups	 of	 the	 female	 population	 such	 as	
adolescent,	adult,	and	elderly	females	because	of	the	possible	differences	to	the	
pharmacological	response	among	them.
	 Comorbidity	 should	 always	 be	 investigated	 among	 women	 affected	 by	
AUDs	as	comorbid	patients	require	more	intensive	treatments	than	patients	without	
other	mental	disorders.	Another	 topic	 to	be	evaluated	 is	 the	possible	difference	
between	women	and	men	in	response	to	the	“placebo	treatment”.	The	response	to	
medical	treatments	of	AUDs	should	be	also	investigated	considering	the	possible	
role	of	different	ethnic	groups.
	 Larger	 efforts	 should	 be	 reserved	 to	 improving	 the	 knowledge	 of	
pharmacological	agents	to	be	administered	to	pregnant	women	affected	by	AUDs.	
Firstly,	these	studies	should	determine	whether	the	potential	benefits	for	the	mother	
outweigh	the	risks	to	the	foetus;	secondly,	they	should	evaluate	the	effectiveness	
and	safety	of	the	different	drugs	during	the	different	periods	of	pregnancy.
	 As	already	mentioned,	AUDs	are	associated	with	numerous	sex-gender	
differences	but	understanding	of	the	mechanisms	behind	the	sex-gender	disparity	
is	 not	 completely	 clear.	 Therefore,	 for	 the	 future,	 it	 is	 of	 major	 relevance	 and	
importance	to	perform	studies	in	order	to	gain	a	more	detailed	knowledge	of	sex	
and	gender	differences.	In	particular,	the	design	of	clinical	and	preclinical	studies	
should	 have	 a	 sex-gender-based	 perspective	 to	 reach	 proper	 conclusions	 on	
efficiency	and	safety	profiles	for	both	sexes	and	to	reduce	the	time	needed	for	the	
translation	of	research	results	into	daily	clinical	practice.	A	sex-gender	perspective	
could	also	help	to	increase	adherence	and	compliance	to	therapy	and	could	lead	
to	more	appropriate	treatment	in	women.
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Introduction
	 Illicit	 drugs,	 alcohol	 and	 other	 addictive	 substances	 including	 those	
medically	prescribed	are	all	drugs.	The	use	of	such	drugs	is	not	a	new	phenomenon	
but	one	that	takes	on	meaning	and	importance	in	relation	to	its	social	context	that	
varies	over	time	and	location	–	for	immigrants	meaning	country	of	origin	and	place	
of	current	residence.	The	history	of	the	drug	and	its	use,	the	social	strata	of	society	
that	uses	it,	the	kinds	of	situations	in	which	it	is	used,	and	the	publicity	and	public	
opinion	about	it	may	all	be	included	in	the	definition	of	a	drug’s	context	that	depends	
on	social,	cultural	and	objective	factors.	The	focus	of	this	chapter	is	on	immigrant	
female	drug	users	from	the	former	Soviet	Union	(FSU)	–	their	profiles	and	special	
needs.	Details	about	drug	use,	health	conditions,	immigration	patterns,	acculturation	
and	comparative	research	are	provided	contributing	 to	 thoughts	about	prevention	
and	treatment	for	this	underserved	population.
Drug Use
	 Millions	of	people	left	the	former	Soviet	Union	(FSU)	to	settle	in	western	
countries	when	exit	policies	were	liberalized	in	the	late	1980’s.	These	immigrants	
came	from	an	environment	with	one	of	the	highest	rates	of	drug	use	in	the	world	
(Pridemore,	 2002).	 The	 vast	 majority	 of	 FSU	 immigrants	 are	 from	Russia	 and	
Ukraine.	Reports	on	drug	use	there	during	the	peak	period	of	emigration	shows.
Russia
	 Russia	was	a	transit	country	for	heroin	and	opium,	most	of	which	comes	
from	Afghanistan,	and	the	majority	of	which	is	destined	for	Europe.	Because	of	the	
porous	nature	of	the	Russian	boarder	with	Central	Asia	and	the	country’s	limited	
support	for	law	enforcement,	it	is	clear	that	Russia	was	ill-equipped	to	handle	the	
inundation	of	Afghan	heroin	into	the	country.	Russia	was	a	consumer	country	of	
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heroin	due	to	the	high	availability	and	low	prices.	Despite	the	low	cost	of	heroin,	
addicts	 resorted	 to	 criminal	 activity	 to	 support	 their	 addiction.	 Production	 of	
amphetamines	and	synthetics	for	domestic	consumption	was	minor	but	increased	
along	with	designer	“club”	drugs	among	Russia’s	youth.	Drug	abuse	within	Russia	
was	a	matter	of	concern	for	national	health	officials.	In	the	beginning	of	2003,	there	
were	340,000	registered	drug	addicts	in	Russia.	This	figure	only	reflected	addicts	
known	 to	health	officials.	The	number	of	drug	users	 in	Russia	was	at	 that	 time	
estimated	to	be	between	3	and	4	million	people.	The	majority	of	 the	drug	users	
were	under	age	30	and	approximately	30	percent	were	heroin	addicts.
	 Presently,	 Russia	 is	 the	 largest	 single	market	 for	Afghan-origin	 heroin.	
There	are	2.5	million	drug	addicts	and	over	5.1	million	drug	users;	and,	HIV	infection	
rates	 are	 up	 to	 61	 percent	 among	 drug	 users	 in	 some	 regions	 of	 the	 country.	
Officials	 estimate	 that	 there	 are	 80,000	 new	 drug	 users	 each	 year;	 and,	more	
than	30,000	people	die	annually	of	drug	overdoses	and	another	70,000	deaths	
per	year	are	drug-related	 in	Russia	(UNODC,	2011;	RIA	Novosti,	2012).	Russia	
is	also	a	significant	market	 for	opium,	hashish,	marijuana,	synthetics	and	other	
dangerous	 illegal	 substances.	Although	not	 as	 significant	 as	 the	 use	 of	 heroin,	
opium	and	hashish,	there	is	growing	concern	about	the	use	of	synthetics	and	other	
pharmacological	narcotics	 that	are	 inexpensive	and	 increasingly	available.	One	
such	 synthetic	 is	 desomorphine	 known	 as	 “krokodil”	 that	 first	 appeared	 on	 the	
Russian	market	in	2003.	More	toxic	than	heroin,	“krokodil”	 is	easily	produced	at	
home	by	mixing	codeine-based	medications,	 iodine	and	red	phosphorus	 from	a	
match	box	(Gahr	et	al.,	2012).
Ukraine
	 The	 number	 of	 officially	 registered	 drug	 addicts	 in	 Ukraine	 exceeded	
199,000	 including	 over	 4,000	 teenagers	 with	 over	 18,000	 new	 registrations	 in	
2003.	Sixty-eight	percent	of	 registered	drug	users	were	under	30	years	of	age;	
nearly	25	percent	were	women,	and	over	78	percent	were	unemployed.	Estimates	
of	 unregistered	 drug	 abusers	 varied	widely,	 up	 to	 one	million	 reported	 by	 local	
NGOs	in	press	reports.	About	15,000	criminal	offenses	were	committed	annually	
by	drug	addicts	(US	Department	of	State,	2004).
	 Ukraine	is	not	a	major	drug	producing	country.	However,	it	is	an	important	
transit	 country	 for	 drugs	 such	 as	 heroin,	 opium	 “poppy	 straw”,	 cannabis,	 and	
methamphetamine.	Heroin	 is	trafficked	from	Central	Asia	(primarily	Afghanistan)	
and	 comes	 into	 Ukraine	 mostly	 through	 Russia,	 the	 Caucasus	 and	 Turkey.	 In	
2010,	there	were	156,300	registered	addicts.	However,	various	experts	estimate	
that	 the	 total	 number	 of	 actual	 drug	 addicts	 in	 Ukraine	 range	 from	 300,000	 to	
500,000.	Drug-related	deaths	over	 the	 last	 few	years	have	averaged	1,000	per	
year	according	to	Ukrainian	health	authorities	(US	Department	of	State,	2012).
Infectious diseases
	 It	is	widely	acknowledged	that	the	spread	of	HIV/AIDS	as	well	as	hepatitis	
B,	C	and	other	blood-borne	viruses	is	 linked,	 in	part,	 to	 injecting	drugs.	Eastern	
Europe	and	Central	Asia	is	the	only	region	where	HIV	prevalence	clearly	remains	
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on	the	rise;	HIV	has	almost	tripled	since	2000	and	reached	an	estimated	1.4	million	
people	 in	2009.	The	epidemic	 in	 the	region	 is	concentrated	mainly	among	drug	
users,	sex	workers,	their	sexual	partners	and,	to	a	much	lesser	extent,	men	who	
have	sex	with	men.	The	following	facts	are	noteworthy:
	 ●		AIDS-related	deaths	continue	to	rise	in	the	region;	an	estimated	76,000	
people	died	from	AIDS-related	causes	 in	2009	compared	to	18,000	 in	
2000,	a	four-fold	increase;
	 ●		the	Russian	Federation	and	Ukraine	together	account	for	nearly	90%	of	
newly	reported	HIV	infections;
	 ●		Ukraine	has	the	highest	adult	HIV	prevalence	in	all	of	Europe	and	Central	
Asia	at	1.1%.	Annual	HIV	diagnosis	in	Ukraine	has	more	than	doubled	
since	2001;
	 ●		in	the	Russian	Federation	more	than	one-third	(37%)	of	the	country’s	1.8	
million	injecting	drug	users	are	living	with	HIV;	and,
	 ●		as	the	HIV	epidemic	spreads	from	people	who	inject	drugs	(predominately	
male)	to	their	sexual	partners,	the	proportion	of	women	living	with	HIV	in	
the	region	is	growing.	By	2009	women	represented	45%	of	people	living	
with	HIV	in	the	Ukraine	compared	to	37%	in	1999	(UNAIDS,	2012).
	 Both	 hepatitis	 B	 virus	 (HBV)	 and	 hepatitis	 C	 virus	 (HCV)	 are	 highly	
prevalent	among	injection	drug	users.	Estimated	prevalence	of	hepatitis	infection	
is	more	than	50%	among	people	who	inject	drugs	in	most	countries.	The	largest	
populations	 of	 infected	 people	 who	 inject	 drugs	 is	 in	 the	 Russian	 Federation	
(73%	estimated	prevalence).	Sharing	contaminated	syringes	is	the	most	common	
method	 of	 infection	 transmission	 (CDC,	 2012;	 WHO,	 2012;	 Medscape	 Today,	
2012).
	 Among	 infectious	 diseases,	 after	 HIV/AIDS,	 tuberculosis	 (TB)	 is	 the	
second	 leading	 killer	 in	 the	world.	HIV	and	TB	are	 closely	 linked	and	up	 to	50	
percent	 of	 those	 people	 living	with	HIV	 can	 expect	 to	 develop	TB.	TB	 is	most	
prevalent	in	crowded	low-income	areas	with	substandard	health	conditions	and	it	
is	linked	to	drug	users	and	alcoholics	who	have	a	history	of	crime,	imprisonment	
and	unemployment	(Migliori	&	Ambrosetti,	1998).	Drug	users	are	two	to	six	times	
more	 likely	 to	 contract	TB	 than	 nonusers	 (NIDA,	 1999).	Reported	TB	 rates	 for	
correctional	system	populations	have	been	10–100	times	higher	than	rates	for	the	
local	civilian	populations,	and	TB	outbreaks	with	a	high	number	of	TB	multidrug-
resistant	 cases	 have	 been	 documented.	 Prisons,	 heavy	 populated	 with	 drug	
offenders,	are	known	as	social	and	sanitary	pathology	reservoirs	 in	which	TB	is	
often	associated	with	chronic	infectious	diseases	caused	by	HIV,	HBV,	HCV.	HCV	
prevalence	among	inmates	is	30%–40%,	which	is	higher	than	that	in	the	general	
population	and	is	related	to	injection	drug	use	(CDC,	2012).
	 In	 the	 former	 Soviet	 Union	 deteriorating	 conditions	 including	 poverty,	
unemployment,	 inadequate	hygiene	and	heath	care,	a	 lack	of	preventive	health	
education	and	poorly	ventilated	prisons	where	inmates	fall	ill	have	provided	fertile	
ground	 for	 the	 rise	 of	 injecting	 drug	 use,	 the	 spread	 of	 HIV	 and	 tuberculosis	
referred	to	as	“Ebola	with	wings”	(Isralowitz,	2004;	Malinowska-Sempruch,	Hoover	
&	Alexandrova,	2003).
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Immigration from the former Soviet Union
	 Since	1989,	with	the	fall	of	the	Soviet	Union	and	removal	of	exit	barriers,	
over	a	million	people	emigrated	from	the	former	Soviet	Union	to	the	United	States,	
Western	Europe	and	Israel.	From	1989-1998	the	Israeli	population	of	4.5	million	
rose	 about	 20	 percent	 primarily	 from	 the	 nearly	 one	million	Soviet	 immigrants,	
mostly	from	Russia	and	the	Ukraine,	who	entered	the	country.	A	large	proportion	
of	 the	Russian	 speaking	 immigrants	 had	 training	 and	 education	 in	 a	 variety	 of	
technical	and	professional	fields;	and,	success	was	an	 important	component	of	
their	worldview	and	culture	(Philippov,	2010).	However,	there	were	immigrants	who	
arrived	 in	 Israel	with	drug	abuse	problems	and	others	became	addicted	during	
the	 absorption	 process	 (Isralowitz	 et	 al.,	 2007).	 Presently,	 Russian	 speaking	
immigrants	are	13	percent	 of	 the	 Israel	 population	but	 about	25	percent	 of	 the	
illicit	drug	users	in	the	country	(Isralowitz	&	Borkin,	2002).	Figure	1	and	Table	1	
provide	information	about	FSU	immigrant	female	drug	user	immigration	patterns	
and	related	characteristics	to	the	southern	region	of	the	country,	the	Negev.
	 As	noted	above,	FSU	 immigrants	came	 from	an	environment	 that	has	
one	of	the	poorest	health	indicators	and	lowest	life	expectancies	in	the	developed	
world.	Such	factors	include	alcohol	consumption,	smoking,	nutrition,	and	others	
(Cockerham,	 1997;	Hofmann,	 2012).	 It	 is	 logical	 to	 believe	 there	 are	 uniform	
data	about	FSU	immigrant	health	 issues	in	the	United	States,	Israel	and	other	
absorbing	countries.	However,	a	review	of	professional	 literature	reveals	scant	
information	about	drug	use,	risk	behaviors,	police	reports	and	service	utilization	
(Guarino	et	al.,	2012;	 Isralowitz,	Straussner	&	Rosenblum,	2006;	 Isralowitz	et	
al.,	2007;	Isralowitz,	Reznik	&	Peleg,	2013).	According	to	the	American	Medical	
Association,	“The	health	picture	of	the	FSU	immigrant	population	has	been	in	the	
early	stage	of	development”	(Meyerovich,	2003).	For	example	in	the	United	States,	
Figure 1: FSU	Female	Drug	Users:	Immigration	Rates	to	the	Negev	–	Israel
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national	and	state	government	data	regarding	FSU	immigrants	in	treatment	are	
not	available	because	country	of	origin	and/or	other	 identifying	 factors	are	not	
recorded.	Some	unpublished	numbers	are	available	based	on	the	U	S	National	
Household	Survey	on	Drug	Abuse	of	lifetime	and	current,	last	30	day,	illicit	drug	
use	among	persons	aged	18	or	older	who	were	born	in	the	former	Soviet	Union.	
Nevertheless,	few	conclusions	can	be	ascertained	because	“many	estimates	are	
suppressed	due	 to	 the	poor	precision	 results	 from	 the	 small	 sample	 sizes”	 of	
FSU	 immigrants	 (personal	 correspondence	with	 J.	Gfroerer,	Office	 of	Applied	
Studies,	US	Substance	Abuse	and	Mental	Health	Services	Administration.	April	
26	and	May	11,	2004).
Acculturation and drug use perspectives: a brief 
review
	 A	number	of	conceptual	models	of	the	relationship	between	acculturation	
and	 psychosocial	 behavior	 exist.	 For	 example,	 the	 acculturative	 stress	 model	
suggests	 that	cultural	 conflict	at	 the	place	of	destination	and	 lack	of	social	and	
economic	resources	for	coping	may	result	in	migrant	drug	use	as	a	maladaptive	
coping	mechanism	(Cheung,	1990-91;	Johnson,	1996;	Mirdal,	1984).	In	addition,	
the	level	of	acculturative	stress	that	an	individual	experiences	may	be	moderated	
by	 factors	 such	 as	 socioeconomic	 status,	 discrimination,	 language	 adequacy,	
social	support,	gender,	and	skin	color	(Cortes	et	al.,	2003;	Hovey,	2000;	Miranda	
&	Matheny,	 2000;	Ward	 &	 Rana-Deuba,	 1999).	 In	 contrast,	 an	 assimilation	 or	
FSU countries origin, % (n)
Russia	 29.9%	(26)
Ukraine	 41.4%	(36)
Other	(Moldova,	Georgia,	Uzbekistan,	etc.)	 28.7%	(25)
Mean	age	of	immigration	(range;	SD)	 21,8	(9-40;	7.1)
Conditions of Immigration, % (n)
Alone	 19.8	(17)
With	partner	and	with/without	children	 23.3	(20)
With	parent(s)	and/or	other	family	members	 45.3	(39)
Other	(e.g.	with	friends)	 11.6	(10)
FSU female
(N=87)(1)
Table 1: FSU	Female	Drug	Users:	Immigration	Related	Characteristics
(1)	up	to	2	subjects	with	missing	data	on	one	or	more	variables
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acculturation	model	suggests	that	as	immigrants	adopt	the	customs	and	practices	
of	the	host	society,	their	patterns	of	alcohol	and	drug	use	begin	to	parallel	those	
of	 their	 new	 environment	 (Amaro	 et	 al.,	 1990;	 Fernandez-Pol	 et	 al.,	 1985;	Gil,	
Wagner	 &	 Vega,	 2000;	 Velez	 &	 Ungemack,	 1989).	 Linear	 models	 of	 stress	
adaptation	 and	 acculturation	 have	 been	 challenged	 by	 other	 researchers	 who	
suggest	that	bicultural	immigrants	(i.e.,	those	who	are	able	to	adapt	to	their	new	
social	environment	while	retaining	important	elements	of	their	native	culture)	are	
less	 likely	 to	develop	drug	use	habits	 (Tucker,	1985;	 Johnson,	1996;	Oetting	&	
Beauvais,	1991;	Cortes,	et	al.,	2003).
	 Current	 trends	 favor	 models	 and	 instruments	 that	 view	 and	 assess	
acculturation	as	a	pliable	process	in	which	individuals	do	not	necessarily	relinquish	
the	values,	behaviors	and	attitudes	prescribed	by	their	culture	of	origin	in	order	to	
adopt	those	of	the	host	culture	(De	La	Rosa,	Vega	&	Radish	2000).
	 Difficulties	 with	 the	 process	 of	 acculturation	 have	 been	 linked	 to	 the	
development	 of	 emotional	 and	 behavioral	 problems	 including	 mental	 illness,	
delinquency,	and	alcohol	and	drug	abuse	(Oetting	&	Beauvais,	1991;	Rogler,	Cortes	
&	 Malgady,	 1991;	 Straussner,	 2002;	 Cortes	 et	 al.,	 2003)	 state	 that	 alcohol	 and	
drug	use	emerges	as	a	coping	mechanism	to	mitigate	the	stresses	that	immigrants	
encounter	in	the	host	society.
	 This	 dynamic	 and	 highly	 complex	 process	 can	 lead	 to	 personal	 stress	
and	interpersonal	conflicts	(Akhtar,	1995;	Gaw,	1993;	Lu,	Lim	&	Mezzich,	1995;	
Sandhu,	Portes,	&	McPhee,	1996).	FSU	immigrants,	regardless	of	the	absorbing	
country,	have	faced	the	challenge	of	acculturation	and	there	is	a	lack	of	information	
about	those	who	are	drug	users	(Isralowtz,	2002;	Isralowitz	et	al,	2007).
FSU immigrant female drug users: profiles and 
needs
	 Considerable	progress	has	been	made	toward	understanding	drug	use;	
however,	 the	 problem	 has	 been	 sorely	 neglected	 in	 women	 (Leshner,	 1998;	
Isralowitz	 &	 Borkin,	 2002).	 Men	 and	 women	 use	 drugs	 for	 different	 reasons.	
Females	are	more	vulnerable	to	abuse	and	addiction	because	they	become	more	
dependent	 on	 drugs	 faster	 and	 suffer	 the	 consequences	 sooner	 than	males.	
Generally,	 female	 drug	 users	 who	 have	 been	 studied	 are	 about	 20%	 of	 the	
heroin-addicted	population	receiving	treatment.	Female	addicts	tend	to	sustain	
their	 addiction	 through	 illegal	 income-earning	 activities	 such	 as	 prostitution,	
and/or	 their	partners	provide	 them	with	drugs	or	supply	 the	money	necessary	
to	purchase	drugs.	Regardless	how	women	support	their	addiction	they	tend	to	
have	 little	 interest	 in	going	 through	processes	of	detoxification	and	 treatment.	
It	 has	 been	 reported	 that	women	who	 abuse	 drugs	 have	 problems	 related	 to	
co-dependency,	 incest,	physical	and	sexual	abuse,	victimization,	sexuality	and	
relations	with	 significant	 others	 (Bush	&	Kraft,	 2001;	 Bryant,	 Eliach	&	Green,	
1990;	 Hurley,	 1991;	Gil-Rivas,	 Fiorentine	 &	Anglin	 1996;	 Isralowitz	 &	Reznik,	
2009;	Swett,	Cohen	&	Surrey,	1991).	Also,	 female	drug	users	cite	a	particular	
stressful	 event	as	a	 reason	 for	 initiating	 the	use	of	 harmful	 drugs;	and,	many	
report	being	victims	of	childhood	physical	and/or	sexual	abuse.	Socioeconomic	
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factors	including	those	related	to	transition	and	acculturation	may	be	attributed	
to	 drug	 abuse	 as	well	 (Bush	&	Kraft,	 2001;	 Isralowitz,	 2003;	 Isralowitz	&	Bar	
Hamburger,	2002;	Olsen	&	Pavetti,	1996;	Straussner	&	Brown,	2002).
	 Women	tend	 to	begin	abusing	drugs	 later	 than	men	and	 they	are	more	
likely	 to	 have	 a	 co-existing	 psychiatric	 problem,	 especially	 depression,	 as	 well	
as	a	greater	history	of	suicide	attempts	and	hostility.	Although	women	drink	and	
use	illegal	drugs	less	frequently	than	men,	they	are	more	likely	to	use	prescribed	
psychoactive	drugs	(Byqvist,	1999;	Moras,	1998;	Petry	&	Bickel,	2000;	Roth,	1991;	
Isralowitz,	Reznik	&	Straussner,	2011).	Health	and	family	problems	are	factors	that	
motivate	women	to	enter	treatment.	Among	those	that	seek	treatment,	many	are	
likely	to	have	an	alcoholic	or	addicted	male	partner	or	to	be	divorced	or	separated.	
Women	with	a	drug	problem	often	lack	education,	job	experience,	self-esteem	and	
assertiveness	skills	making	it	difficult	for	them	to	manage	the	complex	treatment	
and	assistance	network	(Moras,	1998;	Straussner	&	Brown	2002).	Also,	research	
shows	many	drug-using	women	do	not	seek	treatment	because	they	fear	not	being	
able	to	take	care	of	or	keep	their	children,	reprisal	from	their	spouses	or	boyfriends,	
and	punishment	from	authorities	in	the	community	(Isralowitz	&	Borkin,	2002).
Research methods
	 Since	 1995,	 the	 Regional	Alcohol	 and	 Drug	Abuse	 Research	 (RADAR)	
Center,	Ben	Gurion	University,	Israel	has	been	researching	drug	use	among	FSU	
immigrants,	their	background	characteristics,	attitudes	and	behavior.	For	the	most	
part,	the	RADAR	Center’s	sampling	efforts	have	been	geared	to	generating	“useable	
knowledge”	about	life	time	drug	users	for	prevention	and	treatment	purposes.	The	
sites	where	data	have	been	collected	are	similar	to	those	found	nation-wide;	and,	in	
all	information	collecting	procedures,	confidentiality	and	the	human	rights	of	those	
interviewed	have	been	protected.
Instruments and measures
	 The	primary	data	collection	tools	used	by	the	RADAR	Center	have	been	
the	Addiction	Severity	Index	(ASI),	5th	Edition;	the	Substance	Use	Survey	Institute	
(SUSI)	developed	by	the	RADAR	Center;	and	the	Short	Acculturation	Scale	(SAS).	
Approximately	 1,000	 FSU	 immigrant	 drug	 users	 have	 been	 interviewed	 since	
1995.	The	following	is	a	brief	description	of	the	instruments	being	used.
Addiction Severity Index (ASI)
	 The	ASI	is	a	structured	interview	that	assesses	problem	severity	in	seven	
domains	(alcohol,	drug,	medical,	employment,	legal,	family/social,	and	psychiatric)	
and	has	been	validated	with	diverse	populations	in	a	wide	variety	of	settings	(average	
Cronbach	Alpha	score	0.71).	Based	on	information	collected	from	a	client	beginning	
treatment,	a	composite	score	can	be	computed	for	each	domain	to	indicate	severity	
in	that	area;	scores	range	from	0	to	1	with	higher	scores	indicating	greater	severity	
(Mclellan	et	al.,	1992;	McGahan	et	al.,	1986).	The	Russian	language	version	of	the	
ASI	5th	was	used	by	the	RADAR	Center	(EMCDDA,	nd).
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Substance Use Survey Index (SUSI)
	 This	data	collection	 instrument	consists	of	58	questions	about	personal	
background,	 drug	 use	 patterns	 and	 related	 problems	 including	 HIV/AIDS,	
hepatitis	 C	 (HCV)	 and	 tuberculosis	 (TB).	 The	 instrument	 was	 developed	 with	
grant	support	 from	the	US	Agency	 for	 International	Development	–	Middle	East	
Regional	Cooperation	Program	and	input	from	experts	affiliated	with	universities,	
government	agencies	and	regional	non-profit	organizations.	Prepared	in	English,	
the	 questionnaire	 has	 been	 translated	 to	Hebrew	and	Russian	 languages.	The	
questionnaire	is	valid	and	reliable	(Cronbach	Alpha	score	0.	88).
Short Acculturation Scale (SAS)
	 The	Short	Acculturation	Scale	(SAS)	is	used	to	estimate	acculturation	(Marin	
et	al.,	1987;	Zane	&	Mak,	2003).	This	instrument	assesses	an	immigrant’s	use	of	a	
new	language	in	everyday	life.	The	SAS	is	a	reliable	and	valid	questionnaire;	it	was	
translated	by	the	RADAR	Center	to	Russian	and	found	to	be	reliable	(Cronbach	
Alpha	score	0.91).	SAS	scores	are	from	0	(low	level	of	acculturation)	to	1	(high	
level	of	acculturation)	meaning	the	use	of	Hebrew	language.
FSU immigrant female drug users: profile and 
special needs highlights
Country of origin differences
	 Significant	background	characteristics	exist	among	FSU	and	Israeli	origin	
women	in	drug	abuse	treatment	(Isralowitz,	2003;	Isralowitz	&	Bar	Hamburger,	
2002;	Isralowitz	&	Borkin,	2002;	Isralowitz	&	Reznik,	2009).	FSU	females	tend	to	
be	younger,	less	likely	to	be	Jewish	–	a	status	that	affects	government	benefits	
to	 immigrants,	 more	 likely	 to	 be	 married,	 better	 prepared	 for	 work	 through	
specialized	training,	and	employed	than	their	Israeli	counterparts.	Immigrant	and	
native-born	women	report	similar	rates	of	being	victims	of	sexual	and	physical	
abuse	(see	Table	2).	FSU	women	report	more	chronic	medical	problems	including	
HIV/AIDS	and	hepatitis	C	(see	Table	3).	Patterns	of	alcohol	and	opiate	use	are	
higher	among	FSU	women;	Israeli-born	women	use	more	cocaine	and	sedatives	
(see	Figure	2).	FSU	women	prefer	shorter	forms	of	treatment	intervention	such	
as	 detoxification	 and	 are	more	 inclined	 to	 use	 alcohol	 and	 other	 drugs	 while	
receiving	 treatment	 (see	Table	4).	Additional	 findings	 show	FSU	women	have	
a	greater	concern	about	their	personal	health	and	maintaining	custody	of	their	
children	(Isralowitz,	2003;	Isralowitz	&	Bar	Hamburger,	2002;	Isralowitz	&	Borkin,	
2002).
	 Based	on	ASI	composite	scores	of	the	7	domains	used,	no	differences	
were	found	among	Israeli	and	FSU	women	in	drug	treatment	(Table	5).
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Table 2:	FSU	and	Israeli-Born	Female:	Background	Characteristics
*<.05,	**<.001;	comparison	of	FSU	and	Israeli	origin	women	using	t-test	for	means	or	chi	square	for	
percentages
(1)	up	to	2	subjects	in	each	group	missing	data	on	some	variables
(2)	significant	differences	in	employment	status	by	origin	(chi	square	for	3	x	2	table)
(3)	significant	differences	in	living	arrangements	by	origin	(chi	square	for	4	x	2	table)
(1) (1)
(2)
(3)
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Figure 2:	FSU	and	Israeli-Born	Female	Lifetime	Drug	Use	Rates
						Israeli	Female
						FSU	Female
 
1.	Heroin
2.	Alcohol
3.	Cannabis
4.	Sedatives
5.	Cocaine
6.	Amphetamine
7.	Hallucinogens
8.	Inhalants
9.	Opiates
10.	Poly	drugs	use
*<.05,	***<.001;	comparison	of	FSU	and	Israeli	origin	women	using	chi	square	for	percentages
Table 3:	FSU	and	Israeli-Born	Female:	Medical	Status	and	Infectious	Disease	Rates
*<.05,	**<.01;	comparison	of	FSU	and	Israeli	origin	women	using	chi	square	test	for	percentages
(1)	up	to	2	subjects	in	each	group	with	missing	data	on	one	or	more	variables
(1)(1)
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Table 4:	FSU	and	Israeli-Born	Female	Alcohol	and	Drug	Use	Patterns
*<.05,	 **<.01,	 ***<.001;	 comparison	 of	 FSU	and	 Israeli	 origin	women	 using	 t-test	 for	means	 or	 chi	
square	for	percentages
1	up	to	2	subjects	in	each	group	with	missing	data	on	one	or	more	variables
2	significant	differences	in	drug	treatment	by	origin	(from	chi	square	for	3	x	2	table)
(1)(1)
(2)
286
Table 5:	FSU	and	Israeli-Born	Female	ASI	Composites	Scores
1	up	to	2	subjects	in	each	group	with	missing	data	on	one	or	more	variables
Gender differences
	 A	comparison	of	FSU	female	and	male	drug	users	shows	females	tend	to	
be:	younger,	married	or	living	with	a	partner;	not	Jewish	(as	noted	above);	less	likely	
to	have	a	criminal	record	resulting	in	a	conviction,	incarceration	and/or	parole;	and,	
more	sexually	abused	(see	Table	6).	Women	report	more	chronic	illness;	however,	
their	 level	 of	HIV/HCV/TB	 infection	 is	 similar	 to	males	 (see	Table	 7).	Patterns	 of	
heroin,	alcohol	and	other	drug	use	are	similar	among	females	and	males;	cannabis	
use	is	higher	among	males	and	cocaine	use	higher	among	females	(Table	8;	Figure	
3).	Also,	females	are	more	likely	than	males	to	prefer	short-term	detoxification	(only)	
as	a	treatment	intervention.
	 ASI	composite	score	results	show	a	significant	difference	between	women	
and	men	regarding	the	employment	domain	(i.e.,	women	have	more	employment	
related	problems	-	see	Table	9).
	 Research	shows	drug	use	interferes	with	acculturation	in	the	host	country	
(Grusser	et	al,	2004).	A	comparison	of	FSU	drug	users	based	on	gender	status	
shows	women	tend	to	be	more	acculturated	based	on	their	use	of	Hebrew	language	
(see	Table	10).
	 Table	11	shows	FSU	male	and	female	drug	use	before	and	after	immigration	
and	its	 impact	on	acculturation.	Drug	use	appears	to	affect	acculturation.	Those	
who	use	drugs	before	 immigration,	 regardless	of	gender	status,	 tend	 to	be	 less	
acculturated.	Additional	 information	shows	a	possible	 link	between	acculturation	
and	 the	 type	of	 treatment	preferred	by	addicts	 regardless	of	gender	status	(see	
Table	12).
(1) (1)
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Table 6:	FSU	Female	and	Male	Background	Characteristics
*<.05,	**<.001;	comparison	of	FSU	females	and	males	women	using	t-test	for	means	or	chi	square	for	
percentages
(1)	up	to	6	subjects	in	each	group	missing	data	on	some	variables
(2)	significant	differences	in	employment	status	by	gender	(from	chi	square	for	3	x	2	table)
(3)	significant	differences	in	living	arrangements	by	gender	(chi	square	for	4	x	2	table)
Table 7:	FSU	Female	and	Male	Medical	Status	and	Infectious	Disease	Rates
**<.001;	comparison	of	FSU	Females	and	Males	using	chi	square	for	percentages
(1)	up	to	6	subjects	in	each	group	with	missing	data	on	one	or	more	variables
(1) (1)
(2)
(3)
(1) (1)
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Table 8:	FSU	Female	and	Male	Alcohol	and	Drug	Use	Patterns
*<.05,	**<.01,	***<.001;	comparison	of	FSU	Females	and	Males	using	t-test	for	means	or	chi	square	
for	percentages
(1)	up	to	6	subjects	in	each	group	with	missing	data	on	one	or	more	variables
(2)	significant	differences	in	drug	treatment	by	gender	(from	chi	square	for	3	x	2	table)
(1) (1)
(2)
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Figure 3:	FSU	Female	and	Male	Lifetime	Drug	Use	Rates
 
						FSU	Male
						FSU	Female
1.	Heroin
2.	Alcohol
3.	Cannabis
4.	Sedatives
5.	Cocaine
6.	Amphetamine
7.	Hallucinogens
8.	Inhalants
9.	Opiates
10.	Poly	drugs	use
**<.01,	***<.001;	comparison	of	FSU	Females	and	Males	using	chi	square	for	percentages
Table 9:	FSU	Female	and	Male	ASI	Composites	Scores
***<.001;	comparison	of	FSU	Females	and	Males	using	t-test	for	means
(1)	up	to	6	subjects	in	each	group	with	missing	data	on	one	or	more	variables
***<.001;	comparison	of	FSU	Females	and	Males	using	t-test	for	means
(1)	up	to	2	subjects	in	each	group	with	missing	data	on	one	or	more	variables
(1) (1)
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Nika's story
	 The	 following	 story	 about	 “Nika,”	 a	 former	 Soviet	 Union	 immigrant	 and	
drug	user,	is	true.	The	story	reflects	the	interaction	of	individual	and	environmental	
factors	that	influenced	her	vulnerability	to	drug	use,	abuse	and	dependence.	Born	
in	1978,	Nika	emigrated	from	Leningrad	(now	St.	Petersburg)	to	Israel	at	the	age	of	
22.	The	interview	was	conducted	by	a	senior	researcher	of	the	Regional	Alcohol	and	
Drug	Abuse	Resources	Center,	Ben	Gurion	University	with	permission	and	proper	
safeguard	to	her	confidentiality.	The	interview	has	been	edited	for	this	chapter.
The early years
 After many years of trying to became pregnant and give birth, my mother 
succeeded. I was born after 10 years of trying but believe my parents had no real 
desire to have a baby.
 My father was an editor of one of the Leningrad’s newspapers and my 
mother worked as an accountant for a restaurant in one of the train stations. 
Table 10:	Short	Acculturation	Scale	Index
Table 12:	Drug	Treatment	and	Acculturation
SAS Male
(n=454)1
Female
(n=87)1
Total
(n=541)
Mean
(range;	SD)
0.23***
(0.0-0.69;	0.14)
0.34***
(0.08-0.73;	0.12)
0.26
(0.0-0.73;	.14)
SAS	Index
Mean	(SD) 0.25	(0.14) 0.26	(0.12) 0.28	(0.15)
Detox and otherDetox onlyNever once
Drug treatment
Table 11:	Impact	of	Drug	Use	on	Acculturation
**<.01;	***<.001;	comparison	of	FSU	Females	and	Males	using	t-test	for	means
Use drugs before
immigration
Didn't use
drugs before
immigration
Use drugs
before 
immigration
Didn't use
drugs before
immigration
Didn't use
drugs before
immigration
Use drugs
before 
immigration
SAS
Mean,
(SD)
0.20***
(0.13)
0.27***
(0.15)
0.29**
(0.12)
0.37**
(0.11)
0.22***
(0.13)
0.30***
(0.14)
Male Female Total
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She worked all her life in restaurants, later she had a few cafés of her own in St. 
Petersburg. They had a pretty good life and were together for 10 years.
 My father liked the “bitter drop”; he wasn’t an alcoholic but he loved to 
drink. He had a good job and a positive outlook toward his career. My mother 
was always there for him and for him only; she treated him as if he was a big 
child. When I came into his world all the romance and intimacy of their relationship 
disappeared and then the problems began. They divorced 2 years after my birth.
 My father called me once a year on my birthday but we never met even 
when I visited Russia. He was making good money but never provided support 
for my mother and me. My mother went on to marry other men. The first was 
wonderful who I wanted to be near when I was 4 and 5 years old. Mother was 
suspicious of our relationship. I remember how we were lying very close and tight 
to each other once; I was pulled like a string and in that moment my mother came 
in. She had a very strange look on her face. I don’t know any of the details but soon 
afterwards he was gone. Afterwards, she had 4 other husbands.
 There was one, a military man, who was strict and who I did not get along 
with after a couple of years he left the house. The third one was a married man; 
he was in a constant process of leaving his wife but eventually didn’t. When my 
mother understood, after 2-3 years, that he was not going to divorce his wife she 
left him. Afterwards, my mother was alone for many years and then remarried 
again. I lived with my mother in a two bedroom apartment; one room was my 
mother’s, the second was mine and a living room. To be honest, I was sleeping 
with my mother most of my life when her men were not in the way.
 My school life was fine and from the first grade 3 girls remained my closest 
friends to this day. After I finished the 7th grade I joined a children’s choir and was 
able to travel to many European countries. I studied English but it didn’t come easy 
and I had a hard time getting into the university. Mother saved money and bribed my 
way in; after 2 years and failing grades I was expelled. The real reason was that after 
the first year at age 19 I “messed up” with drugs, then my life began to come apart.
Alcohol and drug use: the start
 I began to drink when I was 15 years old with girlfriends. We would buy 
something cheap like port wine “Tri-Semerki or 777”. It was a big bottle more than 
enough for us to “get wasted” and then go out to the city. When I got drunk it 
was fun. We didn’t drink a lot, it was just for the good mood before going out. I 
remember drinking a bottle of liquor in the house, getting drunk and nearly passing 
out when my mother and her husband went out for a few hours. When I got older, 
age 17, my mother and I occasionally had a drink together.
 My mother smoked so when I was 13 I secretly tried a number of times 
but I was fooling around not really smoking - you fill your mouth with smoke and 
then blow it out without breathing in the smoke. I began to really smoke at 17. 
When I started smoking I decided not to hide it from my mother. I simply asked if I 
could join her for a cigarette. She was very surprised and tried to change my mind 
about smoking at first. But then she got used to it. Besides smoking cigarettes and 
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drinking, I used marijuana after graduating high school – several times a month 
with friends including guys who were drug addicts my age who I grew up with in 
the same building.
Friends
 Through high school I had only girlfriends but after graduation when our 
“grown-up” life began we all chose different paths. I made friends with boys as 
well. The first boys I had as friends were three drug addicted neighbors. I had a 
friendship with them, nothing more. I spent a lot of time with them, we regularly 
travelled together, went out of town or swimming. With them I began to smoke 
marijuana. They didn’t keep secrets from me and I was aware that that they didn’t 
smoke only marijuana but also used “cherniah”7 that is black opium. They cooked 
it by themselves and then used it. Several times I came with them to Dybenko 
Street, the city market to buy supplies. I saw how they cooked it several times. 
However, they didn’t use it when I was around. After a while they began offering 
me to try it with them.
 I held myself for almost a year refusing their offers time after time. Then 
somehow I threw it all away - they never stopped bugging me so I gave it a try. We 
took the train to a suburban town where they occasionally bought “cherniah” for 
themselves. Then we walked for long time until we came to a house where they 
cooked it and used it in front of me. When I saw the needle I was shaking from 
fear. They injected themselves and then began to try to inject me but could not find 
the vein. Initially they tried to find a vein in my arm but it did not work; then they 
decided it would be better to try in the leg but it too did not work. I could not stand it 
anymore and I burst into tears and began to swear at them and they left me alone. 
For more than a year they heard me say no but when I finally said “yes” nothing 
happened. If you meet drug addicts on a daily basis and you’re constantly offered 
to try it yourself, so sooner or later even if it take years you give up and accept the 
offer to use at least for the sake of being left alone or out of curiosity.
 About a week later I went to visit one of them in his house. This time we 
didn’t go anywhere, it was in our building. He and another friend told me “let’s go”, 
found my vein and injected. I didn’t feel a thing; I sat with him and the other one 
for an entire hour. They saw nothing was happening and offered me marijuana 
to smoke. They told me that after the marijuana it would start. So we smoked 
and decided to go outside for a walk. When we got to the elevator there was 
another neighbor of mine from my floor. He looked at me in a very strange way so 
I understood that something was wrong with me. When we got out of the elevator 
and went outside I fainted and fell down. Afterwards I felt very sick and told myself 
enough experimenting. I said to those guys that they should stay away from me 
with their “cherniah” and not offer me again.
 Soon after that time I met a new guy and we started dating. We developed a 
more serious relationship. He was a rich kid; we started to go out to nightclubs, discos 
and various “hangouts.” My time with the neighboring friends was over but a new 
period was just beginning, I started sniffing heroin. The first time I was offered to try 
7 “Cherniah or Chernyashka”– cooked opiate suitable for intravenous use
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was by my boyfriend. I knew already what it was and that it was “cool” and popular. 
Thanks to him I meet many people who also used it. I envied them, near them I felt like 
a little girl who didn’t know anything about this life style. Therefore, when he offered me 
I accepted without hesitation. I calmed myself by thinking that to sniff is not the same 
as to inject; injecting is dangerous, but to sniff a couple of times - why not?
 From the first time, at age 20, using heroin made me feel spaced out. 
I began sniffing and everything went well. I was sniffing only with my boyfriend 
but we didn’t see each other every day. Because of his job, as a steward on a 
passenger steam-ship, we wouldn’t see each other for almost two months. During 
these periods I renewed my relations with my drug addicted neighbors. It turned 
out that during the time we weren’t in touch they switched to heroin. When I found 
out that they were using heroin, I started injecting together with them. That’s the 
way it continued; when I met my boyfriend I sniffed heroin and when he was away 
I hooked up with my neighbors and injected with them.
 I was still in school, the university, but it was far from being a top priority. 
I started using a needle on a regular basis. There were withdrawal periods but 
worst of all was what was after the withdrawals stopped. I had enough strength to 
deal with the withdrawals but the really hard part was what came after. Everything 
seemed gray and dull; my legs were taking me to my neighbors for another shot 
and then it would start all over again.
 Thanks to my boyfriend I tried everything - ecstasy, “Trip or LSD”, 
mescaline. I don’t even remember what else. But I was craving only for heroin, 
nothing else, no marijuana, no alcohol, just heroin. In the beginning I was selling 
my videotapes then it was the gold, - 4 thin gold necklaces, my mother’s and mine.
Addiction, abortion and alcohol
 It was a very tough time for me when I was 20 to 22 years old. At home 
there were always scandals that ended with my mother in tears. I broke up with 
my boyfriend, I was tired of “going out” and sniffing heroin was not enough for me 
anymore. I was expelled from the university in spite of a second chance. I didn’t 
have enough money for heroin so each morning began with visiting and calling 
my friends, neighbors and relatives to get loans for my drug. The loaned money 
was returned by my mother. Sometimes she returned the money and sometimes 
she did not, she wasn’t a millionaire you know. Anyway, I did what I could in my 
situation. My drug using friends also managed with whatever they had. During the 
winter we would rob summer houses; we took whatever we could carry and sell 
even if it was for a few pennies. They were already in the “system”, hooked and 
not able to survive one day without the needle. I too was moving in this direction. 
Mother would give me money for groceries so I would go to the supermarket with 
one of my friends and steal what was needed to buy. If we didn’t manage to steal 
one thing we would take something else and tell my mother that it wasn’t on sale 
so I replaced it. Then we would both go and buy heroin.
 I tried to get treatment during that time mostly at my mother’s urging. The 
first time was 6 months after I started using. My mother was reaching her own 
conclusions but until the very end she refused to believe that I was injecting. The 
final straw was when she caught me cooking my portion in the kitchen. When she 
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saw the syringe she raised a cry and started telling me stories about drug addicts. 
I reacted very calmly and told her exactly what I am and that her shouting would 
not change a thing.
 Even after I told her myself, my mother refused to completely believe it. She 
went to speak with the parents of my neighbor who I was using with. His parents 
knew for a long time already. Afterwards, she locked me inside the apartment. After 
6 hours I had such a withdrawal that I can’t even put into words. I was aware of 
what was going to happen but my mother saw it for the first time… she was very 
scared and called an ambulance. They gave me a painkiller and I felt a little better. 
The next day my mother invited a narcologist who gave me an IV and I slept for a 
few days. I woke up feeling empty and confused. I couldn’t understand what was 
happening to me. I had been in this condition for 5 days and felt that I couldn’t 
bear it any more. I had no life without heroin so I went back to my friends and 
used again. Afterwards, there were 7 more attempts to quit and each one ended 
the same way. I would manage to go through the hard withdrawal but a few days 
after I would start all over again. The longest time that I was clean was 8 weeks. I 
realized that I simply didn’t want to live without heroin. I wasn’t in a state of “I can’t 
quit.” I was in the state of “I don’t want to quit”. I realized that it was my choice and 
path.
 The idea of immigrating and starting over didn’t happened instantly. When 
I turned 21, after another unsuccessful attempt to quit, my mother decided to 
send me away to my relatives in Odessa. I hadn’t been there for almost 7 years. 
I had a 3rd grade cousin there the same age. When I arrived I saw how he had 
grown and I started living with him. At first, I slept with him in the same bed. 
They didn’t have another place for me and I didn’t want to sleep on the floor. 
Afterwards we started to date; we went out together and he showed me the 
city. Then after some time I found out that I was pregnant; it was a big surprise 
for me and for him. Besides that, I didn’t have my period from the time I started 
injecting. I saw that I was gaining weight but thought it was the effect of the 
vacation in Odessa. I remember I told my mother: “look how Odessa affected me, 
how well I look”. And then, I do not remember for what reason, my mother and 
I were in the health clinic. We passed by the gynecologist’s office so my mom 
suggested to get in. It turned out that I was 4 months pregnant. I was happy to 
hear this news and also my mother but when we arrived home and started to 
think rationally about what happened and how my life style would affect this 
unborn child. Nevertheless, after another withdrawal and short break I started to 
use again. Mother and I decided that the best thing to do was to abort. I regretted 
this decision and blamed her. From that time we fought a lot and I began using 
even more heroin. I regret it happened this way. Maybe if I had the child I would 
have had motivation to quit using. The doctors didn’t say anything about drug 
use and pregnancy but I stated using birth control methods.
 I used heroin constantly and drank intensively so there were no place for 
pregnancy with this type of life. This went on for another year until I heard about a 
miracle drug that could help me quit without experiencing withdrawal symptoms. 
It was very expensive but many of my acquaintances started to use it to quit with 
the needles. I was very tired and exhausted; the abortion left an impact on me. I 
still can’t talk about it calmly. I decided to try this miracle drug and after a week I 
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realized I could stop using without feeling any withdrawal. To prevent my craving 
I began to drink strong beer. Every time I woke up I would drink a sip of beer 
and then go back to sleep and that’s the way my days went. During that time I 
met a guy and we together decided to quit using but to prevent the cravings we 
often got drunk. My mother and his parents were willing to do anything to prevent 
heroin use. Their approach was it is better to drink.
Immigration, absorption and acculturation
 At this time, my father told me about immigration to Israel during our 
yearly phone call for my birthday. I, as a daughter of a Jew, had the right to 
immigrate there. I didn’t give it much thought at the beginning because I was 
studying at the university and just began to use drugs. When I decided to quit, 
I went to a meeting with the Israeli consul. He asked me to come back after 
a month with all the required documents. When I went to meet him again he 
asked me some questions and I filled up some forms. Then someone called 
from the Jewish Agency and said they found a place for me at some program 
for young people: I should prepare my documents for departure. To the last 
moment I wasn’t sure whether to go or not. My mother told me to leave since 
I was going nowhere with my heroin and alcohol use. She began to draw a 
fabulous picture of my future life in Israel – a new country, new friends, no drug 
use, no alcohol use and everything was going to be ok. In the end she talked 
me into it. I really didn’t know anything about the country. Little was explained 
to me by the recruiting agency except for what documents were needed for 
immigration.
 On leaving Russia I told my friends that I would not survive in Israel 
more than a year so they should not forget me. I got so drunk on the plane 
going there that I don’t remember what happened in the airport. I was sent to 
a youth program and then to an absorption center in the southern region of the 
country. I began to learn Hebrew, studied for two months and kept on with vodka 
even though I was told drug and alcohol use was forbidden and a reason for 
expulsion from the “Ulpan”8 program. In the end the fairy tale about Israel lead 
me to quite a shock going from a life in St. Petersburg to restrictive conditions 
in a desert environment. I adjusted quickly enough and visited Beer-Sheva with 
other immigrants a couple times a week. There we bought vodka and under 
a sweater or in any other way sneaked it to our center. Once a week, after 
receiving the Sabbath, we would drink intensively. I even had a bottle of vodka in 
my closet; I would take a drink from it during the day. Of course after that I had to 
bypass every “Madrich”9  so he would not notice or smell anything.
 After two months in the absorption program, I met Dany who visited the 
program saying he owned a coffee shop. He offered immigrant girls work; easy 
with good wages. What did I know about this “coffee shop”? I agreed. I was the 
only one and drove away with him to see my future workplace. We spoke to each 
other in very basic English.
8 “Ulpan” (heb) – Hebrew learning courses; Studio (example, television studio).
9 “Madrich” (heb) –Instructor.
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 I soon learned it wasn’t a coffee shop when I entered the place. Back then 
I wasn’t an innocent girl but thought I would be working in a regular “sex shop” 
as a saleswoman. I couldn’t even imagine that the situation was worse and that 
an immigrant in Israel could be tricked this way. I am not saying that in Russia 
everything was perfect. There I was also tricked but I understood in what way 
and for what. But the fact is it happened here in Israel. For me it was a low blow. I 
just wasn’t ready for this kind of thing. When I realized where I was, I immediately 
wanted to go back to the absorption center. Dany calmed me down by saying it 
was too late to go back; I should spend the night at his place and return to the 
center in the morning. The next day I returned to find out I was expelled and no 
longer living there.
 I think if I was visiting friends or relatives no one would have said anything. 
But they knew what kind of people came from Beer-Sheva to invite girls to work 
at the “coffee shop”. When I did not return back on time everybody thought that I 
started to work. In addition they remembered all my sins connected to drinking. I 
think Dany knew that it would end this way and that’s why he insisted I spend the 
night in the city.
 Can you imagine my condition - alone in a strange country without knowing 
the local language, without any relatives and without a place to sleep? I did not 
know what to do but I had Dany so I went with him to the: “Sex Shop”, “Strip Club”, 
“Mahon“10 as a strip tease dancer only.
 For an almost a year I began to drink big time. I never imagined that I would 
end up this way. At the beginning I was scared and embarrassed. To overcome I 
drank a lot and don’t remember myself being sober. My first thought when I woke 
up in the morning was whether I had enough vodka to get myself ready for work. I 
forgot about drugs, it was all about alcohol. I wasn’t paid much but Dany provided 
most things. He was making money off of me and only now I realize that I could 
have made up to $3,000 a month.
 After I saved some money I rented an apartment. I paid three months in 
advance. Then Dany suggested I live at his house but not with him. In one part of the 
house he and his wife lived and at the other, my room. I had a difficult relationship 
with Dany. When I was expelled from the absorption center, I realized that I didn’t 
have a choice and I needed to work. I told Dany that I couldn’t do it without vodka. 
He decided to monitor by alcohol use and buy my vodka. I remember getting drunk 
one day taking off my clothes in front of him. I drank more and by morning realized 
we had sex that night. On the Sabbath, we didn’t work but he would get me drunk 
and take advantage of me. In his home if he had any problems with his wife he 
knew that with a liter of vodka his night with me was guaranteed. After 6 months of 
this he kicked me out and deducted the cost of living at his place from my money. 
Again, I was helpless.
 After this experience, I decided to go to back to Russia for a short visit. 
There, my mother had remarried again. It was the fifth time. I had an additional 
10According to Israeli Law, women who practice in prostitution are not being prosecuted for this crime. But 
there is a criminal offense for opening and managing brothels, pimping, incitement prostitution, etc. In 
order to get around existing laws, brothels operate under the guise of massage parlors, health institutions, 
etc. “Mahon” (Institute) - generic name of such agencies, a euphemism brothel.
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step father - Misha, another Jew and a drunk. I told my mother that the main 
reason for my return was to get alcohol treatment. After a week in Saint Petersburg 
she began reminding me why I came in the first place. We went to a narcologist 
and he prescribed me a medicine – “Espiral” – a medical preparation used for the 
treatment of alcoholism. I took it for a while but then I met my old buddies who 
never stopped injecting. After a break for almost a year, I began to use heroin 
again with them.
 When my mother saw what was happening to me she said that I needed 
to go back to Israel. There I just drank and here I started to use drugs again. I had 
no choice so I returned to Israel and back to Dany. I lived at his place for a week 
and thanks to him I met his brother Asher. He also owned “sex-shop”, “peep show” 
and “mahon” all under the same roof. Then I started to work at his place. After I 
returned to Israel I began to drink again. All that mattered for Asher was that I could 
stand on my feet and perform my strip tease number. I was in such a condition that 
I didn’t care about money. Everything that was to do with money was handled by 
Asher; he talked to the clients and all the money went to him. Vodka was important 
for me and a lot of it. I was sleeping at the workplace.
 Since no one was controlling me, I drank enormous amounts when I 
returned from Russia and when I worked for Asher. I remember fragments of my 
life then, walking in the street, drunk, and constantly falling. I would get up, walk 
some steps and fall again. Eventually, I found myself at Soroka Hospital because 
I had terrible abdominal pain; I do not remember how I got there but a couple of 
hours later I ran out of there going from pub to pub for a drink.
 On one evening I met an Arab; he invited me for a drink at his place and 
promised he would not touch me but there he beat me badly and raped me. After 
that I remember being in the hospital again; how I got there I do not know. They 
were treating my wounds and asking me who did this to me. So I told them Asher 
did it. I received treatment and returned to my workplace to spend the night only to 
find the place was closed for three days. I didn’t know where Asher lived and I had 
no place to go for three days on the streets. I was lucky that it was summer at that 
time. Afterwards I found out that Asher was arrested for rape and beating; he had 
to spend the day in jail until they figured out it was not him.
 When we met I asked for his forgiveness in every way I knew. But he 
could not understand how I could have done such a thing - to tell such a lie. I didn’t 
understand either, I was drunk. He didn’t forgive me and kicked me out. I spent 
a couple of days on the streets, I don’t remember from where I got the money for 
alcohol and food. I had to go somewhere so I decided to go to Dany, his brother. 
I told him everything and that I was in no condition to work; he saw my terrible 
bruises. If I was able to do something it was to drink vodka.
 Dany let me stay at his place. He locked me up during the day at the 
“mahon.” I was without a drink for almost 12 hours; I was shaking and shivering 
so Dany called for an ambulance and I was taken to Soroka Hospital again. There 
I had my first epileptic seizure. I lost all control over my body; I was thrown from 
side to side, bent, twisted to arches. They immediately gave me an injection of 
medication and brought me to a patient ward where I spent a couple of days. In 
the hospital I had a couple of more seizures but they were weaker and I began to 
realize that I could not keep drinking the way I do. After Soroka, I began to work 
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for Dany, again for pennies. I didn’t quit drinking but I tried not to get drunk till 
unconsciousness because Dany, as before, had me under his control. But even 
that proved not to be enough when I was offered local heroin by some of the 
clients. I was now sniffing and smoking, forgetting about alcohol. My salvation 
was heroin, not alcohol. In spite of it all, I was going back and forth using heroin 
and alcohol, binge drinking for 5-6 days then going back to smoking heroin. I had 
a double dependence – when I used heroin I didn’t want to drink; when I was 
drinking alcohol I didn’t crave heroin. During the first 2 and a half years in Israel I 
was half of the time drunk and the other half high from heroin. I used cocaine but 
only a few times.
 After I finished with Dany I returned to Asher as a prostitute to earn 
enough money for heroin 5-6 “manot”11 every day. Before then I worked only as 
a strip tease dancer. Asher did not have a lot of clients so we focused on quality 
and not quantity. I had regular clients. On several occasions they invited me to 
their home. I was not greedy for money. If I came across a client that would pay 
additional money for some special service, I preferred to turn the offer down. 
I could have earned more money this way but I just didn’t need to and I was 
concerned about my health.
 After my time in Russia and return to Israel my mother came to visit me 
a couple of times. She would come and see what was going with me, cry and 
leave. Then she and my stepfather immigrated; rather my stepfather did and 
my mother came as a tourist because she was denied a visa. With my mother 
in Israel life became easier for me; she insisted that I quit my job and move 
in with them. I received government disability support and for the first time in 
years began to take care of my health – cirrhosis of the liver at a very serious 
stage.
 Life with my stepfather in Israel was bad from the start. I told my mother 
right away: “Mother, he is shit” We fought regularly except when I drank with 
him. My mother also has a hard time with him but she tried to hold on because 
she didn’t have Israeli citizenship. He could say all sorts of stuff and my mother 
would be deported from the country. He didn’t like living in Israel and began to 
drink more often; we were forced to live together. He couldn’t leave - he didn’t 
have the money to go back to Russia; mother was trapped with him because 
she didn’t have citizenship. Both worked in menial laundry and cleaning related 
jobs. I also couldn’t leave because my path out was only with Dany or Asher.
 I have continued to live with my mother and step father but I took 
methadone for treatment. I didn’t use heroin and occasionally I had a drink. 
I smoked “grass” very often, its not heroin or vodka and you got to have 
something for the soul. All my plans were now linked to my health. I totally 
ruined my liver and needed to start treatment with Interferon. If the treatment 
helped I can talk about the future. If not, in five years I was going to be dead. 
With this kind of diagnosis you don’t live long. Also, I planned to keep going 
with methadone.
11 “ﬂﬂnﬂ” (heb.) - portion (of a drug).
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Epilogue
	 Nika	 was	 able	 to	 stop	 the	 use	 of	 methadone	 and	 alcohol	 when	 she	
decided	 to	 have	 healthy	 children.	 She	 passed	 through	 successful	 treatment	 of	
liver	cirrhosis;	continued	to	smoke	marijuana	and	had	two	children	out	of	marriage	
from	two	different	men.
	 After	 stopping	 heroin	 and	 alcohol	 use	 and	 the	 birth	 of	 two	 children,	
she	 voluntarily	 entered	 an	 outpatient	 psychiatric	 treatment	 program	 to	 address	
unresolved	issues	related	to	the	events	she	experienced.	Nika	took	antidepressants	
on	a	regular	basis;	did	not	work	but	lived	with	her	children	and	mother	who	received	
Israeli	 citizenship.	 Her	 Jewish	 stepfather	 returned	 to	 Russia	 and	 her	 mother’s	
apartment	 in	 Saint	 Petersburg	 was	 rented	 serving	 as	 an	 additional	 source	 of	
income.
Immigrant women & drug treatment services: a 
perspective
	 The	 primary	 function	 of	 treatment	 programs	 for	 drug	 users	 should	 be	
to	enhance	their	well-being	through	functions	that	are	conducted	on	two	levels	
–	societal	and	individual.	Within	this	context,	such	programs	tend	to	have	three	
major	 functions.	 First,	 they	 assume	major	 responsibilities	 for	 the	 socialization	
of	clients	into	various	roles	that	may	be	occupied.	Second,	the	programs	serve	
as	major	 social	 control	 agents	by	 identifying	drug	users	with	problems.	Third,	
these	 programs	 assume	 a	 social	 integration	 function	 by	 providing	 the	means	
and	resources	for	drug	users	to	become	integrated	in	the	community	(Isralowitz,	
2002;	Pickens,	 Leukefeld	&	Schuster	 1991).	 In	order	 to	 fulfill	 these	 functions,	
drug	treatment	programs	have	many	obstacles	to	overcome	including	program	
management	 with	 limited	 resources,	 staff	 turnover	 and	 burnout,	 outreach	 to	
critical	 target	 populations	 and	 the	 challenge	 of	 providing	 treatment,	 relapse	
prevention	and	 follow-up	services	 to	clients	 including	 immigrants	 in	social	and	
cultural	transition	(Isralowitz,	2002).
	 Among	 the	 most	 underserved	 populations	 in	 need	 of	 treatment	 are	
female	 drug	 addicts	 especially	 those	 with	 immigrant	 status	 lacking	 familial	
support.	Generally,	the	majority	of	women	do	not	receive	treatment.	Among	the	
reasons,	as	previously	mentioned,	are	that	they	may	be	more	able	than	men	to	
sustain	their	addiction	to	drugs	through	illegal	income-earning	activities	such	as	
prostitution	and/or	their	partners	may	be	providing	drugs	or	supplying	the	money	
necessary	to	purchase	drugs.	Also,	they	may	be	alone	caring	for	a	child	fearing	
that	exposure	of	their	drug	use	may	result	 in	giving	up	the	child	to	authorities.	
Regardless	of	the	reason,	research	of	immigrant	drug	using	women	evidences	a	
lack	of	interest	in	treatment	especially	that	of	a	long	term	nature.	Detoxification	
only,	a	short	term	fix,	is	the	route	preferred	even	if	it	 is	only	for	modifying	their	
level	of	drug	tolerance.
	 The	general	picture	of	drug	treatment	reflects	a	lack	of	gender-specific	
services	 including	 individual	 and	 group	 counseling	 linked	 to	 the	 needs	 of	
immigrant	 women	 with	 health	 problems,	 child	 care	 responsibilities,	 under	
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and	 unemployment,	 absence	 of	 a	 familial	 support	 network,	 and	 acculturation	
difficulties.	The	world	of	drug	addiction	 treatment	 tends	 to	be	a	male	domain;	
consequently,	 female	addicts	may	 feel	 out	 of	 place	 in	a	 treatment	 facility	 and	
becoming	involved	with	the	services	provided	if	they	are	not	gender-specific	and	
attuned	to	their	cultural	needs.
	 In	Israel,	there	has	been	a	demand	for	treatment	programs	that	address	
the	needs	of	immigrant	drug	abusers.	Residential	‘hostels’	for	women	have	been	
established	and	consideration	has	been	given	to	establishing	treatment	facilities	
for	 Russian	 speaking	 immigrants	 only.	 However,	 this	 approach	 has	 met	 with	
resistance	 because	 of	 the	 belief	 that	 it	 does	 not	 contribute	 to	 the	 adjustment	
and	integration	capacities	needed	for	integration	in	the	country	(Isralowitz	&	Bar-
Hamburger,	2002).	FSU	and	Israeli	origin	women	also	have	different	views	on	
this	 issue	 (see	Table	4).	Most	 Israeli	addicts	do	not	believe	separate	services	
for	FSU	women	are	necessary	because	of	their	cultural	background	and	lack	of	
Hebrew	language.
	 There	 is	 a	 growing	 literature	 on	 female-specific	 treatment	 needs	 and	
approaches	(Straussner,	1997;	Straussner	&	Brown,	2002;	Tuchman,	2010).	Some	
experts	believe	treatment	of	special	populations	such	as	FSU	immigrant	women	
may	be	enhanced	if	their	particular	needs	are	considered	and	met	in	a	treatment	
environment	(American	Psychiatric	Association,	1995;	Bartholomew	et	al.,	2005;	
Kauffman	&	Woody,	1995;	Walton-Moss	&	McCaul,	2006;	 Isralowitz	&	Reznik,	
2009).	 However,	 there	 is	 not	 full	 agreement	 that	 separate	 programs	 for	 drug	
abusing	women	based	on	ethnic	and	cultural	factors	are	superior	to	mainstream	
efforts	with	respect	to	outcomes	(Sullivan	&	Fleming,	1997).	Regardless	of	the	
treatment	approach	much	more	needs	 to	be	done	 to	understand	and	address	
the	ethno-specific	prevention	and	treatment	needs	of	immigrant	women	through	
policy,	programs	and	services	provision.
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gender differences in recovery
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Introduction
 Over the past thirty years, our knowledge of women’s addictions has 
increased dramatically, and we have added significantly to our understanding of 
the treatment needs of women who are addicted to alcohol and other drugs.
 Historically, substance abuse treatment developed as a single-focused 
intervention, based on the needs of addicted men. Counselors focused only on the 
addiction and assumed that other issues would either resolve themselves through 
recovery or would be dealt with by another helping professional at a later time.
 However, research shows that a vast majority of addicted women have 
suffered violence and other forms of abuse, and a history of being abused drastically 
increases the likelihood that a woman will abuse alcohol and other drugs. One of 
the most important developments in health care over the past several decades is the 
recognition that a history of serious traumatic experiences plays an often-unrecognized 
role in a woman’s physical and mental health problems (Felitti, Anda, Nordenberg, 
Williamson, Spitz, Edwards, Koss, & Marks, 1998; Messina & Grella, 2006).
 In one of the first studies on addicted women and trauma, 74 percent of the 
addicted women reported sexual abuse, 52 percent reported physical abuse, and 
72 percent reported emotional abuse. “Moreover, the addicted women were found 
to have been abused sexually, physically, and emotionally by more perpetrators, 
more frequently, and for longer periods of time than their non addicted counterparts. 
The addicted women also reported more incidents of incest and rape” (Covington 
& Kohen, 1984, p. 42). More recent studies confirm that the majority of substance-
abusing women have experienced sexual and/or physical abuse (Kendall-Tackett, 
2005; Ouimette et al., 2000).
Gender-responsive services
 The research also demonstrates that addiction treatment services for 
women (and girls) need to be based on a holistic and woman-centered approach 
that acknowledges their psychosocial needs (Grella, 1999; Grella, Joshi, & 
Hser, 2000; Orwin, Francisco, & Bernichon, 2001). This author defines gender-
responsive, woman-centered treatment as the creation of an environment – 
through site selection, staff selection, program development, and program content 
and materials – that reflects an understanding of the realities of women’s and girls’ 
lives and that addresses and responds to their challenges and strengths.
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The issue of gender
 Awareness of gender issues must be part of the clinical perspective. 
The keys to developing effective services for women are understanding and 
acknowledging the effects of living as a female in a male-based society. In most 
of the world today, the male gender is dominant, and its influence is so pervasive 
that it often is unseen. One result is that programs and policies called “gender 
neutral” are actually male based. For example, program administrators may take a 
traditional program designed for men, change the word “he” to “she,” and call the 
result a “program for women.”
 Research suggests that social and environmental factors (including 
gender socialization, gender roles, and gender inequality) account for many of the 
behavioral differences between women and men. Gender differences are neither 
innate nor unchangeable; they are ascribed by society and relate to expected 
social roles, so it is important to acknowledge some of the dynamics in a gendered 
society.
 Differences also exist between women based on a number of factors 
(such as race and socioeconomic status), and these can influence a helping 
professional’s views of gender-appropriate roles and behaviors. Regardless of 
their differences, all women are expected to incorporate the gender-based norms, 
values, and behaviors of the dominant culture into their lives. As Kaschak (1992) 
states.
 The most centrally meaningful principle on our culture’s mattering map is 
gender, which intersects with other culturally and personally meaningful categories 
such as race, class, ethnicity, and sexual orientation. Within all of these categories, 
people attribute different meanings to femaleness and maleness.
Gender responsive principles
 In a research-based report for the National Institute of Corrections, which 
states the guiding principles for working with women, gender is the first principle. 
A multidisciplinary review of the literature and research on women’s lives in the 
areas of substance abuse, trauma, health, education and training, mental health, 
and employment was conducted as part of this project. The following principles are 
applicable to any setting that serves women (Bloom, Owen, & Covington, 2003):
 ● Gender: Acknowledge that gender makes a difference.
 ●  Environment: Create an environment based on safety, respect, and 
dignity.
 ●  Relationships: Develop policies, practices, and programs that are 
relational and promote healthy connections to children, family, significant 
others, and the community.
 ●  Services: Address substance abuse, trauma, and mental health issues 
through comprehensive, integrated, and culturally relevant services.
 ●  Socioeconomic status: Provide women with opportunities to improve 
their socioeconomic conditions.
 ●  Community: Establish a system of comprehensive and collaborative 
community services.
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Common themes in the lives of addicted women
 Several years ago the United Nations developed a monograph on the 
treatment of drug-addicted women around the world. At a meeting of experts held 
in Vienna, it became clear that many of the issues that addicted women struggle 
with are universal:
 ● Treatment issues.
 ● Systemic issues.
 ● Shame and stigma.
 ● Physical and sexual abuse.
 ● Relationship issues.
 ● Fear of losing children.
 ● Fear of losing a partner.
 ● Needing a partner’s permission to obtain treatment.
 ● Lack of services for women.
 ● Lack of understanding of women’s treatment.
 ● Long waiting lists.
 ● Lack of childcare services.
 ● Lack of financial resources.
 ● Lack of clean and sober housing.
 ● Poorly coordinated services.
 It is important to note that helping professionals around the world report 
an association between addiction and all forms of interpersonal violence (physical, 
sexual, and emotional) in women’s lives (United Nations Office on Drugs and 
Crime, 2004).
A model for women’s recovery: women’s 
integrated treatment
 The recurring theme of the interrelationship between substance abuse 
and trauma in women’s lives indicates the need for a multi-focused approach 
to services. One treatment model, developed by the author, is called “Women’s 
Integrated Treatment” (WIT). The WIT model is based on 1) the definition of and 
principles for gender-responsive services (previously discussed), 2) a theoretical 
foundation (discussed below), and 3) multi-dimensional therapeutic interventions. 
Several studies (e.g., Covington, Burke, Keaton, & Norcott, 2008; SANDAG, 2007), 
including two experimental, randomized, control-group studies (Messina, Calhoun, 
& Warda, 2012; Messina, Grella, Cartier, & Torres, 2010) show positive results for 
the WIT model. These results are discussed in a later section.
Theoretical foundations
 In order to develop gender-responsive services and treatment for women, 
it is essential to begin with a theoretical framework. This is the knowledge base 
on which programs are developed. The three fundamental theories underlying the 
WIT model are: relational-cultural theory, addiction theory, and trauma theory.
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Relational-cultural theory
 A link between understanding women’s addiction and creating effective 
treatment programs for women is understanding the unique characteristics of women’s 
psychological development and needs. Theories that focus on female development, 
such as “Relational-Cultural Theory” (Jordan, 1991) posit that the primary motivation 
for women throughout life is the establishment of a strong sense of connection with 
others. Relational-Cultural Theory (RCT) developed from an increased understanding 
of gender differences and, specifically, from an understanding of the different ways 
in which women and men develop psychologically. According to this theory, females 
develop a sense of self and self-worth when their actions arise out of, and lead back 
into, connections with others. Connection, not separation, is the guiding principle 
of growth for women and girls. RCT describes the outcomes of growth-fostering 
relationships, as well as the impact of disconnections. Disconnections happen 
at the sociocultural level, as well as the personal level, through racism, sexism, 
heterosexism, and classism. The issues of dominance and privilege are two aspects 
of Relational-Cultural Theory (Jordan & Hartling, 2002).
Addiction theory
 In recent years, health professionals in many disciplines have revised 
their concepts of all diseases and have created a holistic view of health that 
acknowledges the physical, emotional, psychological, and spiritual aspects of 
disease. In a truly holistic model, the environmental and sociopolitical aspects 
of disease are also included. The WIT model uses a holistic model of addiction 
(which is essentially a systems perspective) to understand every aspect – physical, 
emotional, and spiritual – of the woman’s self as well as the environmental and 
sociopolitical aspects of her life, in order to understand her addiction. An addicted 
woman typically is not using alcohol or other drugs in isolation, so her relationships 
with her family members and other loved ones, local community, and society are 
taken into account. For example, even though a woman may have a strong genetic 
predisposition to addiction, it is important to understand that she may have grown 
up in an environment in which addiction and drug dealing are commonplace 
(Covington, 2007).
 Although the addiction treatment field considers addiction a “chronic, 
progressive disease,” its treatment methods are more closely aligned to those 
of the acute care medical model than the chronic-disease model of care (White, 
Boyle, & Loveland, 2002). An alternative to the acute-care model for treating 
disease is “behavioral health recovery management” (BHRM). This concept grew 
out of and shares much in common with “disease management” approaches to 
other chronic health problems; it focuses on quality-of-life outcomes as defined 
by the individual and family. It also offers a broader range of services earlier and 
extends treatment well beyond traditional (medical) services. The more holistic 
BHRM model extends the current continuum of care for addiction by including: 1) 
pretreatment (recovery-priming) services; 2) recovery mentoring through primary 
treatment; and 3) sustained, post-treatment, recovery-support services (Boyle, 
White, Corrigan, & Loveland, 2005).
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 An integration of BHRM and the holistic health model of addiction is the 
most effective theoretical framework for developing treatment services for women 
because it is based on a multidimensional framework. It allows clinicians to treat 
addiction as the primary problem while also addressing the complexity of issues 
that women bring to treatment: genetic predispositions, histories of abuse, health 
consequences, shame, isolation, or a combination of these. When addiction has 
been a core part of multiple aspects of a woman’s life, the treatment process 
requires a holistic, multidimensional approach.
Trauma theory
 Violence against women is so pervasive that the United Nations has 
addressed and defined violence against women as “any act of gender-based 
violence that results in, or is likely to result in, physical, sexual or psychological 
harm or suffering to women, including threats of such acts, coercion or arbitrary 
deprivations of liberty, whether occurring in public or private life” (United Nations 
General Assembly, 1993).
 The third theory integrated into the WIT model is based on the principles 
of trauma-informed services (Harris & Fallot, 2001) and the “Three-Stage Model of 
Trauma Recovery” developed by Dr. Judith Herman (1997).
Understanding trauma
 Trauma is not limited to suffering violence; it includes witnessing violence 
as well as stigmatization because of gender, race, poverty, incarceration, or sexual 
orientation. The terms violence, trauma, abuse, and post-traumatic stress disorder 
(PTSD) often are used interchangeably. One way to clarify these terms is to think 
of trauma as a response to violence or some other overwhelmingly negative 
experience (e.g., abuse). Trauma is both an event and a particular response to an 
event. PTSD is one type of anxiety disorder that results from trauma.
The symptoms of PTSD fall into four categories:
 ●  Intrusive symptoms: flashbacks, nightmares, and intense or prolonged 
distress.
 ●  Avoidance symptoms: isolation and disconnection from others; avoiding 
people, places, and situations that are triggers or reminders.
 ●  Negative emotions and thoughts: blaming, excessive negativity, fear, 
anger, shame, and diminished interests.
 ●  Arousal and reactivity: angry outbursts, reckless and dangerous 
behavior, hypervigilance, difficulty sleeping, and an increased startle 
response (American Psychiatric Association, 2013).
 There are two types of PTSD: simple and complex. Complex PTSD usually 
results from multiple incidents of abuse and violence (such as childhood sexual 
abuse and domestic violence). A single traumatic incident in adulthood (such as a 
flood or accident) may result in simple PTSD.
 A review of studies that examine the combined effects of post-traumatic 
stress disorder and substance abuse found more co-morbid mental disorders, 
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medical problems, psychological symptoms, in-patient admissions, interpersonal 
problems, lower levels of functioning, poor compliance with aftercare and motivation 
for treatment, and other significant life problems (such as homelessness, HIV, 
domestic violence, and loss of custody of children) in women with both disorders than 
in women with PTSD or substance abuse alone (Najavits, Weiss, & Shaw, 1997).
Gender differences
 There is a difference between women and men in terms of their risk for 
physical and sexual abuse. Both female and male children are at relatively equal risk 
from family members and people known to them. However, as males age, they are 
more likely to be harmed by enemies or strangers, whereas women are more likely to 
be harmed by their lovers or partners (Covington, 2003, 2008; Kendall-Tackett, 2005).
 In adolescence, boys are at risk if they are gay, young men of color, or 
gang members. Their risk is from people who dislike or hate them. For a young 
woman, the risk is in her relationships, from the person(s) to whom she is saying, 
“I love you.” For an adult man, the risk for abuse comes from being in combat or 
being a victim of crime. His risk is from “the enemy” or from a stranger. For an adult 
woman, the primary risk is again in her relationship with the person to whom she 
says, “I love you.” Clinically, we think that this may account for the increase in mental 
health problems for women. In short, it is more confusing and distressing to have 
the person who is supposed to love and care for you do harm to you than it is to be 
harmed by someone who dislikes you, is defined as an enemy or is a stranger.
Figure 1 and 2 from the Bureau of Justice Statistics indicate some of these gender 
differences.
Figure 1 Source: Bureau of Justice Statistics. (2000). Sexual assault of young children as reported to law 
enforcement: Victim, incident, and offender characteristics. Washington, DC: U.S. Department of Justice.
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Figure 2 Source: Bureau of Justice Statistics. (2000). Sexual assault of young children as reported to 
law enforcement: Victim, incident, and offender characteristics. Washington, DC: U.S. Department of 
Justice.
 Figure 1 shows that a significant number of males are sexually abused as 
children. From ages one to ten, approximately 35 percent to 20 percent of victims 
are male and 65 percent to 80 percent are female. However, in adult life, victims of 
sexual abuse are almost 100 percent female.
 Figure 2 indicates that the age of greatest risk for males is age five; for 
females it is age fourteen.
 Of course, different women have different responses to violence and 
abuse. Some may respond without trauma because they have coping skills that 
are effective for a specific event. Sometimes trauma occurs but is not recognized 
immediately, because the violent event is perceived as normal. Many women 
who used to be considered “treatment failures” because they relapsed are now 
recognized as trauma survivors who returned to alcohol or other drugs in order 
to medicate the pain of trauma. By integrating trauma treatment with addiction 
treatment, we reduce the risk of trauma-based relapse.
Becoming trauma-informed
 As the understanding of traumatic experiences increases among clinicians, 
mental health theories and practices are changing. It is important for service 
providers to understand trauma theory as a conceptual framework for clinical 
practice and to provide trauma-informed services for their clients. According to 
Harris & Fallot (2001), trauma-informed services do the following:
 ● Take the trauma into account.
 ● Avoid triggering trauma reactions or retraumatizing the woman.
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 ●  Adjust the behavior of counselors and staff members to support the 
woman’s coping capacity.
 ●  Allow survivors to manage their trauma symptoms successfully so that 
they are able to access, retain, and benefit from the services.
 There are five core values that treatment services need to incorporate in 
order to be trauma informed (Fallot & Harris, 2008):
 ●  Safety: Ensuring physical and emotional safety.
 ●  Trustworthiness: Maximizing trustworthiness, making tasks clear, and 
maintaining appropriate boundaries.
 ● Choice: Prioritizing client choice and control.
 ● Collaboration: Maximizing collaboration and sharing power with clients.
 ● Empowerment: Prioritizing client empowerment and skill building.
 These five core values need to be in place for staff members as well as 
clients. It is not realistic to expect that they can be incorporated for clients but not 
experienced by the staff as well.
 For treatment providers who want to include or expand trauma services, 
the following model provides a description of how to integrate trauma-informed 
services and trauma treatment into addiction treatment programs.
A three-stage model for trauma recovery
 In Trauma and Recovery, psychiatrist Judith Herman (1997) defines 
trauma as a disease of disconnection. She presents a three-stage model for trauma 
recovery: 1) safety, 2) remembrance and mourning, and 3) reconnection. These 
three stages are interdependent and usually do not occur in a linear fashion.
Stage 1: safety
 The first stage focuses on caring for oneself in the present. Upon 
entering addiction treatment, a woman typically is in Stage 1 and her primary 
need is safety. “Survivors feel unsafe in their bodies. Their emotions and their 
thinking feel out of control. Often, they also feel unsafe in relation to other people” 
(Herman, 1997, p. 160).
 If we want to assist women in changing their lives, we must create a safe 
environment in which the healing process can begin to take place. Counselors 
can help women to feel safe by ensuring as much as possible that there are 
appropriate boundaries between the clients and all the helping professionals (that 
is, the environment is free of physical, emotional, and sexual harassment and 
abuse). Although it may be possible for a clinician to guarantee absolute safety 
only in a private-practice setting, participants in treatment programs need to know 
that the environment is likely to be safe for them. Counselors also should assess 
each woman’s risk of domestic violence and, if needed, provide resources to a 
woman so that she can get help. These resources include telephone numbers for 
the local domestic violence hotline and the local women’s shelter.
 Many chemically dependent trauma survivors use drugs to medicate their 
anxiety or depression because they know no better ways to comfort themselves. 
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Counselors can teach women to feel safe internally by teaching them to use 
grounding exercises or self-soothing techniques, rather than drugs, to alleviate 
anxiety and depression. Many grounding exercises are based on use of the 
breath and other forms of mindfulness. Self-soothing can include activities such as 
reading, walking, music, and bubble baths.
 Herman emphasizes that a trauma survivor who is working on safety issues 
needs to be in a woman-only recovery group (including the facilitator). Until they are 
in Stage 3 (reconnection), women may not want to talk about sensitive issues in 
groups that include men. Herman cites Twelve Step groups as the type appropriate 
for Stage 1 (safety) recovery because of their focus on present-tense issues of self-
care in a supportive, structured environment. This safety stage focuses on issues that 
are congruent with the issues of beginning recovery. However, it is also important to 
note that some trauma survivors do not feel safe in co-ed Twelve Step groups when 
there are men who aggressively pursue them.
Stage 2: remembrance and mourning
 A woman who is stabilized in her addiction treatment may be ready to begin 
Stage-2 trauma work. Stage 2, remembrance and mourning, focuses on trauma that 
occurred in the past. For example, in a survivors’ group, participants tell their stories 
of trauma and mourn their old selves, which the trauma destroyed. During this phase, 
women often begin to acknowledge the incredible amount of loss in their lives. Although 
the risk of relapse can be high during this phase of work, the risk can be minimized 
through anticipation, planning, and the development of self-soothing mechanisms.
Stage 3: Reconnection
 Stage 3 focuses on developing a new self and creating a new future. Stage-3 
groups traditionally are unstructured and heterogeneous. This phase of trauma 
recovery corresponds to the ongoing recovery phase of addiction treatment. For some 
women, this work can occur only after several years of recovery. 
The trauma informed environment
 In women’s treatment programs, sensitivity to trauma-related issues is 
critical for a healing environment. A calm atmosphere that respects privacy and 
maximizes the choices a woman can make will promote healing. Staff members 
should be trained to recognize the effects of trauma, and clients should have a 
clear understanding of the rules and policies of the program. A trauma-informed 
environment includes:
● Attention to boundaries – between staff members and participants, among 
participants, and among participants and visitors. For example, clients should be 
given permission to say “no” to hugs. Hugging may be an expression of positive 
emotion for some women, but for those who have been traumatized it could 
represent an undesired intrusion into their personal spaces.
● Language that communicates the values of empowerment and recovery. Punitive 
approaches, shaming techniques, and intrusive monitoring are not appropriate.
● Staff members who adopt the “do no harm” credo to avoid damaging interactions. 
Conflict is dealt with through negotiation.
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Women in the criminal justice system
 Understanding the impact of trauma is particularly important when working 
with women in the criminal justice system. Unfortunately, standard management 
practices – such as searches, seclusion, and restraint – may traumatize or 
retraumatize many females. Experiences in the criminal justice system can trigger 
memories of earlier abuse. It can be retraumatizing when a survivor of sexual abuse 
has a body search or must shower with male correctional officers nearby. It can be 
retraumatizing when a battered woman is yelled at or cursed at by a staff person. 
Incarceration can be traumatizing in itself, and the racism and class discrimination 
that are characteristic of the criminal justice system can be further traumatizing.
The link between trauma, substance abuse and 
other health issues
 The following chart helps to explain the process of trauma and its 
interrelationship with substance abuse and other disorders. Trauma begins with 
an event or experience that overwhelms a woman’s normal coping mechanisms. 
Figure 3 Source: Beyond Trauma: A Healing Journey for Women, by Stephanie S. Covington. Copy-
right © 2003 by Stephanie S. Covington.
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Victims have physical and psychological reactions in response to traumatic events 
– defined as normal reactions to an abnormal or extreme situation. This creates a 
painful emotional state and subsequent behaviors. The behaviors can be placed 
into three categories: retreat, harm to self, and harm to others. Women are more 
likely to retreat or be harmful to self, while men are more likely to harm self and/or 
others (Covington, 2003).
 As noted earlier, one of the most important developments in health care 
since the 1980s is the recognition that serious traumatic experiences often play 
an unrecognized role in a woman’s physical and mental health problems. For 
many women, a co-occurring disorder is trauma related. The Adverse Childhood 
Experiences Study (Felitti et al., 1998; Felitti & Anda, 2010) shows a strong link 
between childhood trauma and adult physical and mental health problems. Ten types 
of childhood traumatic events were assessed (emotional abuse and neglect, physical 
neglect, physical abuse, sexual abuse, family violence, family alcoholism, parental 
separation/divorce, incarcerated family member, and out-of-home placement). A 
score of four or more increased the risk of both mental and physical health problems 
in adult lives. This study was a model for research done on women in the criminal 
justice system. For women who scored seven or more, the risk of a mental health 
problem was increased by 980 percent (Messina & Grella, 2006).
 Addicted women are more likely to experience the following co-occurring 
disorders: depression, dissociation, post-traumatic stress disorder, other anxiety 
disorders, eating disorders, and personality disorders. Mood disorders and anxiety 
disorders are the most common. Women are commonly diagnosed as having 
“borderline personality disorder” (BPD) more often than men are. Many of the 
descriptors of BPD can be viewed differently when one considers a history of childhood 
and adult abuse. The American Psychiatric Association is considering adding the 
diagnosis of “complex PTSD” in the next edition of the DSM (Herman, 1997).
The process of recovery for women
 Over the years, the definition of recovery has shifted from a focus on 
what is removed or eliminated from a woman’s life (i.e., alcohol, drugs, cigarettes, 
criminal activity, depression, hospitalizations) to what has been added to her life. 
Recovery is a process through which severe problems with alcohol and other 
drugs, as well as co-occurring disorders, are resolved and there is a development 
of physical, emotional, spiritual, and relational health.
The spirals of addiction, recovery, and trauma
 We can envision the process of addiction as a downward spiral and the 
process of recovery as an upward spiral, as is illustrated in Figure 4. The line that 
goes through the middle of the spiral represents the addiction, which is ever-present 
in the woman’s life. The downward spiral (constriction) shows how addiction pulls 
her into ever-tightening circles as she becomes completely focused on the drug of 
choice and it becomes the organizing principal in her life. Using alcohol or other 
drugs, protecting her supply, hiding her addiction from others, and cultivating her 
love hate relationship with her drug begin to dominate her world.
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Figure 4 Source: Helping Women Recover: A Program for Treating Addiction, by Stephanie S. Coving-
ton. Copyright © 1999, 2008 by Stephanie S. Covington.
 When a woman is in this downward phase of constriction, the counselor’s 
task is to break through her denial. The woman must come to a point of transition, 
in which she shifts her perceptions in two ways. She must shift from believing “I 
am in control” to admitting, “I am not in control.” She must stop believing “I am not 
an addict” and admit, “I am an addict.” Both shifts can feel humiliating. The UN has 
noted that many societies have a double standard that attributes far more shame 
to a woman who has an addiction than to a man who does (United Nations Office 
on Drugs and Crime, 2004). The effects of alcohol on pregnancy (fetal alcohol 
spectrum disorder) contribute to the stigmatization of addicted women. Even when 
not pregnant or parenting, a substance-abusing woman is characterized as a “fallen 
woman” or a “slut,” which adds to the stigma of seeking help for her addiction. 
Although society may stigmatize a male addict as a “bum,” it rarely attacks his 
sexuality or his competence as a parent. We must understand that a woman who 
enters treatment may come with a heavy burden of shame. She does not need to 
be shamed further; rather, she needs to be offered the hope that she can heal.
 The upward spiral of recovery (expansion) still revolves around the drug 
but in ever-widening circles, as the addiction loosens its grip and the woman’s 
world expands away from it. Her world grows to include new, healthy activities; 
new, healthy relationships; an expanded self-concept; and richer sexual and 
spiritual lives.
 Notice that the process is not merely one of turning around and ascending 
the same spiral but one of profound change, so that the woman ascends a different 
spiral. When women speak of recovery, they speak of a fundamental transformation: 
“I’m not the same person. I’m different than I was.”
 Because so many addicted women have been traumatized, it is important 
to consider the process of trauma and recovery. The same concept of a spiral can 
be used, because trauma also constricts and limits a woman’s life. The traumatic 
Transformation
Addiction
(constriction)
Recovery
(expansion)
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events in her life often become a central issue for her (as represented by the 
line through the middle of the downward spiral). Again, there is a turning point 
at the bottom of the spiral. The upward spiral can also represent the process of 
healing from trauma. For many women it is a concurrent process of recovery 
(from addiction) and healing (from trauma). As a woman becomes more aware of 
how trauma has affected her life, she experiences less constriction and limitation. 
With new behaviors and coping skills, there is greater opportunity for growth and 
expansion. If the woman has experienced trauma, it is still a thread in the tapestry 
of her life but it is no longer the core.
 Using the spiral example, we can expand our definition of recovery for 
women. Recovery means growth and expansion, it means having the inner self 
(thoughts, feelings, beliefs, and values) consistent with the outer self (behaviors and 
relationships). This means that there is cohesion, congruence, and consistency in 
the woman’s life. What she is thinking and feeling are now congruent with what 
she is doing. In essence, helping a woman to recover is about helping her to build 
integrity in her life and, ultimately, to experience profound, transformational change.
Seven gender-responsive, trauma-informed 
curricula
 In developing gender-responsive services, the curriculum or material 
used is crucial to the success of the treatment. The following are descriptions of 
seven manualized curricula that the author has designed for working with women 
and girls. They are theoretically based and trauma informed. Each includes a 
facilitator’s guide and a participant’s workbook. Each uses cognitive-behavioral, 
relational, mindfulness, and expressive arts techniques. These materials not only 
help to provide services but also can be used to educate staff members1.
Helping Women Recover: a program for treating 
addiction
 This evidence-based resource provides a comprehensive, seventeen-
session curriculum that includes the information and tools that counselors, mental 
health professionals, and program administrators need to implement an effective 
program for women’s recovery in varied settings. Helping Women Recover is 
organized in four modules that address key areas that women in treatment identify 
as triggers for relapse: self, relationships, sexuality, and spirituality. The content 
addresses the issues of self-esteem, sexism, family of origin, relationships, 
domestic violence, and trauma. The curriculum is built on the integration of theories 
of women’s psychological development, trauma, and addiction.
 A step-by-step guide for facilitating each session is provided. It includes 
lectures, activities, and discussions, as well as timing and notes for the facilitator. 
1 More information on the curricula described in this chapter and other gender-responsive and trauma-in-
formed materials for women can be found on two websites: www.stephaniecovington.com and www.center-
forgenderandjustice.org
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A participant’s workbook, A Woman’s Journal, is filled with self-tests, checklists, 
and exercises to enable each participant to create a personalized guide to 
recovery. The Helping Women Recover program can be implemented by a staff 
with a range of training and experience (Covington, 2008).
 Helping Women Recover is widely used in addiction treatment programs, 
mental health clinics, eating disorder programs, and domestic violence services. 
There is a special edition for women in the criminal justice system. It provides 
specific information about women in correctional settings to staff members in 
such programs.
Beyond Trauma: A Healing Journey for Women
 Beyond Trauma: A Healing Journey for Women also is designed for 
practitioners to use in any setting (outpatient, residential, therapeutic community, 
criminal justice, or private practice) to assist women in understanding trauma, 
its impact, and ways of coping. It includes a facilitator’s guide, a workbook for 
women, facilitator training DVDs, and a client DVD.
 The curriculum’s eleven sessions cover topics such as the connections 
between violence, abuse and trauma; reactions to trauma; grounding skills; the 
mind-body connection; and healthy relationships. It draws on psychoeducational, 
cognitive-behavioral, expressive arts, mindfulness, and relational-therapeutic 
approaches to support a strengths-based framework responsive to women’s 
gender-specific needs for healing and support. The Beyond Trauma curriculum 
can be used alone or in addition to the Helping Women Recover curriculum. It can 
expand and deepen the trauma work in the Helping Women Recover curriculum.
Healing trauma: strategies for abused women
 This five-session intervention is designed for women who have been 
abused. There is introductory material on trauma for the facilitator and then 
detailed instructions (specific lesson plans) for the group sessions. The session 
topics include: the process of trauma, power and abuse, grounding and self-
soothing, and healthy relationships. There is a strong emphasis on grounding 
skills.
 Healing Trauma is an adaptation of Beyond Trauma (see description 
above). It is particularly designed for settings that require a shorter intervention, 
such as short-term addiction treatment, domestic violence agencies, sexual 
assault services, and jails.
 The materials – a facilitator’s guide and participant’s workbook – are on 
a CD-Rom for ease of duplication (with the workbook in Spanish and English). 
They focus on the three core elements that staff members and clients need to 
know: an understanding of what trauma is, the process of trauma, and its effects 
on both the inner self (thoughts, feelings, beliefs, and values) and the outer self 
(behavior and relationships).
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Voices: a program of self-discovery and empowerment 
for girls
 Voices was created to address the unique needs of adolescent girls and 
young women. It encourages them to seek and celebrate their “true selves” by 
providing a safe space, encouragement, structure, and the support they need 
to embrace their journeys of self-discovery. The program includes modules on 
self, connecting with others, healthy living, and the journey ahead, which can be 
delivered in eighteen group sessions. Each session has an opening section, a 
teaching on a topic, an interactive element (e.g., discussion of issues, questions), 
an experiential component (activities to try out new skills and learning), and a 
closing section to facilitate reflection. The program’s theoretical foundations 
include theories of gendered psychological development, attachment, resilience, 
addiction, and trauma. Trauma is addressed in the program both explicitly and 
implicitly though attention to self-esteem, connections with others, body image, 
emotional wellness, good decision-making, and so on.
 Voices is used in many settings (e.g., outpatient and residential substance 
abuse treatment, schools, juvenile justice, and private practice). It includes a 
facilitator’s guide and a participant’s workbook. The participant’s workbook utilizes 
an evidence-based process called Interactive Journaling®. In the context of girls’ 
lives, structured journaling provides an outlet for creativity, personal expression, 
exploration, and application of new concepts and skills.
A Woman’s Way through the Twelve Steps
 A Woman’s Way through the Twelve Steps includes the original self-
help book based on interviews with recovering women about their experiences 
and understanding of the Twelve Steps, plus a facilitators’ guide; a participants’ 
workbook; an app; and a DVD for clients, family members, and facilitators who 
want to learn how women and girls can utilize the Twelve Steps in a safe, nurturing 
way. (The self-help book and the workbook are available in English and Spanish.)
 When offered as a thirteen-session program, A Woman’s Way through the 
Twelve Steps includes an opening session followed by one session for each of the 
twelve steps of Alcoholics Anonymous. It uses interactive activities to help women 
understand the principles or themes in each of the steps. Staff members who 
participate in the A Woman’s Way training groups are able to develop a deeper 
understanding of the basic tools for living embedded in the steps.
Beyond Violence: A Prevention Program for Criminal 
Justice-Involved Women
 Beyond Violence: A Prevention Program for Criminal Justice-Involved 
Women was developed for women who commit violent or aggressive crimes. The 
curriculum consists of twenty sessions (two hours per session), and the program 
materials include a facilitator’s guide, a participant’s workbook, and a DVD. The 
focus is on the violence or aggression that the women have experienced as well as 
on what they have perpetrated. The interactive activities are based on cognitive-
behavioral, relational, and experiential therapeutic approaches.
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 Beyond Violence uses a social-ecological model (Dahlberg & Krug, 2002) 
to contextualize and explain violence. This model considers the complex interplay 
between the individual, relationship, community, and societal factors that put 
people at risk for experiencing and/or perpetuating violence. Applying a gender 
lens to the social-ecological model results in a program that is specific to women’s 
life experiences.
 This is the first researched-based curriculum on this topic; it is suitable 
for use in domestic-violence agencies and community corrections as well as in 
institutional settings.
Beyond Anger and Violence: A Prevention Program 
for Women
 This curriculum was developed for women who are struggling with the 
issues of anger and violence in their lives but are not involved in the criminal justice 
system. It is an adaptation of the Beyond Violence program and uses the social-
ecological model to contextualize violence. It also incorporates information on 
gender differences in the expression and acceptability of anger. The focus is on both 
the anger and aggression that women feel and the aggression or violence they have 
experienced. The curriculum is designed for use in a variety of community-based 
settings, such anger management programs, substance abuse treatment, domestic 
violence programs, VA hospitals, and other mental health settings.
Research on the curricula
 One study of the “Women’s Integrated Treatment” (WIT) model using 
Helping Women Recover and Beyond Trauma, with women in a residential 
program with their children, demonstrated a decrease in depression (using Beck’s 
Depression Inventory) and trauma symptoms (using the Trauma Symptom Checklist 
– 40 scale) (Covington et al., 2008; SANDAG, 2007). The first forty-five days in 
treatment were used as an orientation phase. The decrease in symptomatology from 
admission to day 45 indicates the importance and potential impact of the treatment 
environment itself. The women then participated in the seventeen-session Helping 
Women Recover (HWR) program, followed by the Beyond Trauma (BT) program. 
There was a significant decrease in both depression and trauma symptoms at 
the completion of HWR (p<.05). There was further improvement (p<.05) when the 
women participated in the BT groups that followed HWR.
 Empirical validation for HWR and BT was rigorously tested in two 
experimental studies funded by the National Institute on Drug Abuse (NIDA). 
Evidence from the first NIDA study shows significant improvement during parole 
among previously incarcerated women who were randomized to a women’s 
integrated prison treatment program using HWR and BT sequentially, as 
compared to women who were randomized to a standard prison therapeutic 
community. Women who participated in the WIT program were significantly more 
likely to be participating in voluntary aftercare treatment services (25 percent 
versus 4 percent) and significantly less likely to be incarcerated at the time of 
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the six-month follow-up interview (29 percent versus 48 percent), compared to 
women who participated in the standard treatment (Messina & Grella, 2010). 
Another randomized study among women participating in drug-court treatment 
settings found that the women in the gender-responsive treatment group (using 
HWR and BT) had better in-treatment performance, more positive perceptions 
related to their treatment experience, and trends indicating reductions in PTSD 
(Messina et al., 2012).
 Focus-group results also indicate strong support for and high satisfaction 
of the curricula mentioned above from drug-court and prison participants and 
staff (Bond & Messina, 2007; Calhoun, Messina, Cartier, & Torres, 2010; Messina 
& Grella, 2008).
 Research projects also have been conducted on Beyond Violence. 
Short-term outcomes were examined in relation to mental health symptoms of 
anxiety, depression, serious mental illness, and post-traumatic stress disorder, 
as well anger, aggression, and hostility. Short-term outcomes of the pilot of 
Beyond Violence demonstrated statistically significant improvements in women’s 
mental health symptoms and reductions in anger as a result of the intervention. 
These results provide preliminary evidence of the success of the intervention in 
reducing mental health symptoms that often are common for women convicted 
of violent offenses, including sub-populations of women with life sentences and 
women meeting dual-diagnosis criteria (i.e., meeting criteria for a substance-use 
disorder and a mental health disorder). The research team is currently monitoring 
administrative data to determine if the successful short-term outcomes lead to 
longer-term reductions in recidivism and/or improvements in institutional behavior 
(Kubiak, Kim, Fedlock, & Bybee, 2012).
 Based on the positive results of the piloting of Beyond Violence, a 
randomized control trial is underway was conducted comparing Beyond Violence 
to Assaultive Offender Programming at a state women’s prison in the general 
population setting. The results show that women who participated in Beyond 
Violence have significant changes in measures of mental health symptoms and 
forms of anger expression.
 Women who completed the BV intervention attended 97 percent of 
the scheduled sessions and reported high rates of satisfaction, as well as over 
90-percent agreement that their needs were met and that they benefited from 
the material. Overall, women found the group experience transformative, and 
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many stressed that the group facilitated their becoming better persons; gaining 
accountability for the past, present, and future; and realizing self-worth (Kubiak et 
al., 2012).
Learning the curricula: staff development
 If a treatment program uses a specific curriculum with women, one of the 
best ways to train staff members, supervisors, and administrators is to have them 
participate in the curriculum themselves as a group (Covington, 2012). This has 
been done in a variety of settings, including residential, outpatient, and correctional 
programs. An hour or an hour-and-a half session can be conducted in a weekly 
staff meeting or over lunch, with a different staff member facilitating each week. 
For the program director, these sessions offer a team-building tool and also help to 
reveal staff members’ strengths and challenges.
 When planning to implement this process, it is important to be able to 
explain the differences between a therapy group and a learning (training) group.
Providing treatment
 Trauma can skew a woman’s relational experiences and hinder her 
psychological development. Because it can affect the way a woman relates to 
staff members, her peers, and the therapeutic environment, it is helpful to ask, “Is 
this person’s behavior linked to her trauma history?” However, traditional addiction 
and/or mental health treatment often does not deal with trauma issues in early 
recovery, even though it is a primary trigger for relapse among women and may 
be underlying their mental health disorders. Many treatment providers lack the 
knowledge and understanding of what is needed in order to do this work.
 Here are three important things that can be done in treatment programs:
● Educate women as to what abuse and trauma are. Women often do not know 
that they have been abused. Nor do they have an understanding of PTSD.
● Normalize their reactions. It is important that women learn that their responses 
are normal, given their experiences. The DSM states that trauma responses are 
normal reactions to abnormal situations.
● Provide coping skills. There are grounding and self-soothing techniques (e.g., 
breathing exercises) that women can learn to help themselves cope with their 
traumatic experiences. (See Covington, Beyond Trauma: A Healing Journey for 
Women for specific techniques to use in individual and group therapy).
Avoid revictimization and retraumatization
 A woman who has experienced a traumatic event also experiences 
increased vulnerability. She may have difficulty tolerating, expressing, and/or 
modulating her emotions. This results in what is called “emotional dysregulation.” 
An example of this is when she over responds to neutral cues and under responds 
to danger cues. Therefore, traumatized women are at increased risk of similar, 
repeated revictimization. “Retraumatization” refers to the psychological and/or 
physiological experience of being “triggered.” That is, a single environmental cue 
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related to the trauma – such as the time of year, a smell, or a sound – can trigger 
a full fight-or-flight response. Often, substance abuse treatment providers hesitate 
to provide trauma services for women in their programs because of the fear of 
“triggering” them. Triggers in the environment cannot be completely eliminated. 
Therefore, it is important to create a safe environment in which women can learn 
coping skills. This is the reason that the therapeutic environment is so important 
for women. They must feel safe.
Conclusion
 Historically, substance abuse treatment programs were designed for the 
needs of predominantly male clients. Over the past three decades, researchers 
and treatment providers have begun to identify the characteristics and components 
of successful treatment programs for women. A solid body of knowledge has now 
been developed that reflects the needs of women in treatment, and there is both 
a definition of and principles for the development of gender-responsive treatment. 
Women’s exposure to violence has emerged as a critical factor in treatment. 
Therefore, it is imperative that substance abuse treatment services become 
integrated, incorporating what we have learned from relational-cultural theory 
(women’s psychosocial development), addiction theory, and trauma theory. Such a 
gender-responsive and trauma-informed program can provide the safe, nurturing, 
and empowering environment that women need to recover, heal, and find their 
inner strengths.
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Introduction
 The World Health Organization has declared violence against women as a 
priority public health matter, owing to its high prevalence, morbidity, and mortality. 
Physical, psychological and/or sexual assaults, whether exceptional or repeated, 
whether of high or low intensity, occasion irreparable losses in the biological, 
psychological, and social sphere of women (WHO, 49th World Health Assembly).
 Health policies aimed at addressing violence against women have been 
principally focussed on physical, emotional, economic, and sexual abuse by a 
partner or ex-partner. However, in today’s society other forms of violence against 
women exist. Sexual violence, practised by people who are known or strangers, 
with objectives such as domination, control and humiliation, is the most invisible 
and minimized form of violence. Three types of sexual violence have been defined:
1  Sexual assault, which is any act against the sexual liberty of another 
person using violence or intimidation. The most serious form is rape, 
which is defined as the introduction of the penis into the vagina, anus, or 
mouth, as well as digital penetration and the introduction of objects into 
the first two of the orifices mentioned.
2  Sexual abuse, which is the violation of the sexual liberty of another person, 
in which violence and intimidation are not used but deception, coercion. This 
includes abuse committed against people who cannot give valid consent due 
to their limited capacity for volition (minors, the mentally ill, the disabled).
3  Sexual harassment is the demand for favours of a sexual nature in which 
the harasser takes advantage of a situation of superiority in the workplace, 
as an educator, or similar. The refusal to accede means punishment and 
threats for the victim.
 It is estimated that one in every five women will be sexually assaulted during 
her life. (“Prevalence, Incidence and Consequences of Violence”, 1998). Even 
though sexual assault is one of the most frequent crimes committed against women, 
it is difficult to know the rates of incidence and prevalence in its various forms, due 
in part to social minimalization and banalization of the phenomenon (Ramos-Lira, 
Saltijeral-Méndez, Romero-Mendoza, Caballero-Gutiérrez and Martínez-Vélez, 
2001). The data available to us indicate that between 15 and 25% of women are 
the objects of a sexual assault at some moment in their lives and that in young 
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women the figure is as high as 32% (Sipsma, Carboles, Montorío, and Everaed, 200; 
Fuertes, Ramos, Martínez, López and Tabernero, 2006). In 2007 in Spain a total of 
7,000 sexual assaults were reported (IM, 2009). Rape is one of the most traumatic 
experiences of sexual assault and the most threatening to a woman’s physical and 
psychological integrity (Echeburúa, Corral and Amor, 2002). The majority of rape 
victims present psychological alterations during the first weeks (Rothbaum, Foa, 
Riggs and Murdock, 1992) and between 50 and 70% will develop Post Traumatic 
Stress Disorder (PTSD) in the long term, with highly incapacitating consequences 
(APA, 1994) (Resnick, Acierno, Holmes, Kilpatrick and Jager, 1999).
 Sexual violence is a crime that carries a heavy impact on the physical 
and psychological health of its victims, which must be treated and re-established 
from different settings (healthcare, social, judicial and law enforcement), and with 
strategies from public services, which are efficacious and avoid re-victimization. 
This treatment will mean the intervention in the short and long term, in a coordinated 
and interdisciplinary manner, of different healthcare, social, judicial, and law 
enforcement facilities and specialists. In order to deal correctly with the medical, 
social, and judicial problems derived from the assault, and to prevent or reduce their 
consequences, it is necessary to design a circuit of action in which professionals 
have the necessary training and sensitivity to not increase victimization, sense of 
blame, or disorientation.
 The effects of sexual violence are produced on a physical and psychological 
level:
 The principal risk factor to be a victim of a sexual assault is being a woman. 
There is no specific profile of woman; we frequently find women of varying ages, 
cultures, and occupations who need treatment to relieve the pain and the effects 
produced by the act committed against them.
 In order to address this reality, in 1994 the Hospital Clínic of Barcelona 
(HCB) signed an accord with judicial, law enforcement, and social entities in 
Table 1. Physical health
Table 2. Psychological health
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Barcelona through which it was accorded the qualification and responsibility for 
constituting the reference centre in emergency care for women who are victims of 
sexual assault and/or sexual abuse in the city.
 By this accord, emergency care for sexually assaulted women in Barcelona 
is centralized in the Emergency Services of the HCB, where the necessary 
professional teams, such as police, forensic doctors, and healthcare specialists, 
can be found.
 Subsequently, the victim is offered the chance to attend the Programme 
for the Prevention and Treatment of Psychic Effects in Sexually Assaulted Women 
(AGRESX-TEPT), in the Psychiatry and Psychology Service of the HCB.
 In this chapter there is a brief description of the HCB programme of integral 
treatment of victims of sexual assault, the phenomenon of drug-facilitated sexual 
assault, and the HCB programme’s experience. At the end of the chapter specific 
recommendations are proposed.
Hospital care and assistance programme for the 
sexually assaulted woman
 Recently the Commission for Intrafamily and Gender Violence (VIG) at 
the HCB designed a treatment protocol for the emergency care of victims of 
sexual assault, giving special attention to the aspects of health that have been 
particularly affected by the assault (gynaecological, infectious, surgical and 
psychiatric) and the judicial aspects (the duty court is informed, and there is a visit 
by the forensic doctor in emergency services and by the police). Subsequently, 
the Programme for the Prevention and Treatment of Psychic Effects in Sexually 
Assaulted Women (AGRESX-TEPT) was established in 2006 in order to offer 
information and counselling to women who have suffered from sexual assault 
and who wish to treat any possible psychological after-effects, such as post 
traumatic stress disorder (PTSD) or depressive disorder, and to return to normal 
functioning.
 The first attention is carried out at the emergency services of the hospital, 
which has a specific circuit of immediate attention in a protocol-based setting. 
The treatment circuit consists of various professionals who are trained to perform 
in a quick and coordinated way that avoids re-victimization. The attention circuit 
and the principal functions of each professional are shown in Figure 1.
 Throughout the process the patient must remain accompanied, and the 
procedure by which she will receive integrated treatment will be explained to her, 
as will the visits by professionals. She will also be offered the opportunity to report 
the offence to the police. At the moment of discharge from hospital the patient 
is given a self-help guide for women who are victims of a recent sexual assault, 
which was created by the professionals of the AGRESX-TEPT programme based 
on experiences of other patients, as an information and support tool to favour self-
healing and the restoration of psychological well-being (http://blog.hospitalclinic.
org/es/2009/05/guia-dautoajuda-agressions-sexuals).
 The Emergency Service of HCB deal with an average of approximately 200 
sexual assaults a year. The majority (91%) of people who attended the Emergency 
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Figure 1. Treatment Protocol for Sexual Assaults in the HCB Emergency Service
Service as victims of sexual assault are women (VIG, 2011). The demographic 
data and characteristics women attended during 2011 in the Emergency Service 
of the HCB can be seen in Table 3.
 Experience shows that the majority of women who are victims of a 
sexual assault experience psychological symptoms during the first few weeks, 
with alterations to their sleep, appetite, mood, and habitual functioning. The 
psychological impact may include everything, from an immediate emotional reaction 
in the form of acute stress to consolidated psychiatric disorders such as PTSD or 
depressive disorder, changes in lifestyle such as increased substance use, and 
profound changes in personality, functioning, and interpersonal relationships. It is 
considered that early intervention can reduce possible psychological reactions and 
prevent them from becoming chronic disorders.
 The Psychiatry and Psychology Service of the HCB has an interdisciplinary 
team of professionals from the areas of psychiatry, psychology, social work, 
and nursing, specializing in psychiatric and psychological disorders associated 
with stress as a consequence of a sexual assault. This is a programme of brief 
intervention, aimed at women who have been victims of a sexual assault in the last 
three months. The treatment objectives are to: a) offer information and support; b) 
reduce the initial psychological reaction; c) prevent psychic side effects; d) treat 
psychiatric disorders, such as depressive and post-traumatic disorders; e) re-
establish the social area of the patient; and f) recover the patient’s prior quality of 
life and functioning.
335
 In the first days after the assault the programme’s nurse actively contacts 
the women within the first days after the emergency visit (by telephone) to offer them 
support and providing a link to the programme to receive assistance. The intervention 
is carried out in three phases (figure 2): stabilization, processing of the trauma, and 
integration and rehabilitation (Herman, 1997). In the event that there is significant 
post traumatic symptomatology, a specific psychiatric and psychological intervention 
will be carried out, making use of psychopharmacology and the psychological 
techniques that have shown greatest efficacy for the treatment of PTSD (prolonged 
Table 3. Sociodemographic data and sexual assault’s characteristics of the women attending.
Reasons for suspecting that it was under the effects of a drug
n  Total anterograde amnesia.
n  Partial anterogrande amnesia.
n  Conscious paralysis (Immobilized but awake).
n  Loss of consciousness or blacks outs.
n  Inarticulate speech.
n  Blurred vision.
n  Drowsiness.
n  Confusion.
n  Sensationa of "hangover" or symptoms inconsistent with the quantity of alcohol or drugs
     consumed.
n  Disinhibition.
n  Delirium or hallucinations.
n  Altered judgement.
n  Dizziness.
n  Psychomotor alterations.
n  Nausea or vomiting.
n  Has acted in a way inconsistent with her personality and/or the quantity of alcohol and/or
     drugs ingested.
Sociodemographic data and sexual assault's characteristics of the women attended in the
AGRESX-TEPT Programme during the year 2011
n  Spanish (47%), foreigners (53%)
n  Single (75%) and without children (78%)
n  Aged 18-25 (47%)
n  Medium/high level of studies (71%)
n  Working 49%, Studying 29%
n  Personal psychiatric history (28%)
n  History of consumption of abused substances (18%)
n  History of alcohol abuse or dependence (11%)
n  Intellectual disability (3%)
n  63% consumed alcohol prior to the assault, 17% other drugs
n  34% believed themselves to be involuntarily under effects of some drug
n  50% of assaults occur at home, 25% in the public thoroughfare, 7% in leisure aseas, 2,4% in
     the workplace
n  In 67% the mechanism of the assault is vaginal, 5% anal, 3% oral, 11% toughing
n  In 62,6% the assailant is unknown, 8% partner or ex-partner, 5% friend, 3% relative, 1%
     colleague
n  82% make a police report
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exposition (Foa, Hembree, & Rothbaum, 2007), cognitive processing therapy (Resick 
& Schick, 1993) and eye movement desensitization and reprocessing (Shapiro, 
201). Furthermore, the patient’s substance use will be monitored systematically, 
using motivational techniques aiming to reduce her consumption habits.
Sexual assault and substance use
 The consumption of alcohol and drugs is often intimately related to sexual 
conduct. Voluntary consumption of alcohol and drugs of young women in Spain is 
currently rising in prevalence (Household drug survey, 2009).
 According to data corresponding to victims of sexual assaults during the 
year 2009-2011 at the Emergency Services of the HCB, approximately two thirds 
(63%) of sexually assaulted women had consumed alcohol and/or drugs in the 
hours immediately before the assault. 40% of the women had consumed only 
alcohol or alcohol in combination with other drugs, 20% cannabis, 18% cocaine, 
15% benzodiazepines, 7% amphetamines and derivatives, and 2% methadone and 
opiates. 27% had consumed more than one substance (Valls, et al., 2011; HCB’S 
non-published data). (Figure 3).
Drug Facilitated Sexual Assault (DFSA)
 Drug Facilitated Sexual Assault (DFSA) occurs when the victim of a sexual 
assault is hindered from giving her consent to sexual relations or from offering 
resistance to an aggressor, because she is under the effects of alcohol and/or 
other drugs (whether their administration is voluntary or forced). DFSA may pass 
unnoticed by healthcare staff and it may causes alarm when reported to the media. 
 Presently two types of DFSA are recognized: proactive and opportunist. 
Proactive DFSA refers to a situation in which the assailant gives an incapacitating 
or disinhibiting substance to the victim, with the objective of subjecting her sexually. 
Opportunist DFSA occurs when the assailant maintains sexual activity with a 
person whose level of consciousness is diminished as a consequence of an acute 
intoxication, voluntary and/or involuntary (Howarth, 2005).
 More than 50 different substances have been identified in the commission 
of DFSA (SOFT, 2007). The most commonly used drugs are ethyl alcohol, 
benzodiazepines, gammahydroxybutyric acid (GHB), cannabinoid derivatives, 
hypnotics such as zolpidem, zoplicone, fentanyl, LSD (lysergic acid diethylamide), 
atropine, and scopolamine (“burundanga”). Compared to other types of sexual 
assault, victims of DFSA suffer from a longer period of latency, receive less 
assistance from law enforcement agencies, and DFSA is associated with a lower 
incidence of genital and extragenital injuries (McGregor et al., 2003). Women under 
the age of 20 are particularly vulnerable to this form of sexual assault (McGregor et 
al., 2004).
 In Spain, epidemiological studies on the prevalence and incidence of 
DFSA do not exist. Yet based on statistics from other countries, it can be expected 
that more than 20% of sexual assaults are cases of DFSA. In Catalonia, there is 
a growing interest among professionals from various disciplines in DFSA and its 
incidences in Spain, and different documents have been developed on protocols 
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of multidisciplinary healthcare action (Commission for Intrafamiliy and Gender 
Violence, HCB, 2013) and forensic action (Xifro et al., 2012).
Indicators for Suspicion of Drug Facilitated Sexual 
Assault
 Suspicion of DFSA will be based on the clinical information of the 
anamnesis, physical and psychological examination, manifestation of consumption 
of abuse drugs and/or psychopharmacological substances during the hours prior 
to the assault and on the results of toxicological analysis.
 It must be borne in mind that the non-detection of alcohol, 
psychopharmacological substances and/or other abused drugs in a biological 
Figure 2. Phases of the interdisciplinary intervention on the consequences of sexual assault in the 
AGRESX-TEPTProgramme
Figure 3: Detection of abused drugs in toxicological analysis at HCB Emergency Services during the 
years 2009-2011 (Valls et al, 2011; HCB’S non-published data).
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Table 4. Indicators for suspicion of drug facilitated sexual assault (adapted from Du Mont et al., 2009)
sample from a victim of sexual assault does not necessarily mean that a DFSA 
has not occurred. A delay in the taking of biological samples may give a negative 
toxicological result due to the time that has passed between the consumption of 
the substances and the performance of the test.
 A positive toxicological result will support the suspicion of DFSA, although 
the results of the anamnesis and complementary examinations will have to be 
taken into account (García-Respetto, 2011).
Clinical Presentation of Drug Facilitated Sexual Assault
 In cases of DFSA, the accounts given by the women who are victims 
have points in common. It is usual that the victim attends the emergency services 
and mentions having been at a party, a bar or a disco, having taken alcohol and/
or other drugs, explains a sudden feeling of intoxication, as well as a loss of 
bodily control, and does not remember anything about what has happened. In 
the physical examination few genital and extra-genital injuries are found, possibly 
due to the conditions in which the assault happens, a low state of consciousness, 
immobilization and the inability to defend herself.
 The clinical symptoms which are presented are unspecific and may bring 
to mind those of an ethyl intoxication or an organic disorder, and for this reason 
the DFSA may pass unnoticed. Symptoms such as total or partial amnesia, 
automatic conduct, spatial and temporal disorientation, behavioural disinhibition or 
automatic conduct, drowsiness, associated or not with the sensation of nausea and 
vomiting, headache, vaginal/anal discomfort, the presence of unexplained injuries 
and/or haematoma and the woman’s suspicion of having had sexual relations 
unconsciously, should alert the team of emergency professionals that they may be 
dealing with a possible case of DFSA (Cruz-Landeira and cols., 2008).
Substances Involved in Drug Facilitated Sexual Assault
 The substances that may be used in DFSA have some common 
characteristics that make them suitable for the end pursued by the assailant, 
which is no other than to diminish the capacity for volition and resistance of the 
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victim. They tend to be substances whose action is rapid but of short duration, 
odourless, colourless and insipid, active at low dosages and easy to obtain. They 
are usually substances that depress the central nervous system such as alcohol 
and benzodiazepines. Illegal abused substance whose use is more frequent in a 
recreational context, such as cannabis, cocaine, GHB and ketamine, have also 
been known to be involved.
Biological matrices useful in the detection of voluntary 
or involuntary consumption of abused substances
 In the year 2003, the French Society for Toxicological Analysis (SFTA, 
2003) agreed on a protocol which was broadly accepted at international level, 
which establishes that in the study of DFSA samples of blood, urine and hair must 
be collected systematically.
 Blood is a biological matrix that gives information about recent consumption 
of a substance (between 6 and 48 hours) and allows the establishment of 
correlations between the concentration in the blood and clinical symptoms.
 Urine gives information about recent consumption, and offers the 
advantage of a wider window of detection than blood, which makes it very useful 
for the detection of substances that may appear in the urine up to a week after their 
ingestion (cannabis derivatives and benzodiazepine metabolites).
 It must be taken into account that the times of detection of these substances 
in blood and urine will depend fundamentally on the dose administered and the 
sensitivity of the analytical method used.
 In situations in which a collection of samples is not performed immediately 
after the sexual assault or the victim does not report the offence until weeks or 
months after suffering the sexual assault, the multi-sectional analysis of hair may 
be useful for the retrospective investigation of consumption and in the differentiation 
between an acute exposure and chronic use of a specific substance (SOHT, 2008).
 Sweat can be a complementary biological matrix: it is considered 
substances can be detected between 3 and 7 days after the assault (SOFT, 2007).
 Occasionally used non-biological samples related to the victim such as 
drugs found at the scene of the assault, objects used by the victim (glasses and 
bottles), as well as foodstuffs or drinks suspected of being used to commit DFSA, 
may also complement the toxicological investigation.
Approach to the phenomenon of Drug Facilitated Sexual 
Assaults in the city of Barcelona
 Since the start of the AGRESX-TEPT Programme, we have detected that 
there were a group of women attending the Programme with a similar physical 
symptomatology, unable to remember some or all of the assault, and with an 
emotional reaction which was more affective than post traumatic. This was a group 
of women with indicators of drug facilitated sexual assault (DFSA). We considered 
the need to study this phenomenon in order to discover the prevalence, incidence 
and prognostic characteristics of the evolution from the initial emotional reaction to 
PTSD or a major depressive episode.
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 The sample that we present was taken at the emergency service of the 
HCB during the months from June 2010 to December 2012. All the women aged 
18 or over who were attended at the emergency service of the HCB for suspected 
sexual assault were included. We have excluded women with difficulties of language 
comprehension in the completion of the self-administered questionnaires.
 During the time at the emergency service sociodemographic information, 
clinical variables and information about the sexual assault were gathered following 
a protocol. The anxiety and degree of distress during and immediately after the 
sexual assault were evaluated. The criteria of the Canadian research team were 
applied for the classification of the case as drug facilitated sexual assault (DFSA) 
versus non-drug facilitated sexual assault NDFSA (Du Mont et al. 2009), Table 4.
 The final sample is composed of 199 women. The 54% of the women 
attended by the Emergency Service have been classified, following the indicators 
for suspicion, as having suffered a drug facilitated sexual assault. In the comparison 
of both sub-populations (DFSA vs. NDFSA), we can observe some significant 
differences which are listed in Table 5.
 Our data point to the definition of a profile of drug facilitated sexual 
assault (DFSA) which is characterized by occurring predominantly in young 
women, aged 18 to 25, who attend Emergency Services on their own initiative, 
between the hours of 16.00 and 24.00, more usually at weekends, who relate that 
the assailant is an unknown man and the main type of assault is vaginal. They 
report having consumed, prior to the assault, principally alcohol and to a lesser 
degree cannabis and cocaine, which corresponds to the profile of consumption for 
recreational use. They report that they do not remember anything from a particular 
moment onwards, or having partial recollections in the form of flashbacks (total or 
partial anterograde amnesia). They report nausea, vomiting, headaches, genital 
discomfort and the perception of having unconsciously had sexual relations. 
The evaluation of peritraumatic symtpomatology at the moment of the visit to the 
Emergency department showed a lower intensity. Moreover, the assault occurs 
with less physical violence, possibly due to the diminished state of consciousness 
of the victim and her inability to defend herself.
Table 5. Bivariant analysis between drug facilitated sexual assaults (DFSA) and non drug facilitated 
sexual assaults (NDFSA). Analysis between DFSA and NDFSA
DFSA (n=108) NDFSA (n=91) Sig.
68% unknown assailant 52% unknown assailant
0,9% partner involved 26% partner involved <.001
30,6% known 22,2% known
0,9% physical violence 7,8% physical violence ns
82,4% vaginal 70% vaginal <.01
8,3% anal 17,8% anal <.05
41% go to emergency services on own initiative 16% go to emergency services on own initiative 
<.001
67% referred to emergency services by police 38% referred to emergency services by police
Time of arrival at emergency services between 16:00 and 00:00 Time of arrival at emergency services between 00:00 and 08:00 <.01
Peritraumatic symptoms 26,37 (9,33) Peritraumatic symptoms 30,53 (11,47) <.05
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Summary and recommendations
 ●  Between 20% and 50% of sexual assaults could be catalogued as cases 
of drug facilitated sexual assault, due to the voluntary or involuntary 
exposure of the victim to some psychoactive substance which produces 
a diminishment in the state of consciousness. Her free will and the ability 
to defend herself become nullified.
 ●  A high percentage of victims of DFSA admits previous voluntary 
consumption of some psychoactive substance.
 ●  The voluntary consumption of alcohol, psychopharmacological 
substances or drugs of abuse increases significantly the risk of suffering 
a sexual assault.
 ●  Healthcare staff in general should be familiar with this phenomenon, 
and more specifically those who have to assist victims, such as the staff 
of the Emergency Services, primary care or gynaecology, infections, 
psychiatry, psychology, nursing and social work.
 ●  Detection of DFSA is made more difficult by the delay in requesting help 
on the part of the victim and the covering up of the symptomatology 
presented by an acute ethyl intoxication.
 ●  Negative results in the presence of alcohol, psychopharmacological 
substances or other abused substances in a biological sample do not 
permit us to rule out the possibility of a drug facilitated sexual assault.
  The current lack of visibility of sexual violence in general and the 
phenomenon of DFSA makes evident the need to:
 ●  Promote their detection and treatment, offering adequate training in 
gender violence and sexual violence to professionals of the healthcare 
network.
 ●  Raise awareness in the general population and particularly women about 
the risk of sexual assault, associated with the voluntary or involuntary 
consumption of abused substances.
 ●  Promote primary preventive actions in the at-risk population (actions in 
nightlife venues, information campaigns in the youth population).
 ●  Increase research on sexual violence. Carry out studies to improve 
knowledge about the prevalence, groups at risk, and the different abuse 
substances associated with DFSA, and the consequences on physical 
and social health.
 ●  Provide educational materials accessible to the vulnerable population, 
with indications to be taken into account related with substance use 
and with interpersonal relationships, aimed at the female and male 
population.
 ●  Promote the transversal nature of the gender perspective in the 
programmes of the healthcare network to foment detection, intervention 
and referral to specific programmes.
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Introduction
 The SHIELDS for Families’ Exodus Therapeutic Community is a unique 
model in which comprehensive family-centered treatment, follow-up, and related 
social services are provided within an 86-unit apartment complex. It is currently 
the only program in the United States that allows for the entire family unit to live 
in the treatment environment in individual family apartments. Treatment, child 
development and youth services, case management and vocational services are 
offered on-site at the facility. A maximum of 45 families are active in treatment at 
any given time. After completion of treatment services (12-24 months), families are 
able to remain in their housing for a transitional period of up to one year, allowing 
for adequate time to develop vocational, educational and/or supportive systems 
necessary for ongoing recovery and family maintenance. This article describes 
the treatment model, the array of primary treatment interventions, and the parallel 
services provided to children and youth.
Treatment model
 The Exodus Program accepts clients from throughout Los Angeles 
County, although clients are primarily from the Compton and Watts communities 
in South Central Los Angeles where the program is located. The majority of clients 
are referred from the Department of Children and Family Services (55%) or are 
self referrals (30%). Currently, approximately 45% of the clients are African-
American and 50% are Latina. The primary drugs of choice are cocaine and 
methamphetamine, with marijuana as the secondary drug of choice. One hundred 
per cent of clients are homeless at admission, less than 30% have a high school 
diploma and 95% have experienced significant trauma in their lifetime including 
physical and sexual abuse and domestic violence.
 Upon admission to the program, clients sign a contract for treatment services 
and a lease agreement for their housing. Women who lease apartments assume 
responsibility for payment of rent. Comprehensive psychosocial assessments are 
conducted on each woman and their family members within 30 days of admission. 
Psychosocial assessments include: family, drug history, medical, legal, vocational, 
education and mental health information. Additionally, clients receive medical, 
psychological and vocational assessments, as well as psychiatric evaluations 
when indicated. A treatment plan is developed by the primary counselor and 
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the client along with her family and/or significant others, in conjunction with the 
multidisciplinary treatment team. Treatment plans are reviewed and updated every 
90 days for the length of the program. Clients are provided and/or referred to 
services as indicated through the development of the treatment plan to ensure the 
comprehensive needs of families can be met. Clients are maximally involved in all 
aspects of their treatment plan and program services. As clients progress through 
the program they are provided the opportunity to serve as peer counselors for new 
clients. Clients are also asked to participate in program planning to ensure that 
services provided are sensitive and relevant to their needs.
Treatment services
 The provision of adequate, comprehensive, family focused services 
assists in creating the elements necessary for the family to survive. The program 
philosophy incorporates maximum client participation, flexibility, availability, and 
accessibility of services which assists with client retention in the program. The 
comprehensive services provide families with a supportive framework in which to 
grow and develop, while providing essential services to ensure healthy outcomes 
for mother and child. 
Services include:
 Individual Counseling - Individual counseling sessions are designed to 
allow the primary counseling staff to evaluate the total patient status (strengths 
and problems), assist the client (in conjunction with the treatment team) with 
individualized recovery, aftercare, and discharge planning, facilitate program 
interpretation and understanding, provide crisis intervention, and facilitate problem 
solving. All clients receive individual counseling a minimum of once per week. Crisis 
intervention services, as well as a 24-hour hotline are available for addressing 
situations that present an imminent risk to the client and/or her family.
 Family/Collateral Counseling - Experts who have studied families 
with a problem of addiction have discovered that family members react to the 
situation with similar patterns, taking on roles in the family unit that assist them with 
“managing” the addictive lifestyle. The dysfunction experienced by such families is 
commonly referred to as co-dependency. Leaders in the field have identified that 
the entire family, not only the addict, is in need of recovery. Additionally, the client’s 
recovery is often dependent upon the recovery of the entire family unit and their 
understanding and awareness of this disease. Family counseling sessions and 
family education groups are provided a minimum of once per week.
 Group Counseling - Group counseling sessions focus on assisting the 
clients and family members to deal with psychological, social, and economic issues 
that contributed to or may have developed as a result of the client’s substance abuse. 
The groups are designed to provide participants an environment conducive to self-
examination and change, and to obtain objective and non-judgmental feedback 
on their behaviors, attitudes, feelings, and methods of relating to themselves and 
others. Groups focus on a variety of issues including self-awareness, self-worth/
self-esteem, self-discipline, social skills, sensitive treatment issues as they relate 
specifically to women, including child and/or adult physical abuse and/or sexual 
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abuse, and acceptance of counseling for problem areas. Program services include 
the following groups: women’s issues, trauma, grief and loss, sexual abuse, and 
domestic violence.
 Mental Health Services - A full range of mental health services is provided 
on site by three full-time therapists. This includes individual, group, and family 
therapy, psychological and psychiatric evaluations, and medication support.
 Case Management - Case management is an interactive, interpersonal 
process that involves: (a) assisting the family with identifying, accessing, and 
linking them to needed services; (b) organizing and integrating the services into the 
family treatment plan (c) working with the treatment team to ensure that services 
are coordinated; and (d) negotiating and bargaining for services on behalf of the 
family.
 Life Skills - Training is provided to help develop skills in the areas of 
problem solving, stress reduction, life management (including financial planning 
and social skills development), and time management.
 Health Education - Educational groups are provided to all clients on 
health and nutrition, AIDS, tuberculosis, STDs, drugs and alcohol, as well as family 
planning. Topics include general health education and hygiene (with an emphasis 
on women’s and children’s issues), drug and alcohol abuse education, relapse 
prevention and recovery issues, nutrition, and AIDS education.
	 Family	 Reunification	 - Family dynamics or issues present significant 
problems for women in treatment and are often precursors for relapse for mothers, 
and behavioral and school problems for children. To respond to the issues that 
arise with the reunification process, a family focused group is provided specifically 
for those families who are entering into or preparing for reunification.
 Family Support - Substance abuse affects the entire family of the identified 
client. Therefore, in order to treat the client, the entire family must be treated. 
Family members, including children, are offered the opportunity to participate in 
family therapy. In addition, significant others are provided an on-site weekly support 
group and/or individual counseling. Referrals are provided to family members for 
services not provided by SHIELDS. In addition, children of clients, whether in their 
custody or not, are given the opportunity to participate in child development or 
youth program services.
 Relapse Prevention - Relapse prevention strategies are integrated into 
the educational curriculum provided at the apartment complex, as well as being 
an integral part of individual and group counseling. Specific relapse prevention 
groups are provided a minimum of once per week.
 Client Council - The Client Council is a segment of the client population 
whose purpose is to represent all clients in treatment. The Client Council helps 
to build, shape, and formulate some of the program policies as they relate to 
daily client procedures, rules, and cultural sensitivity and responsiveness of the 
project. The major purpose of this collective body is to promote ownership and to 
enhance accountability of client participation in the program. The Client Council 
meets weekly. Clients elect an Executive Board and manage the meeting. Issues, 
recommended changes, and concerns are presented to the program administrative 
staff. Representatives from the Client Council are elected to represent the program 
on the SHIELDS Consumer Advisory Board. The Consumer Advisory Board meets 
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with the Chief Executive Officer and other representatives from the agency’s 
management team on a monthly basis. They are responsible for assisting with 
policy development and agency-wide activities.
 Aftercare Services - Aftercare is essential for accomplishing the long-
term goal of reintegration with society at large. Although clients show significant 
improvement during treatment, their gains tend to decrease in the time period 
following, since support and supervision is no longer immediately available. Lifetime 
aftercare services are provided which include support groups, self-help groups, and 
participation in the alumni organization. Aftercare assists in the reduction of relapse 
by providing a mechanism for the client to receive follow-up from the program, in 
addition to assistance in accessing community services as needed.
Child development services
 The Child Development Center is located on-site at the Exodus program. 
The target population is children 0-5 years of age, exposed to substance abuse 
prenatally or environmentally, who are at high risk for physical, social, emotional, 
and developmental delays. The primary goal of the Child Development Program is 
to promote the healthy development, social and emotional well-being, and school 
readiness of these children through the provision of therapeutic and developmentally 
appropriate services. Staffing includes 5 full-time Child Development staff and 
a Child Development Specialist. Consultants are utilized to provide specialized 
services. Children with special behavioral needs are referred to the SHIELDS 
Therapeutic Nursery for more intensive mental health services. SHIELDS provides 
developmental assessments and evaluation for all children enrolled in the program. 
Developmentally appropriate intervention plans and activities are designed and 
implemented for each child. Child development and parenting skills education 
groups are presented to mothers in order to provide clients with information that 
will assist them to be better prepared to care for and interact with their children. 
Mommy and Me parent/child interaction classes and parenting education classes 
are each provided one time per week.
Youth services
 The Exodus Heros and Sheros Program provides afterschool and full day 
programming (during summer and school vacations) to a static capacity of 200 
youth, ages 5-18, whose parents are enrolled in treatment. The goal of Heros and 
Sheros is to decrease risk factors and increase protective factors by addressing 
five risk domains: individual, family, school, peers, and community. Services 
are designed to increase self- esteem, improve family functioning, increase 
decision-making and problem-solving skills, improve academic performance, and 
to increase community awareness of negative factors affecting youth. Program 
services include individual and group counseling, mental health services, cultural 
enrichment, alcohol and substance abuse education, life skills, recreational 
activities, computer training, leadership development, and educational support. 
During the school year, Heros and Sheros staff also provides on-site services to 
our youth at the local schools they attend. In addition, in partnership with local 
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Catholic Schools, SHIELDS youth are eligible for scholarships that cover their 
tuition, books and fees. 
 In the summer of 2013, SHIELDS is expanding their Heros and Sheros 
program to provide a Charter High School for our youth in 9th through 12th grade. 
Staffing for the program at the Exodus site includes six full-time mental health case 
managers, eight full-time therapists, a clinical coordintor, a site supervisor and a 
program manager.
Educational and vocational services
 Employment and vocational training services are designed to prepare 
individuals to be financially independent by providing a variety of services that 
include: remedial education, high school diploma program, employment preparation, 
computer training, job placement, certificate training programs in fiberoptics, 
child development, alcohol and drug counseling, construction, janitorial, office 
management, and medical billing. SHIELDS also partners with local community 
colleges in order to transition clients to an AA or BA degree program. Completion 
of a high school diploma and a reading level of 10th grade is a requirement for 
program completion.
Outcomes
 Outcome data has been closely monitored, since the program was 
implemented in 1994. During the initial stages of the program (1994-1999), 
Exodus was part of a national evaluation through the Center for Substance Abuse 
Treatment, in addition to a local evaluation through SHIELDS. National evaluation 
results established the program as a best practice model for the federal government 
in 2001. Evaluation outcomes of the program over the past five years (2002-2007) 
conducted through the SHIELDS Research Division include:
● An 81.2% completion rate (national average = 25%).
● Family reunification rates of 85%.
● An average of 646 days in treatment (national average = less than 90 days).
● All clients obtained a high school diploma.
 In the past 5 years, a total of 236 children (95%) have received at least 
1 developmental screening. Overall, 85% of children received scores that fell 
within the normal range of development, and 15% of children were identified with 
potential delays and referred for additional assessment and specialized services. 
Evaluation outcomes of the child development component include:
● Increase in parental knowledge of child development and parenting skills with 
parents scoring an average of 90% on post-test scores.
● Over 200 parents received completion certificates for parenting and child 
development classes.
● Success in achieving low rates of Very Low Birth Weight among infants born to 
enrolled mothers (average= 4.5% over the last six years, 0% in the last year).
● High rates of entry into prenatal care (average=67% over the last six years, 77% 
in past year).
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● Immunization rates among enrolled children averaged 80% in the past 5 years.
● Of a total of 264 infants who were born in the program in the past 6 years, less 
than 5% had positive toxicology screens.
 Outcomes for Hero and Shero youth have been monitored through the use 
of seven standardized assessments, which are administered on a quarterly basis. 
Results indicate that the program has had a positive impact on participating youth:
● 60% of participants improved attitudes towards school and education;
● 75% of participants improved grades in math and English;
● 77% of participants improved self esteem and self confidence;
● 77% of participants improved cultural awareness/identity and community 
mobilization skills;
● 80% of participants improved awareness of substance abuse related issues and 
made a commitment to live drug free.
Summary
 The problems and issues that a substance - abusing woman faces are 
related to her womanhood equally as much as they are related to her addiction. For 
such women the effects of addiction are far reaching. Not only are their personal 
lives dramatically affected in terms of physical, social, emotional, and interpersonal 
dysfunctions, but also, and sometimes even more devastating, are the effects on 
their unborn fetuses and the growth and normal development of their children. 
Treatment services that demonstrate effectiveness in addressing these issues 
utilizing a comprehensive, holistic and family-centered approach are essential. 
When services are provided in this manner, we are not only ensuring successful 
outcomes for the women we serve but for our future generations.
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The story of Dolores
 Dolores was a 33 year old Latina with three children when she entered 
Project Pride. Prior to that, she was a proudly defiant leader of her peer group, a 
group of highly cohesive troublemakers though not officially a gang. Dolores and 
her children barely managed to survive on her part time jobs and public assistance 
while slipping more and more deeply into the drug culture that surrounded them. 
She had sufficient charisma to be both feared and loved and she scorned any 
efforts to engage her in getting help. After being sent to jail in San Francisco and 
offered the choice of residential treatment or more jail time, she entered a residential 
treatment programme. She found the tight structure and intense demands for 
participation intolerable, and left after less than a week. She had decided to do it 
“her way.”
 Several more years passed, during which her alcohol and cocaine use 
escalated, her health deteriorated, and she lost custody of her children. She was 
in and out of treatment programs and managed to get herself sent away from 
every program in San Francisco. She formed a strong bond with a drug dealing 
boyfriend who drew her further and further into street life. She was raped, shot 
at, and prostituted for drugs. She had an infant child who died under ambiguous 
circumstances. Her 10 year old daughter was placed in the custody of her parents, 
and her 2 year old son and 4 month old daughter were in a foster home after they 
were taken out of her arms at court by Child Protective Services.
 Before coming to Project Pride, Dolores’s partner and the father of her two 
youngest children was shot and killed in San Francisco. The killing was deemed a 
homicide and the killer remained at large. She witnessed his killing and worked with 
the San Francisco Police Department to find her partner’s killer. She did not go to 
her partner’s funeral because she was hospitalized with pneumonia, the result of 
being on the street and not taking care of her health. Once she was released from 
the hospital, she appeared very subdued to her friends, but she was still determined 
to convey the impression that she was very much in charge. Nevertheless, she 
could not bring herself to go to her boyfriend’s grave site. However, in a visit with 
her children, she found herself weeping inconsolably and went on an extended 
cocaine binge soon afterward. She was arrested and once again given the choice 
of treatment or jail. She chose treatment and entered Project Pride.
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 Project Pride is a division of the East Bay Community Recovery Project 
(EBCRP) in Oakland, California. Oakland is an ethnically diverse, medium sized 
city across the bay, six miles east of San Francisco. Project Pride was launched 
in 1994 as part of a U.S. federal government demonstration grant, seeking to 
create and disseminate new models for addressing alcohol and other drug use in 
pregnant and postpartum women. The development of this effort began in 1974, 
with a series of studies on opioid dependent pregnant women, funded by the U.S. 
National Institute on Drug Abuse (NIDA). In the early 1990’s, the cocaine epidemic 
required a shift in target population and NIDA funded the “Perinatal 20”, a group of 
studies designed to determine the effective ingredients of treatment for pregnant 
and postpartum women using cocaine and other drugs. Funds supported the 
treatment for women and their children, as previous findings indicated that including 
children might improve outcomes. In 1989, the U.S. Center for Substance Abuse 
Treatment (CSAT) built on these findings and funded demonstration projects to 
identify and disseminate effective models. Evaluation was required and funds for 
this were included. EBCRP sought and received this funding.
 During the CSAT grant period, the California demonstration programs 
were designed, reviewed and evaluated against rigorous outcome standards and 
compared with similar programs nationally. These standards have been maintained 
and the programs continue to demonstrate dramatic positive outcomes. In 2009, 
program completion rates averaged between 60-75%. An average of 70% of 
the women remained drug free at six months post treatment. Criminal justice 
involvement is significantly reduced by 90%. Sixty-five percent of the women 
are employed or in job training at the time of discharge and 75% are reunified 
with other children who had been placed in foster or kinship care. The children 
benefit significantly, as well. All programs report positive outcomes for children as 
indicated by: improved physical, mental and social health of children; improved 
school performance; improved family bonding and social functioning. Despite 
being high risk pregnancies, 90.3% of the children were born full term, free from 
substances, and without any known medical problems.
History
 Dolores has known trauma since a young age. She moved to the United 
States from El Salvador at age two with her parents and three older siblings. In El 
Salvador, they had an extended family and her parents had respectable professions. 
They came to the US with the hope of improving their lives. However, the absence 
of the extended family exposed the family in general, and Dolores and her siblings, 
in particular to a new reality that they were ill equipped to handle. Her oldest brother 
started to use drugs and joined a gang. Dolores never had much of a relationship 
with her sisters because they were much older. One sister left home as soon as 
she could and distanced herself once she realized Dolores was hanging out with 
a destructive crowd. When Dolores entered Project Pride, they were talking to 
each other on an irregular basis. Her other sister was concerned enough to call 
the county’s Children’s Protective Services (CPS), which resulted in her children 
being taken away in an emotional and traumatic court scene. Dolores was angry 
and refused further contact. Her mother cared for Dolores’s oldest daughter and 
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sometimes watched the two younger children on the weekends to give her a break, 
although she did describe Dolores as “very manipulative.” Dolores has not been able 
to talk to her father in over four years due to his anger about her drug use. He denied 
her existence by not allowing family members to talk about her in his presence, by 
not talking to her himself, and by not allowing her to come to the house while he 
is there. He behaved as if she did not exist. In the context of this family’s cultural 
background, where family was everything and without a family one was nothing, this 
was a particularly painful and traumatizing issue.
 When Dolores entered Project Pride, her 10 year old daughter had been 
placed with her parents by Child Protective Services, and both her 2 year old son 
and her infant daughter were in foster care. They had been removed from Dolores’ 
care by CPS because her sister reported that she was engaged in prostitution to 
support her drug use. This had created an unhealthy and unsafe environment for 
both mother and the children and landed her in numerous legal entanglements. In 
addition, her family and CPS underlined the fact that Dolores had been unable to 
resolve the self-destructive cycle she was in, by herself.
Assessment/diagnosis
 Dolores was diagnosed with Post Traumatic Stress Disorder with 
depressive symptoms, and a Substance Use Disorder. She did not readily 
acknowledge her depression, partly because she was accustomed to numbing her 
feelings and partly due to her investment in trying to function no matter what. She 
did not connect her irritability to depression. Upon coming to Project Pride, she had 
not recognized or worked on any of her trauma issues, and did not acknowledge 
her destructive use of alcohol and illegal substances.
 Dolores was articulate and capable of insight, especially about the people 
around her. Her strengths manifested themselves in her leadership qualities and 
rebellious streak that could be redirected through building rapport, understanding 
and empathizing with her experience, and educating her about the experience of 
trauma. All these could be harnessed to validate her experiences and give her 
permission to express her emotions in a constructive rather than destructive ways.
Treatment plan(s)
 In developing the Treatment Plan, it was important for us to offer Dolores 
a gender specific and trauma informed plan. The goal was to provide her with 
a sense of purpose and trust, which are the cornerstones of trauma informed 
services. Her initial treatment plan identified the following tasks: 1) address her 
ambivalent motivation about being in treatment and rebellion against its tight 
structure; 2) facilitate her engagement in the treatment community; 3) pre-empt 
her tendency to leave treatment prematurely by helping her to recognize this as 
part of her destructive pattern; 4) begin to educate her about her depression and 
PTSD and the role they played in her life trajectory to date; 5) help her understand 
the benefits of accepting and communicating vulnerability rather than concealing it; 
6) preparing her for reunification with her children, including bringing her 2 year old 
into Project Pride. In helping her settle into the residential treatment environment, 
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we focused on her needs, using empathic connections, and other therapeutic 
techniques to engage her motivation.
 Once she settled into treatment, later treatment plans included: 1) preparing 
her to work on her trauma history, reducing the effects of the trauma through validating 
her experience, and focusing on her strength. It is important to begin this work 
while she is in the safety of residential treatment; 2) addressing her issues around 
judgment, impulse control and problem solving, and relating these problems to her 
substance use. Her strong motivation to stay out of jail and reunite with her children 
was a powerful asset; 3) managing her depression, including the possibility of using 
antidepressant medications to manage symptoms and improve functioning. Staff 
monitor adherence to medication regimens if the client choses to use medications 
after assessment by the physician; 4) improving her parenting skills.
 Throughout her treatment, Project Pride staff remained attentive to her 
medical, psychological, social, spiritual, cultural, vocational and legal issues. 
Services not available on site were provided through community linkages.
Course of treatment
 Dolores’ behavior was erratic during the first 4-6 weeks of treatment. She 
precipitated several crises about whether she would remain in treatment. Staff 
members were not intimidated by her defiance, and worked calmly and patiently 
to build rapport and bring her key issues into focus. Gradually, she began to settle 
down, talk about her difficulty sharing painful feelings, and form some positive 
relationships with specific residents and staff. She slowly developed her sense 
of trust, which was essential for continued treatment of her PTSD. In particular, 
she came to understand her irritable outbursts as signals of more painful feelings 
beneath. Once this happened, she could learn to express herself in more 
appropriate ways.
 Since Dolores came to the US as a two year old, her culture was American. 
Her own strong-willed nature made her rather obstinate and unforgiving when it 
came to her parents’ ‘old country’ attitudes and language. She wanted to belong. 
She wanted to be a part of a meaningful group, a group functioning as a family 
that understood her: her ‘gang like’ group of trouble makers. The therapeutic task 
was to reorient her to more constructive social groups, starting with the Project 
Pride community. The sense of trust that she developed was an important tool for 
accomplishing this task.
Relationships with other women
 Dolores’initial behavioral problems intimidated the other residents to the 
point that they did not want to be in the same room as her. She was very loud and 
aggressive. When confronted with this she denied being aggressive and said “this 
is just the way I am, I can’t change it.” The posture of strength and bravado that 
Dolores has adopted while with her peer group on the outside, only served to deny 
and camouflage her personal vulnerability. Her decision to “do it her way and go it 
on her own” was an example of her strength and determination, but also of the lack 
of trust that she felt. Project Pride, a residential community, triggered additional 
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issues related to living with people in intimate proximity. It frequently evoked her 
many issues about her family, especially her father. These situations provided both 
a challenge and an opportunity.
 Staff worked to help her identify her problems with impulse control in 
general and make a commitment to change this behavior. They also worked 
simultaneously with the community of women as a whole to address Dolores’s 
behavior, provide constructive ideas for behavior for the other residents and for 
Dolores herself. This teamwork, once achieved, is a powerful catalyst for change 
in residential treatment, adding greatly to the impact of professional staff.
Relationships with staff
 Dolores’s initial attitude of “I will do it myself” presented a challenge to 
the counselors and staff at Project Pride. One of the most important early staff 
intervention was to listen patiently to what she had do say, remaining fully present 
without endorsing or challenging her perspective.
 This allowed her to begin to develop a sense of safety and trust. Staff 
had to respect her need to be self-sufficient because growing up she was not 
able to count on her parents to provide for her emotional needs. In addition, 
she experienced trauma as a result of their choices and behaviors. Early staff 
discussions focused on how to give her appropriate forms of autonomy while firmly 
setting limits, and how to maintain calm in the face of her outbursts. They did that 
by identifying and developing her strengths. Program rules and enforcement, which 
can be reminders of feeling trapped in a bad situation, were expressed in terms of 
the residents’ needs for health and safety. Dolores was also asked for input, which 
was seriously considered and many times accepted, even if sometimes in ‘edited’ 
format. These ‘co-equal’ interactions were less traumatizing and did not mirror 
past abusive relationship. As she gradually began to share her vulnerability and 
work on painful issues, most staff and residents found her more engaging and she 
began to build rewarding relationships. 
 Later in treatment, as she became one of the community “elders”, she was 
able to reclaim leadership status based on being a positive influence on others. 
Her insight and articulateness served her well as she consolidated a new type of 
self-image. This gave her a sense of purpose, which is another important element 
in overcoming trauma and addiction.
Individual counseling
 Individual counseling served multiple functions. It provided an arena 
to ventilate her frustrations and when possible, reframe her issues in a more 
constructive manner so she could work on them more productively in groups. In 
the initial phases of treatment, the daily availability of her counselor in a supportive 
listening environment, allowed her to defuse some of her anger prior to acting on 
it, thus strengthening her impulse control and reducing the possibility of premature 
departure or involuntary discharge. Her counselor was always mindful of the 
need to encourage her to work productively in groups, and helped her recognize 
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progress in this direction. As she became increasingly engaged, her counselor 
began to prepare her to address her trauma issues and her depression.
Groups
 Project Pride offers a variety of groups and Dolores became increasingly 
able to make good use of them. She attended Seeking Safety, an early stage 
stabilization group for people with PTSD and substance abuse (www.seekingsafety.
org). It is a research-based, manualized treatment consisting of 25 sessions that 
can be done in an individual or group format (Najavits, 2002). It is designed to 
teach coping skills and create a framework for addressing trauma issues.
 She also attended Anger Management Group (Reilly & Shropshire, 2002), 
a cognitive behavioral skills training group designed to increase her ability to 
recognize and appropriately express angry feelings and frustration as they occur. 
Over time, clients frequently report a decrease in the frequency and intensity of 
angry feelings, an opinion usually confirmed by staff. The Dialectical Behavior 
Therapy group (Linehan, 1987) is complementary with the other groups. Its goal 
is to help clients identify intense feelings as they occur and increase the ability to 
self-regulate emotionally, offering an opportunity to practice in the group as well as 
review earlier attempts that were less successful than hoped.
Parenting skills
 Her two year old daughter, Adelita, joined her in Project Pride after she had 
been there a month. A residential treatment program that includes children offers 
unparalleled opportunities for improving parenting skills. Most clients have poor role 
models and display inappropriate behaviors in the course of daily life. The parenting 
group takes a psycho-educational stance, teaching specific skills, particularly 
coming to understand child development and learning congruent and appropriate 
communication, the importance of modeling, and giving the opportunity for mothers 
to express their frustrations. Dolores was initially punitive towards her child, but was 
also overindulgent due to her guilt about past abuse and neglect. Knowing that every 
participant has reasons to be ashamed of previous behaviors promotes an honesty 
that is harder to achieve in classes in the community. The residential treatment setting 
allowed Dolores to practice what she had been learning and receive feedback from 
other clients and staff during normal daily activities.
Working on psychological issues
 Although most people who are exposed to serious trauma experience 
symptoms of post-traumatic stress, not everyone exposed to a serious trauma 
develop the full PTSD syndrome. More often than not, individuals develop 
PTSD due to various personal vulnerabilities and a history of multiple traumatic 
experiences. For Dolores the cultural shock and economic hardships her family 
experienced as a result of the move from El Salvador laid the foundation for Dolores’ 
own feelings of being an outsider. In addition, her father was both demanding 
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and inflexible in his expectations. In searching to find a place for herself where 
she will be welcomed and feel like she belonged, she associated with a crowd 
where the drug culture reigned. The numerous experiences and the actions that 
led to her being incarcerated were traumatic, including possible head trauma from 
street fights. These culminated in witnessing the murder of her boyfriend who was 
the father of her two youngest children. The posture of strength and bravado that 
Dolores adopted while with her peer group, only served to deny and camouflage 
her personal vulnerability. Her decision to “do it her way and go it on her own” 
was both an example of her strength and determination but also exposed her to 
additional traumatic experiences while she was prostituting.
 Addressing Dolores’s trauma issues presented a challenge.Coming from 
a culture that thrived on community, she felt a deep need to have one. She felt 
disowned by her father, which made the Project Pride community both more 
needed and therefore more powerful. In this paradox of rejection versus need she 
was searching to find a place for herself where she will be welcomed and feel like 
she belonged. 
 To acknowledge that she had clinically significant anxiety meant to her that 
she needed to acknowledge that she was vulnerable. The residential treatment 
environment triggered memories of ‘gang like’ life experiences. The more anxious 
she got, the more posturing and louder she became, especially in her efforts to 
become ‘the leader.’ A critical incident occurred around holiday planning, in which 
other residents shared that they appreciated her ideas and willingness to work to 
make the event a success, but resented her domineering manner. Feeling attacked 
by everyone, she suddenly burst into tears. The group rallied to her support, giving 
feedback on her positive qualities and achievements during her stay. This marked 
the beginning of reshaping her leadership tendencies to a more congenial style.
Family participation and challenges
 Dolores eventually acknowledged that she was coping with her problems 
and feelings by using alcohol and other drugs, that it was unsuccessful, and that 
as a result she had lost custody of her children and her relationship with her sister 
and father. Although she was angry with her sister for reporting het toCPS and 
angry at her mother for bringing her into Project Pride, she came to realize that 
they probably saved her life and also helped her to regain custody of her children. 
This could make it possible for her to mend her relationship with her father and, as 
a result, her relationship with her family as a whole.
 Project Pride offers the Celebrating Families Program, which works 
with family members to strengthen recovery from addiction, address other family 
problems, and promote healthy reunification. This is a family centered program. 
Families learn to communicate about difficult issues that make healing possible. 
It strengthens recovery; increases successful family reunification; and improves 
family life. Each session includes a family dinner, followed by structured activities 
for the adults and the children, all in separate age groups. When Dolores was told 
about Celebrating Families and it was explained to her, she was very reluctant to 
participate. She stated that she had no supports that she wanted to invite. Upon 
discussing this further, she came to the realization that although her sister and her 
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mother did things at the time that she did not like nor understand, they could end 
up being her biggest supports. She was willing to put aside her feelings of shame 
and anger long enough to find out. Seeing the other residents in the community 
looking forward to this family evening made her curious and increased her desire 
to participate.
 She participated regularly in our Celebrating Families evenings for over 
seven months before leaving Project Pride. After attending the first event by 
herself, she saw how Celebrating Families could help her family as well as herself 
and perhaps give them all a chance to understand what it was like for her while 
she was in her addiction. She decided to invite her mother and her sister to the 
next Celebrating Families event and they attended for the duration of her stay. She 
and her family especially liked the session on “Chemical Dependency Affects the 
Whole Family.” Her family could resonate with a lot of the lesson plan that evening 
and finally felt that they were in a safe enough environments to let Dolores know 
how her addiction had affected them over the years. She and her family processed 
a lot of feelings that evening and were able to hug each other upon leaving.
 Staff noticed that Dolores had less angry outbursts after that Celebrating 
Families session. She stated that she felt much more confident knowing that she 
would have her family as support once she left Project Pride. She and her family 
expressed interest in coming back to Celebrating Families once she left, which is 
always welcome.
Towards treatment completion
 Once Dolores passed the watershed event of experiencing the community 
rallying to her support - which marked the beginning of her reshaping of her 
leadership tendencies to a more congenial style - her counselor started to help her 
focus on the next two important goals in her recovery: employment and housing.
 Tasks for Employment: Dolores’s counselor provided her with access to 
a computer to start gathering information to be put on her resume. She needed 
to get school certificates, past jobs dates and confirmations, and letters of 
recommendations from past employers. She was guided to identify an appropriate 
format for her resume and coached when entering all her education and employment 
information onto it. Her counselor provided her with an opportunity to do mock 
videotaped interviews, so that she could practice for the real ones. She was then 
coached in applying for both full time and part time jobs.
 Tasks for Housing: Concurrent with the above, Dolores actively explored 
housing options. She did not want to move in with her parents, although her 
mother and one of her sisters continued to be very supportive. Indeed, her mother 
volunteered to provide childcare, when and if Dolores got a job. She again used the 
computer for both public listings and for low income housing, available for single 
mothers in her situation. Her counselor continually assessed her progress and 
supplied additional resources as needed, since it was important not to overwhelm 
her with too many options at the same time.
 Dolores left Project Pride with a completed employment resume and halfway 
to completion of her General Education Degree. She found housing at a Transitional 
Housing Program for single mothers close enough to her parents, where she could 
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stay for a year while she found a job and would be able to afford to pay a rent. She 
and her family were also referred to a local Family Resource Center where she and 
her family will be receiving individual therapy, additional vocational and job search 
assistance, educational assistance to complete her GED, parenting support, financial 
support, and family support.
Conclusion
 Dolores’ path shows us that despite multiple problems and a stormy 
treatment entry, it is possible to bring about change in a long term residential 
setting. It is essential for the program to have the capacity to address co-
occurring mental health and substance use disorders in an integrated way, as 
most clients who enter residential treatment have multiple burdens. Staff must 
walk a fine line between engaging the clients through positive interactions, and 
communicating clear expectations and limits. It is not necessary for all staff to have 
advanced degrees, but it is essential for them to be carefully trained, especially 
in understanding trauma-informed principles in order to provide trauma-informed 
treatment. The opportunity to enter treatment with a child and include other family 
members in treatment is crucial to improving parenting skills and creating a system 
to sustain long term change.
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A collection of good practices in the 
prevention, treatment and recovery 
of female addiction
Alice P. Brizi (1), Vittoria Luda di Cortemiglia (2) 
(1) Junior Fellow, United Nations Interregional Crime and Justice Research Institute
 
(2) Programme Officer, United Nations Interregional Crime and Justice Research Institute
 This section contains a collection of good practices implemented in the 
field of prevention, treatment and recovery of female addiction.
 The practices listed in this section were collected and selected through 
analysis of open-source information and, in particular, on websites of United 
Nations entities and agencies and websites of governmental and non-governmental 
institutions. Additional information on good practices was collected through the 
analysis of dedicated publications, which are listed at the end of this section.
 The good practices collected have been divided into three main sub-
sections: Prevention, Treatment and Recovery. The initiatives collected were placed 
in specific thematic areas, identified for each sub-section.
 The main objective of this survey was to identify those initiatives which have 
been successfully implemented and which could be replicated in other geographical 
contexts.
Prevention
Adoption of a gender-specific approach in 
preventive interventions in terms of content, setting 
and practice
 The Declaration on the Guiding Principles of Drug Demand Reduction 
indicates that demand reduction programmes should be designed to address the 
needs of the population in general, as well as specific population groups, such as 
females.
 Prevention programs should be tailored to address risks specific to target 
audience, such as age, gender, and ethnicity, to improve programme effectiveness 
(United Nations General Assembly, Declaration on the Guiding Principles of Drug 
Demand Reduction Resolution S-20/3, 1998).
 Several studies provide evidence of the need to adopt a gender-specific 
approach in preventive intervention in terms of content, setting and practice.
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 Risk and protective factors differ enormously between sexes. Female 
and male perception of drug use is different also in relation to age groups. Many 
studies show that females change their attitudes toward drug use when they move 
from primary to secondary school or when they go to college or start to work, with 
a more favourable attitude to drug use than males. Specific preventive actions 
should be therefore implemented at key transition points.
 Good practices in the field of prevention of substance use and abuse are 
listed below.
 A) Peer Education Groups:
Peer education groups for female students in schools have proven efficient in 
many cases.
Case Studies:
Peer or community-based projects across Europe
The peer-to-peer approach often takes the form of harm-reduction intervention 
in recreational context. The emphasis is placed on the importance of the 
educator’s age in establishing credibility with the audience. There is a good 
number of peer or community-based projects implemented, for instance, 
across Europe.
The Project CREW, (Edinburgh, Scotland):
Crew developed around 1992 in response to the rapid expansion of 
recreational drug use and it was envisaged as a peer education and peer 
led organization. The learning by volunteers who engaged with people who 
were using Ecstasy (MDMA) and other substances was used in combination 
with the most up to date research findings that volunteers could get hold of 
in order to produce informative and culturally credible information for people 
using these illicit substances. Volunteers from the dance and other drug using 
scenes were recruited and trained as peer educators. The project Crew is 
now a peer education project, which includes a range of services from drugs 
counseling, outreach, drop in and training in substance use and sexual health. 
These services are operated by staff and volunteers through peer education 
and support.
More information at: www.crew2000.co.uk
The Project Drogart (Ljubljana, Slovenia):
The Project Drogart was established in 1996 as a project group, and then it 
was registered in 1999 as a non-governmental, non-profit association. The 
major aims of Drogart was to research on and alleviate the main problems 
associated with regular, temporary or experimental drug use and abuse. Its 
InfoPoint and cyber cafe (Internet access) and advisory team of people are 
located next to Ljubljana Railway Station. The target population is 15 to 25 year 
olds, mainly involved in electronic music sub-culture. Drogart uses different 
tools and it works through popular media, pedagogic work with the young and 
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preventive workshops for pupils and students, offering Internet access to useful 
information, publishing brochures and flyers and organizing youth culture 
projects (e.g. ‘Dance with your Head On’), educational activities for trainers and 
teachers and lectures and film screenings. The members of Drogart participate 
often in rave parties and they undertake research into drug abuse in Slovenia. 
The Drogart Info Point is a part of the Ljubljana Network of Info Points (L’MIT). 
Its work is co-funded by the Ministry of Work, Family and Social Affairs, the 
Ministry of Health, Ljubljana Urban Municipality and the Youth Office of the 
Republic of Slovenia.
More information at: www.drogart.org; http://www.culture.si/en/Depot:DrugArt
Other projects:
Keep Smiling (Lyon, France) www.keep-smiling.com
Eclipse (Berlin, Germany) www.eclipse-online.de
 B) Prevention within the families
Family-based prevention programs should enhance family bonding and 
relationships and include parenting skills; practice in developing, discussing, and 
enforcing family policies on substance abuse; and training in drug education and 
information.
Case Study:
Family, a Context for Prevention: Parental Education in Portugal
The project was developed in some quarters of the Concelho de Vila Franca 
de Xira (Frank of Xira Village). It was the result of a joint needs assessment 
between different entities of the district that have a role in the area of education 
and social support. The existing gaps had been identified by different structures 
of the district concerning interventions with risk families. The project was able 
to benefit and work in synergy with interventions already running in the district 
developed by some of these local structures.
The project’s base was the identification and analysis of the different situations, 
joint definition of strategies and methodologies of intervention, follow-up and 
evaluation of the activities. The project contemplated the application of a 
Program of Families Skills in two different types of population:
i) Families in risk - through the implementation of individual Plans with the 
families. The Plans identified different areas of the life of the families. The 
implementation took place in the homes and in the Gabinetes de Atendimento 
dos Centros Comunitários (Reception Office of the Communitarian Centers). 
In the beginning of the intervention some difficulties were encountered in 
commitment to attend and the completion of tasks. Nevertheless, stable 
relations with the professional staff were created and the involvement of the 
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families in the intervention process revealed itself through small changes in the 
behaviors and attitudes in the different working areas.
ii) Families in general - school of parents that ran in some schools of 1.st 
cycle of basic education. The program covered areas of child development 
(development of the child from 6 to 10 years), health education, parental 
education (family and parental practice) and citizenship (relation school-family-
community).
Some methodologies had been used: debates/discussions concerning problems 
of the school and familiar daily life of the children, involvement of the parents in 
joint activities with the children, group dynamic to promote the establishment of a 
favorable communication channel.
Source: EMCCDA 
http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=5198
Case Study:
Strengthening Families Program for Parents and Youth (10-14) in the US
The project Strengthening Families Program for Parents and Youth (10-14) is an 
example of a universal family-based program, providing rural parents guidance 
of family management skills, communication, academic support, and parent-child 
relationship.
Recognising it can be difficult to attract parents to this program, the researchers 
encourage participation through flexibility in scheduling and location. Offering 
conveniences such as babysitting, transportation, and meals make participation 
more practical for many rural parents, while enhancing the program’s success in 
reaching its goals.
Source: NIDA, Preventing Drug Use among Children and Adolescents, 2003.
 C) Interactive techniques with peers and parents
Prevention programmes are most effective when they employ interactive 
techniques, such as peer discussion groups and parent role-playing, that allow for 
active involvement in learning about drug abuse and reinforcing skills. Meetings in 
schools with adolescents (alternative, artistic activities, competitions in schools on 
how to transmit the message through multi-media activities) have proven effective.
Case Study:
Interactive teaching strategies and the life skills approach at schools
A life skills approach is a way of teaching and interacting with young people that has 
the potential to lead better health and drug abuse prevention learning outcomes 
and may ultimately influence student drug use. Life skills are best taught through 
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interactive methods and are most effective when applied and practiced in potential 
drug use situations that are relevant and meaningful to the social situations of 
students.
Education for drug abuse prevention is more successful when it is student-focused 
and uses interactive methods, with experiential learning and small group work as 
its basis.
Source: UNODC, Schools. School-based education for drug abuse prevention, 
2004.
 D) Prevention in schools
The main objective of drug use/abuse prevention programmes in school is to 
prevent the use of substances, included licit substances such as alcohol and 
tobacco (RAND, What Are the True Benefits of School-Based Drug Prevention 
Programs?, RB-6009-RWJ, 2002).
Case Study:
Unplugged: European Union Drug Abuse Prevention (EU-DAP) in Croatia
The Unplugged program is a school-based prevention program which targets 
young people aged 12-14 years and their parents. It is based on a life skills 
education and social influences approach. The program goals are: Increased 
health related awareness and knowledge of social influences; delayed onset of 
drug use; improved knowledge, attitudes and skills concerning health behaviors 
and drug use; reduction in the use of tobacco, alcohol and cannabis and a 
reduction in the likelihood of future drug abuse.
The program includes students and parents arm. Pupils arm consists of 12 
one-hour units delivered weekly by teachers at the participating schools. The 
curriculum consists of three parts: the first aims to improve knowledge of risks 
and protective factors, as well as to build attitudes against substance use; the 
second focuses on interpersonal skills, beliefs, norms and realistic information 
about prevalence; the third aims to develop intrapersonal skills, such as coping 
competences, problem solving/decision making and goal setting. Parent arm 
includes three two-hour meeting on the following topics: (1) Understanding better 
the teenagers, (2) Parenting a teenager means growing up together, (3) A good 
relationship with my child also means setting up rules and limits. The program 
includes 3 day education/training of teachers and social pedagogues who deliver 
the program in schools, as well as supervision.
Source: EMCDDA
http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=HR-
04&tab=overview
Prevention programs should include teacher training on early prevention and on 
management of novelty seekers.
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Case Study:
Practical tool for Teacher’s training
Teacher training is as important a component of any drug abuse prevention 
programme as are content, resources and teaching method. Education for drug 
abuse prevention is more effective when teachers receive formal training and 
ongoing advice and support.
Training for teachers in drug abuse prevention education, rather than focusing 
on training teachers in the use of specific set of resource materials, should focus 
on providing them with an orientation to drug abuse prevention education that 
enables them to select content and use a wide range of strategies, appropriate to 
meeting students’ needs.
To achieve this goal, for example in Australia, a practical tool Skills for Drug 
Education in Schools: A Manual for Teachers and Trainers has been developed. 
This is a manual for training teachers, or other health educators, as facilitators 
of interpersonal skills activities to support drug education in schools. It is a 
comprehensive training manual on skills for education for drug abuse prevention 
in schools and includes sections on group facilitation, communication, decision-
making, self-esteem building, assertion and other personal skills. It is student 
focused, using experiential learning and small work group as its basis.
Source: UNODC, Schools. School-based education for drug abuse prevention, 
2004. 
The Manual is available at: http://education.qld.gov.au/health-safety/promotion/
drug-education/docs/pd-part-a.pdf
 E) Prevention within communities
Creation/support of structures/activities on the territory (e.g. youth camps for team 
building etc.).
Case Study:
Youth Power Centers in Uzbekistan, Tajikistan, Kyrgyzstan, and Kazakhstan
The Youth Power Center Program was established along drug trafficking routes 
in geographic areas of Central Asia that were characterized as “drug using 
neighborhood”; parts of the cities and regions with a concentration of drug 
trafficking, supply, and use. There are currently seven Youth Power Centers 
operating in the three target countries of the USAID Drug Demand Reduction 
Program, namely Uzbekistan, Tajikistan, Kyrgyzstan, and Kazakhstan.
Each Youth Power Center serves as a drug-free, safe place where at-risk youth 
can socialize. Youth Power Centers employ peer educators recruited directly from 
the target group and trained to provide behaviour change communications with at-
risk youth to prevent initiation of drug use as well as reduce both drug-related and 
sexual HIV risk behaviours.
Youth Power Centers provides a menu of activities based on the target groups’ 
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interest. These include: sports, games, vocation training, language lessons, and 
social groups. Peer counseling is provided by peer educators, with personal 
experience of issues related to drug use. Each Youth Centre also has on staff 
one or more professional counselor to provide psychological counseling to at-risk 
youth with emotional, psychological, or other problems.
Source: Alliance for Open Society International, Youth Power Centers, USAID-
funded drug Demand Reduction Program in Uzbekistan, Tajikistan, and the 
Fergana Valley Region of Kyrgyzstan, Best Practice Collection, 2007.
 F) Early detection training for primary care physicians and 
paediatricians should be delivered
Case Study:
Training primary-care workers: United States primary-care initiative
Focusing on primary-care providers is important because women are most likely to 
use these services. In the United States, the National Institute on Drug Abuse has 
launched a primary-care initiative to address training issues. It includes a physician 
outreach initiative to involve primary health-care providers in the early recognition 
and assessment of, and intervention with, substance-abusing adolescents and 
their families.
This programme includes early care and education for children from birth through 
age 8; early intervention and special education; health, mental health and nutrition; 
and services to strengthen and engage families in their children’s development 
and learning.
Source: UNODC, Substance abuse treatment and care for women: Case studies 
and lesson learnt, 2004.
 G) The use of social networks
Case Study
Use	of	social	networks	for	information	dissemination	by	nonprofits
Social networks can be a powerful and efficient vehicle of information for 
preventive anti drugs interventions. Facebook Pages include functions that allow 
organizations to promote their work by posting mission statements, news, contact 
information, details on upcoming events, and other items related to their work. 
Quick and widespread dissemination of information to the Facebook community 
is useful when spreading the word about events and activities and for increasing 
attendance at conferences, workshops and volunteer opportunity.
According to one non-profit social media expert, “Facebook is about raising friends 
and awareness”. Facebook offers nonprofits both conventional and creative 
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methods, such as social “listening”. Comments or questions are often posted on 
nonprofit-affiliated Facebook spaces, such as message boards or blogs.
Source: Calafat A. and Members of the Pompidou Group Prevention Platform, 
Lifestyle and drugs, Prevention interventions in recreational settings, P-PG/Prev 
(2010) 7, 201.
 H) Setting
For effective prevention, the setting should be different for women and men. 
According to EMCDDA studies, women prefer settings that allow informal exchange 
and extroverted forms of expression such as small workgroups. Reflections on 
personal experience and role images as well as the gender of the trainer and of the 
contact person are also considered important (EMCDDA, Annual report: the state 
of the drugs problem in Europe, 2006).
Case Study
Gender-specific	approach	in	preventive	interventions	in	the	EU
For effective prevention, the setting should be different for women and men. 
According to reports, women prefer settings that allow informal exchange and 
extroverted forms of expression such as small workgroups.
Gender-specific prevention projects in Germany, Austria and Nordic countries 
mostly consist of separate workshops or seminars for girls and boys in order to 
encourage positive body image, identity development, self-reliance and action 
competence and to avoid the reiteration of gender stereotypes.
In Belgium and Denmark gender-specific projects are mostly found within the 
vocational education system, where social problems such as drugs use are more 
frequent. Several school programmes in Germany (Sign) and Austria (Selbst 
sind die Kids, Eigenstandig warden, I luag uf mi) take gender-specific aspects 
into account. The German-Austrian project “Step-by-Step” also takes into account 
gender-specific differences, e.g. training of teachers to recognise the early signs 
of drug use in boys and girls.
Ethnicity and gender are targeted together in interventions in Belgium, Luxembourg 
and the Netherlands. In Belgium, the Tuppercare project targets women from the 
Turkish and Moroccan communities. Key women in the community host meetings 
of family members and friends at which prevention workers of the same ethnic 
origin can provide information about sensitive issues such as drug use. A joint 
Dutch-Luxembourgish peer-to-peer education project (‘Chebbab’ in Nijmegen) 
involving young Moroccan men in a socially vulnerable position has proved to be 
successful.
Anti-tobacco campaigns in Germany and in France use gender-specific target 
messages, e.g. the contradiction between seduction and the effects on beauty or 
between addiction and the quest for freedom.
Source: EMCDDA, Annual report: the state of the drugs problem in Europe, 2006
Available at: http://www.emcdda.europa.eu/publications/annual-report/2006
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1. Elimination of barriers to treatment access. Promoting 
gender responsive services
 As stated by UNODC/WHO Principles of Drug Dependence Treatment, 
drug dependence and its associated social and health problems can be treated 
more effectively if people have access to continuum of available and affordable 
treatment and rehabilitation services in a timely manner. To this end, all barriers 
limiting accessibility to treatment services need to be minimized for people to have 
access to the treatment that best fits their needs. Also, services tailored to gender-
specific treatment needs can improve accessibility by responding to differential 
stigmatization, child care needs, and issues in pregnancy (UNODC/WHO, Principles 
of Drug Dependence Treatment, 2008, p.4-5).
 Available research indicates that women generally have more severe 
problems at treatment entry and potentially greater obstacles to accessing 
treatment than men. Despite differences between cultures and countries, 
women in different regions of the world experience many of the same barriers to 
accessing and remaining in treatment. These barriers have to do most often with 
their responsibilities as wives or partners and mothers, the difficulties associated 
with having a substance-using sexual partner, and the significant additional 
stigma attached to women’s substance use problems (UNODC, Substance abuse 
treatment and care for women: Case studies and lessons learned, 2004, p. 17).
 Women face many obstacles and challenges in engaging in treatment 
services: lack of collaboration among social service systems, limited options for 
women who are pregnant, lack of culturally congruent programming, few resources 
for women with children, fear of loss of child custody, and the stigma of substance 
abuse. Treatment services for women must extend beyond standard care to address 
specific needs for women, pregnant women, and women with children such as 
medical services, health promotion, life skills, family and child-related treatment 
services, comprehensive and coordinated case management, and mental health 
services (US Department of Health and Human Services, Substance Abuse 
Treatment: Addressing the Specific Needs of Women, A Treatment Improvement 
Protocol, 2009).
 Female drug users living with HIV/AIDS have also been shown to have 
great difficulty in accessing substance abuse treatment services, and to be in 
greater need of secondary prevention interventions (WHO, Treatment of injecting 
drug users with HIV/AIDS: promoting access and optimizing service delivery, 
2006).
 Providing comprehensive health-care services taking into account 
the needs of women throughout their lives, as well as their multiple roles and 
responsibilities, is highlighted as a key gender-responsive approach to women’s 
health in the Beijing Platform for Action. (WHO, Integrating Gender into HIV/AIDS 
programmes in the health sector, 2009, p. 19).
 Case studies on positive initiatives implemented in the field of treatment of 
substance use and abuse, with particular reference to the elimination of barriers, 
are listed below.
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Minimum standards:
• Create an environment based on safety, respect, and dignity. A safe, consistent, 
and supportive environment is the cornerstone of a treatment and rehabilitation 
of women making use of drugs and other substances. The treatment setting 
has a profound effect on a woman’s recovery. A profile of women in the criminal 
justice system indicates that many have grown up in less than optimal family and 
community environments. In their interactions with women offenders, criminal 
justice professionals must be aware of the significant pattern of emotional, physical, 
and sexual abuse that many of these women have experienced (Covington S., 
Bloom B. E., Gender-Responsive Treatment and Services in Correctional Settings, 
Women and Therapy, Elaine Leeder, Editor, Vol. 29, No. 3/4, 2006, p.4).
• Cultural relevance and user friendliness. Current knowledge indicates that a 
treatment climate that is culturally sensitive, preferably multi-professional, team 
orientated, and that encourages patient participation and involvement in treatment 
facilitates patient access and retention in treatment, and ultimately improved 
treatment outcomes. Cultural mediators and interpreters should be available 
whenever necessary in order to minimize cultural and language barriers for 
minorities (UNODC/WHO, Principles of Drug Dependence Treatment, 2008, p. 4 
and 13).
• Timeliness and flexibility of opening hours. A wide range of opening hours will 
facilitate access to services for individuals with employment or family responsibilities 
(UNODC/WHO, Principles of Drug Dependence Treatment, 2008, p.4).
 A) Information/training to sensitize primary care physicians and 
gynaecologists to drug/pregnancy problems
The role of primary health care professionals in treating people with 
substance use disorders
WHO in its recent study identifies that integrating the treatment of substance use 
disorders and other mental disorders into the general health system will minimize 
the treatment gap.
In a new conceptualization of the treatment system, primary care workers (including 
medical practitioners, nurses, social workers and other health personnel) would 
have a major role in detecting persons with substance use disorders in the early 
disease stages, while psychiatrists, addictologists or narcologists, would be 
involved in the treatment of more severe cases. Combining enrolment in self-help 
groups and ensuring continued participation in such groups beyond treatment 
would be encouraged to expedite recovery and to prevent relapse.
Networking between primary and specialized care is encouraged in order to 
reduce the costs of treatment by early detection of relapse and by ensuring prompt 
referral to a more specialized level of care when symptoms intensify.
Source: WHO, ATLAS on substance use. Resources for the prevention and 
treatment of substance use disorders, 2010, p.76.
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 B) Creation of dedicated services for pregnant women using drugs. 
Services for women in primary health care and facilities for children of parents 
with drug dependence should be built in close relationship with drug dependence 
treatment programs (UNODC/WHO, Principles of Drug Dependence Treatment, 
2008, p.5).
Case Study
Guidelines for professions to gain understanding of what services for 
pregnant women with complex social factors could look like
The guidelines contain a number of recommendations on standards of care of 
pregnant women with complex social factors. It showcases the examples from 
practice that where identified and provides the contact details of the people 
involved so that further information can be obtained.
The guidelines are dedicated to professional groups who are routinely involved 
in the care of pregnant women, including midwives, GPs and primary care 
professionals and also for those who are responsible for commissioning and 
planning healthcare and social services. In addition, the guidelines will be of 
relevance to professionals working in social services and education/childcare 
settings, for example school nurses, substance misuse service workers, reception 
centre workers and domestic abuse support workers.
Examples of service for women who misuse substances:
i. The PrePare Team, Edinburgh, UK.
ii. Kings College Hospital, London, UK.
iii. The Women’s Alcohol and Drug Service, Nottinghamshire, UK.
iv. Manchester Specialist Midwifery Service, Manchester, UK.
i. The PrePare Team, Edinburgh
The PrePare team in Edinburgh is a multi-agency service for drug using pregnant 
women for antenatal care and care up to 3-6 months after birth. It was established 
in July 2006. It is staffed with two full-time addiction nurses, a full-time health visitor, 
a full-time midwife, a full-time senior nursery officer, one full-time and one part-time 
nursery officers, a fulltime manager (with social work background) and a part-time 
administrator. The team has many years’ experience in working with families who 
have difficulties with substance misuse and other social issues including poverty 
and poor housing.
PrePare is an outreach programme and appointments are held where they 
are needed. There is a drop-in session with the midwife and addictions nurse 
every Thursday from 2-4 p.m. at the Harm Reduction Service in Edinburgh. 
Appointments can be held at doctors surgeries where appropriate, and the 
midwife can hire rooms in children’s’ centers or do home visits. There is a weekly 
team meeting to discuss new referrals and allocations as well as case planning. 
A package of care is determined by the team and the orange book guidelines for 
Lothian’s “Working with children living in families affected by parental substance 
use” is followed.
PrePare accepts referrals from all agencies as well as from individuals: however 
378
51% of referrals received to date came from community midwives. The women 
referred to PrePare must: have suspected or known illicit drug or alcohol use; be 
over 16 years; have a confirmed pregnancy; and not be engaging with mainstream 
services. Additionally, they may have had experience with child protection concerns 
surrounding previous children.
The antenatal appointments are more frequent and longer than standard care. 
They happen every two weeks and are at least an hour long. The midwife’s main 
remit is health of the women and baby, but the midwife can also help with benefits, 
child protection issues and other problems.
Source: National Institute for Health and Clinical Excellence, Description of 
services for pregnant women with complex social factors, 2012.
Case Study:
Perinatal follow-up of drug addicted pregnant women by the Mobile Addiction 
Team (AMT) of the Port Royal-Cochin hospital group of Paris, France
The Drug addiction Mobile Team’s (EMA) was created in 1998 on the request of 
a federation of associated medical activities. It came after the establishment of 
the Cochin hospital group of diverse structures devoted to the struggle against 
drug addiction: specialised drug addiction treatment centres, several detoxification 
hospital beds and a specialised consulting service to follow-up seropositive 
women. Few hospital wards offer such pregnancy healthcares specific to drug 
addicted women. Pregnancy is a considerable psycho-emotional and psychic 
event for drug addicted women and it constitutes a good time to initiate drug 
addiction treatment or medical follow-up.
At the heart of EMA action, the main objective at stake is the future of the unborn 
baby. The EMA is multi-disciplinary and composed of 5 members: a psychiatrist 
general practitioner both specialised in drug addictions, a social worker, a nurse 
and, what is specifically to this team, a midwife. The general objective of the 
intervention is helping pregnant drug addicts to gain or regain their parental 
abilities during pregnancy and during the delivery and post-partum period, in order 
to maintain the relationship between mother and child. Regarding drug addicted 
mothers and mothers-to-be, current knowledge defends the establishment and 
maintenance of mother-child relation, enabling the mother to care for the child.
Source: EMCDDA
http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=5876
379
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), A gender 
perspective on drug use and responding to drug problems, Lisbon, 2006.
Available at: http://www.emcdda.europa.eu/html.cfm/index34880EN.html
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Differences 
in patterns of drug use between women and men, Lisbon, 2005
Available at: www.emcdda.europa.eu/attachements.../att_34281_EN_TDS_gender.pdf
Instituto da Droga e da Toxicodependência, Manual de Boas Praticas em Reinsercao, 2007
Available at:
http://www.emcdda.europa.eu/attachements.cfm/att_101813_EN_5.%20PT06_
Manual%20Reinser%C3%A7%C3%A3o%201%C2%BA%20caderno%20revisto.doc
Santé Canada, Meilleures pratiques. Intervention précoce, services d’approche et liens 
communautaires pour les femmes ayant des problémes attribuables à al consommation 
d’alcool et d’autres drogues, Ottawa, 2006.
Available at http://www.hc-sc.gc.ca/hc-ps/pubs/adp-apd/early-intervention-precoce/
index-fra.php
National Institute for Health and Clinical Excellence, Description of services for 
pregnant women with complex social factors, 2012.
Available at: http://www.nice.org.uk/nicemedia/live/13167/51326/51326.pdf
Substance Abuse and Mental Health Services Administration (SAMHSA), Substance 
Use Treatment among Women of Childrearing Age, in “The NSDUH Report National 
Survey on Drug Use and Health”, 2007.
Available at: http://www.oas.samhsa.gov/2k7/womenTX/womenTX.pdf
Substance Abuse and Mental Health Services Administration (SAMHSA), The Dasis 
Report: Adolescents Treatment Admissions by Gender: 2005, 2007
Available at: http://www.samhsa.gov/data/2k7/youthTX/youthTX.pdf
United Nations Office on Drugs and Crime (UNODC), Compilation of Evidence-Based 
Family Skills Training Programmes, 2010.
Available at: http://www.unodc.org/docs/youthnet/Compilation/10-50018_Ebook.pdf
United Nations Office on Drugs and Crime (UNODC), TreatNet, Drug Dependence 
Treatment: Community Based Treatment Good Practice, 2008.
Available at: http://www.unodc.org/docs/treatment/CBTS_AB_24_01_09_accepted.pdf
United Nations Office on Drugs and Crime (UNODC), Substance abuse treatment and 
care for women: Case studies and lessons learned, 2004.
Available at: http://www.unodc.org/pdf/report_2004-08-30_1.pdf
References
380
UNODC/WHO, Principles of Drug Dependence Treatment, 2008.
Available at:
http://www.who.int/substance_abuse/publications/principles_drug_dependence_
treatment.pdf
World Health Organization (WHO), ATLAS on substance use, Resources for the 
prevention and treatment of substance use disorders, 2010.
Available at: http://www.who.int/substance_abuse/activities/msbatlaschfour.pdf
WHO/UNODC/UNAIDS, Substitution maintenance therapy in the management of 
opioid dependence and HIV/AIDS prevention: position paper, 2004.
Available at:
http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf
381
Treatment
2. Integrating gender into substance abuse treatment
 Several subgroups within the larger population of individuals affected by 
drug use disorders require special consideration and often specialized care. These 
groups with specific needs include adolescents, women, pregnant women, people 
with medical and psychiatric co-morbidities, sex workers, ethnic minorities, and 
socially marginalized individuals. A person may belong to more than one of these 
groups and have multiple needs (UNODC/WHO, Principles of Drug Dependence 
Treatment, 2008, p. 12).
 Women tend to have a different experience with both drug dependence 
and treatment, from that of men. There are major issues related to the high 
levels of both physical and psychological co-morbidity of women with opioid 
dependence, which need to be taken into account in the provision of treatment 
(WHO/UNODC/UNAIDS, Substitution maintenance therapy in the management of 
opioid dependence and HIV/AIDS prevention: position paper, 2004, p. 26).
 Clinicians and program administrators are increasingly aware of the 
important differences between men and women with regard to the physical effects 
of substance use and the specific issues related to substance use disorders. They 
are also recognizing that these differences have an impact on treatment—that 
gender does make a difference. When women’s specific needs are addressed 
from the outset, improved treatment engagement, retention, and outcomes are the 
result (SAMHSA, Substance Abuse Treatment: Addressing the Specific Needs of 
Women, 2009, p. xvii).
 Research shows that addiction for women is a multi-dimensional issue 
involving complex environmental and psychosocial challenges. Addiction comprises 
a piece of a larger mosaic that includes a woman’s individual background and 
the social, economic, political, and cultural forces that shape the context of her 
life. Recent studies confirm that gender differences exist among men and women 
substance abusers regarding their relationships with family members; for example, 
women substance abusers tend to have severe family and social problems 
coupled with minimal family support upon entering treatment. In essence, gender 
differences are critical considerations when developing substance abuse programs 
for women. According to research, clinical services for addiction treatment that 
focus on women’s specific issues and needs are more effective for women than 
traditional programs originally designed for men (Covington S., Bloom B. E., 
Gender-Responsive Treatment and Services in Correctional Settings, Women and 
Therapy, Elaine Leeder, Editor, Vol. 29, No. 3/4, 2006, pp. 9-33).
 Providing comprehensive health-care services that take into full account 
the needs of women throughout their lives, as well as their multiple roles and 
responsibilities, is a principle highlighted as key gender-responsive approach to 
women’s health in the so-called Beijing Platform of Action.
 Treatment facilities are usually organised around the needs of opioid 
addicts, who are mainly men. Those treatment interventions that do have a gender-
specific component are mainly targeted to women’s needs and, in particular, to 
pregnant drug users or women with children. A the EU level, according to the 
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EMCCDA, the most common types of gender-specific intervention include case 
management approaches that facilitate the mediation of care for pregnant drug 
users, services that specifically address the mothers and fathers of small children 
and specially designed outreach projects targeted at sex workers (EMCDDA, 
A gender perspective on drug use and responding to drug problems, Lisbon, 
November 2006, p. 34).
 Studies suggest that factors that encourage a woman to stay in treatment 
include supportive therapy, a collaborative therapeutic alliance, onsite child care 
and children services, and other integrated and comprehensive treatment services 
(SAMHSA, Substance Abuse Treatment: Addressing the Specific Needs of 
Women, 2009). For instance, women who are allowed to bring along their children 
during treatment have demonstrated higher rates of retention (UNODC, TreatNet, 
Drug Dependence Treatment: Community Based Treatment Good Practice, 2008, 
p.29).
Core Principles for Gender Responsive Treatment for Women
According to the US Department of Health and Human Services there are core 
principles for gender responsive treatment for women, such as:
• Acknowledging the importance as well as the role of the socioeconomic issues 
and differences among women.
• Promoting cultural competence specific to women.
• Recognizing the role as well as the significance of relationships in women’s lives.
• Addressing women’s unique health concerns.
• Endorsing a developmental perspective.
• Attending to the relevance and influence of various caregiver roles that women 
often assume throughout the course of their lives.
• Recognizing that ascribed roles and gender expectations across cultures affect 
societal attitudes toward women who abuse substances.
• Adopting a trauma-informed perspective.
• Using a strengths-based model for women’s treatment.
• Incorporating an integrated and multidisciplinary approach to women’s treatment.
• Maintaining a gender responsive treatment environment across settings.
• Supporting the development of gender competency specific to women’s issues.
Source: SAMHSA, Substance Abuse Treatment: Addressing the Specific Needs 
of Women, 2009
Minimum standards:
•	Identify	the	range	of	services	that	women	need in the specific context. This 
includes information about and services related to: prevention of HIV, ongoing HIV 
counselling, family planning; pregnancy-related care; treatment for reproductive 
and sexually transmitted infection and for opportunistic infections such as 
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tuberculosis (WHO, Integrating gender into HIV/AIDS programmes in the health 
sector, 2009, p.19).
•	Individualize	treatment	plans,	and	match	treatment	to	identified	strengths	
and issues. Although there are common threads because of gender, it is important 
to be sensitive to differences and to acknowledge both similarities and differences 
(Covington S., Bloom B. E., Gender-Responsive Treatment and Services in 
Correctional Settings, Elaine Leeder, Editor, Vol. 29, No. 3/4, 2006, pp. 9-33).
•	 Analyze	 the	 livelihoods of drug dependent women in relation to the 
livelihoods of their communities by identifying and increasing their strengths, 
opportunities, and assets in key areas such as human capital, natural capital, 
financial capital, physical and social capital. Acknowledging the likelihood that 
women will return to their partners, programmes need to integrate them in the 
therapeutic process, and develop “couples-specific” programming (UNODC, 
TreatNet, Drug Dependence Treatment: Sustained Recovery Management 
Good Practice, 2008, p.15 and 29).
• Establish a system of community supervision and reentry with comprehensive, 
collaborative services (Covington S., Bloom B. E., Gender-Responsive Treatment 
and Services in Correctional Settings, Women and Therapy, Elaine Leeder, Editor, 
Vol. 29, No. 3/4, 2006, pp. 9-33).
•	 Provide	 women	 with	 opportunities	 to	 improve	 their	 socioeconomic	
conditions (Covington S., Bloom B. E., Gender-Responsive Treatment and 
Services in Correctional Settings, Women and Therapy, Elaine Leeder, Editor, Vol. 
29, No. 3/4, 2006, pp. 9-33).
 A)  Develop a formal or informal referral network among various 
services (WHO, Integrating gender into HIV/AIDS programmes in the health 
sector, 2009, p.19).
Case Study:
DAPHNE Project: Addiction as Chance of Survival? For Women with 
Experience of Violence
A European project covering the issue of women, violence and addiction led by 
selected women specific and addiction specific services in Austria, Germany, 
Ireland and the Netherlands. The project aimed to improve the living conditions of 
addicted women with experience of violence by provision of target services and 
improved cooperation between addiction and women specific facilities.
Connections between experiences of violence and addiction behaviour with 
women have been discussed for a long time but adequate programmes and 
projects are still missing. Against this background, women-specific and addiction-
specific institutions from Austria, Germany, Ireland and the Netherlands dealt in the 
framework of the DAPHNE Project “Addiction as a Chance of Survival for Women 
with Experience of Violence?” with the connections between addiction, violence 
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and gender in case of women and possible measures, offers and cooperation’s 
within a common translational project.
The project aimed to improve the living conditions of addicted women with 
experience of violence by provision of target specific services and improved co-
operation between addiction and women specific facilities. In addition, special 
focus was given to the improvement of the knowledge base regarding the living 
conditions of the target group as well as their needs concerning target group 
specific support and care. Thus, a survey amongst clients was carried out as part 
of the evaluation.
The results confirm the similarities of socio-demographic characteristics and living 
conditions of clients of women-specific and/ or addiction-specific institutions. The 
socio-economic living conditions of the women are very precarious (unemployment, 
low income, insecure housing etc.). 43 women (83%) have already experienced 
violence themselves. In the course of the project new target group-specific 
offers have been developed by the participating institutions and/ or existing ones 
have been reinforced. The networking between addiction and women specific 
institutions were re-enforced in a strong way on a structural level (contacts, 
exchange, cooperation agreements etc.), case-related cooperation however were 
still quite rare. In the mixed-gender institutions the DAPHNE project has very 
much promoted the discussion on the topic of “gender” and the “consciousness of 
gender” within the team and the management.
Source: EMCDDA
http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_id=3697
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Recovery
Integrating gender into sustainable substance abuse 
rehabilitation
 Drug dependence treatment - within an acute care, symptoms-focused 
paradigm- has fallen short of properly addressing the complex, multi-factorial 
nature of drug dependence that often follows the course of a relapsing and 
remitting chronic disease. There is disillusionment with the “admit, treat, and 
discharge”, revolving door cycles of high dropout rates, post-treatment relapse, 
and readmission rates. As a response to this situation there is a shift towards 
a more long-term perspective of sustained recovery management that is much 
broader and holistic in scope than linear recovery models (UNODC, TreatNet, 
Drug Dependence Treatment: Sustained Recovery Management Good Practice, 
2008, p.14).
 Social rehabilitation for drug-addicted individuals should be an integral 
part of their treatment from the very beginning, and the steps to be followed to 
reintroduce them into society must begin to be taken during their pharmacological 
treatment in order to best take advantage of the pharmacotherapy’s stabilizing effect 
(Dipartimento Politiche Antidroga, Measures and Concrete Actions for the Prevention 
of Drug-Related Diseases, edited by Serpelloni G. e Simeoni E., 2009, p.5).
 Drug dependent persons frequently experience crises in the areas of 
medical, psychological, social, vocational, and legal well-being, partly due to their 
particular vulnerability related to negative health and social consequences of drug 
use and often co-occurring disorders. Women are particularly vulnerable from this 
point of view. In addition, they face the social stigmatization and punitive barriers 
that often hamper sustained recovery and social reintegration. Therefore, a 
continuum of care approach, addressing a range of areas, is especially necessary 
for sustainable drug rehabilitation and social reintegration efforts (UNODC, 
TreatNet, Drug Dependence Treatment: Sustained Recovery Management Good 
Practice, 2008, p.22).
 According to WHO, psychological and social interventions have 
demonstrated to be effective in rehabilitation and relapse prevention, both in out-
patient and residential settings. Psychotherapies such as cognitive behavioural 
therapy, motivational interviewing and contingency management, have shown 
promising results. Social support interventions like employment programmes, 
vocational training and legal advice and support have been demonstrated to 
be effective in facilitating social inclusion (UNODC/WHO, Principles of Drug 
Dependence Treatment, 2008, p. 9).
 On the other hand, the initial risk factors that served as a direct or indirect 
path to substance use often are the same risk factors that reappear in early 
recovery and sabotage involvement in continuing care, recovery activities, and 
abstinence. As an example, women who have a history of substance use that 
involves a significant relationship appear more likely to leave care prematurely due 
to the influence of a boyfriend, spouse, or significant other (SAMHSA, Substance 
Abuse Treatment: Addressing the Specific Needs of Women, 2009).
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 For women, the ability to regain custody of children can significantly motivate 
mothers to not only enter and pursue treatment but also to maintain motivation for 
ongoing recovery after treatment. Mothers in early recovery can face numerous 
challenges and stressors associated with reunification, including time pressures 
in establishing recovery to avoid termination of parental rights, the maintenance 
of recovery activities while assuming the parenting role, the management of affect 
associated with the impact of their past drug and alcohol use on their children’s 
physical and mental health, effective implementation of parenting skills, and others. As 
a provider, it is important to not only acknowledge the mother’s initial enthusiasm and 
motivation for reunification, but also incorporate preparatory skills, including parenting, 
stress and anger management, and problem solving to help fortify personal resources 
in anticipation of future parenting and childcare issues and challenges (SAMHSA, 
Substance Abuse Treatment: Addressing the Specific Needs of Women, 2009).
 Family involvement, social supports, and leisure activities have thus 
proven to contribute to better outcomes in the treatment and rehabilitation process.
The key elements of the recovery framework
The international scientific literature has identified a series of key elements that 
could be defined as essential in an effective recovery framework.
• Has a strengths-based, client-centred focus. The model empowers the 
individual to move towards a healthy, productive, and meaningful life. Thus the 
ultimate owner of successful rehabilitation and social reintegration is the client.
• Is recovery outcomes driven. Recovery is intended as a continuum 
process. With access to good practices and evidence based services the client 
can be assisted through the stages of rehabilitation and social reintegration to build 
the necessary resources for a meaningful life in the community. There are many 
pathways to long-lasting change and stability, regaining a sense of self-identity and 
self-esteem, (re)discovering one’s meaning and purpose in life; and developing 
stronger interpersonal and community relationships. Recovery supports can help 
explore the ways that are best suited to a client’s needs.
• Realizes	that	context	influences	the	recovery	process	and	the	likelihood	of	
recovery outcomes. A person’s background, culture, gender, past experiences, 
external factors (e.g., punitive policies promoting social exclusion, stigma and 
discrimination, and adverse agro-ecological factors; institutional barriers), 
employment and training opportunities, housing and social exclusion, all greatly 
influence recovery outcomes.
• Promotes cultural relevance and gender sensitivity. It is open to the 
integration of cultural practices and community support into treatment and social 
reintegration. Also, it facilitates gender mainstreaming by taking into account, while 
planning projects, the barriers that make access to treatment difficult for women 
(e.g., stigma, inflexible schedules, distance from home, and lacking day-care for 
children).
• Aims at promoting assertive approaches to integrated and continuing 
care. These approaches emphasize building long-term supportive relationships 
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with clients, and providing continuity of service to increase their recovery capital. 
Duration and intensity of check-ups and monitoring also vary during periods of 
increased vulnerability for relapse.
•	 Integrates	 clients’	 respective	 families	 and/or	 significant	 others	 as	 both	
participants and partners in the recovery process. This is demonstrated by 
actively involving them in client engagement, development of clients’ recovery 
plans and processes. Social support can play an important role in the process of 
rehabilitation and reintegration.
• Sees the community as a reservoir of resources, opportunities, and 
support. Recognizing that no single organization and/or institution can provide 
all the essential resources necessary to provide a continuum of care, it favors 
and promotes developing recovery supports through community networking 
and collaboration with multiple entities and resource. The focus is on educating 
the public, through advocacy, on the benefits of recovery, and collaborating with 
existing recovery support resources to develop integrated recovery strategies and 
services. Creating meaningful participation in the community is a key component 
of the recovery framework.
• Recognizes that combating and overcoming the stigma of drug dependence 
is essential to gain and maintain the community’s support in the individual’s 
recovery process. Therefore, advocacy to influence and convince decision 
makers, educate service providers, and society at all levels about the issue of drug 
dependence and the benefits of drug dependence treatment and rehabilitation for 
the individual and the community is encouraged.
Source: UNODC, TreatNet, Drug Dependence Treatment: Sustained Recovery 
Management Good Practice, 2008, p.15-16.
Case Study
Women’s Collective: ARKEN (Norway)
The women’s’ cooperative ARKEN is a treatment institution for women drug users. 
ARKEN utilizes a great deal of the ideology associated with the AA movement’s 
12-step program (Alcoholics Anonymous). Through treatment one seeks to create 
a gradual transformation in the drug addict’s thought patterns related to lifestyle 
and priorities.
ARKEN and the Stensløkka resource centre (aftercare/work rehabilitation 
institution) comprise a treatment package with clear goals and work together to 
get the client through the process towards a drug-free independent existence. The 
treatment alternative provides a framework that gives the women both care and 
social inclusion. Stensløkka resource centre seeks to take care of the women’s’ 
needs through a rehabilitation process that reflects the entire spectrum of daily 
activities; that is both education/work, housing and leisure activities.
Evaluations from 1996 show that 17 of the 40 women addicts were drug-free after 
treatment. These had either had shorter stints with drug intoxication or had fewer 
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traumatic experiences than the other women. 13 of them had completed treatment, 
against a small number who currently use drugs. 16 of the 17 drug-free women 
are in school or working. The drug-free women had changed their relationships. 
They choose drug-free partners and friends, and take better care of themselves in 
conflict ridden relationships. They seek rehabilitation, and their demand for social 
services has dropped dramatically.
Source: EMCDDA
http://www.emcdda.europa.eu/html.cfm/index52035EN.html?project_
id=3136&tab
Case Study:
Vocational Training and Promotion of Micro-enterprises in the Cochabamba 
Tropics BOLIVIA
This case study describes an experience in an interagency cooperation project 
between UNODC and the International Labour Organization (ILO), which has 
applied a strategy in support of integral development in coca production areas. 
Recognizing urban tendencies and population dynamics in the coca producing 
area of the Tropics of Cochabamba, a vocational training and support plan for the 
micro-enterprise sector strategy was designed specifically to promote labour skills 
for the non-agricultural market among young people between 15 and 34 years of 
age.
Process/Activities:
• Specific courses were identified for women based on their interests and 
competencies.
• Ninety-eight training modules were developed based on market demand. The 
courses lasted from 1 to 6 months with an average strength of 25 students. Some 
of the courses identified were: Food processing; dress making/tailoring; harvesting 
and packing of agricultural crops; carpentry; masonry; baking and cooking; 
hospitality services; painting; electrical work; car mechanics; and artisan crafts.
• Micro enterprises were promoted, by addressing issues such as production 
process, business administration, cost calculation, and access to credit.
• Ongoing coordination with government offices was encouraged and implemented.
• Human resources development was undertaken to support various projects.
Lessons Learned:
• Removing barriers that could prevent women from participating in the project 
were taken into account (e.g., schedules, distance from home, custody of small 
children, and teaching in the local language).
• The methodology of learning-by-doing was most effective.
Source: UNODC, TreatNet, Drug Dependence Treatment: Sustained Recovery 
Management Good Practice, 2008, p. 52.
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Case Study:
Family Therapy Programme and Vocational Training, Chenai, India
TT Ranganathan Clinical Research Foundation (also known as TTK Hospital) 
started their primary care treatment programme for drug-dependent individuals 
in 1982.
The families who accompanied clients for treatment were deeply affected 
emotionally and economically through the drug dependence of their family member, 
especially in the case of relapses. Recognizing the fact that relationship with the 
family is an essential element in recovery, in 1985, TTK Hospital developed and 
initiated an exclusive two-week programme for families. One family member must 
attend this free programme, which was designed with the twin purposes of helping 
families to get out of their problems and become functional while, at the same 
time, developing their preparedness to support the patient in recovery.
At some point, the centre felt the need to equip some family members with a 
vocational skill leading to economic and social rehabilitation. TEJAS Vocational 
Training Centre was set up at the TTK Hospital in 1999 with support from Deutscher 
Orden and the European Commission. Tejas, which means “brightness” in 
Sanskrit, offers a safe and supportive environment for family members to acquire 
training in a vocational skill.
Process/Activities:
In the family therapy programme, the day starts with the serenity prayer and a 
meaningful story conveying a thought for the day. This approach gives families an 
opportunity to reflect on and share their feelings about the thought. This is followed 
by input sessions that provide information about drug dependence and practical 
coping methods. Trained counsellors provide group therapy and individual 
counselling. Al-Anon meetings are also held twice a week at the premises to 
enable mutual assistance in handling problems.
On completion of the two-week programme, family members who are looking for 
vocational skills training to earn a livelihood join TEJAS to learn tailoring. Tailoring 
was identified as a viable vocation skill because of market demand. It is also easy 
to learn, and entrepreneurship is possible with a small investment.
Contact was made with potential buyers. A ready market was found in industrial 
areas in the form of cooking contractors who would place orders for bags. Once 
training was completed, small loans were made available to those interested in 
buying tailoring machines to work on their own; others would take orders from the 
centre and work from their homes.
Some persons in recovery and their families continue to work in the unit and earn 
a stable income.
Lessons Learned:
• The centre found that family therapy, including learning a vocational skill, 
empowers families, which is the ultimate gain.
• By learning tailoring skills, family members are able to be economically 
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independent and take care of their children in spite of their spouses’ repeated 
relapses. This has also contributed to the strengthening of self-confidence in 
family members.
• Many women have established their own small tailoring units in their homes, and 
are able to manage their families’ needs with the income earned.
Source: UNODC, TreatNet, Drug Dependence Treatment: Sustained Recovery 
Management Good Practice, 2008, p. 74-78.
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DAWN First Plenary Conference: 
conclusions and recommendations
Rome, 28-30 March 2011
I. ESTABLISHING A RELIABLE KNOWLEDGE BASE:
● Need to rely on a set of statistical and epidemiological data for the correct 
understanding of the social and medical aspects of addiction, at least at the 
European level, with particular regard to: drug use behaviours, type of substances 
used, patterns of use, trends of use.
● Analysis of specific aspects include: initiation to drug use, the role of gateway 
drugs, the trends of stimulants abuse and of the non prescribed use and abuse of 
prescription drugs (growing trend in Europe), globalization and its effects on male/
female drug taking behaviours (females consuming trends and behaviours more 
and more similar to males), specific female vulnerability.
II. FOCUSSING ON SPECIFIC CRITICAL AREAS (TO BE 
DEVELOPED AND/OR THAT NEED FURTHER RESEARCH):
● Adolescents at risk: self esteem/self perception in teenager girls: sexy photos 
and images posted on social networks and/or blogs in exchange for drugs or for 
small tokens such as cell telephone cards etc.
● Non-medical use and abuse of prescription drugs among adolescents.
● Unwanted pregnancies.
● Management of drug use during pregnancy.
● Children of parents who use/abuse substances: balance to be found between 
the need to protect the child and the need to avoid separation from natural parents, 
especially the mothers. Special case: children participating in the recovery process 
(living with their parents in rehabilitation communities or in protected shelters). 
Need for teaching parental functions to mothers who use/abuse substances.
● Prostitution as a means to obtain drugs/maintain addiction.
● Sexual abuse and violence against women.
● Women who get involved in drug trafficking/criminal offences due to their drug 
addiction or due to a drug addicted partner; women in the criminal justice system.
● Increased vulnerability of women due to partner’s addiction.
● HIV and other STD incidence in women.
● Eating disorders and correlation with use/abuse of cocaine and stimulants.
● Psychiatric disorders and suicidal risk in women.
● Immigrant women and stigmatization from society and from same ethnic group 
members.
● Effectiveness of selective prevention vs universal prevention. Selective 
prevention programmes should be directed at least to youth, parents teachers.
● Treatment through adequate pharmacological therapy and psychological 
support.
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● Prevention and treatment of related pathologies and of related physical violence.
● Recovery and rehabilitation with long term follow up and accompaniment.
III. ESSENTIAL REQUIREMENTS FOR GENDER-ORIENTED 
OFFERS AND SERVICES (SUSTAINABLE AND EVIDENCE 
BASED EFFECTIVENESS):
● Effectiveness of prevention, treatment and rehabilitation programmes provided 
by private and public health addiction units and departments should always be 
measured on scientific evidence and sustainability.
● Adequate monitoring systems and accountability procedures should always 
be in place within public health systems for drug addiction, in order for health 
professionals to be able to provide outcome indicators and cost analysis for the 
services delivered. This would allow for policy makers to make better decisions 
in the identification and allocation of relevant financial resources and for 
health and social services to be more protected from budget cuts, especially in 
times of economic crises or budgetary shortages, as the services provided and the 
financial costs attached to them would be seen in terms of long term investments 
in public health.
● The need for monitoring and evaluation of results is also reinforced by the fact 
that according to the latest statistics, public health services for drug addiction is 
used by less than 50% of the total estimated population of drug users and that, 
on average, a drug user first contact with the public health services happens 7 - 8 
years after the beginning of his/her addictive career.
● Finally, next to the recognition that women drug users are more subject to social, 
psychological and health vulnerability than men, we should also stress out that 
women are more resilient when faced with difficulties.
● The concept of Resilience should be valued in all programmes, as there is 
increasing evidence that teaching how to build resilience is more important and 
useful than simply teaching how to not use drugs.
● Overall, further research and insight is needed to clarify and explore the concepts 
of accessibility, affordability and acceptability of services to women, especially 
through direct interviews with and the administration of questionnaires to clients of 
addiction services. 
Annex III
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United Nations
Economic and Social Council 
Commission on Narcotic Drugs
Fifty-Fifth Session, 12-16 March 2012
Resolution 55/5
Promoting strategies and measures addressing specific needs of women 
in the context of comprehensive and integrated drug demand reduction 
programmes and strategies
 The Commission on Narcotic Drugs,
 Stressing the commitments contained in the Political Declaration and Plan 
of Action on International Cooperation towards an Integrated and Balanced Strategy 
to Counter the World Drug Problem,1 adopted during the high-level segment of 
the fifty-second session of the Commission and by the General Assembly in its 
resolution 64/182 of 18 December 2009, in which it was stated that Member States 
should ensure that a broad range of drug demand reduction services provided 
approaches that took into account gender considerations and served the needs of 
vulnerable groups,
 Recalling the Declaration on the Guiding Principles of Drug Demand 
Reduction,2 which states that demand reduction programmes should be effective, 
relevant and accessible to those groups most at risk, taking into account differences 
in gender, culture and education,
 Recalling also the Declaration on the Elimination of Violence against 
Women,3 which states that women are entitled to the right to the highest attainable 
standard of physical and mental health,
 Recalling further the commitments that must be made to inform all 
activities of the United Nations system with respect to the human rights of women, 
as expressed in the Vienna Declaration and the Programme of Action adopted by 
the World Conference on Human Rights,4
1 See Official Records of the Economic and Social Council, 2009, Supplement No. 8 (E/2009/28), chap. I, 
sect. C.
2 General Assembly resolution S-20/3, annex.
3 General Assembly resolution 48/104.
4 A/CONF.157/24 (Part I), chap. III.
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	 Reaffirming the commitments to end all discrimination against women 
expressed in the Convention on the Elimination of All Forms of Discrimination 
Against Women,5 and in specific the commitment to achieve equal treatment for 
women in access to health services,
 Recalling the commitments made in the United Nations Millennium 
Declaration6 to promote gender equality,
 Recalling also that the Millennium Development Goals Report 20107 
stressed that access to care for women was still very problematic in several 
regions,
 Recalling further its resolution 54/5 of 25 March 2011, in which it recognized 
that drug dependence was a chronic but preventable and treatable multifactorial 
health disorder, and stressing the need to provide a full continuum of policies and 
programmes that promote prevention, early detection and intervention, treatment, 
care and related support services for rehabilitation, social reintegration and 
recovery,
 Recalling the Beijing Declaration and Platform for Action adopted at the 
Fourth World Conference on Women,8 which states that women have the right to 
the enjoyment of the highest attainable standard of physical and mental health, 
and convinced that girls and women should be provided access to health services 
developed specifically for their needs,
 Recalling also General Assembly resolution 65/228 of 21 December 
2010, in which the Assembly adopted the updated Model Strategies and Practical 
Measures on the Elimination of Violence Against Women in the Field of Crime 
Prevention and Criminal Justice, and General Assembly resolution 65/229 of 21 
December 2010, in which the Assembly adopted the United Nations Rules for the 
Treatment of Women Prisoners and Non-custodial Measures for Women Offenders 
(the Bangkok Rules),
 Recognizing that there is a need for more evidence-based information on 
all aspects of substance abuse, in particular regarding women-specific aspects, 
including physiological and psychosocial effects, the characteristics of women with 
substance use problems and their treatment experiences and also a need to use 
that information while developing and implementing programmes and strategies,
 Concerned that women with substance abuse problems are often deprived 
of or limited in their access to effective treatment that takes into account their 
specific needs and circumstances,
5 United Nations, Treaty Series, vol. 1249, No. 20378.
6 General Assembly resolution 55/2.
7 United Nations publication, Sales No. E.10.I.7.
8 Report of the Fourth World Conference on Women, Beijing, 4-15 September 1995 (United Nations 
publication, Sales No. E.96.IV.13), chap. I, resolution 1, annex I.
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 Aware that enhanced educational and employment opportunities for 
women significantly decrease the risk of their drug abuse and dependence and 
their involvement in drug-related crimes,
 Taking into account the need to develop and implement drug demand 
reduction measures so that they respond best to the specific needs of drug-
dependent women and women who abuse drugs, including designated services 
specifically devoted to those women,
 Noting with great concern the adverse consequences of drug abuse for 
individuals and society as a whole, reaffirming its commitment to tackle those 
problems in the context of comprehensive, complementary and multisectoral 
drug demand reduction strategies, in particular such strategies targeting youth, 
noting with great concern the alarming rise in the incidence of HIV/AIDS and other 
blood-borne diseases among injecting drug users, reaffirming its commitment 
to work towards the goal of universal access to comprehensive prevention 
programmes and treatment, care and related support services, in full compliance 
with the international drug control conventions and in accordance with national 
legislation, taking into account all relevant General Assembly resolutions and, 
when applicable, the WHO, UNODC, UNAIDS Technical Guide for Countries 
to Set Targets for Universal Access to HIV Prevention, Treatment and Care for 
Injecting Drug Users,9 and requesting the United Nations Office on Drugs and 
Crime to carry out its mandate in this area in close cooperation with relevant 
organizations and programmes of the United Nations system, such as the World 
Health Organization, the United Nations Development Programme and the Joint 
United Nations Programme on HIV/AIDS,
 1.  Urges Member States to consider incorporating femaleoriented 
programmes in their drug policies and strategies;
 2.  Encourages Member States to integrate essential femalespecific 
services in the overall design, implementation, monitoring and evaluation of policies 
and programmes addressing drug abuse and dependence, where needed;
 3.  Recommends that Member States consider and accommodate 
the specific needs of drug-dependent parents, including childcare and parental 
education;
 4.  Also recommends that Member States, in designing, implementing 
and evaluating integrated drug prevention and treatment and HIV prevention 
programmes, take into account the needs of women who have experienced sexual 
and other violent trauma related to drug abuse;
 5.  Encourages Member States to take into account the specific needs 
of women in the prevention, early detection and intervention, treatment and care 
of drug dependence and drug-related diseases, including infectious diseases and 
psychiatric disorders, as well as related support services, including for rehabilitation, 
9 Geneva, World Health Organization, 2009.
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reintegration and recovery, and to consider designing those services using a multi-
agency approach so as to include specific femaleoriented measures, promoting 
effective modalities such as special group offerings for women in inpatient and 
outpatient settings, familybased treatment and extra occupational training for 
women as part of recovery activities;
 6.  Invites Member States to consider implementing, where needed, 
female-oriented guidelines and quality standards in their drug policies in order to 
maximize coherence with existing activities, efficient allocation of resources and 
positive outcomes for drugdependent women and their children;
 7.  Encourages Member States to consider promoting the implementation 
of the updated Model Strategies and Practical Measures on the Elimination of 
Violence against Women in the Field of Crime Prevention and Criminal Justice, 
as well as the United Nations Rules for the Treatment of Women Prisoners and 
Noncustodial Measures for Women Offenders (the Bangkok Rules), particularly 
those provisions related to prevention and treatment programmes designed 
for women substance abusers, including those in prison settings, taking into 
account incidents of violence against women, prior victimization, the special 
needs of pregnant women and women with children, and their diverse cultural 
backgrounds;
 8.  Urges Member States to identify and firmly counter discrimination 
against, as well as degrading and undignified treatment of, drug-dependent 
women and women who abuse drugs, while simultaneously offering such women 
timely access to counselling, including voluntary HIV counselling and testing, and 
treatment and support services for rehabilitation and social integration that take 
into account the specific needs of women, including parental responsibilities and 
recovery from trauma related to drug abuse suffered as a result of sexual or other 
forms of violence;
 9.  Encourages Member States to consider providing a wide range 
of measures that match the specific needs of women affected by drug abuse, 
including pregnant women and women who are parents or guardians with children;
 10. Calls upon Member States to pay due attention to the specific needs 
of women while applying the relevant target goals as set forth in the Political 
Declaration on HIV and AIDS adopted by the General Assembly in its resolution 
65/277 of 10 June 2011 and incorporating those goals in their relevant national 
strategies and measures as set forth in the Political Declaration and Plan of Action 
on International Cooperation towards an Integrated and Balanced Strategy to 
Counter the World Drug Problem;10
 11.  Invites the United Nations Interregional Crime and Justice Research 
Institute to share with it and with the United Nations Office on Drugs and Crime the 
information on experiences with respect to relevant programmes and measures 
10 See Official Records of the Economic and Social Council, 2009, Supplement No. 8 (E/2009/28), chap. I, 
sect. C.
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addressing specific needs of women, with a view to considering appropriate follow-
up measures;
 12.  Encourages the United Nations Office on Drugs and Crime to 
raise awareness among United Nations agencies regarding the need to design 
educational and employment opportunity modules that may be used in programmes 
and strategies to prevent drug abuse and dependence and the involvement of 
women in drug-related crimes;
 13.  Invites the United Nations Office on Drugs and Crime to work with 
relevant United Nations agencies, including the United Nations Interregional Crime 
and Justice Research Institute, to assist and support Member States in developing 
and adapting measures and strategies, at the national, regional and international 
levels, addressing the specific needs of women as an essential element of more 
effective, just and human rights-based policies;
 14.  Requests the United Nations Office on Drugs and Crime to facilitate 
the gathering and dissemination of information provided by Member States on 
their efforts to implement the present resolution;
 15.  Also requests the United Nations Office on Drugs and Crime to 
integrate into its future public-awareness campaigns information emphasizing the 
importance of an integrated approach to the specific needs of women;
 16.  Invites the United Nations Office on Drugs and Crime to coordinate as 
appropriate with civil society and the private sector in addressing the specific needs 
of women in the context of drug demand reduction, with a view to the expansion of 
the range and coverage of programmes addressing drug abuse and dependence 
of women, in accordance with national legislation and in full compliance with the 
international drug control conventions;
 17.  Invites Member States and other donors to consider providing 
extrabudgetary resources for these purposes in accordance with the rules and 
procedures of the United Nations.
 9th Plenary Meeting
 16 March 2012
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